690,913,AUC,BACKGROUND,BCA,BLADDER,CHINESE,DOR,HOWEVER,KNOWLEDGE,LABEL,LIBRARY,METHODS,MIBCA,NLR,PLR,RESULTS,SEPTEMBER,WANFANG
001,FEW,FGFR3,GOVERNMENT,GSTM1,PRESS,PUBLISHED,TACC3,THERE,TMEM129,UGT1A,UNIVERSITY,USING
233,899,967,AIM,BACGROUND,BCG,JANUARY,KOLMOGOROV,LABEL,MARCH,METHODS,NIMBC,NMIBC,RESULTS,SEX,SMIRNOV,THESE,TUR,UNLABELLED
DESPITE,INTENSE
270,BACKGROUND,CARCINOMA,CONCLUSION,EXCLUSION,INCIDENTAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROGNOSIS,RESULTS,USG
160,169,233,COPYRIGHT,INC,PUBLISHED,SOCIETY
001,CONCLUSION,CTS,DVH,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS
177,AUC,CONCLUSION,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SOLID,WORLD
CONCLUSION,DWI,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
000,099,100,181,193,236,449,453,464,507,AMONG,CALIFORNIA,COHORTS,CRUDE,EXPOSURES,HODGKIN,IMPORTANCE,LABEL,METHODS,OBJECTIVE,PERMANENTE,RELEVANCE,RESULTS,SETTING,STUDIES
001,160,169,177,475,513,CONCLUSION,COPYRIGHT,CTV,D99,INC,LABEL,MATERIALS,METHODS,MLC,MULTILEAF,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE,V65
006,114,122,138,452,8TH,ABOUT,BACKGROUND,CARCINOMA,CONCLUSION,DEPARTMENT,EMPLOYEES,GRADE,GROSS,LABEL,LATERAL,LOW,MALIGNANT,METHODS,PAPILLARY,PATHOLOGY,POTENTIAL,RESULTS,TCC,UROLOGY,UROTHELIAL
160,945,DESALTING,MALDI
169,COPYRIGHT,ERK,IRELAND,LTD,MEK,PD98059,PUBLISHED,T24,THESE
003,005,117,169,177,327,BCA,CONCLUSION,COPYRIGHT,COX,DIVERSION,INC,LABEL,MEIER,METHODS,OBJECTIVE,RATES,RESULTS,SEPTEMBER,SURGERY,THREE
CAUCASIANS,CHINESE,CIS,HAN,III,ORS,STRATIFIED
876,AGE,BASED,CRC,INSURANCE,SIR,SPM
10878,261,262,BACKGROUND,KRUSKAL,LABEL,METHODS,RESULTS,ROC,UNITS,UPY,URINARY
011,013,101,167,169,231,303,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,COX,CSS,INSTITUTE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,RNU,UNIVARIATE,UUTUC,WOMEN
001,HOLMIUM,NMIBC,RESULTS,THEREFORE,TURBT
BACKGROUND,BLADDER,CK7,KIT,LABEL,METHODS,RESULTS,T24,UROVYSION
169,COPYRIGHT,INC,MANCHESTER,MRI
001,107,169,177,3M0,4N0M0,4N1,COPYRIGHT,DFS,FIFTEEN,INC,IQR,KARNOFSKY,LABEL,MATERIALS,MEIER,METHODS,NETWORK,OBJECTIVE,PURPOSE,RESULTS,SCC,SEVENTY,SMALL,THERE
169,ACCORDING,COPYRIGHT,DMEAN,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OHS,PCA,PELVIMETRY,PURPOSE,RADIATION,REGARDING,RESULTS,SIX,THERAPY
169,256,287,310,326,ALONE,BECAUSE,BEM,COPYRIGHT,CTV,EVALUATION,GROUP,INC,JACCARD,LABEL,LOCALLY,MARSDEN,MATERIALS,METHODS,OBJECTIVE,PIVOTAL,PTV,PURPOSE,RADIATION,RESULTS,RMH,ROYAL,SEVEN,THERAPY
169,177,COPYRIGHT,CSS,CYBERKNIFE,DMEAN,ERASMUS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS,USING,V40GYEQ,V60GYEQ
CONVENTION,COPYRIGHT,ORLEANS,PROUS,QUARTER,SCIENCE,SHARING,UROLOGICAL
0CM,125,145,169,1CM,250,BACKGROUND,COPYRIGHT,CTV,DVH,GTV,IRELAND,LABEL,LDR,LTD,METHODS,MRI,MULTI,OBJECTIVE,PURPOSE,RESULTS,TRANS
169,296,29E,385,46E,COMMISSION,CONCLUSION,FDG,FETAL,HOWEVER,IMAGING,INC,LABEL,MBQ,METHODS,MOLECULAR,NUCLEAR,PET,PROTECTION,RESULTS,SIX,SOCIETY,THREE,UNLABELLED
169,ACCORDING,BESIDES,HOWEVER,INCIDENCE,INDONESIA,INDONESIAN,NON,PRESS,PUBLISHED,RADICAL,THEREFORE,UNIVERSITY
956,COMPOUNDS,HOSHINO,HUH,PTP1B,THREE
169,ACTIVATING,BASAL,BCC,CARCINOMA,COPYRIGHT,DESPITE,GLI,SMO
UROTHELIAL,WORLD
BLADDER,OTHER
CGA,LARGE,SYN,THESE
BACKGROUND,COLLISION,CONCLUSION,LABEL,METHODS,THREE
ACIDS,APOPTOSIS,CATDS,COGOI,DOI,FINALLY,RES,T24
025,032,144,BACKGROUND,CCNE1,CCNE2,CONCLUSION,LABEL,MEIER,METHODS,RESULTS
169,945,COPYRIGHT,HOWEVER,INC,KOREA,LUCIFERASE,PHELLINUS,SANGHWANG
001,009,155,156,169,517,CONCLUSION,COPYRIGHT,COX,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,RESULTS
169,233,BCG,COPYRIGHT,INC,PUBLISHED,SOCIETY
HOWEVER,THREE
AFTER,CARIBBEAN,CONCLUSION,LABEL,METHODS,REGARDING,RESULTS,SAN,SECONDARY,UNLABELLED,VTE
ALPHA,AVAILABLE,GLIFLOZINS,GLITAZONES,GLP,HBA1C,JOHNSON,METFORMIN,PRESCRIRE,STEVENS,THERE,THESE
100,954,BACKGROUND,CIS,CONTEXT,LABEL,METHODS,MPM,OBJECTIVE,RESULTS,SEVENTY,UROTHELIAL
003,169,ANTICANCER,COPYRIGHT,CRC,GROUP,INSTITUTE,LMS,OVERALL,SEVENTY,THERE
169,947,ADC,CARLO,CONCLUSION,COPYRIGHT,D02,D50,D95,INC,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TCP
005,035,THERE
THERE,TURBT
128,153,226,BACKGROUND,CELSIUS,CIS,LABEL,METHODS,NBI,NMIBC,RESULTS,TURBT,WLC
BLADDER,UPPER,UROTHELIAL
146,169,197,681,726,955,AGE,AUTHORS,BJU,END,FATAL,HEIGHTENED,LABEL,METHODS,OBJECTIVE,RESULTS,UTC
112,125,138,152,165,178,200,300,ASSESSMENT,BIO,CHINA,CHINESE,EIGHT,EVALUATION,GRADE,GRADING,HOWEVER,JOURNAL,LABEL,LIBRARY,MATERIALS,MCC,MDP,METHODS,NDO,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,TABLE,UTI,VIP,WANFANG
169,MANAGEMENT,OAB,SINCE,SMALL,THESE,TRAUMATIC,URINARY,WHITE,WMD
169,177,2CC,COMPARISON,CONCLUSION,COPYRIGHT,DEFORMABLE,DUE,IB1,IRELAND,IVA,LABEL,LTD,MATERIALS,METHODS,OAR,OBJECTIVE,PARTIAL,PURPOSE,RESULTS
320,48H,620,780,956,BAX,BCL,CONCLUSION,IGF,LABEL,METHODS,MTT,MYC,OBJECTIVE,RESULTS,VITAMIN,WESTERN
150,192,200,215,2CC,CONCLUSION,EBS,KNOWLEDGE,LABEL,METHODS,OAR,OBJECTIVE,POINT,RESULTS,THERE
665,690,BACKGROUND,BLADDER,CONCLUSION,ITALIAN,LABEL,METHODS,ORS,RESULTS
169,CONCLUSION,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THREE,UES,USING
169,192,214,796,838,875,AUC,BACKGROUND,INC,LABEL,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS,RFS,URINARY,WILEY
150,BACKGROUND,FINALLY,LABEL,METHODS,RESULTS,TAKEN,THESE
169,BMS,COPYRIGHT,CYTOTOXIC,INC
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,RESULTS
100,169,733,AIM,ANTICANCER,AUC,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,OMEGA,POC,RAPID,RESULTS,ROC,THESE,UBC,URINE
169,ANTICANCER,CONCERNING,COPYRIGHT,HOWEVER,HPV,INSTITUTE
001,008,169,HODGKIN,INC,NHL,USING,WILEY
AKT,EVALUATION,INDUCTION,KANK3,SULF2,THESE
001,133,233,899,967,AIM,BACKGROUND,BCG,CONCLUSION,JANUARY,KOLMOGOROV,LABEL,MARCH,METHODS,MFDGT,NMIBC,OBJECTIVE,RCT,RESULTS,SFDGT,SMIRNOV,THESE,TUR
177,954,BACKGROUND,COHEN,CTU,LABEL,METHODS,NPV,OBJECTIVE,PPV,RESULTS
001,169,COPYRIGHT,CTV,FIFTEEN,GTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PGI,PTV,PURPOSE,RESULTS,RGI,TCP
0050501,295,340,DSS,UBUCS,UCS,UTUCS,VIA
169,BACKGROUND,END,ESOPHAGEAL,GISTS,HODGKIN,HOWEVER,LABEL,METHODS,OVARIAN,RESULTS,SIR,SOCIETY,SPR,THERE,THESE
FVS,GREEN,LIBRARY,POWER,SEPTEMBER,WILLY
219,563,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PFS,RECURRENCE,RESULTS
956,DU145,NTUB1,SOLANUM
169,COPYRIGHT,INC
169,183,250,251,261,263,524,BACKGROUND,CONGO,CONSENTING,COPYRIGHT,DEMOCRATIC,FUNDING,KENYA,LABEL,LEONE,LTD,MARCH,MAY,METHODS,NIGER,NIGERIA,OUTCOME,RESULTS
169,945,CAL,COPYRIGHT,HGF,INC,MCP,MIGRATION,RT112,UBC
169,COPYRIGHT,GLUT1,GLUT3,GPT,INC,LDH,NUCLEAR,PFK,RESONANCE,RT4,THESE
001,115,127,177,AFTER,BACKGROUND,COX,DSS,JANUARY,LABEL,MARSDEN,MEIER,METHODS,NEO,PFS,RESPONDERS,RESULTS,ROYAL,SEVENTY,T4AN0M0
169,ADC,COPYRIGHT,DIFFUSION,LTD,MRI
169,222,272,AFTER,COPYRIGHT,COX,CUMULATIVE,END,GRADE,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,UAE
013,037,169,177,ACUTE,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SERUM,THERAPY,VITAMIN
169,COPYRIGHT,CPG,DNAZYME,DNMT1,DNMTS,EPIGENETIC,INC
128,148,150,169,177,AFTER,CONCLUSION,EUK,EXM,FDG,IMAGING,INC,INJECTION,LABEL,MBQ,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,THERAPY,UNLABELLED,WHOLE
169,COPYRIGHT,DESPITE,INC
169,BLADDER,COPYRIGHT,INC,INCREASED,RADICAL
169,COPYRIGHT,INC,NMIBC
169,COPYRIGHT,INC,NOVEL,SINCE
169,ATLAS,COPYRIGHT,INC,PROFILING
169,COPYRIGHT,HOWEVER,INC,TUR
169,COPYRIGHT,INC,THESE
INC,NOVEL,PUBLISHED,RADICAL,SEVERAL,TREATMENT
169,233,BCG,BLADDER,COPYRIGHT,FINALLY,INC
ASSESSMENT,BLADDER,INC,MOLECULAR,PUBLISHED
169,440,BACKGROUND,DESPITE,INC,LABEL,LND,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,TTR,WHILE,WILEY
146,169,212,BACKGROUND,LABEL,LEVEL,METHODS,RESULTS,SOCIETY,THERE,THESE
BMJ,BRITAIN,COX,CVD,FURTHER,GREAT,GROUP,IHD,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR
169,COPYRIGHT,INC
ACCORDING,BACKGROUND,CONCLUSION,HOWEVER,IA2,IB1,LABEL,NERVE,QOL,RADICAL,THERE
169,CONCLUSION,COPYRIGHT,INC,INTRINSIC,ISD,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY
BLADDER,INC,PUBLISHED
169,183,476,AMONG,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METHODS,OBJECTIVE,RESULTS,USING
HODGKIN,THERE
233,262,ADDITIONAL,CYFRA,CYFRA21,ENGLISH,MEDLINE,SCIENCE,SIXTEEN,THEREFORE,WEB
177,326,BESIDES,CLINICALLY,CONCERNING,GLEASON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,RCP,RESULTS
104,CONCLUSION,CYSTECTOMY,EBL,LABEL,LNY,LOS,LRC,METHODS,OBJECTIVE,OPT,ORC,PSM,RADICAL,RESULTS,ROBOT,THERE
169,505,551,577,595,763,BACKGROUND,CHANGES,CRT,DESPITE,FUNCTIONAL,GROUP,INDEX,LABEL,METHODS,RADIATION,RESULTS,SOCIETY,THERAPY,THERE
060,169,174,322,360,COPYRIGHT,CPT,EDUCATION,ICD,INC,INTERSTIM,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
115,152,81H,HTS,INITIAL,UBC,URINARY,UTS
COMMUNITY,METASTATIC
946,ADP,CONCLUSION,FAS,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,SUNITINIB,T24,TCC,WESTERN,WOUND
100,169,COPYRIGHT,GIVEN,LTD,SCC
169,ASPECTS,COPYRIGHT,DESPITE,INC,ITALIAN,MEDICAL,PHYSICS,SEVERAL
160,169,177,COPYRIGHT,FTP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,STP
100,102,103,108,160,169,177,ADAPTATION,COPYRIGHT,CORRECTION,CTV,DAILY,EUD,EVALUATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,THREE,TREATMENT
001,100,105,160,169,945,946,COPYRIGHT,IDL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PLAN100,PURPOSE,RESULTS,TCP,THERE
BACKGROUND,CONCLUSION,LABEL,METHODS,SIX
120,190,300,310,630,AIM,BACKGROUND,CONCERNING,CONCLUSION,LABEL,METHODS,OBJECTIVE,RADICAL,RESULTS,T3A,T3B,T4A
145,182,BAX,BCL2L12,BLADDER,INSTEAD,MTT,PCR,T24,THEREFORE,WESTERN
000,100,169,960,BKV,HCT,IGG,INC,PRE,WILEY
269,302,684,ACM,AGE,BASED,BLOOD,COX,CSM,IQR,LABEL,METHODS,OBJECTIVE,PURPOSE,RADICAL,RESULTS,UCB
100,BOWEN,DIAGNOSIS,JAMES,PAGET,SIR
169,COPYRIGHT,DESPITE,LTD,METASTATIC,ONGOING
GPI,HOWEVER,TLR,USING
169,237,247,BETWEEN,CHRONIC,CKD,COPYRIGHT,CUMULATIVE,DISEASE,EDUCATION,EPI,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TREATMENT,UROLOGICAL,USC
215,ABDOMINAL,CLOSE,FIFTEEN,THERE,TREATMENT
169,AIM,CLAVIEN,CONCLUSION,COPYRIGHT,DINDO,INSTITUTE,LABEL,LOCAL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,AMONG,COPYRIGHT,FEMALES,INC
105,160,169,180,210,287,335,BASED,BETWEEN,BLADDER,CONCLUSION,COPYRIGHT,FUNCTIONAL,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,SOCIETY,THESE
003,150,160,169,CONCLUSION,COPYRIGHT,COX,FIFTY,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
169,AUTHORS,CRK,DEPLETION,ERK,LTD,MET,PTY,PUBLISHING,SCIENCE,SU11274,TAKEN,WILEY
TBARS
169,327,FGFR3,MUTATIONS,RTL,WHILE
FDG,PET,ROC,SUMMARY,TEN
150,AMONG,D769N,HOWEVER,SEVERAL,THEIR,THREE,UBC
107,133,143,145,169,224,279,FINALLY,IMPORTANT,PCR,PRESS,PUBLISHED,TOTAL,TREATMENT,UNIVERSITY
100,BACKGROUND,CONCLUSION,LABEL,METHODS,NSE,THERE,TUR,URINARY
AFRICAN,BACKGROUND,CONCLUSION,LABEL,METHODS,SMALL,SMOKING
AMONG,COLLEGE,NEPAL,OCTOBER,PATHOLOGY,SEPTEMBER,THERE,UROTHELIAL
169,945,ASK,BLADDER,COPYRIGHT,CURRENT,GRP78,INC,JNK,KNOCKDOWN,T24,THESE,TRAF2
169,AFTER,CONCLUSION,COPYRIGHT,DCE,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILAR,TUMOURS
001,003,010,018,026,072,111,169,171,BETWEEN,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,MIUCB,RAS,RTK,TAKEN,USING
169,956,ADDITIONAL,COPYRIGHT,GROUP,HOWEVER,WORKING
169,COPYRIGHT,ESPECIALLY,NOTCH,PUBLISHED,UROLOGY
169,AUTOPHAGY,BLADDER,BP1,COPYRIGHT,INC,INHIBITION,J82
043,044,056,105,110,AIM,BACKGROUND,CONCLUSION,CRT,LABEL,MATERIALS,METHODS,OBJECTIVE,PERCENT,PET,RESULTS
CONCURRENT,HMB45,LAM,MYOID,OTHER,TSC
168,647,ABCF1,CAL,CCL17,CCL21,CXCL1,HELIX,HLH,LABEL,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,WST
058,271,AFTER,BLADDER,BLOOMBERG,CONTROL,DESPITE,ENGLAND,GOVERNMENT,HAMPSHIRE,HOPKINS,JOHNS,MAINE,PRESS,PUBLISHED,SMOKING,UNIVERSITY,VERMONT
BLADDER,HFC,OTHER,RENILLA,T24,UTR,VARIOUS
AREAS,BACKGROUND,BCG,COVERED,HOWEVER,LABEL,MEDLINE,METHODS,NMIBC,OPINION,TURBT
169,956,ALLYL,BAX,COPYRIGHT,HOWEVER,NATURAL,RT4,S100P,SMAD4,T24,THEREFORE,THESE
AGE,BACKGROUND,BLADDER,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
ORS,RESULTS,THEREFORE,TOTALLY
000,036,058,100,154,289,295,347,433,531,533,543,587,600,624,741,CRS,ESTIMATES,HODGKIN,ITALIAN,ITALY,LABEL,MATERIALS,MEN,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,PREVALENCE,REGISTRIES,RESULTS,VALIDATED
100,956,ADHERENCE,CANDIDA,CSH,HANSENULA,LABEL,MATERIALS,METHODS,MIC,OBJECTIVE,PATHOGENIC,PROTOTHECA,PURPOSE,RESULTS,THERE
160,169,65288,65289,946,AFTERWARD,BENZIDINE,COPYRIGHT,EMT,ERK,HUC,INC,JNK,MMP,PROLONGED,SNAIL,TAKEN,U0126
233,BCG,CIS,CONVERSELY,CYSTECTOMY,LABEL,NMIBC,NON,OPINION,STATEMENT,TREATMENT,UNASSIGNED,WHILE
001,002,003,124,142,233,291,CONCLUSION,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,RFS,TUR,UNIVARIATE,WORLD
002,008,011,169,302,CD103,CD8,COPYRIGHT,COX,EDUCATION,HOWEVER,INC,INTRATUMOR,LABEL,MATERIALS,MEIER,METHODS,NOTABLY,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,169,CBCTS,CONCLUSION,COPYRIGHT,CTS,CTV,HOWEVER,INC,LABEL,MATERIALS,METHODS,NODAL,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THESE
001,002,009,169,215,260,COPYRIGHT,CRT,GROUP,HOWEVER,IDENTICAL,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,THEREFORE,UNIVARIATE
169,COPYRIGHT,DESPITE,INC,OAR
169,CD49F,CISPLATIN,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SYNERGY,UROLOGICAL
001,169,243,COPYRIGHT,DACH2,DACHSHUND,INC,METASTASIS,MFS,UCB
100,748,BACKGROUND,BLADDER,ITALIAN,ITALY,LABEL,METHODS,NETWORK,OBJECTIVE,RESULTS,SECTION,SOCIETY,TURBT
215,233,ADC,BCG,CONCLUSION,DWI,GADOLINIUM,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,BACKGROUND,BECAUSE,BLADDER,HIV,LABEL,METHODS,ORS,RESULTS,SOCIETY
116,233,238,343,ADT,AFTER,AHT,BCG,RECURRENCE,SEVERAL
169,ALDH1,BACKGROUND,BCG,CENTRAL,CONCLUSION,CONTROLLED,COPYRIGHT,LABEL,LTD,MEDLINE,METHODS,MINIMALLY,NOMOGRAMS,RESULTS,SOCIETY,UPPER
645,749,AMONG,BACKGROUND,CRUDE,DIAGNOSIS,HODGKIN,LABEL,METHODS,RESULTS,SIMILARLY
001,AWARENESS,BACKGROUND,CAM,CLEAR,ENGLAND,ENGLISH,GPS,LABEL,LIFESTYLE,MEASURE,METHODS,OCTOBER,RESULTS,STATISTICS
953,AUDIT,BACKGROUND,DIAGNOSIS,ENGLISH,LABEL,LARYNGEAL,METHODS,PRIMARY,RESULTS
169,5H1,AVERAGE,CD8,CONCLUSION,COPYRIGHT,DSS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,REMAINING,RESULTS,SPOTS,THERE
BFTC905,EFFECTS,J82,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,RT112,RT4,SFRP1,WNT

169,COPYRIGHT,POINT,SCIENCE,THESE
160,946,BLADDER,MTT,PCR,POK,POKEMON,RELATED,SNAIL,T24,TGF,THESE,TRANSWELL,TWIST,WESTERN,WHILE
AFTER,RADIATION,THREE
001,436,ATLAS,BACKGROUND,BLADDER,ELISA,EPCAM,EPIDERMAL,LABEL,MEASURING,METHODS,PROTEIN,PROTEOMICS,RESULTS,SOLUBLE,THESE,URINARY
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PERFORMING,PUBLISHED,SETTING,TOTAL
104,167,356,BACKGROUND,BASED,BLADDER,EMPLOYING,ESPECIALLY,HOWEVER,LABEL,RESULTS,THROUGH,WGCNA
001,005,115,169,180,340,AGE,AMONG,BACKGROUND,CHINA,CHINESE,CIS,GLEASON,INC,LABEL,METHODS,OVERALL,PCA,PSA,RESULTS,UCA,WILEY
068,ANNOTATION,BACKGROUND,BLADDER,CDC20,DISCOVERY,EXPRESSION,GENECHIPS,GRB14,INTEGRATED,ITGA7,LABEL,LIMMA,METHODS,OBJECTIVE,OMNIBUS,PSMB1,RESULTS,RETRIEVAL,RPS14,S14,S15,SEVERAL,THESE
000,100,180,195,217,239,AMONG,CONTINENTS,INCIDENCE,OVERALL,RESULTS,THERE,THYROID,USING
113,142,152,AFTER,LESIONS,STAGE,UBC,UROTHELIAL
181,EARLY,HOWEVER,STAGING,TUR,TURBT
169,239,307,377,522,AFRICAN,AMONG,BACKGROUND,CIS,CLINICIANS,DISTANT,END,INCREASING,LABEL,METHODS,ORS,RESULTS,SOCIETY,SUICIDE,THERE
BI3,HCV29,PC2,PC3,PCA,THEREFORE,THESE,TOF
29C,668,802,BACKGROUND,DESPITE,EXPRESSION,FUNCTIONAL,GES,LABEL,METHODS,NMIBC,OBJECTIVE,OMNIBUS,RESULTS,SMAD3,SMAD5,SMAD7,TARGETSCAN,UBC
BACKGROUND,ESI,LABEL,MEG,MEI,METHODS,OBJECTIVE,RESULTS,TOF,URINARY
AMONG,BTC,CONCLUSION,FIFTEEN,GRADE,HAI,HEPATIC,HOWEVER,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS
001,008,047,3DCRT,796,ACUTE,CONCLUSION,CURRENT,INTESTINAL,LABEL,MATERIALS,METHODS,NRI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,TOMOSIB
112,130,178,184,208,CLAVIEN,CONCLUSION,DINDO,EARLY,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,ROBOT,ROBOTIC,VINCI
279,336,372,AFTER,AMONG,BCE,CONCLUSION,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RECURRENCE,RESULTS,RNU
169,ALK,FN1,IMT,INC,WILEY
001,003,157,160,169,275,BPT,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,UBC
007,133,169,210,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,THERE,UNIVARIATE,UNIVERSITY,UUT
169,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,MTT,NONTARGET,OBJECTIVE,PPCAT,PUBLISHED,PURPOSE,RESULTS,RT4,TREATMENT,UROLOGICAL
160,169,233,BCG,BLADDER,CONCLUSION,COPYRIGHT,INC,INCREASING,LABEL,METHODS,OBJECTIVE,RESULTS,T24,VIABILITY
169,177,220,ADDITIONAL,BLAND,CONCLUSION,DYNAMIC,GFR,GLOMERULAR,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PCC,PEARSON,PET,PETINITIAL,PETLATE,RESULTS,SOCIETY,THERE,UNLABELLED
003,008,021,041,121,157,159,161,375,669,CHI,COX,MCNEMAR,MEIER,TNM
EARLY,OCT,OPTICAL,SEVERAL
160,NUC,TENGION,WHILE
WHILE
141,169,182,183,30B,BASEL,CASES,CONCLUSION,LABEL,MEASURING,METHODS,MICRORNAS,OBJECTIVE,PCR,RESULTS,THERE,UCC
BPS,INDICATORS,NDN,RCAS1,THESE,TIT
DESPITE
215,ENGLISH,PRIMARY
BLADDER,FIFTY,NEOPLASMS,URINARY,UROTHELIAL
AIM,BACKGROUND,CONCLUSION,CONTEXT,EMA,EPITHELIAL,KERATIN,LABEL,LYMPH,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE,THREE,TURBT
169,ADP,ANTICANCER,CHINESE,COMET,COPYRIGHT,H2A,INSTITUTE,RESULTS,USING
169,954,ANTICANCER,B19,COPYRIGHT,CURCUMA,EPHB2,HDAC4,INSTITUTE,SEPP1,STAT3
HISTOLOGIC,HOWEVER
001,169,275,AMONG,COMMUNITY,CONCLUSION,INC,LABEL,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,RCS,RESULTS,WILEY
000,100,128,160,169,194,482,510,767,860,923,AMONG,BACKGROUND,COPYRIGHT,FACTORS,FOUNDATION,HISPANICS,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RATES,RESULTS,SETTING,SIR,THESE
001,003,160,169,657,674,ACT,AGE,AMONG,BLADDER,CONCLUSION,COPYRIGHT,COX,CYSTECTOMY,INC,LABEL,METHODS,OBJECTIVE,ONTARIO,PATHOLOGY,RESULTS,SUBOPTIMAL
177,THERE,WHETHER,WITHOUT
BECAUSE,CYP,NH2,OXIDATIVE,SOLVENT,SUDAN,UNION
233,SEVEN,SIX
102,169,182,CHINESE,FGFR3,HAN,PRESS,THESE,UBC,WESTERN
100,COX,DICER,EIF2C,THEIR,THERE,WESTERN
169,27A,BLOOD,COPYRIGHT,INC,SNP
FGFR3,SEVERAL
COEXISTENT,OPHN1,OTHER,PECOMAS,PSF,RRAGB,ST3GAL1,TSC
000,169,900,BACKGROUND,BETWEEN,END,LABEL,METHODS,OVERALL,PREDICTING,RESULTS,SINCE,SOCIETY
ABC,AKT,CISPLATIN,FDA,FGFR2,LABEL,MET,OPINION,PI3,REPORTS,STATEMENT,THEREFORE,UNASSIGNED
001,027,128,144,169,177,272,565,AIM,ASSOCIATES,BACKGROUND,BLADDER,COPYRIGHT,ELISA,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SERUM
330,345,405,417,500,515,LABEL,METHODS,OBJECTIVE,PURPOSE,RARCS,RESULTS,ROBOT,TEN,THERE
017,019,028,031,113,HMGB3,HOWEVER,IHC,MTT,UBC,USA
IMAGE,INTENSIVE,OPTIMISING,SECTION,STORZ,TCC,TECHNOLOGY,URO,UROLOGY
100,105,120,150,200,CK7,GII,III,SCC
IHC,SCC,THERE,USING
CROHN
CONCLUSION,CTV,GLEASON,IMAGE,LABEL,MAXIMUM,METHODS,OBJECTIVE,PCA,PSA,PTV,RESULTS,SCORE
FOLEY,RADICAL
APRIL,ARM,CONCLUSION,EGYPT,III,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SEPTEMBER,T4AN0M0
124,BACKGROUND,BELLINI,HOTEL,LABEL,LEBANON,MATERIALS,METHODS,PATHOLOGY,RCC,RESULTS,SAINT,UNIVERSITY
001,106,177,185,221,325,466,AIM,ALTERED,BACKGROUND,BLADDER,ELISA,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SOCS3,URINARY
000,100,109,112,138,150,684,999,BACKGROUND,FAO,HOUSEHOLD,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,SHATT,THESE
695,AMONG,BACKGROUND,KERMANSHAH,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,UNIVERSITY
169,COPYRIGHT,CYDONIA,DYSURIA,IRANIAN,ITM,LTD,MALVACEAE,PORTULACA,THEREFORE
169,BIOLOGY,HOWEVER,IAP,INC,MKN45,MOLECULAR,SOCIETY,TREATMENT,YM155
000,006,008,137,544,AIM,ARTICLE,BCG,CONCLUSION,HOWEVER,LABEL,LOW,MEDLINE,METHODS,NMIBC,OBJECTIVE,OCTOBER,RESULTS,THERE,TUR
160,21D,AFTER,BACKGROUND,DESPITE,LABEL,METHODS,OCTOBER,RADICAL,RESULTS,SHORT,SIX
007,063,ICHUSHI,MEDLINE,RCC,REGARDING,SCIENCE,WEB
120,137,169,BRITISH,EDITORIAL,JOINT,SOCIETY,SURGERY,THA,THESE
BLADDER,THERE
001,005,033,039,045,056,501,624,782,849,COX,ENDOTHELIN,PFS
160,169,306,320,AUTHORS,BJU,III,ORC,PFS,RAZOR
184,946,BASED,CREB3L1,HENCE,HTRA3,J82,TGF,THESE
169,BLADDER,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLASMID,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
168,169,BLACK,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STATE,UROLOGICAL
001,002,003,019,021,042,169,295,340,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TRANSCRIPT,UROLOGICAL,UROTHELIAL
169,COPYRIGHT,INC,THESE
000,001,092,160,169,170,190,279,467,500,AFTER,AMONG,CALIFORNIA,CONCLUSION,COPYRIGHT,INC,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,RESULTS,USING
005,169,440,494,ADHERENCE,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NMIBC,OBJECTIVE,PUBLISHED,QALYS,RESULTS
160,169,230,346,500,CONCLUSION,COPYRIGHT,ENDOSCOPIC,FIFTY,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,AMONG,BLADDER,CONCLUSION,COPYRIGHT,ESTIMATED,FOUNDATION,GRADE,INC,INSTITUTE,LABEL,METHODS,NETWORK,OBJECTIVE,RESULTS,SOCIETY,TESTICULAR,UROLOGY,WEB
160,169,CONCLUSION,COPYRIGHT,FIFTEEN,INC,LABEL,METHODS,OBJECTIVE,RESULTS
001,10B,160,169,183,188,210,221,23A,29C,AFTERWARD,COPYRIGHT,INC
AMONG,BMJ,GROUP,LTD,PUBLISHING,SECONDARY,THESE
160,169,176,947,BLADDER,COLLIMATOR,COPYRIGHT,EUD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROTATIONS,S78,SIMULATED
160,945,947,ABOUT,BACKGROUND,BCG,BLADDER,DCS,ELISA,HOWEVER,IFN,LABEL,METHODS,NIMBC,NMIBC,OBJECTIVE,OBJECTIVES,PBMCS,PRODUCTION,RESULTS,T24,TH1,TH2,TNF,TUR,VARIOUS
114,130,244,DIPLOTYPE,GENOMIC,HOWEVER,MMC,PCR,RFS,XRCC1
091,100,141,164,177,215,766,899,ADC,BONFERRONI,CONCLUSION,DCE,DWI,METHODS,MRI,NEITHER,OBJECTIVE,RESULTS,ROC,THREE,USING
169,486,532,566,575,BLADDER,COPYRIGHT,EDUCATION,INC,INCREASED,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STATISTICS,UROLOGICAL
169,CEQ,COPYRIGHT,IRELAND,LTD,THESE,UGS
954,BIM,DMAPT,H3K36,H4K20,KMT3A,KMT3B,KMT5C,SETD2,THESE
APART,BILIARY,DUE,EUS,MRI,PET,ULTRASOUND,VATER
274,459,CAUCASIANS,OVERALL,PRO187SER
18F,CYSTOSCOPY,FDG,MRI,PET
DIAGNOSIS,HODGKIN
001,DPC,INTESTINAL,LABEL,LRH,METHODS,OBJECTIVE,RESULTS
710,AFTER,BACKGROUND,BCG,FURTHER,LABEL,MATERIALS,METHODS,RESULTS,SIXTY
107,160,ACCORDING,BACKGROUND,LABEL,METHODS,PTH,PTH1R,PTHRP,RENAL,RESULTS,SEVEN,THESE
BACKGROUND,CBM,CIS,DESPITE,FALSE,LABEL,METHODS,NAD,ORS,OVERALL,PCR,PRO187SER,RESULTS,THESE,UNASSIGNED
113,254,BMJ,DETERMINE,GROUP,LABEL,LIMITED,METHODS,NON,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,RHEUMATOID,RRS,THESE,ULCERATIVE
0MG,169,1MG,531,556,5MG,ADJUSTMENT,AVERAGE,BACKGROUND,BLADDER,CONCLUSION,COPYRIGHT,HISTORICAL,HOWEVER,INC,LABEL,METHODS,NITRATE,RESULTS,SPAIN
HT1,HT2,SEROTONIN,SERUM
001,004,022,169,AMONG,AUTHORS,BJU,FOXP3,LABEL,METHODS,OBJECTIVE,OTHER,OVERALL,RESULTS,TARGETING,UCB
263,360,485,824,993,AFRICAN,ASIAN,DANES,EASTERNERS,EUROPEANS,HRS,IRANIAN,LOW,NORTH,ORDINAL,PANCREATIC,SOUTHEAST,SWEDISH,TURKISH,TURKS
247,300,496,CLAVIEN,DINDO,EBL,FIFTY,KOREA,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY,WOUND
001,005,104,ALTERED,EXPRESSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
100,127,COMPARISON,OVERALL,SCC,SQD
ABERRANTLY,BACKGROUND,BLADDER,CHINA,LABEL,LUCIFERASE,METHODS,PCR,RESULTS,T24,TARGETSCAN,TCC,WESTERN
ABP,BLADDER,HOWEVER,LIVER,TAKEN,UDP,UGT
169,BACKGROUND,CARLO,COPYRIGHT,INC,ISPOR,LABEL,METHODS,MONTE,NETWORK,NMA,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,USING
RIGID
945,AD9OC,ADLCY,CD133,HIF,HRE,ORE,THEREFORE
128,483,AIM,BACKGROUND,CIS,ELISA,LABEL,METHODS,NMIBC,NMP22,RESULTS,UROVYSION
169,AMERICANS,HODGKIN,MARIJUANA,ORS,STUDIES,THERE,THREE
169,170,274,BACKGROUND,HOPKINS,JOHNS,LABEL,METHODS,RESULTS,SOCIETY,UTF
169,170,274,444,459,BACKGROUND,FIFTEEN,FORTY,LABEL,METHODS,RESULTS,SOCIETY,UTF
221,BAX,BCL,J82,MMP,T24
ATM,BCA,CFA,DDR,DOC,DSB,KU55933,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,T24,WESTERN
419,BACKGROUND,COX,DSS,HOWEVER,LABEL,METHODS,PRIMARY,RESULTS,SIR
169,CONVERSELY,OPTIMAL,PRESS,PUBLISHED,SINCE,THEREFORE,UNIVERSITY
169,COPYRIGHT,EXTRARENAL,INC,MRT,THERE
ANTEGRADE,KSS,LABEL,OBJECTIVE,PURPOSE,RADICAL,RESULTS,RNU,SEGMENTAL,SUMMARY
HOWEVER,LABEL,OBJECTIVE,PERTINENT,PURPOSE,RESULTS,ROSRC,SUMMARY,THESE
CURRENT,FINALLY,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,WHILE
EVALUATION,NOTCH,USING
757,972,CIS,ELECTRONIC,HLA,HOWEVER,ORS,THEREFORE
EMT,ERCC1,HOWEVER,SEVERAL
HOWEVER,THERE,THESE
100,169,181,34A,COPYRIGHT,GAE,LTD,MYC,PCR,PRE,WILEY
001,169,BACKGROUND,CONCLUSION,COPYRIGHT,EDUCATION,FOUNDATION,IDENTIFIER,INC,KRUSKAL,LABEL,MEDICAL,METHODS,OBJECTIVE,OCTOBER,PLIN2,PUBLISHED,RCC,RESULTS,THESE,TRIAL,URINE,WESTERN
CHALLENGE,DETECTION,GRAND,IMAGE,MRI,OPTIMAL,OSD,PROMISE,SURFACE,THESE
956,JUSTICIDIN,RT4,USING
921,CRT,INC,MEDICAL,OAR,PTV,REGARDING,SYSTEMS,USA,V30,V40
480,PATIENT,SIX,SURGERY
169,ENGLISH,LABEL,METHODS,OBJECTIVE,RESULTS,SELECTING,SOURCES,STUDIES,SYSTEMATIC
192,BAX,BCL,MCL,MIR,MTT,TAKEN,WESTERN
905,GFP,INDUCTION,RESISTANCE,SEVERAL,TREATMENT
APRIL,BACKGROUND,CONCLUSION,LABEL,MALIGNANT,MARCH,METHODS,NIGERIA,PROSTATIC,RESULTS
125,126,139,AFTER,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,QUALITY,RESULTS,ROUND,SIX,SUBSEQUENT
001,007,500,796,800,843,901,910,ADC,BESIDES,BLADDER,DIFFUSION,LABEL,METHODS,OBJECTIVE,RESULTS,WHITNEY
AST,CONVERSELY,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,T2W
919,934,AUC,BCA,EARLY,FINALLY,ROC,URINE
180,200,310,385,476,690,800,BACKGROUND,CONTINENCE,FUNCTIONAL,FURTHER,HOWEVER,III,LABEL,METHODS,RARCS,RESULTS,ROBOT
001,002,169,215,233,880,CENTRAL,CONCLUSION,CONTROLLED,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SOCIETY,T1B,THESE,TNM
BACKGROUND,CIS,LABEL,MATERIALS,METHODS,MOLECULAR,RESULTS
001,003,177,264,290,606,ACCORDING,BACKGROUND,HODGKIN,LABEL,MASHHAD,MATERIALS,METHODS,NON,OVERALL,RESULTS,SCREENING,THERE
169,177,945,946,COPYRIGHT,INC,LABEL,LOWER,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIMILAR,SOCIETY
169,ACT,AIM,ARW,CCC,COLLEGE,CONCLUSION,COPYRIGHT,DISTANCES,ERC,FIFTY,INSURANCE,INTER,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PAC,PUBLISHED,RESULTS,ROYAL,SUM
ARYLAMINES
BECAUSE,EXTENSIVE
CAREFUL,NEOBLADDER,PREGNANCY,STAGE
MICROSCOPY,SINCE
100,BCA,BLADDER,CANDIDATE,HOWEVER,RS72552316,UTR,VARIOUS
BACKGROUND,EXPRESSION,LABEL,METHODS,NE1,PCR,RESULTS,SMALL
451,EMT,J28,MICRORNAS,MTT,PCR,RESULTS,SNAIL,T24,TNM
169,ADP,AMERICA,ANTICANCER,BACKGROUND,BAX,CONCLUSION,COPYRIGHT,DU145,INSTITUTE,LABEL,LNCAP,MATERIALS,METHODS,NORTH,PC3,PETASIDES,PETASIN,RESULTS,T24,THESE,WESTERN
397,BCR,THERE
001,169,362,573,844,CONCLUSION,LABEL,MEIER,METHODS,OBJECTIVE,PREDICTORS,PURPOSE,RESULTS,SOCIETY
516,AFTER,FURTHER,HOWEVER,INSURANCE,NHI,SIR
112,169,224,BACKGROUND,INC,LABEL,METHODS,PEDIATRICA,PROCEDURE,PROJECT,RESULTS,TEN,UNB,UROTHELIAL,WILEY
169,954,DESPITE,MEMBERS,NUCLEAR,PRESS,PUBLISHED,SIGNALING,THEREFORE,UNIVERSITY
169,947,AMONG,COPYRIGHT,PSEN1
ATLAS,MYC,NOTABLY,THESE,TTP,ZFP36
332,587,BCA,BLADDER,INITIAL,SINCE
169,A3B,BECAUSE,COPYRIGHT,HPV,IMPORTANCE,KNOCKDOWN,LABEL,OBJECTIVE,SEVERAL,TAKEN,UNLABELLED
150,AIM,FGFR3,FGFR3WT,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,TP53MUT
111,BACKGROUND,BCG,COX,HGT1A,HGT1B,INCLUSION,LABEL,MANAGEMENT,METHODS,RESULTS,SUBSTAGING,T1A,T1B,TNM,TUMOURS,TUR
BLADDER,BMJ,GROUP,LTD,PUBLISHING,TREATMENT,URODYNAMIC,VAGINAL
BLADDER,INTERESTS,MARKERS
169,AFTER,ARTIFICIAL,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SIX,TOTAL,UROLOGICAL
176,HSA,INC,PET,PUBLISHED,RSA,TFP,THESE
BLADDER,HOWEVER
LOW,UROTHELIAL
INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
CW2,H2052,MKN45,NCI
118,120,128,143,181,ITC,SFN,SIMILAR,T24,THESE
AIM,CHE,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PVR,RESULTS
008,124,151,211,AIM,CONCLUSION,EORTC,FIFTY,LABEL,METHODS,MITOMYCIN,NMIBC,OBJECTIVE,OCTOBER,RESULTS,THEREFORE,TUR
CRK
169,2CC,BICRU,COMMISSION,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,MAXIMUM,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,REPORTING,RESULTS,SOCIETY,THERE,UNITS,VAGINAL
001,169,COMPETENCE,CONCLUSION,CONTENT,COPYRIGHT,EIGHT,EVALUATION,INC,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS,ROBOTIC,UVA
177,444,LTS,MALIGNANCY,MEIER,OCTOBER,SIR,TAIWANESE,THERE
ATP,HOWEVER,JNK,JUN,LON,ROS,TAKEN,TMA,TNM
169,COPYRIGHT,EDUCATION,INC,LABEL,LPA,MATERIALS,METHODS,NOTABLY,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROCK1,T24,UROLOGICAL,USING
ENTROPY,LIEBLER
HAP,HOWEVER,OFF,THESE
045,256,845,COX,DETECTION
223,DU145,HOWEVER,LNCAP,MICRORNAS,MIR,NOTABLY,PC3,PCA,SEPT6
BRCA1,HGSCS,HOWEVER,INCIDENTAL,SURGERY,THERE
DUE,SMALL
160,BACKGROUND,BLADDER,III,JANUARY,LABEL,MEDLINE,METHODS,PHASE,RESULTS,SYSTEMATIC,THESE
BACKGROUND,END,LABEL,METHODS,ORP,RESULTS,THERE
169,COPYRIGHT,SEVERAL
169,BACKGROUND,COPYRIGHT,ICAHN,INC,LABEL,LMICS,MOUNT,OBJECTIVE,PUBLISHED,RESULTS,SINAI,WOMEN,WORLD
160,169,BACKGROUND,BURKITT,CHRONIC,CLONORCHIS,CONCLUSION,COPYRIGHT,EPSTEIN,HIV,HODGKIN,HPV,ICAHN,INC,INFECTION,LABEL,MOUNT,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SINAI,WIDESPREAD
169,ALCOHOL,BACKGROUND,CANCERS,CONCLUSION,COPYRIGHT,ICAHN,INC,LABEL,LMICS,MOUNT,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,SINAI,TOBACCO
000,100,169,ASIAN,ASR,BACKGROUND,BAHRAIN,CANCERS,COPYRIGHT,COUNTRIES,ICAHN,INC,IRANIAN,LABEL,LEBANON,METHODS,MOUNT,OBJECTIVE,OBJECTIVES,PUBLISHED,QATAR,RESULTS,SAUDI,SINAI,THEREFORE,THESE,TURKISH,WESTERN
BACKGROUND,BLADDER,LABEL,METHODS,THERE
AFTER,BACKGROUND,CASPASE,IFN,KSY,LABEL,METHODS,MTT,RESULTS,SIN,TNF,TUNEL,UNDER,YIN
DESPITE,UROTHELIAL
001,006,024,107,177,263,321,354,388,403,497,742,RADICAL,THERE,THEREFORE
169,208,AFTER,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,MULTIPLEX,OBJECTIVE,PCR,PERIPHERAL,RESULTS
409,LOH,NGS,RESULTS,UCS
FIRST,SFRP4,WNT
169,BASEL,CURRENT,CYSTOSCOPY,DESPITE,DUE,HOWEVER
892,ARG,ARG399GLN,CAUCASIAN,GLN,MONGOLOID,XRCC1
177,ANNEXIN,EXPRESSION,FOLLOWING,MTT,T24,WESTERN
169,AKT,BCA,COPYRIGHT,CTLA4,DM1,EARLY,INHIBITORS,LTD,MEK,SMALL,TREATMENT
000,100,102,169,AVERAGE,COPYRIGHT,EDUCATION,FILES,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,RESULTS,RUCCS,RURAL,STATISTICS,UROLOGICAL,UROLOGIST
001,034,036,141,146,169,287,504,ASSOCIATES,COPYRIGHT,COX,LABEL,LTD,METHODS,OBJECTIVE,OCD,ORTHOTOPIC,PUBLISHED,PURPOSE,RESULTS,TOTAL
100,10A,143,145,15A,205,221,223,452,CONCLUSION,EXTRACTION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RNU,THERE
128,141,143,169,284,30994,660,AFTER,APRIL,AUG,BACKGROUND,COPYRIGHT,EORTC,FUNDING,GRADE,HOWEVER,IMMEDIATE,IQR,LABEL,LILLY,LTD,METHODS,NEITHER,OVERALL,RESULTS,SOCIETY
001,160,169,BACKGROUND,BLADDER,CONCLUSION,COPYRIGHT,EIGHT,FIFTEEN,INC,IRELAND,IRISH,JANUARY,LABEL,METHODS,MORTALITY,RENAL,RESULTS,SIR,SIXTY,SOLID,TRANSPLANT
001,021,169,188,219,283,475,569,579,621,948,AUTHORS,BJU,BLC,CIS,LABEL,LTD,METHODS,NMIBC,OBJECTIVE,PUBLISHED,RESULTS,SPAIN,SPANISH,THERE,WILEY,WLC
109,BECAUSE,CIL,CSV,FINALLY,ISOMS
BACKGROUND,CONCLUSION,LABEL,METHODS,THEREFORE
160,BACKGROUND,BASED,CONCLUSION,HOWEVER,LABEL,METHODS,SARCOID,SINCE
100,APRIL,BACKGROUND,BASED,CONCLUSION,III,KARNOFSKY,KEY,LABEL,MEDICINES,METHODS,RESULTS,VINFLUNINE
120,139,145,177,1ST,BACKGROUND,BPH,CALABAR,CONCLUSION,EPI,HOWEVER,IMAGING,IUC,LABEL,LOWER,METHODS,RESONANCE,RESULTS,SEVENTY,THERE,TOMOGRAPHY,UNIVERSITY,URINARY
ATLAS,MOLECULAR,PROTEIN
0008083,001,002,005,169,296,340,BACKGROUND,CONCLUSION,DSS,INC,INCREMENTS,INHBA,INHIBIN,LABEL,METHODS,QUANTIGENE,RESULTS,UBUCS,UROTHELIAL,UTUCS,WHILE,WILEY
000,059,147,163,169,538,912,ADDITIONAL,COPYRIGHT,EXCELLENCE,G1PTA,INC,INSTITUTE,LABEL,MARCH,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,OLA,PDD,RESULTS,THERE
029,169,BASED,COPYRIGHT,FDG,INC,LABEL,METHODS,OBJECTIVE,PATIENT,PET,RESULTS,UPSTAGING
169,233,945,BACKGROUND,BCA,BCG,COPYRIGHT,INC,LABEL,LIBRARY,METHODS,MITOMYCIN,PFS,RCT,RESULTS,RFS
074,169,935,BLADDER,COPYRIGHT,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,UPPER
001,019,100,169,CLAVIEN,CONCLUSION,COPYRIGHT,DEFINITIVE,INC,LABEL,METHODS,OBJECTIVE,ORC,RESULTS,THERE,UNIVERSITY
100,169,BACKGROUND,COMBINING,INC,LABEL,METHODS,NMP22,NPV,OPTIMAL,OVERALL,RESULTS,URINE,WILEY
169,777,BRITAIN,CONTINUED,COPYRIGHT,GREAT,INC,LABEL,METHODS,OBJECTIVE,PAF,PURPOSE,RESULTS
169,945,AMONG,CDP,CHOLINE,RSM
134,947,OVERALL,SUV39H2
ARF,PERIOSTIN,STRIKINGLY,THESE
183,1970S,1990S,2000S,AUTHORS,CURRENT,GEORG,RMS,STUTTGART,SURGERY,USING
169,COPYRIGHT,THEREFORE,THESE,UDC
DR4,DR5,EPI,HOWEVER,KU7,RT112,SYNERGY,T24,THESE,TRAIL,TREATMENT
169,178,18MIN,356,BLADDER,CONCLUSION,COPYRIGHT,EIGHT,EMPTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,177,BACKGROUND,COCHRAN,DESPITE,ICD,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,NIS,NORTHEAST,PATIENT,RESULTS,SOUTH
169,CONCLUSION,COPYRIGHT,FEDERATION,GRADE,GYNECOLOGY,INC,IVA,LABEL,MATERIALS,METHODS,OBJECTIVE,OBSTETRICS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,STAGE,TREATMENT
100,160,956,ARECAIDINE,T24,THESE
BLADDER,TEA
162,548,559,5MC,946,956,975,BECAUSE,RESULTS,SPAIN,THM,UBC
174,AKT,ATP,GEFITINIB,JUN,MET,OTHER,OVERALL,RSK
169,BLADDER,COPYRIGHT,HOWEVER,INC,THERE
113,947,BACKGROUND,COX,HOWEVER,LABEL,MEDICAL,MEIER,METHODS,RESULTS
169,CONCLUSION,COPYRIGHT,DISCS,HOWEVER,INC,KNOCKDOWN,LABEL,MEIER,THESE,UNLABELLED
ABCC4,DDT,GSH,LLC,PK1,ZEBRAFISH
001,169,688,ACM,AFTER,CCI,CONVERSELY,COPYRIGHT,CSM,LABEL,LTD,METHODS,MVA,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,SUBGROUPS,USING
169,178,AIM,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,DESPITE,IMPROVING,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PATIENT,RESULTS,THERE,THESE
001,122,220,C228T,C250T,DISTANT,HOWEVER,PCR,RPC,THERE,UTUCS
002,282,298,729GC,BLADDER,CD4,CD8,CHINA,CHINESE,HOWEVER,RESULTS,SIMILARLY,THESE
CAUCASIANS,HENCE,OVERALL
169,AMONG,BACKGROUND,BASEL,LABEL,METHODS,RESULTS,TEN,THERE,URACHAL
945,946,CERTAIN,DECREASED,EMT,GLYCOV4,HCV29,INTEGRATED,PCR,TAKEN,TGF,THESE
CSC,CYTOTOXIC,FURTHER,WHILE
ANOTHER,BECAUSE,THESE
BACKGROUND,DISEASE,HOWEVER,LABEL,METHODS,NUX,RECURRENT,RENAL,RESULTS,TCC,THERE,THEREFORE
001,002,004,016,029,040,121,C30,CNS,EORTC,HRQOL,LGG,QLQ,QOL,QUALITY,RADIATION,TREATMENT,USING
184,ATLAS,BACKGROUND,CIS,EPIGENETIC,IRS,J82,LABEL,METHODS,MSP,PCR,RESULTS,RT112,RT4,ST6GAL1,THESE
100,169,253,500,BIOLOGY,ECM,FURTHER,METASTATIC,SOCIETY,USING
169,262,AFTER,COPYRIGHT,EDUCATION,HOWEVER,INC,INCREASING,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PREDICTORS,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,160,169,AMONGST,AUTHORS,CIS,CONTINUOUS,FIFTEEN,INSTITUTE,LTD,PROJECT,RESULTS,RRS,SMOKING,WILEY,WORLD
169,181,344NGML,425,5PGML,7PGML,APOA2,COPYRIGHT,FET,FRIEDEL,LOD
169,945,946,99M,COPYRIGHT,CURRENTLY,EC145,FOLIC,LTD,PHASE,THEREFORE,VINCA
001,043,169,COPYRIGHT,HRS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
169,AUTHORS,COPYRIGHT,EXTRACTING,ICA,INC,PPARG,PUBLISHED
100,169,177,2GY,AFTER,COPYRIGHT,D90,DOSES,ENDPOINTS,GRADE,HDR,IMAGE,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
001,169,26A,BACKGROUND,CONCLUSION,COPYRIGHT,HMGA1,LABEL,MATERIALS,METHODS,PCR,RESULTS,SAS,UBC
001,169,ACCORDING,BACKGROUND,CCI,COPYRIGHT,END,INDEX,LABEL,LTD,METHODS,MORTALITY,RESULTS,T4A
169,611,BRAIN,CONCLUSION,FACBC,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTEEN,SOCIETY,UNLABELLED
169,BACKGROUND,COPYRIGHT,LABEL,METHODS,MUC,RESULTS,SAMPLES,URINARY
169,189,COPYRIGHT,DESPITE,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,UROLOGICAL
001,169,782,AFTER,COPYRIGHT,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,UROLOGICAL,USING
169,COPYRIGHT,IIB,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,WHOLE
BLADDER
005,100,122,169,COPYRIGHT,GATA3,INC,INVUC,UCS,UROPLAKIN,UROPLAKINS
169,370,COPYRIGHT,FEDERATION,PUBLISHED,SOCIETIES,THEREFORE
169,COPYRIGHT,D90,DVH,EGO,GRAPHICAL,GRO,HOWEVER,IIP,INC,INVERSE,LABEL,MATERIALS,METHODS,OBJECTIVE,PDR,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TREATMENT
169,COPYRIGHT,HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
004,169,COPYRIGHT,FIFTEEN,INCREASES,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,THRESHOLDS
010,014,021,169,COPYRIGHT,HOWEVER,TAKEN
015,169,COPYRIGHT,COX,EDUCATION,END,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
001,132,134,169,233,916,CASES,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,THERE,THEREFORE,TOTAL,UROLOGICAL
169,COPYRIGHT,HOXC9,IRELAND,LTD,PARALLELED,PUBLISHED,SRSF2
169,335,337,AUTHORS,CONCLUSION,CONTINENCE,COPYRIGHT,INC,LABEL,LRC,METHODS,NEOBLADDER,OBJECTIVE,OCTOBER,PUBLISHED,RESULTS,UMBILICAL
001,032,169,CONCLUSION,COPYRIGHT,COX,CSS,ELECTRONIC,INC,INDIVIDUAL,LABEL,LND,LOW,MATERIALS,METHODS,OBJECTIVE,ONTARIO,RESULTS
169,AFTER,CANONICAL,COPYRIGHT,DMA,HENCE,LTD,MULTI,PUBLISHED,RESULTS
169,BLADDER,CONCLUSION,COPYRIGHT,COXEN,GROUP,INC,INSTITUTE,LABEL,MATERIALS,METHODS,MRE11,NCI,NOVEL,OBJECTIVE,RESULTS,S1314,SOUTHWEST,THERAPY
010,025,169,827,847,COPYRIGHT,COSTS,GREATER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QUALITY,RECURRENCE,RESULTS,THERAPY,USING
169,BECAUSE,COPYRIGHT,HCL,INC,NURSING,PUBLISHED
169,247,316,563,929,945,946,947,AUC,BED,BETWEEN,COPYRIGHT,INC,LABEL,LIKELIHOOD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,102,169,177,215,CARLO,COPYRIGHT,INC,IONIZATION,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TPS,VIEWRAY
100,169,177,CALCULATED,CONCLUSION,COPYRIGHT,CTS,D99,DRR,DSC,FURTHER,GAMMA,GENERATED,HOUNSFIELD,INC,LABEL,MAE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIM
001,008,169,187,217,ADVERSE,AUTHORS,COPYRIGHT,DVH,GR1,GR2,GR3,GR4,GR5,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,POTENTIAL,PUBLISHED,PURPOSE,RESULTS,TECHNIQUES,THERE,TRANSIENT,UNIVARIATE,V75
017,100,169,177,178,216,2CM,716,AFTERWARD,AMONG,COMMISSION,COPYRIGHT,DICRU,DIGITAL,GRADE,IMAGING,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,UNITS
500,ACCORDING,CALYPSO,CTS,CTV,D99,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TEN
001,003,006,013,023,025,081,169,177,5FC,5MC,BACKGROUND,CONCLUSION,COPYRIGHT,EIA,GROWING,HRP,LABEL,METHODS,PUBLISHED,RESULTS
169,187,200,370,600,867,AFTER,BLADDER,CONCLUSION,CONTINENT,COPYRIGHT,EFFORTS,GERMANY,INC,INCREASED,INPATIENT,LABEL,METHODS,OBJECTIVE,POPULATION,RESULTS,UROLOGY
169,COPYRIGHT,FURTHER,LTD,MONOCLONAL,NSCLC,RCC
001,109,169,177,347,808,CIS,COPYRIGHT,LND,LOCAL,LVI,PRDSS,PUBLISHED,SEX
100,108,150,162,173,BASED,BETWEEN,BUC,CONCLUSION,DIFFERENCE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,120,132,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UBC,UROLOGY
ASSESSMENT,CONCLUSION,CYSTECTOMY,ENGLISH,FUNCTIONAL,INDEX,JANUARY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERAPY,THERE,VANDERBILT,VCI
NSC7455889,NSC745885,THESE
289,379,668,946,BESIDES,CROHN,DUTCH,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,STOMA,STOMAPANEL
100,500,BACKGROUND,CONCLUSION,GRADE,LABEL,METHODS,ORR,PEMETREXED,PFS,RESULTS,SECONDARY,SEVEN
BACKGROUND,LABEL,METHODS,ORS,REGULAR,RESULTS,UBC,UTI
001,118,EMT,EPITHELIAL,EXPRESSION,HOWEVER,THERE,TWIST
135,175,AFTER,BACKGROUND,BAJORIN,CONCLUSION,GRADE,LABEL,MARCH,METHODS,METRONOMIC,RESULTS
160,BECAUSE,CD274,FDA,HOWEVER,MPDL3280A,PATIENT,PDCD1,RESPONSES,THERE,THEREFORE,THESE,UBC
100,157,282,439,CEACAM6,CEACMA6,SMALL
ADVERSE,BACKGROUND,CUTANEOUS,EARLY,IDENTIFIER,IMPORTANCE,INSTITUTE,INSTITUTES,LABEL,MET,METHODS,OBJECTIVE,OCTOBER,REACTIONS,RELEVANCE,RESULTS,RET,SETTING,TRIAL
BCA,BECAUSE,BIOLOGICAL,BLADDER,CYFRA,DISCOVERY,LITERATURE,MMP,VALIDATION
BACKGROUND,CONTEXT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,SOURCES
169,GRADE,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SECONDARY,UNIVERSITY
ADVERSE,BACKGROUND,BPH,CHANGES,CLAVIEN,DESPITE,DISCUSSION,INSTITUTE,LABEL,METHODS,PAE,SCORE,SYMPTOM,TRIAL,TUR
169,233,945,BCG,IL2,IL8,LABEL,METHODS,MMC,NMIBC,OBJECTIVE,PURPOSE,RESULTS,TAM,TNF,URINARY,URINE
1960S,BIOLOGY,CHARLES,CONGDON,GVH,LABORATORY,OAK,PHD,RIDGE,WHILE
BACKGROUND,CONCLUSION,CONTEXT,LABEL,METHODS
169,181,213,394,ADVERSE,BACKGROUND,BLADDER,COX,LABEL,MAXIMUM,METHODS,PBT,PCA,RBE,RESULTS,SOCIETY
166,BACKGROUND,BCL,BUC,LABEL,MATERIALS,METHODS,P53,RESULTS,WESTERN
EPIGENETIC,THERE,UROTHELIAL
233,269,299,473,502,510,655,662,663,673,687,698,727,746,BACKGROUND,BCG,BLADDER,DISEASE,HOWEVER,LABEL,LIBRARY,METHODS,NMIBC,RANDOMIZED,RESULTS

161,169,COG,D9803,DPE,GRD,GROUP,III,IRS,LOCAL,RMS,SEVENTY
AREAS,BACKGROUND,COVERED,ENGLISH,FARXIGA,FDA,FORXIGA,INCREASED,LABEL,METHODS,OPINION,SGLT2
001,023,025,027,036,043,075,160,18A,238,907,COX

128,292,ACTIVATION,AUC,GEO,ONCOFINDER,PAS,PATHWAY,SIGNALING,THESE
003,169,APRIL,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE,V33,V60,V65,V70,V75,V80
169,ACTUARIAL,ACUTE,ADVERSE,COPYRIGHT,DEFINITIVE,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SEPTEMBER,SIX,SMALL,SOCIETY,THREE
001,102,169,499,4B951,AMONG,AUTHORS,BJU,COX,GROUP,LABEL,LTD,LVI,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SOUTHWEST,TTR,UCB,VARIABLES,WILEY
AMONG,BLADDER,PAK
191,400,434,595,ABOUT,BACKGROUND,CNV,LABEL,MEN,METHODS,RESULTS,TETRASOMY,UROSCREEN,UROVYSION,WHETHER
169,6TH,7TH,AGE,AMONG,BACKGROUND,CHANGES,COLLECTION,COMMITTEE,END,JOINT,LABEL,METHODS,RESULTS,SEVERAL,SOCIETY,STAGE,STAGING,UROLOGICAL,WORLD
169,283,400,578,591,6TH,7TH,BACKGROUND,COLLECTION,COMMITTEE,END,GLEASON,IIA,IIB,JOINT,LABEL,METHODS,PROGRAM,RESULTS,SOCIETY,STAGE,T3A,VERSION
320,ADDITIONAL,CIS,LABEL,MATERIALS,METHODS,NBI,NMIBT,OBJECTIVE,OBJECTIVES,RESULTS,TURBT,WLC
156,296,361,ABOUT,GROUP,HISTOLOGY,LABEL,LOCALLY,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
130,260,BCG,BPV,CIS,CONCERNING,LABEL,MATERIALS,METHODS,NBI,NMIBT,OBJECTIVE,OBJECTIVES,RESULTS,TUR,TURBT,WLC
001,103,ALDH2,BACKGROUND,CCNE1,COX,CURRENT,FUNCTIONAL,HOWEVER,LABEL,MEIER,METHODS,RESULTS,SMAD3
AREAS,CTV,GROUP,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RADIATION,RESULTS,TEN,THERAPY
180,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,THREE
23B,27B,HOWEVER,LUCIFERASE,MET,THEREFORE
LABEL,MATERIALS,METABOLIC,METHODS,MONTI,OBJECTIVE,PURPOSE,RESULTS

290,365,AIM,ASA,BACKGROUND,BETWEEN,EARLY,INTRA,LABEL,LRC,METHODS,OCTOBER,RADICAL,RESULTS
169,181,AMONG,RRS
RELIEFF
MDR

BLADDER,NF1
GHET1,HOWEVER,TAKEN
CONCLUSION,CTC,CURRENTLY,CZECH,LABEL,MATERIALS,METHODS,OBJECTIVE,OSTRAVA,PERIPHERAL,RESULTS,SEVERAL,UBC
LABEL,METHODS,OBJECTIVE,PCR,RESULTS,UCC
DESPITE,FUNCTIONAL,III,SIRT6
113,154,177,5FR,AFTER,BACKGROUND,BETWEEN,FOGARTY,HOLMIUM,LABEL,MAY,METHODS,RESULTS,RNU,THERE,TUDUBOD
169,COPYRIGHT,H9049,INC,UTI
001,040,064,091,233,256,271,282,BCG,PCR,SPECIMENS,THERE
233,BCG,FDG,INCIDENTAL,PET
FDG,FINALLY,HOWEVER,PET
252,BMJ,GROUP,LTD,PUBLISHING
UROTHELIUM
945,BCG,CHRONIC,TNF,WHILE
001,032,045,105,169,BUC,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,UCS,UPIII,UROPLAKIN,UUTUC
169,194,ALGORITHM,ALGORITHMS,AMONG,MEDICAL,NETWORK,PPV,SIR,STUDIES,USING
001,014,104,332,COX,ICH,LABEL,MATERIALS,MEIER,METHODS,NMIBC,OBJECTIVE,OCTOBER,RESULTS,SNAIL
169,587,695,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,SOCIETY
169,196,623,BACKGROUND,CHA,DISCLOSURE,GOVERNMENT,LABEL,METHODS,PERCEIVED,RATES,RESULTS,SOCIETY,USA
HOWEVER,PPM1D,PROTEIN,T24
737,945,946,ABT,AKT,BCL,HOWEVER,KIT,LOW,MCL,PDGFR,RAF,SORAFENIB,T24,THESE,TKI
169,179,386,552,967,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THESE
001,169,790,BACKGROUND,CALIFORNIA,LABEL,METHODS,RESULTS,SIXTY,SOCIETY,TOBACCO,UROLOGISTS
ADDITIONAL,FDA,HODGKIN,MPDL3280A
C18,HOWEVER,URINE
006,242,442,BCA,LABEL,LIBRARY,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS
BETWEEN,HAEMATURIA
BACKGROUND,CONCLUSION,LABEL,METHODS,NMP22BC,RESULTS,SECTORS,THESE,URINE
160,169,AAN,AFTER,BCG,NMIBC,TOLERANCE,UNDER
160,FIFTY,GRADE,III,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SIX,THERE
109,EVALUATION,FIFTY,GROSS,HOSPITALS,IBN,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,STRUCTURED
411,700,BACKGROUND,CAUCASIANS,LABEL,MATERIALS,METHODS,RESULTS,SMOKING
HOWEVER
000,100,107,111,946,CTV,D90,DSO,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIFORM
160,64257,946,954,BCA,BLADDER,CHRONIC,PCR
095,169,224,549,BACKGROUND,COMPONENT,EMOTIONAL,END,HODGKIN,HRQOL,LABEL,MCS,METHODS,PCS,RESULTS,SCALE,SHORT,SOCIETY,SUMMARY,SURVIVORS
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,III,INSTITUTE,LABEL,MATERIALS,METHODS,POSITIVITY,RESULTS,THESE,UROTHELIAL
000,169,CROSSROADS,IMMUNOLOGY,METASTATIC
169,NOTCH
169,GDP,RAL,SMALL
BACKGROUND,BECAUSE,CAUSE,CYSTOSCOPY,ENGLISH,LABEL,METHODS,OUTCOME,THEREFORE
169,205,CMT,CONCLUSION,DSS,GIVEN,GROUP,III,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RADIATION,RESULTS,SOCIETY,T4A,THERAPY
THEIR,THESE
169,ADP,ATP,AUTHORS,DESPITE,EPI,FURTHER,IVC,LTD,MMC,NON,PTY,PUBLISHING,SCIENCE,TUR,WILEY
160,ACCORDING,AMONG,BACKGROUND,CONCLUSION,GLEASON,HEMATURIA,LABEL,METHODS,REGARDING,RESULTS,SECONDARY,SPP,TCC,THEREFORE,URMIA
169,COPYRIGHT,HOWEVER,NETWORK
001,610,RRS,THERE,VITAMIN
001,048,109,131,177,AIM,CHINA,CONCLUSION,ELISA,LABEL,METHODS,NAMPT,OBJECTIVE,RESULTS,SERUM,SICHUAN,UNIVERSITY
169,233,BCG,BLADDER,COPYRIGHT,SCIENCE,USING
169,COPYRIGHT,SCIENCE
CARAT,CCL20,CURRENT,HUC,IL22RA1,IL22RA2,IL7,MR1,MR2,USING,WHILE
99A,DU145,FOLLOWING
BACKGROUND,DLT,LABEL,METHODS,MTD,RESULTS
AKT,BACKGROUND,BP1,CELLTITER,CONCLUSION,DUSP1,EDU,ERK,FOLLOWING,LABEL,METHODS,RESULTS,TREATMENT
112,169,AZD7762,CHK
169,946,BIOLOGY,DAC,DNMT1,DNMTS,HAUSP,MSP,PC3,PCR,SOCIETY,T24,UHRF1,WESTERN,WIF,WNT,WST
124,169,ACADEMY,BIOLOGICAL,BIOLOGY,CHINESE,ECTOPIC,EDITORIAL,INSTITUTE,INSTITUTES,MICRORNAS,MIR,PRESS,PUBLISHED,TAKEN,TARGETSCAN,UNIVERSITY,UTR
142,ACUTE,CONFORMAL,DETAILS
001,012,113,303,ADC,AUC,BACKGROUND,DWI,IMAGING,LABEL,MATERIALS,METHODS,MRI,NODAL,RESULTS
019,367,420,CHINESE,ORS,RESULTS,SNP
169,COMPARISON,HOWEVER,MARCH,METABOLIC,OUTCOME,PATIENT,PUBLISHED,UROLOGICAL
001,005,133,169,225,341,AUC,BACKGROUND,GENOMIC,IBCNC,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SELECTING,UNIVERSITY
SOC
2CC,320,ANOVA,BACKGROUND,BD2CC,CONCLUSION,IMAGE,LABEL,METHODS,OBJECTIVE,RESULTS,V40,V50,V60,V65
169,99M,BECAUSE,CONCLUSION,IMAGING,INC,LABEL,METHODS,MIP,MOLECULAR,NUCLEAR,PCA,RESULTS,SOCIETY,SPECT,UNDER,UNLABELLED,WHOLE
102,160,AMONG,BACKGROUND,DISTANT,EMA,III,LABEL,METHODS,RESULTS,VINFLUNINE
169,945,ADENOSINE,ADORA2A,CD127,CD8,HOWEVER
001,028,038,121,140,240,260,300,321,354,386,420,CONCLUSION,DISTENTION,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,URINARY
169,329,335,564,972,AMONG,ANGELES,BACKGROUND,BECAUSE,END,LABEL,LOS,METHODS,MORTALITY,PATIENT,RESULTS,SOCIETY
BASED,THESE
ADM,ANXA1,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
120,150,169,260,310,AT13387,CONCLUSION,DLT,EXPOSURES,HSP70,HSP90,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SIXTY
BACKGROUND,DFS,DSS,HRS,LABEL,METHODS,MVD,REPORTING,RESULTS,THERE
141,183,AMONG,AUC,BACKGROUND,BCA,BIOMARKERS,FURTHER,HGF,HOWEVER,LABEL,MET,METHODS,MIBCA,NORMALIZED,RESULTS,ROC,TOTAL,URINARY
BMJ,ENGLISH,GROUP,HOWEVER,LCNEC,LIMITED,LTD,PUBLISHING
137,FURTHER,PAQR3,SILENCING,THERE,THESE
ANY,CK7,DEPARTMENT,JANUARY,MPC,MURES,ROMANIA,THREE,TIRGU,TUR,UROLOGY
105,10MLS,50OVA,842,ACCORDING,BACKGROUND,CONCLUSION,CONFIDENCE,ENUGU,ESCHERCHIA,HEAVY,INFECTION,INTENSITY,KNOWLEDGE,LABEL,METHODS,PREVALENCE,RATIO,RESULTS,STATE,THESE,URINE
100,BLADDER,LERICHE,OVERALL,SURGERY,THESE
121,122,142,ANN,CONCLUSION,INDEX,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS
DFS,FGF,FGFR1,FGFR3,FGFR4,FVIII,MVC,PROTEIN,VSA
001,003,005,011,035,036,130,COX,HMG,MEIER,PCR,SRY,T24
160,198,EGFR2,ERBB2,MBC,MUTATIONS,NEU
AFTER,ORBITAL,PATHOLOGY
001,041,393,872,FORTY,HOWEVER,III,JANUARY,LABEL,MATERIALS,METHODS,NMIBC,OBJECTIVE,PURPOSE,RESULTS,ROUTINE,SUSPICIOUS,TURBT,UNDER,VII
531,704,722,724,745,759,832,836,894,BETWEEN,COX,CUETO,EORTC,HARRELL,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,SPANISH,TREATMENT,UROLOGICAL
169,CTL,CURRENT,DESPITE,EFFORTS,IMMUNOLOGY,IPILIMUMAB,SOCIETY
160,ADC,GLEASON,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC
129,223,299,518,522,EXPRESSION,FUNCTIONAL,OMNIBUS,PATHWAY,THERE,THESE
160,169,CPG,HOWEVER,MEIER,PHD,RGS,THESE,UBIQUITIN,UHRF1
BLADDER,HOWEVER,PHYSICIANS
013,024,169,19Q12,215,265,857,942,CCNE1,GWASS,MOLECULAR
109,169,COPYRIGHT,EXPRESSION,LABEL,LYNCH,METHODS,MMR,MSI,OBJECTIVE,OBJECTIVES,PATHOLOGY,REGARDING,RESULTS,SOCIETY
001,054,066,112,160,207,236,505,556,593,598,610,774,966,AFTER,BACKGROUND,C00,C96,CANCERS,DETAILS,FEWER,ICD10,IRELAND,LABEL,METHODS,OVERALL,RESULTS,THESE
169,BMP,COPYRIGHT,FK506,INC,SHH,SONIC
169,COPYRIGHT,INC,NOTCH,THESE
511,AFTER,THERE

001,002,013,016,021,177,GROUP,JANUARY,LABEL,MATERIALS,METHODS,NATURAL,OBJECTIVE,OCTOBER,RESULTS
177,400,CONCLUSION,CRT,CTV,LABEL,MATERIALS,METHODS,OBJECTIVE,ORGAN,PTV,RESULTS
BACKGROUND,IVA,LABEL,MATERIALS,METHODS,RESULTS,SHELDON,SURGERY,THREE,URACHAL
001,002,013,100,KRUSKAL,LABEL,METHODS,OBJECTIVE,PEARSON,RESULTS,S4F,SINCE,TESTICULAR,THREE
028,163,169,AUTHORS,BACKGROUND,COPYRIGHT,IAC,LABEL,LTD,MATERIALS,METHODS,PUBLISHED,RESULTS,SUCCESSFUL
BACKGROUND,GENBANK,LABEL,LOXL4,NM_032211,NR_029710,OXIDATIVE,RESULTS
001,045,645,ACS,ASA,BACKGROUND,BPH,CLASS,COLLEGE,FURTHER,HOWEVER,LABEL,LVP,METHODS,NSQIP,OVERALL,PATIENT,PROGRAM,QUALITY,RESULTS,SOCIETY
169,549,929,CD2,COMPLEX,COPYRIGHT,DIC,DICLOFENAC,FRIDOVICH,H2O,MCF,T24
152,PPI,PPINS,THEIR
002,003,018,022,028,049,169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OLDER,PRDSS,RESULTS,UROTHELIAL
169,COPYRIGHT,DIAGNOSIS,INC,LABEL,METHODS,NMIBC,OBJECTIVE,RESULTS
169,COPYRIGHT,INC,QUALITY,RADICAL,ROBOT,WORKING
106,169,COPYRIGHT,ELISA,IRELAND,LTD,LUCIFERASE,PCR,USING,UTR,WESTERN
001,014,100,103,125,130,154,169,174,449,478,520,620,697,753,927,ADVERSE,AUC,AUT,BLADDER,COPYRIGHT,COX,D20,D90,GRADE,INC,JANUARY,LABEL,LDR,LUT,MATERIALS,METHODS,OBJECTIVE,PALLADIUM,PURPOSE,RESULTS,ROC,STRUCTURES,THESE
001,002,031,119,169,201,BASICALLY,COPYRIGHT,CRT,CSS,FOLLOWING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TURBT
001,028,031,036,038,039,040,042,114,141,COX,GREEN,LOG
AUTHORS,BACKGROUND,BIOMEDICAL,CARCINOMA,CBM,CENTRAL,CHINESE,COLLECTION,CONTROLLED,DSS,DUE,GRADE,GROUP,HDR,ISSUE,LABEL,LDR,LIBRARY,LITERATURE,MARCH,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RANDOMISED,RESULTS,RFS,RRS,SELECTION,SINCE,THESE,WHETHER
SLC14A1
BCG
AUC,ONCOFINDER,THESE,USING
001,016,043,134,169,503,ACTUARIAL,AUTHORS,BJU,CLAVIEN,COX,CSS,EAU,FURTHER,IQR,IVB,LABEL,LRC,MEIER,METHODS,MINOR,OBJECTIVE,RESULTS,RFS,URO,UROLOGY
00002,00014,007,011,014,045,1188A,174,251,261,AFTER,IRANIAN,UTR
BACKGROUND,DISCUSSION,LABEL,LARGE,METHODS,OCTOBER,PRIOR,RESULTS,SMALL,URINARY
169,BIOLOGY,ENDOGENOUS,HNE,I217R,INC,MOLECULAR,PR3,SOCIETY,THESE,WEGENER
150,AFTER,BACKGROUND,LABEL,METHODS,MTS,PCR,PDCD4,RESULTS,T24,TARGETSCAN,THEREFORE
169,177,186,236,240,353,355,945,946,947,956,AFTER,CD1,CONCLUSION,EDS,EXM,ICRP103,IMAGING,INC,LABEL,MBQ,METHODS,MOLECULAR,NUCLEAR,ODS,PET,RADIATION,RESULTS,SOCIETY,UNLABELLED
107,129,169,233,COPYRIGHT,CYSTOSCOPY,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
016,037,090,169,185,438,451,COPYRIGHT,EDUCATION,GAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
169,CPG,DNMT1,INDUCED,NMIBC,PC3,SP1,THESE,TIS21
ARSENIC,HOWEVER,INORGANIC,KOREA,SOUTH,THERE,WHILE
AREAS,BACKGROUND,BLADDER,COVERED,DIFFERENT,FGFR3,INHIBITING,LABEL,METHODS,OPINION
101,132,233,795,ACADEMY,AIM,AUC,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LVI,MEDICAL,METHODS,OBJECTIVE,ORGAN,RECEIVING,RESULTS,ROC,STAGING,TUR
ALGEBRAIC,CNR,FOLLOWING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
059,238,287,500,952,966,ASSOCIATED,BASED,CARLO,CTV,D90,DICOM,DIFFERENCE,ENGER,LABEL,MATERIALS,MED,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,STUDENT,TG186
086,169,309,313,640,AFTER,BLADDER,CONTINENCE,COPYRIGHT,DRY,EDUCATION,ENCRYPTED,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SECONDARY,THERE,UROLOGICAL
025,045,15Q24,169,215,558,EUROPEANS,MYC,PRESS,PUBLISHED,SLC14A1,SNP,THROUGH,UNIVERSITY
169,ALCOHOLIC,BACKGROUND,CONCLUSION,LABEL,METHODS
BACKGROUND,BNA,CIS,DISCUSSION,ITEMS,LABEL,MEDLINE,METHODS,MOOSE,ORS,OVERALL,PREFERRED,REPORTING,REVIEWS,STUDIES,SYSTEMATIC
945,AKT,BBN,BCA,EARLIER,IHC,MECHANISM
001,008,011,021,025,043,105,CRT,FIF,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PTV,RESULTS,THEREFORE,TREATMENT
105,112,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,WORKING
013,111,AFTER,APRIL,BMI,FUNCTIONAL,HEART,LABEL,METHODS,NECESSITY,OBJECTIVE,OBJECTIVES,QUERLEU,RANDOMIZED,RESULTS,SETTING,SYSTEMATIC,UNIVERSITY
CPG,KISS1,KNOCKDOWN,PCR,PHD,THESE,UBIQUITIN,UHRF1
169,ACCORDING,COPYRIGHT,FURTHER,HOWEVER,HPV,INFECTIOUS,LTD,PUBLISHED,SEVERAL,SOCIETY
001,114,EPSTEIN,OHORI,SECTIONING
CHRONIC,LYMPHOMAS
CURRENT,DIAGNOSTIC,IMT,URINARY

ETS,FREQUENCY,PCR,THESE
945,AKT,GLUT3,HIF,HK2,LDH,PKM,SEVERAL,WARBURG,WESTERN
145,252,BURKITT,CAL,DAUDI,HAH,HELIX,HIH,HLH,KLH,THEREFORE,THP
169,2D3,945,BLADDER,COPYRIGHT,FURTHER,HOWEVER,ISSUE,LTD,PATHWAY,SPECIAL,THEREFORE,VDR,VITAMIN
GROWING,HOWEVER,RADICAL
100,120,APRIL,AUS,AUTHORS,BACKGROUND,BPH,CENTRAL,CIS,COLLECTION,CONTROLLED,GROUP,HOWEVER,JANUARY,LABEL,MARCH,MEDLINE,MEN,METHODS,OBJECTIVE,OBJECTIVES,RANDOMISED,RESULTS,SELECTION,THERE
001,006,2N0,CONCLUSION,CRT,D50,EORTC,GLEASON,GRADE,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,SIXTY,THERE,V70
169,CLINICALLY,ECTOPIC,RAB,SILENCING,TAKEN
169,1CM,BACKGROUND,CARLO,COPYRIGHT,HDR,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
122,169,177,AVERAGE,CONCLUSION,COPYRIGHT,DISEASE,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,THEREFORE
CHT,JANUARY
24H,945,946,BMI,CHRONIC,CONSISTENT,HUC,SMI,TGF,THESE,TNF,URINARY
169,233,242,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
BACKGROUND,CENTRAL,CONTROLLED,GIVEN,LABEL,METHODS,NMIBC,RESULTS,SEVEN,TURBT
ESTIMATES,HYGIENE,JOURNAL,MWF,OVERALL,REPORTS,SYNTHETIC,THERE,THOSE
160,AFFILIATED,BACKGROUND,CHINA,CONCLUSION,FIRST,LABEL,MEDICAL,METHODS,OCTOBER,PANCREATIC,PMS,RADICAL,RESULTS,SEVEN,THREE,UNIVERSITY
006,015,100,169,233,283,COPYRIGHT,EDUCATION,FURTHER,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PROGNOSIS,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WHILE
BMJ,GROUP,HOWEVER,LTD,PUBLISHING,SINCE,SMALL,TURBT,TYPICALLY
169,BLADDER,E2F,HOWEVER,THESE,WHOLE
0GY,4GY,ACUTE,BACKGROUND,BETWEEN,CRT,LABEL,LOCAL,METHODS,NAC,OVERALL,PFS,RESULTS,TEN,TURBT
AGE,AIM,APRIL,BCA,FIFTY,FURTHER,JANUARY,LABEL,METHODS,OBJECTIVE,PET,RESULTS,TNM
169,COPYRIGHT,INC,MRI,NEWER
HOWEVER,NEITHER,RADICAL,THESE
151,169,174,176,177,215,251,299,328,AVERAGE,BIOLOGICAL,BOWEL,COPYRIGHT,CTS,EMPTY,GIVEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRV_BOWEL,PURPOSE,RESULTS,SEVENTEEN
000,001,100,169,250,300,956,CELLS,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SW780,UROLOGICAL
JANUARY,OWING
000,200,BLC,CURRENT,FDA,HAL,NMIBC,SINCE,USA,WLC
169,ABSTRACTS,BECAUSE,ENGLISH,HOWEVER,JAPAN,MEDICAL,RELATED,SOCIETY,UPPER,UROLOGICAL
147,167,169,314,381,420,ACS,BETWEEN,COPYRIGHT,IAP,INC,PRESENTING,SEPTEMBER
102,169,BACKGROUND,BCA,COPYRIGHT,DUE,FDG,LABEL,LNS,LTD,LYMPH,METHODS,NPV,PET,PPV,RESULTS,SIXTY
100,169,BASED,COMPARING,CONCLUSION,COPYRIGHT,CROWN,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,RESULTS,SEVENTY
100,100UG,169,200,200UG,400,400UG,500UG,ABOVE,BACKGROUND,BFD,BLACKFOOT,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,POISSON,RESULTS,THERE,USING
082,125,169,AFTER,BRITISH,COPYRIGHT,COX,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OLDER,PURPOSE,RADICAL,RESULTS,SIR
000,110,169,200,AMERICA,AMONG,DESPITE,INFECTIOUS,PRESS,PUBLISHED,REFINED,SAHARAN,SOCIETY,THREE,UGS,UNIVERSITY
001,215,AS1,ASSET,BRC,IFNW1,PRC,PRESS,PUBLISHED,RCC,RS10511729,SNP,TUSC1,UNIVERSITY
107,165,169,404,APRIL,CONCLUSION,COPYRIGHT,FIFTY,HOWEVER,INC,LABEL,MAY,METHODS,MINIMUM,OBJECTIVE,RESULTS,SEPTEMBER,SIXTY
001,003,169,266,579,CONCLUSION,COPYRIGHT,COX,INC,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,TURBT
017,101,169,197,465,936,COPYRIGHT,COX,INC,LABEL,LNS,MATERIALS,MEIER,METHODS,OBJECTIVE,PVLNS,RESULTS,RFS,THERE
STROMAL
001,004,005,023,177,COX,CSS,LABEL,LOWER,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHELDON
169,947,COPYRIGHT,FINALLY,IFN,INC,OCT
169,293,BRITISH,CONCLUSION,CYC,GPA,INCREASED,LABEL,METHODS,NMSCS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEVENTY,SIR,SOCIETY,UNIVERSITY
ALTOGETHER,BACKGROUND,BLADDER,EUKARYOTIC,FBLN1,FIBULIN,LABEL,METHODS,NMIBC,PCR,RESULTS,WESTERN
001,020,BACKGROUND,HOWEVER,LABEL,LMR,MEIER,METHODS,NOVEL,RESULTS,SIXTY,TTR
001,169,388,445,COPYRIGHT,COX,EDUCATION,INC,IQR,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,177,215,233,463,726,BACKGROUND,BLOOD,COX,LABEL,METHODS,PCR,RESULTS,SHORTER,THEREFORE
AFTER,HOWEVER
000,THERE,THESE,UPPER
DEPENDING,NMIBC,NON,TUR
DESPITE,LABEL,LIFESTYLE,MEN,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE
233,BCG,DESPITE,UBC
169,945,CONCLUSION,HOWEVER,LABEL,METFORMIN,METHODS,OBJECTIVE,RESULTS
169,APOPTOSIS,CISPLATIN,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T24R2,UROLOGICAL,WESTERN
BACKGROUND,FACULTY,FINAL,HOWEVER,LABEL,MATERIALS,METHODS,PREDICTIVE,RECORDS,RESULTS,SIRIRAJ
169,BRCA1,KDM6A,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOMATIC,UTX
032,046,100,160,169,235,321,416,422,772,942,959,965,BLADDER,COPYRIGHT,COX,MEIER,PUBLISHED,YOUNG
145,DEPENDING,FOLLOWING,FORTY,THESE
001,100,169,177,CAL29,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RT112,SENSITIZER,T24,TRANSIENT
169,ACTIVATING,CDH16,ECTOPIC,EPCAM,FGFR3,HOWEVER,LABEL,MMP10,OVERALL,SILENCING,THESE,TNC,UNLABELLED
120,225,956,AFTER,CONCLUSION,DIFFERENT,FORTY,IIA,IIB,LABEL,METHODS,OBJECTIVE,PURPOSE,PVP,RESULTS
169,COPYRIGHT,COX,JOURNAL,LAMBERT,LTD,PARAMETRIC,STATA,THROUGH,WEIBULL,WILEY
169,667,721,BASED,COPYRIGHT,DIAGNOSES,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ONTARIO,PUBLISHED,PURPOSE,RESULTS,THESE,URACHAL,UROLOGICAL
100,169,BETWEEN,COPYRIGHT,D90,GRADE,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,T2B,T3A,T3B
BLADDER,CIS,SCC,UCA,WHETHER
103,107,126,190,230,307,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
001,003,004,006,031,045,169,225,240,COMBINING,CONCLUSION,COPYRIGHT,FURTHER,HOWEVER,INC,INDIANS,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS,SLC14A1,SNP,TERTC,TP63C,WHITE
045,047,048,159,AMONG,BACKGROUND,BCG,CONCLUSION,DANENBERG,DPD,DTP,HOWEVER,LABEL,METHODS,RESULTS,THEREFORE
169,COPYRIGHT,DESPITE,FGFR3,HOWEVER,INC,LABEL,MATERIALS,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,RESULTS
115,215,316,400,BLADDER,BMI,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,THESE,THREE
OCT4A
CONVERSELY,ENTEROBIUS,NET
009,165,169,177,629,967,ANCTS,ANOVA,BPH,CHI,COPYRIGHT,IHC,NMIBC,PCR,STUDENT,TCC
169,AUTHORS,EMT,EPITHELIAL,PUBLISHED,YET
AREAS,BACKGROUND,COVERED,DESPITE,FDA,LABEL,METHODS,OPINION,THERE
001,160,169,ASSESSMENT,AUTHORS,EPIGENETIC,EXPRESSION,FOUNDATION,JOURNAL,LTD,MICROARRAY,MOLECULAR,MSP,NPT,PCA,PHENOTYPIC,WILEY
005,159,169,439,615,862,CONCURRENT,GROUP,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RADIATION,RESULTS,UNIVERSITY
000,100,102,104,177,AGE,ASR,BACKGROUND,EXCEL,INCIDENCE,LABEL,METHODS,RESULTS
169,COPYRIGHT,FINALLY,FIRST,FURTHER,INITIAL,PCR,SOCIETY,USING,WESTERN
100,13R,945,947,BLADDER,COCHRAN,GOVERNMENT,GRADE,HOWEVER,HUVEC,IHC,III,ISH,LTD,PCR,PREVIOUSLY,PUBLISHED,SIMILARLY,STATISTICS,TEN,THESE,TMA,USA,WILEY
426,891,CIS,HYPOTHESIS,LABEL,LIBRARY,METHODS,OBJECTIVE,OVERALL,RESULTS,RRS,THERE
100,176,320,370,395,415,420,430,455,525,BWF,NEITHER,SAMPLES,WATER
100,130,150,192,200,ANOTHER,HENCEFORTH,OAR,PTV,TPS
BIOLOGICAL,DVH,HOWEVER,MASTERPLAN,OAR,OMP,PTV,QUALITY,THREE,TPS
52427,62225,HODGKIN,HOWEVER,VDR
169,COPYRIGHT,IRELAND,LTD,RADICAL
CHRONIC,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TREATMENT,URINARY
BNC,LABEL,MANAGEMENT,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY
013,018,ADC,BASED,CONCLUSION,DIFFUSION,IRB,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,TESLA,TNM,TUR
945,946,CONVERSELY,ERK,FOXO3,HUC,INITIALLY,PTXA2,SIRT1,U0126,UMUC3
169,AIM,ANTICANCER,BACKGROUND,BMS,BOWEL,CONCLUSION,COPYRIGHT,D95,D97,IMRTS,INSTITUTE,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,SPARING,THERE,V10GY,V30GY,V35GY,V40GY,V45GY,V50GY,WPB
000,01287,100,169,ANTICANCER,BLOOD,COPYRIGHT,INSTITUTE,PERITONEAL
041,895,BLADDER,BMJ,CASES,CIS,ENGLAND,GROUP,LABEL,LIMITED,METHODS,MWF,NON,OBJECTIVE,OBJECTIVES,ORS,PUBLISHED,PUBLISHING,RESULTS,THESE
001,008,009,151,169,BAX,BIOMARKER,BIOMARKERS,COPYRIGHT,COX,EDUCATION,FGF,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
233,BACKGROUND,BCG,CHT,FEWER,III,LABEL,LIBRARY,METHODS,NMIBC,RANDOMISED,RESULTS,TECHNIQUES
PRESUMABLY,PRIMARY

000,001,005,013,019,022,027,160,539,COX,MEIER,UBC,UROTHELIAL
178,BACKGROUND,CDH13,COX,LABEL,METHODS,MSP,NMIBC,PCR,RESULTS
ART,ARTESUNATE,BLADDER,CHINESE,COX,ELISA,HENCE,MTT,PCR
001,002,016,032,049,116,ASA,BASEL,COX,CSS,LABEL,LVI,MATERIALS,METHODS,NEITHER,OBJECTIVE,OUTCOME,PFS,RESULTS,UCB
173,BACKGROUND,CONCLUSION,FURTHER,HOWEVER,KEY,LABEL,MDT,MEMBERS,METHODS,RESULTS,SPLITTING,THERE,UROLOGISTS
001,027,169,BACKGROUND,CONTEXT,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PURPOSE,RESULTS,THERE
001,1A1,ARG,ARG213HIS,BACKGROUND,CAUCASIANS,LABEL,METHODS,NAVIGATOR,RESULTS,SCIENCE,SEVEN,SULT1A1,THERE,WEB
BLADDER,DUSPS,FGFR3,NOTCH,RAS
HISTOLOGY,THERE,ULTRASOUND,URACHAL
169,CK7,COPYRIGHT,MAC,NPH,P63,PAC,PSA,SAS,TCC
003,105,169,540,ACUTE,BOTHELL,BVI,BVS,COPYRIGHT,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,ORGAN,PUBLISHED,PURPOSE,QOL,RADIATION,RESULTS,SOCIETY,THERE
100,102,169,211,325,336,631,CBCTS,CTV,CTVPB,DESPITE,GUERBET,IMAGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,USING
173,177,CONCLUSION,DIODE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,PVR,RESULTS,SCORE,SYMPTOM,WHILE
100,105,235,362,AFTER,AUSTRIA,BACKGROUND,HOWEVER,LABEL,METHODS,PREDICTION,RESULTS,STATISTICS,THEREFORE,TYROL
169,AKT,ANG,ANGIOGENIN,COPYRIGHT,FINALLY,GST,HOWEVER,INC,RNASE,TAKEN,THEREFORE
AE1
FINALLY,IIA,SALVIAE,TAN,TANSHINONE
230,AFTER,BACKGROUND,JANUARY,LABEL,METHODS,NUX,OPERATIVE,RESULTS,THERE
128,252,375,CHO,GUO,HOWEVER,LARYNGEAL,LIANG,NON,PROJECT,THEIR,THEREFORE,THESE
AGE,AIM,CONCLUSION,LABEL,LNS,METHODS,OBJECTIVE,PET,RESULTS,SIX,T1A,T2B,TNM
954,MAX,MYC,NOTCH,OXIDATIVE,SRSF2,THREE
169,956,ACADEMY,BIOLOGICAL,BIOLOGY,CDK,CHINESE,EDITORIAL,INSTITUTE,INSTITUTES,MTT,PRESS,PUBLISHED,T24,UNIVERSITY
231,956,BACKGROUND,FC101,FURTHER,HACAT,HUC,LABEL,MCF,MDA,PC3,RESULTS,SCC
101,CTV,D95,D99,EVALUATION,LABEL,LINAC,METHODS,MLC,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE,V65,WITHOUT

100,169,520,878,CONCLUSION,CYSTECTOMY,HOWEVER,III,LABEL,METHODS,OBJECTIVE,POPULATION,PURPOSE,RADICAL,RESULTS,SOCIETY,THERE
000,COMMUNITY
110,169,5MM,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TREATMENT,VAGINAL
ACTIVATION,ARRAYSCAN,CELLOMICS,CMFDA,EMT,METASTASIS,PATHWAY,PR1,THERE,TSU
ALVIMOPAN,BACKGROUND,FIFTY,INDIANA,JANUARY,LABEL,MARCH,MATERIALS,METHODS,RARCS,RESULTS,THERE,URINARY
169,177,774,967,ANCTS,ANOVA,BLADDER,BPH,CEP55,CHI,COPYRIGHT,IHC,NMIBC,PCR,STUDENT,TCC,UNTIL
BACKGROUND,FINALLY,LABEL,METHODS,RESULTS,TCC
169,945,BACKGROUND,BLADDER,CARIS,CONCLUSION,COPYRIGHT,INC,KIT,LABEL,MATERIALS,MET,METHODS,MOLECULAR,PUBLISHED,RESULTS,SERUM,SPARC,THESE
CAREFUL,CHRONIC,RENAL,URINE
033,046,368,AFFYMETRIX,BACKGROUND,EDNRA,ENRICHMENT,GEM,HOWEVER,LABEL,METHODS,RESULTS,SET,T4A
160,ACTIVATION,BAD,BCL,CISPLATIN,HOWEVER,KIT,RG3,SYNERGISM,T24R2,WESTERN
000,100,106,110,AGE,ALGERIA,APC,ASR,BACKGROUND,BETWEEN,INCIDENCE,INSTITUTE,LABEL,METHODS,RESULTS,SETIF,STATISTICS
160,954,CDK,EPO,FINALLY,MMP,THESE,TREATMENT,U0126
100,136,169,288,AVERAGE,COPYRIGHT,INC,LOW,NUCLEAR,SNF,SWI,THERE
169,545,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
ESPECIALLY,HENCE,URINARY
BLADDER,ENGLISH,HOWEVER,TREATMENT
61547,954,BACKGROUND,KAPPA,LABEL,MATERIALS,METHODS,RAW,RESULTS,SINCE,THERE
001,BACKGROUND,CLAVIEN,CONCLUSION,DINDO,FIFTY,FINAL,GRADE,III,LABEL,MATERIALS,MEDICAL,METHODS,MINOR,OVERALL,RESULTS,RNU,TEN,THREE,UNIVARIATE
AFTER,BACKGROUND,BCG,DESPITE,FDA,FURTHER,LABEL,MATERIALS,METHODS,RESULTS,THOSE,UROVYSION
169,233,456,BACKGROUND,BASEL,EIGHT,LABEL,METHODS,RESULTS,THREE,TREATMENT
EMT,FAK,HOWEVER,MMP,PANCREATIC,SNAIL,SRC
252,HIPPO,TAZ,YAP
319,655,718,777,BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS
015,033,272,291,AMONG,COX,CRT,HOWEVER,PFS
169,AUTHORS,BLADDER,CONCLUSION,COPYRIGHT,INC,LABEL,MAJOR,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,WRITTEN
001,048,054,169,286,361,405,509,ACT,AUTHORS,BJU,COX,CSS,FACTORS,LABEL,LTD,LVI,MAGNITUDE,METHODS,OBJECTIVE,ONTARIO,PUBLISHED,RESULTS,WILEY
169,AVERAGE,CONCLUSION,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,TYPES
169,366,822,AFTER,CIS,CONCLUSION,COPYRIGHT,FSC,FSS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
003,042,048,072,169,182,ALK,COPYRIGHT,FORTY,FURTHER,IMT,INC,LOCAL,MEDLINE,REFERENCE,REGARDLESS,SCHOLAR,SCIENCE,WEB
169,945,954,AKT,COPYRIGHT,LNCAP,MMP,THEREFORE,THESE,TIANEPTINE,TNF,TSS,USING
159,169,174,240,250,267,276,329,COLLEGE,COPYRIGHT,EDUCATION,III,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OSAKA,PUBLISHED,PURPOSE,RESULTS,T3B,TISN0,TXN,UROLOGICAL
947,ACCORDING,BACKGROUND,CANONICAL,CONCLUSION,EFFECTS,EXPRESSION,INHIBITORS,LABEL,METHODS,NOTCH,PATHWAY,PCR,RESULTS,THESE,WESTERN
BLADDER,DEPENDING,EARLY,THERE,TREATMENT
GNP,TELOMERASE
946,COMPOUNDS,HOWEVER,HUANG,MURRAYA,NMR,THESE
074,112,138,169,FURTHER,LABEL,LNCRNAS,METHODS,OBJECTIVE,PURPOSE,RESULTS
177,200,650,A01,A02,A12,A13,ABOUT,BACKGROUND,CONCLUSION,LABEL,METHODS,PCR,QURAN,RESULTS,Y20
169,AMONG,BACKGROUND,BRAZILIAN,DISCUSSION,HODGKIN,INC,LABEL,METHODS,MOR,RESULTS,WILEY
001,002,570,679,CYSTECTOMY,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PROMETRICS,PURPOSE,RADICAL,RESULTS,SOCIETY,THERE
025,027,028,111,124,169,177,202,223,334,BETWEEN,COPYRIGHT,CSS,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,RFS,SEPTEMBER,T3A,T3B,T4A,THESE,TOTAL
106,169,AUNPS,COPYRIGHT,HAASE,RSD

001,007,177,BLADDER,CONCLUSION,CTV,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
169,ASSESSMENT,BASED,BLADDER,DIAGNOSTIC,INC,LABEL,METHODS,NETWORK,NEWCASTLE,OBJECTIVE,OBJECTIVES,PUBLISHED,QUALITY,REPORTING,RESULTS,SCALE,STANDARDS,STUDIES
169,174,COPYRIGHT,EDUCATION,ERBB2,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,THOSE,UROLOGICAL
ADULT,ENGINEERED,HOWEVER,THESE
169,482,516,AIM,APE,BOWEL,BRITAIN,COLORECTAL,CONCLUSION,DENMARK,DISEASE,FLUTS,GREAT,IRELAND,KNOWLEDGE,LABEL,LAR,METHODS,OBJECTIVE,RESULTS,SVQ,URGENCY,URINARY,VAGINAL,VALIDATED
169,3DCRT,COPYRIGHT,CTV,DAILY,INC,ITV,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PTV,PURPOSE,RESULTS
023,025,109,169,316,AUA,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
169,ART,CBCTS,COPYRIGHT,CTS,DVF,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,VRS
169,609,670,696,CHINESE,COPYRIGHT,INC,PUBLISHED,THESE,TSP
954,CON,HMGB1,MTT
038,169,354,441,BACKGROUND,BOARD,CAIRO,CONCLUSION,COPYRIGHT,DEPARTMENT,DOCTORATE,III,INSTITUTE,IRB,LABEL,MEDICAL,METHODS,NCI,OBJECTIVE,PRODUCTION,RESULTS,UNIVERSITY,WHILE
177,384,520,AGA,CONCLUSION,DEPARTMENT,JANUARY,KARACHI,LABEL,METHODS,OBJECTIVE,PLACE,RESULTS,SEPTEMBER,SURGERY,THREE,UNIVERSITY
EXTRA,TYPICALLY
CIS,EFFECTIVE,EPHB2,EPHB4,EPHRINS,HSA,TCC,THESE,TREATMENT,WESTERN
169,CK5,LTD,OTHER,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
112,DE3,GDP,GST,HIV,RHO,RHOGDI2,TAT,THESE,UMUC3,USING,WESTERN
169,800,BASED,CLEARLY,COPYRIGHT,EPSILON,ERV,GENOMES,HOWEVER,IMPORTANCE,LABEL,OBJECTIVE,SEVERAL,SOCIETY,THEREFORE,THESE,UNLABELLED,WORLD
001,004,006,017,104,160,169,3731249,A148T,ARTIFICIAL,AUTHORS,CHROMOSOME,COX,HPV,KOHONEN,LTD,SOM,THESE,WILEY
100,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,URINARY
HOWEVER,METASTATIC,RCC,SIX,THERE,THREE
AFTER
001,005,068,120,169,BASEL,CYSTOSCOPY,DELAYED,DYSURIA,LABEL,METHODS,OBJECTIVE,RESULTS,UCB
001,002,015,100,135,158,169,187,233,402,AMONG,JANUARY,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,THREE,UNIVERSITY
001,007,011,033,046,227,555,BASEL,CCI,COX,LABEL,MATERIALS,METHODS,NEITHER,OBJECTIVE,RESULTS,UCB
001,012,026,036,050,265,ACS,BASEL,CONTINUOUS,COX,CRP,DSS,EASTERN,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS,RFS,RNU
115,151,152,177,277,348,386,814,881,CONCLUSION,ITV,ITV_STUDY,JANUARY,KNOWLEDGE,LABEL,METHODS,MVCTS,OAR,OBJECTIVE,OCTOBER,POPULATION,PRE,PTV,PTV_STUDY,REPLANNING,RESULTS,SDS,_EBFB
016,166,173,235,308,409,BACKGROUND,ELISA,EVALUATING,FEW,FURTHER,LABEL,MMP,RESULTS,URINARY,URINE
160,BACKGROUND,DR1,FURTHER,HOWEVER,LABEL,METHODS,PCR,RESULTS,TMED5
120,AMONG,BJF,CONCLUSION,DESPITE,IRB,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,100,102,177,3RD,455,BACKGROUND,BIPOLAR,BPE,CLAVIEN,DINDO,EVALUATED,EXCLUSION,GYRUS,HOWEVER,INCLUSION,INDEX,KINETIC,LABEL,METHODS,OBJECTIVE,OPERATION,PFR,PURPOSE,PVR,QOL,RESULTS,SCORE,SYMPTOM,USA
CD138,CK7,GATA3,KNOWLEDGE,SIMILAR,THERE,TUNEL
22K,310,946,974,GENESPRING,JUN,LABEL,MATERIALS,METHODS,MICROARRAY,MITOGEN,OBJECTIVE,PURPOSE,RESULTS,SMAD4,TGF
169,OPTICAL,SOCIETY
102,169,697,CONCLUSION,COPYRIGHT,INC,LABEL,MALDI,MATERIALS,METHODS,MSI,OBJECTIVE,RESULTS
000,169,175,1ST,2ND,365,3RD,ANOTHER,BECAUSE,COPYRIGHT,HBA1C,IAT,INC,LABEL,METHODS,OBJECTIVE,ONCOLOGIC,PANCREATIC,RESULTS
169,ALA,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
120,169,233,CONCLUSION,COPYRIGHT,HOWEVER,INC,ITEMS,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PREFERRED,REPORTING,RESULTS,REVIEWS,SYSTEMATIC
152,160,439,821,BLADDER,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,TREATMENT
016,037,039,047,156,COX,EXPRESSION,IHC,MEIER,PCR,TRANSIENT,TRP,TRPM8,UCB
169,COPYRIGHT,EPIGENETIC,HOWEVER,INC
100,252,BACKGROUND,CAM,CAUCASIAN,CD117,CK7,CLEAR,GLEASON,HMB,III,LABEL,METHODS,OTHER,PAX,PSA,RCC
BMJ,CYSTOSCOPY,FINAL,GROUP,LTD,MRI,PECOMAS,PRIOR,PUBLISHING,TURBT
001,117,INITIAL,PCR,T24,TCC,URINE,UROTHELIAL
233,AIM,BACKGROUND,BCG,COMMITTEE,GROUP,HYALURONIC,LABEL,METHODS,NMIBC,RESULTS,SCALE,SCORE,SYMPTOM,THESE,THREE,TOR,TRIAL,VAS,VERGATA
AIM,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,REPORTS,RESULTS
BACKGROUND,BASED,CALCIUM,CONCLUSION,DISCUSSION,LABEL
009,046,312,413,430,477,AMONG,BACKGROUND,DEPARTMENT,LABEL,METHODS,NUTRITION,RESULTS,SIMILAR,STANDARDS,THERE,UCC
GFP,JNK,JUN,MEF,REDUCED,T24
100,CONCLUSION,EARLY,FCH,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PET,PSA,PURPOSE,RESULTS
BACKGROUND,COX,FURTHER,HOWEVER,ICH,LABEL,MEIER,METHODS,NOTABLY,PCR,RESULTS,THESE,UCB,WESTERN
001,002,043,176,231,570,664,746,AFTER,CISPLATIN,COX,CSS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,002,121,237,556,695,956,CADMIUM,WHILE
323,ASIAN,CIS,ORS,SEVERAL
BASEL,DECISIONS,LIMITED
003,526,961,BARRINGTON,BRAIN,GERMANY,LABEL,LOWER,METHODS,MRI,OBJECTIVE,PMC,RESULTS,THERE,URODYNAMIC
169,181,500,BACKGROUND,FILLING,HSA,ICG,INC,LABEL,LYMPH,METHODS,NIR,OBJECTIVE,OBJECTIVES,RESULTS,SLN,WILEY
169,RAMAN,THESE,VCH,WILEY
160,169,190,419,838,889,ADRB3,AUTHORS,CONCLUSION,COPYRIGHT,FIXED,INC,LABEL,LAMC1,MAJOR,MAY,METHODS,NAVIGATOR,OBJECTIVE,OTHER,PUBLISHED,RESULTS,THESE
169,176,BACKGROUND,BPH,CD3,FRESH,HOWEVER,INC,LABEL,METHODS,RESULTS,VARIOUS,WESTERN,WILEY
160,169,527,COPYRIGHT,HOWEVER,INC
101,ANNEXIN,COX,HOWEVER,INHIBITION,LUCIFERASE,MTT,T24,THESE
102,103,169,175,177,232,ASSESSMENT,CAUCASIAN,CONCLUSION,COPYRIGHT,CYSTECTOMY,FUNCTIONAL,HRQOL,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,SEPTEMBER,THERAPY,VANDERBILT
001,004,008,035,042,105,169,206,324,946,ANY,ASA,AUTHORS,BJU,CONCLUSION,FINALLY,HEART,LABEL,LOS,MEIER,METHODS,OBJECTIVE,RESULTS,ROC,SOCIETY,TCC,VC0,VCO,WHITNEY
160,252,ANNEXIN,BIU87,EFFECTS,INHIBITION,MTT,NOTCH,PCR,PENDING,PSIRNA1,T24
ICC,OBTAINING,USING
169,425,APS,BACKGROUND,COPYRIGHT,CPS,CYBERKNIFE,IRELAND,LABEL,LTD,MATERIALS,METHODS,MULTIPLAN,OBJECTIVE,OVH,PTV,PURPOSE,RESULTS,ROBOTIC
233,424,469,CONCLUSION,COX,EORTC,LABEL,MEIER,METHODS,NMIBC,OBJECTIVE,PURPOSE,RESULTS,RFS,TREATMENT,UROLOGY
169,176,COPYRIGHT,FACTORS,INC,LABEL,METHODS,OBJECTIVE,RESULTS,ROC,SETTING,THERE,UNIVERSITY,VARIOUS
100,19A,BACKGROUND,CCK,HOWEVER,LABEL,MEANWHILE,METHODS,PCR,RESULTS
956,ALZHEIMER,ANNEXIN,BACKGROUND,CONCLUSION,DISEASE,FINALLY,HOWEVER,INDICATOR,LABEL,METHODS,MTT,RESULTS,RT4,SELADIN,SELECTIVE,WESTERN
010,014,017,031,100,147,169,BETWEEN,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,UNIVARIATE,USING
100,101,169,272,CARCINOMA,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROSTATIC,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
031,037,044,088,177,215,21M,362,516,522,556,626,643,709,736,754,811,ADC,AUC,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,WHILE,WHOLE
CURRENTLY,PARASITIC,THERE,THEREFORE
101,435,ATX,BLEOMYCIN,HOWEVER,IMPAIRING,PCI,T24
169,938,BACKGROUND,CROSS,CURRENT,FORTY,LABEL,METHODS,RESULTS,ROUGHLY,SMOKING
169,COPYRIGHT,NETWORK
169,945,954,ELISA,LCB,MMP,PCR,SOCIETY,SRB,T24,THESE,WESTERN
169,ADDITIONAL,COPYRIGHT,HPV,INC,IUP,RAS,STUDIES,UCA
169,ACTIVATED,ALCAM,PRESS,PUBLISHED,UNIVERSITY
169,BRISTOL,CHECKPOINT,FDA,MARCH,MYERS,SOCIETY
169,236,APPEX,BACKGROUND,BECAUSE,CONTACT,COXSINGLE,LABEL,METHODS,PRESS,PUBLISHED,SUMMARY,SUPERPC,TIMEROC,UNIVERSITY,WEB
169,HOWEVER,SOCIETY,UROTHELIAL
200,956,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,RESULTS,TURBT,USING
ABOUT,ADT,BLADDER,DEPENDING,LABEL,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SUMMARY,THERE,TUR
312,326,336,370,AMONG,ARG399GLN,ASN,ASP,ASP312ASN,BACKGROUND,BELARUS,CAUCASIANS,CONTEXT,CYS,EASTERN,ERCC6,HARDY,LABEL,MET1097VAL,METHODS,OBJECTIVE,PCR,RESULTS,SER,SER326CYS,SLAVS,XPD,XRCC1
002,008,133,166,185,BACKGROUND,CONCLUSION,FDG,FUROSEMIDE,LABEL,METHODS,OVERLAP,PET,RESULTS
034,169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,MET,METHODS,PHASE,PROGRAM,RCC,RESULTS,SIX
169,3DCRT,COPYRIGHT,INC,INSTEAD,LARGE,MEDICAL,OAR,PTV,PUBLISHED,THESE,TREATMENT,V18,V30,V40,V45
102,131,169,177,BECAUSE,COPYRIGHT,INC,INTENSITY,MEANWHILE,MEDICAL,MLC,MUS,OAR,PRV,PUBLISHED,THESE,V20,V30,V40
073,210,463,617,620,633,855,ACC,ARRAYTRACK,ECM,GENOMES,KYOTO,LASER,METABOLISM,PATHWAY,SWISS
BCL,BID,BIU,BLADDER,E1A,FAS,MTT,PSCAE,UROPLAKIN
013,160,169,ADDITIONAL,COPYRIGHT,CTV,D90,INC,LABEL,MATERIALS,MAX,METHODS,MRI,OAR,OBJECTIVE,PLANS,PUBLISHED,PURPOSE,RESULTS,SIGMOID,SOCIETY,TGT,USING
169,COPYRIGHT,DESPITE
22RV1,PAE,PLASMONIC,TAKEN
ALK,ANAPLASTIC,ARM,BACKGROUND,CNA,CURRENTLY,GENOMIC,HISEQ,IHC,IIX,LABEL,METHODS,MINOR,ONCOMAP,RESULTS,SAMPLES,WHOLE
140,169,28000,AML,AMONG,BACKGROUND,CIS,FURTHER,LABEL,METHODS,NORWEGIAN,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SIR,SOCIETY,UNIVERSITY
169,COMPANY,COPYRIGHT,JOURNAL,LTD,PEDIATRIC,PUBLISHED,UROLOGY
010,169,AFTER,CANCERLIT,COPYRIGHT,INC,IVR,LABEL,LIBRARY,MAY,MEDLINE,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RNU,TIS,UNTIL
945,946,THESE
225,510,TOTAL,URUGUAY
241,695,BACKGROUND,EXPRESSION,FORTY,HOWEVER,JUN,LABEL,MYB,MYC,NETWORK,PDGFR,RESULTS,RUNX1,SMC,THESE
HOWEVER,LACKING
AFTER,BACKGROUND,CONCLUSION,HOWEVER,LABEL,RESULTS
ENGLISH,EWING,FOLLOWING,THERE
001,003,005,177,222,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,PCR,RESULTS
215,400,938,ADC,CONCLUSION,KNOWLEDGE,LABEL,LOCALIZED,METASTATIC,METHODS,MRI,OBJECTIVE,RESULTS,THESE
169,DIFFUSION,UROLOGICAL
169,233,366,514,576,604,633,693,764,APRIL,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,SPANISH,TREATMENT,UROLOGICAL
000,800,BACKGROUND,BTC,CONCLUSION,DLT,EVERY,LABEL,MAJOR,METHODS,RDS,RESULTS,THEREFORE
001,002,008,009,011,014,022,023,210,542,CAUCASIAN,DESPITE,GLN,GLU,GLU185GLN,OVERALL
ADDITIONAL,DIFFUSE,IMAGING
001,112,115,239,BACKGROUND,III,LABEL,METHODS,RESULTS,STMN1,T24
AIM,BETWEEN,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,OVERALL,RESULTS,THERE
198,80S,LABEL,METHODS,MICROARRAY,OBJECTIVE,POLYSOMAL,PURPOSE,RESULTS,RT112,T24,UBC
107,120,169,AUSTRALIAN,AUTHORS,BJU,LABEL,MDM,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS
169,BACKGROUND,HOWEVER,HPV,INK4A,ISH,LABEL,LOW,METHODS,RESULTS,SOCIETY
169,945,BCL,COPYRIGHT,INC,MCL,STAT3,TNF,TRAIL,TREATMENT
ACQ,AIE,FIRST,HAASE,THESE,TPE
169,BLADDER,COPYRIGHT,EDUCATION,HOWEVER,INC,INDEX,INVENTORY,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SECONDARY,THERE,URINARY,UROLOGICAL
160,169,954,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NAC,OBJECTIVE,RESTAGING,RESULTS
001,008,013,169,215,COPYRIGHT,COX,INC,LVD,MMP,SIMILARLY,SMOKING
169,ACIDS,CURRENTLY,NUCLEIC,PRESS,PUBLISHED,SEVERAL,UNIVERSITY
125,144,169,AUM,DUD90,DUP90,GRADE,JANUARY,JAPAN,PRESS,PUBLISHED,RADIATION,SOCIETY,UNIVARIATE,UNIVERSITY,URINARY
150,174,HEM,LABEL,MEDICAL,METHODS,OBJECTIVE,PATIENT,RESULTS,RVF
252,340,LABEL,LRC,METHODS,OBJECTIVE,OCTOBER,RESULTS,ROBOT
169,225,BACKGROUND,CPU,HOWEVER,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
233,BACKGROUND,BESAG,CONCLUSION,LABEL,METHODS,MOLLI,RESULTS,SPAIN
99MTC,AFTER,AFTERWARDS,SIMILAR,THESE,USING
001,027,030,160,169,411,AFTER,AUTHORS,BJU,LABEL,LTD,MEIER,METHODS,NON,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SQD,WHILE,WILEY
BACKGROUND,GENE2MESH,INGENUITY,IPA,JACCARD,LABEL,METHODS,PATHWAY,RESULTS,TOBACCO,TUD
169,BACKGROUND,ENGLAND,INC,INTENSITY,LABEL,METHODS,MWF,RESULTS,THESE,WILEY
001,138,169,BACKGROUND,COX,CSS,FACTORS,HOWEVER,INC,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RFS,USING,WILEY
CTV,DEFINITIVE,HDR,HELICAL,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
169,468,BIOLOGY,CAI,CO2,HOWEVER,INC,MDA,MOLECULAR,RT112,SOCIETY
169,CISPLATIN,COPYRIGHT,HOWEVER
ADJUNCT,BLADDER,HOWEVER,TEN,TURBT,US4,US5,USA
ATLAS,CISPLATIN,METASTATIC,MODULATING,NETWORK,RAS
174,269,ALPHA,ASSOCIATED,BACKGROUND,CTCAE,CYBERKNIFE,GEORGETOWN,GRADE,HOWEVER,LABEL,METHODS,OVS,PATIENT,PRIOR,RESULTS,TRANSIENT,TREATMENT,UNIVERSITY
212,219,289,312,321,408,468,876,FURTHER,JANUARY,MEDLINE,THERE,THREE
160,169,COPYRIGHT,D90,DISEASE,FORTY,GRADE,INC,LABEL,LARGE,LOCAL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SMALL,SOCIETY,TREATMENT
CONCLUSION,HOWEVER,LABEL,OBJECTIVE
CURRENTLY,DUE,SINCE
233,945,BCG,CYTOKINES,HOWEVER,ISOLATING,THERE,TNF,TRAIL
001,169,176,177,COPYRIGHT,EARLIER,HTP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAR
III,LABEL,MOLECULAR,OBJECTIVE,PURPOSE,RAMAN,RESULTS,SUMMARY,WHILE
BLADDER,COMPETING,LABEL,NONCODING,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE
AMONG,ASSESSING,BASED,HOWEVER,LABEL,NMIBC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
049,510,548,549,667,AFTER,ECM,EXOC4,GENOMES,KYOTO,LASER,MMP,MYH10,PATHWAY
105,165,239,866,954,BCA,EXPRESSION,GENOMES,KYOTO,OMNIBUS
022,028,029,CAP,HNSCC,JHU,LRR,MTT,NOKSI,SCC25,WESTERN
EARLY,HSP74
ALT,BESIDES,MUTATIONS
ACCORDING,BMI,CONCLUSION,JANUARY,LABEL,LOS,MARCH,MATERIALS,METHODS,OBJECTIVE,PCA,POI,PRIOR,PURPOSE,RCICS,RESULTS,SOCIETY
001,004,011,169,294,500,852,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PERFORMING,PURPOSE,RESULTS,SIXTY
046,274,330,BACKGROUND,COMPETING,CONCLUSION,HOWEVER,IQR,LABEL,LOS,METHODS,RESULTS,RFS,THESE
439,991,FINLAND,FINNISH,HODGKIN,LABEL,LIFESTYLE,METHODS,NHL,OBJECTIVE,OBJECTIVES,RESULTS,SIR,THERE
559,718,BACKGROUND,CONCLUSION,INCREASED,LABEL,METHODS,PCA,RESULTS,SIR,THERE
COURT,UNIVERSITY
108,110,169,239,435,673,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,177,BETWEEN,CLAVIEN,CONCLUSION,DINDO,FATTY,III,LABEL,MAY,METHODS,OBJECTIVE,PURPOSE,QOL,QUALITY,RALPS,RESULTS,THERE
215
946,AMONG,HOWEVER,J82,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,T24,TGF,THERE
001,007,026,147,COX,GLASGOW,GPS,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RNU
BETWEEN,CONCLUSION,GROUP,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,VARIOUS
169,COPYRIGHT,HODGKIN,LTD,WHEREAS,WILEY
169,221,233,465,509,BACKGROUND,BCA,BCG,CIS,COPYRIGHT,COX,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RESULTS,SETTING,SUMMARY,UROLOGY,USING
169,COPYRIGHT,HOWEVER,PUBLISHED,THESE,UROLOGY
ATM,ATR,CONSISTENT,EFFECTS,INK4D,INSTEAD,NHU,TAKEN,THESE,WHILE
169,COPYRIGHT,LASSO,LTD,NUMERICAL,WILEY
145,C228T,DESPITE,GENOMIC,NEITHER,PCR,SCC,SMALL
177,281,345,BACKGROUND,EBL,III,LABEL,MATERIALS,METHODS,PATIENT,PLD,RESULTS,ROBOTIC,THERE,THESE,THREE,VAS
002,004,006,012,972,APRIL,CAUCASIANS,CIS,ENGLISH,HOWEVER,ORS,OVERALL,PUBLISHED,SNP309T
005,177,2CC,307,945,946,BACKGROUND,BETWEEN,COMMISSION,DVH,HDR,HOWEVER,LABEL,MARCH,MATERIALS,MAY,METHODS,OAR,RADIATION,RESULTS,STUDENT,UNITS,USING
169,ASCENDING,UROLOGICAL,USING
149,169,COMBINING,LABEL,LTD,METHODS,OBJECTIVE,OUTCOME,RESULTS,TMA,WILEY
001,008,018,019,169,184,226,304,534,714,ADDITIONAL,COX,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
SEVERAL,THESE,URINARY,URODYNAMIC
000,169,COPYRIGHT,CURRENT,EARLY,FOCAL,INC
100,169,AB1,AB2,COPYRIGHT,PEC
BLADDER,CONVERSELY,NMIBC
BMJ,GROUP,HISTOLOGY,LTD,MRI,PUBLISHING,URODYNAMIC
001,169,398,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHR
AMONG,ASIAN,DATABASES,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORS,OVERALL,RESULTS,STRATIFIED
215,CHINESE,CLEAR,FINALLY,HOWEVER,JANUARY,THERE,TYPICAL
ABCG2,ATP,CD133,CSC,HOWEVER,SW780,THESE
001,009,160,169,177,AFTER,CONTOURING,COPYRIGHT,ESTIMATED,HOWEVER,INC,LABEL,MATERIALS,METHODS,MRI,PUBLISHED,PURPOSE,RESULTS,SOCIETY,UNASSIGNED
001,110,712,714,894,COX,PCR,STAGE,WIF,WNT
169,COPYRIGHT,FDG,INC,PET
946,AMACR,CK5,E12,ERG,GATA3,GLEASON,HMWCK,IHC,P501S,PAP,PATHOLOGY,PCA,PSA,SOCIETY,UROLOGICAL
AE1,AE3,CK5,CONFERENCE,CURRENTLY,GATA3,HMWCK,IHC,LIMITED,PATHOLOGY,PRACTICES,SMA,SOCIETY
169,COMMITTEE,COPYRIGHT,COX,HOWEVER,INC,JOINT,LABEL,LNS,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,RFS,TNM
000,106,164,169,183,BACKGROUND,CDS,CONCLUSION,COPYRIGHT,END,EXPERIENCE,INC,LABEL,LMS,METHODS,OVERALL,REDUCED,RESULTS,THEREFORE
001,169,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,INCLUDING,LABEL,LND,LYMPH,MEDLINE,METHODS,RESULTS
160,169,202,AFTER,AMONG,COPYRIGHT,COX,DETECTION,INC,LABEL,MATERIALS,METHODS,NCT,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,TEE
169,BOWEL,COLLEGE,COMPOSITE,CONCLUSION,COPYRIGHT,EFFECTS,HDR,INDEX,LABEL,LTD,MANAGEMENT,MARCH,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,ROYAL,SCORE,SUBJECTIVE,SYMPTOM,THERE,TISSUES
DEPARTMENT,IMT,LABEL,PRESENTED,UNASSIGNED,UNLABELLED,VIRTUAL
100,BACKGROUND,FEDERATION,FIFTY,GYNECOLOGY,HOWEVER,LABEL,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,OBSTETRICS,PRIMARY,RESULTS,STAGING,THERE,THESE
ASSESSMENT,BLADDER,HYPOTHESIS,IIQ,INVENTORY,LABEL,MAXIMUM,METHODS,OBJECTIVE,RESULTS,SECONDARY,UDI,UDS,UNIVARIATE,UROGENITAL
145,946,BCA,EMT,FUNCTIONAL,PPM1A,PROTEIN,SMAD2,TGF,THESE
023,041,ALK,AURKA,AURKB,CCND1,CCND2,ERBB2,FGFR1,KDR,KIT,MET,MYC,NMIBC,RECURRENCE,RET,SMO,TOP2A
PUBLISHED
ARTICLE,IHC,MEMBERS,PATHOLOGY,SOCIETY,SPECIAL,UROLOGICAL
CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,COPYRIGHT
151,169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PDD,RESULTS,UROLOGY,WLC
000,200,300,AUC,DOVITINIB,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TREATMENT

CONCLUSION,CONFLUENT,CTL,HMGN2,HOECHST,KLEBSIELLA,LABEL,MATERIALS,METHODS,MTT,NATURAL,OBJECTIVE,RESULTS,SDS,T24,THESE,THP,TRICINE
169,22Q11,COPYRIGHT,FINALLY,INC,MALIGNANT,MRT,SMARCB1
169,194,324,399,647,ARG,ARG194TRP,ARG399GLN,COPYRIGHT,DMA,GENOMIC,GLN,HOWEVER,INC,LYS751GLN,PCR,THR241MET,TRP,URINARY,XPD,XRCC1,XRCC3
100,169,200,300,400,475,500,800,ADDITIONAL,BONFERRONI,COPYRIGHT,INC,IQR,LABEL,MAJOR,METHODS,OBJECTIVE,OBJECTIVES,ORC,RESULTS,RPBCS,WHITNEY
6TH,MALIGNANT,MFH,PROGNOSTIC,URINARY
AFTER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,RRP,THESE
001,002,174,179,180,196,6TH,GROUP,LABEL,LOC,LRP,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,UVA
200,946,EMT,FOLLOWING,MMP,T24,TGF,WESTERN
174,181,300,954,AKT,BLADDER,HOWEVER,MMP,NARINGENIN,TRANSWELL,TREATMENT
132,164,169,200,430,BRICKER,CLAVIEN,COPYRIGHT,EDUCATION,GOING,III,INC,LABEL,MATERIALS,METHODS,NERVE,OBJECTIVE,OPERATIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WALLACE
169,ADDITIONAL,COPYRIGHT,LTD,PPI,PSMA3,RIG,TCR,UBC
100,169,CK7,COPYRIGHT,ERG,GATA3,IHC,LABEL,METHODS,NOVEL,OBJECTIVE,OBJECTIVES,PATHOLOGY,PCA,PSA,RESULTS,S100P,SOCIETY,UCA
001,025,026,034,067,082,129,149,169,COPYRIGHT,DECREASED,FORTY,LABEL,MEIER,METHODS,NMI,OBJECTIVE,OBJECTIVES,OVERALL,PATHOLOGY,RESULTS,SOCIETY,THESE
007,009,BCC,HOWEVER,LOW,SCC
270,375,600,CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SCORE,SIX,SYMPTOM,THERE
102,106,AD5,CMV,E1A,KU7,LUC,TAKEN
169,COPYRIGHT,DEFORMABLE,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS
HSA,KNOCKDOWN,MICRORNAS
CANCEROUS,CIP2A,INHIBITOR,MYC
177,BACKGROUND,CKD,ENDOSCOPIC,ETU,FIFTEEN,HARNU,LABEL,LAP,MEDICAL,METHODS,PRIMARY,PUC,RESULTS,STUDIES,THREE
DSS
99A,BACKGROUND,HOWEVER,LABEL,METHODS,PPV,RESULTS,UCB
169,176,916,ACIDS,GST,MAZ,NUCLEIC,PRESS,PUBLISHED,SP1,UNIVERSITY
005,169,960,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,V50,V80,V90
BACKGROUND,EMT,HAKAI,LABEL,METHODS,MG132,MTT,RESULTS,SW780,T24,UMUC3,VFL,VINFLUNINE,WESTERN
104,AFTER,BASEL,GLEASON,MEN,RRP
136,144,228,262,323,518,527,976,BACKGROUND,BASEL,BCA,CONCLUSION,CSD,HOWEVER,HRS,LABEL,MAY,METHODS,PET,RESULTS,THERE,THEREFORE
956,ATP,BACKGROUND,EFFICIENT,EXPRESSION,HDAC8,LABEL,METHODS,PCR,RESULTS,USING
169,383,BASAL,COPYRIGHT,MOLECULAR,SCIENCE
AGS,AMONG,BAD,BASED,BAX,BCL2L11,CASP7,CIDEA,CIDEB,HOWEVER,PCR,TNFRSF10B,TNFRSF11B,TRAF2,TRAF3,UNCOVERING
174,500,BACKGROUND,CONTROLLED,CURRENT,DEPARTMENT,DISCUSSION,DISEASE,END,FAILURE,LABEL,METHODS,RENAL,RIFLE,SECONDARY,STAGE,TRIAL,UNIVERSITY,UROLOGY
169,BECAUSE,COPYRIGHT,CPG,SEVERAL,SOCIETY,T24,THESE
169,945,946,947,EXPRESSION,FAK,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,T24
ONGOING,UROTHELIAL,WHILE,WHITE
169,BACKGROUND,BASED,BLC,CONTEXT,COPYRIGHT,HAL,INCREASING,LABEL,METHODS,NMIBC,NON,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,SUMMARY,SYNTHESIS,TURBT,UROLOGY,WLC
AIM,TRP,TRPV2
00001,007,287,461,748,CLAVIEN,CONCLUSION,EBL,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORC,PRIMARY,RESULTS,ROBOTIC,RRC,SECONDARY,THERE,UNLABELLED
145,169,COPYRIGHT,IGF,PUBLISHED,SMALL,TAKEN,UTR
169,COPYRIGHT,FEDERATION,FOXM1,PUBLISHED,SOCIETIES
169,BBN,BLADDER,COPYRIGHT,CPG,GSTM1,GSTO1,INC,MOUSE,NQO,SP1,THESE,WESTERN
000,005,021,034,119,169,187,429,498,772,840,877,890,909,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NAC,OBJECTIVE,OBJECTIVES,QALYS,RESULTS
004,011,019,030,2E1,303,337,510,560,565,593,613,733,766,858,905,947,957,BACKGROUND,CAUCASIANS,CIS,CYTOCHROME,FEB,FURTHER,HOWEVER,LABEL,METHODS,ORS,POR,RESULTS,SUMMARY,THERE
DIFFERENT,INADEQUATE,SIMILAR
169,251,ATM,BRCA1,CADM1,CDH13,COPYRIGHT,GATA5,GSTP1,IGSF4,INC,MGMT2,MOLECULAR,NMI,PATHOLOGY,PAX5A,PUBLISHED,RB1,SOCIETY,STK11,TSG,WT1
208,429,725,BMI,FINNS
169,174,BLOOD,CELLSEARCH,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
100,160,169,233,500,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TIS,TREATMENT,UROLOGICAL
160,BRG,DEPLETION,NOTABLY,SUBSEQUENT
160,ADP,BAX,BCL,EBP,ROS,T24,TAKEN
028,030,038,042,045,058,ACUTE,COMPOSITE,CONCLUSION,CRANBERRY,FORTY,INDEX,LABEL,MEN,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
005,100,169,174,CELLDETECT,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
CONCLUSION,DWI,LABEL,MCNEMAR,METHODS,OBJECTIVE,PURPOSE,RESULTS
COX,MOLECULAR,NTUB1,THESE,TREATMENT
BACKGROUND,BCR,JANUARY,LABEL,LNU,METHODS,ONU,RESULTS,SIXTY,TCC,UUT
089,183,956,ALZHEIMER,BLADDER,DIGESTIVE,INCIDENCE,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,THERE
169,LABORATORY,PRESS
160,169,AIM,CONTOURED,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY
002,005,011,169,177,188,243,CONCLUSION,COPYRIGHT,FEDERATION,GYNECOLOGY,INDEX,IRELAND,LABEL,LTD,MARCH,METHODS,OBJECTIVE,OBSTETRICS,OVERACTIVE,POP,PUBLISHED,RESULTS,SYMPTOM,THERE,WOMEN
AFTER,BETWEEN,BRICKER,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RETROGRADE,UPPER
001,005,007,008,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,CXC,CXCR4,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,174,ANTICANCER,BACKGROUND,CC3,CD3,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,RESULTS,RT4
000,001,945,BLADDER,BNC,FURTHER,MNC,TUNISIA,WHITNEY
203,CONVERSELY,HOWEVER,LASP1,LIM,LNCAP,PCA,PCR,PSA,SEVERAL,SH3,SUBSEQUENT,THESE
003,014,048,097,148,946,AMONG,ARF,CALCA,CCNA1,CCND2,PCR,RAR,TIMP3,UCC
HOWEVER,QOL,SIMILARLY
BLADDER,HOWEVER,NMIBC,THROUGHOUT
008,116,ACUTE,ADVERSE,BACKGROUND,CONCLUSION,CRT,CTCAE,EVENT,LABEL,METHODS,RESULTS
001,002,134,174,AU1,BACKGROUND,CONTEXT,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES,UROPLAKIN
169,250,465,AUTHORS,COMPETING,HARRELL,HUNDRED,INC,MEIER,NMIBC,OVERALL,PFS,PUBLISHED,RFS,UBC,WILEY
233,ANDROGENS,BASIC,LABEL,OBJECTIVE,OVERALL,PROMISING,PURPOSE,RESULTS,SEX,SUMMARY,WHEREAS
370,417,486,899,ACS,BACKGROUND,COLLEGE,CPT,CURRENT,ICD,IVC,JANUARY,LABEL,MATERIALS,METHODS,NSQIP,OPERATIVE,PROCEDURAL,PROGRAM,QUALITY,RESULTS,THERE,TURBT,USING
122,134,350,748,BACKGROUND,FEW,JANUARY,LABEL,MATERIALS,METHODS,NAC,NSQIP,PROGRAM,PROPENSITY,QUALITY,RESULTS
011,131,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,MRI,NABOTHIAN,OBJECTIVE,PURPOSE,RESULTS,SERUM,SEVENTY,SPECT,THERE,TSH
128,169,COMPOSITE,CONCLUSION,INDEX,LABEL,METHODS,NERVE,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THEREFORE,URINARY,UROLOGICAL
169,24H,ARCHAZOLID,BACKGROUND,COA,COPYRIGHT,HMG,HMGCR,INC,LABEL,LDL,METHODS,RESISTANCE,RESULTS,SREBP,T24,WESTERN
133,206,HDAC4,HOWEVER,SFR,WHILE
006,138,345,ACUTE,AIC,BACKGROUND,CONCLUSION,CRITERION,CTCAE,DMEAN,EUD,GRADE,JANUARY,LABEL,MAY,METHODS,RESULTS,THREE,URINARY,V35GY
001,BACKGROUND,CTV,DOSIMETRIC,HDR,LABEL,METHODS,MRI,OVERALL,RESULTS,SIMILAR,SIX,THREE
118,137,169,455,771,APRIL,BACKGROUND,CONCLUSION,FOUNDATION,LABEL,LESIONS,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,RIS
ERBB1,ERBB2,LAPATINIB,RT112,UBC
11Q,13Q,15A,17P,CLL,EXPRESSION,MICRORNAS
100,177,1CC,2CC,5CC,BACKGROUND,D90,D95,DOSES,DOSIMETRIC,GRAYS,HDR,LABEL,MATERIALS,METHODS,OAR,RESULTS,SIMILARLY,SIXTY,TREATMENT
045,169,199,251,BACKGROUND,BASEL,BOLZANO,CENTRAL,CLAVIEN,COMPARING,CORNELL,DINDO,III,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,WEILL
115,11Q13,169,230,349,ANTICANCER,BACKGROUND,CCND1,CCNE1,COPYRIGHT,DELINASIOS,DISCUSSION,INSTITUTE,LABEL,MATERIALS,METHODS,RESULTS,SIX,UROTHELIAL
181,388,AKT,BASED,CCK,ERK,MEK,NVP,THREE
126,CRK,HOWEVER,MIR,SGC
169,BACKGROUND,BASEL,GRADE,LABEL,METHODS,OPTIMOX,RESULTS,THEIR
169,AKT,BACKGROUND,CAV,COPYRIGHT,EMT,HOWEVER,INC,KNOCKDOWN,LABEL,METHODS,RESULTS,T24,UMUC3
169,315,ANNEXIN,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PROTEIN,RESULTS,THESE
001,085,128,169,520,548,809,944,ACT,AMONG,COPYRIGHT,ELECTRONIC,INC,LABEL,METHODS,OBJECTIVE,ONTARIO,OVERALL,PURPOSE,REASONS,RESULTS,THERE
BACKGROUND,CONFIDENCE,DISCUSSION,HODGKIN,ICD,INCIDENCE,INTERVALS,ITALIAN,ITALY,LABEL,METHODS,NON,NORTH,NPCSS,ONGOING,PROJECT,REGISTRIES,RESULTS,SIR,SITES,SOUTH
FORTY,PATHOLOGIC,THERE
BACKGROUND,CAUCASIAN,LABEL,METHODS,THERE
100,1LILLIE,2DAKOTA,BACKGROUND,COX,ICC,K9TCC,LABEL,METHODS,PDGFR,RESULTS,T24,TCC,VEGFR,WESTERN
104,169,192,BASED,COPYRIGHT,INC,LABEL,MEDICAL,METHODS,NMIBC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,UNIVARIATE
120,169,215,233,759,787,884,906,90Y,ADC,BCA,COPYRIGHT,DIAGNOSTIC,FURTHER,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,PARAMETRIC,RESULTS,ROC
001,0CM,106CM,169,176,191,3CM,5CM,6CM,9CM,COLLECTED,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
001,023,028,043,152,15B,169,240,250,27A,30A,899,COX,MEIER,MISEQ,NMIBC,PCR
916,945,947,BASAL,ERBB2,ERBB3,FGFR3,LUMINAL,MIBCS,WHOLE
101,118,169,194,219,233,343,444,BLADDER,COPYRIGHT,EDUCATION,INC,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,THREE,UROLOGICAL
254,ADDITIONAL,CONCLUSION,DESPITE,FURTHER,ICI,LABEL,METHODS,OBJECTIVE,RESULTS
001,019,038,160,169,919,BETWEEN,CONCLUSION,COPYRIGHT,FURTHER,HEALTHCARE,INC,INDICATORS,INPATIENT,LABEL,METHODS,MIC,NATIONWIDE,OBJECTIVE,PATIENT,PSI,QUALITY,RESULTS,THERE
043,109,169,754,828,COPYRIGHT,COX,HARRELL,INC,NMIBC,PFS,RFS,SYND1
169,CYBERKNIFE,HDR,HOWEVER,JAPAN,PRESS,PTV,PUBLISHED,RADIATION,SOCIETY,THESE,UNIVERSITY,V40,WHILE
143,183,223,600,ART,BACKGROUND,CBCTS,CONCLUSION,DAILY,LABEL,METHODS,PTV,RESULTS,SMALL,UNLABELLED
BACKGROUND,CONCLUSION,DIR,DVH,DYNAMIC,FINALLY,INITIALLY,LABEL,METHODS,RADIATION,RESULTS,THERAPY
240,241,BACKGROUND,CONCLUSION,GLEASON,GRADE,GROUP,IRELAND,LABEL,METHODS,PSA,RESOLUTION,RESULTS
100,99A,BACKGROUND,CCK,HOWEVER,INCREASING,LABEL,MEANWHILE,METHODS,PCR,RESULTS
001,016,040,169,278,BLADDER,COPYRIGHT,COX,INC,INDIANA,INSTEAD,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCV,RESULTS,UNIVERSITY
000,139,169,600,BACKGROUND,CALIFORNIA,FARMERS,INC,LABEL,METHODS,NHW,RESULTS,STAGE,THESE,UFW,WILEY,WORKERS
001,169,COLLEGE,CONCLUSION,COPYRIGHT,COX,CSS,CYSTECTOMY,DEFINITIVE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,ONTARIO,PUBLISHED,RESULTS,ROYAL,THERE,TREATMENT
007,169,905,COPYRIGHT,EGGER,HOWEVER,INC,LABEL,LIBRARY,LVI,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCIENCE,TESTS,TURBT,WEB
145,169,COPYRIGHT,EXPRESSION,INC,J82,LABEL,METHODS,MICRORNAS,MMP,OBJECTIVE,OBJECTIVES,RESULTS,T24,THROUGH
169,954,COPYRIGHT,ERK,FINALLY,HOWEVER,MMP,PUBLISHED,THESE,TREATMENT,U0126
169,224,COPYRIGHT,INC,PIM,PUBLISHED,SGI
169,COPYRIGHT,HOWEVER,INC,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,RMS,SIXTEEN
169,AGE,AIM,BACKGROUND,COPYRIGHT,GROSS,INC,LABEL,MATERIALS,METHODS,MGCTS,OBJECTIVE,RESULTS,THESE
002,29C,946,AKT,GSK,PCR,T24,WHILE
108,109,160,177,213,217,CONCLUSION,CURRENTLY,EVALUATION,FUROSEMIDE,LABEL,MAXIMUM,METHODS,OBJECTIVE,OVERALL,PATIENT,PCA,PET,PURPOSE,RESULTS,SUV,THEREFORE
BMJ,GROUP,LTD,PUBLISHING
001,167,168,169,187,327,470,COPYRIGHT,COVARIATES,COX,DFS,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERUM,UNIVARIATE
10878,169,262,343,372,AUC,BACKGROUND,COPYRIGHT,CTV,EMLASSO,IRELAND,LABEL,LTD,MATERIALS,METHODS,MODEL,OBJECTIVE,PCA,PREDICTOR,PURPOSE,RESULTS,VARIABLES
169,186,200,CONCLUSION,COPYRIGHT,FEDERATION,GYNECOLOGY,INC,JANUARY,LABEL,METHODS,OBJECTIVE,OBSTETRICS,RECURRENCE,RESULTS
001,028,049,169,233,276,30911,546,77075,822,957,BACKGROUND,BCG,COPYRIGHT,COX,EORTC,INH,INSTITUTE,LABEL,METHODS,NMIBC,OBJECTIVE,OUTCOME,OVERALL,PATIENT,PUBLISHED,RESULTS,SETTING,SUMMARY,TREATMENT,TRIAL,UROLOGY
168,169,COX,LABEL,METHODS,MOLECULAR,OBJECTIVE,RESULTS,UROLOGICAL
000,14284,200,20202,486,BACKGROUND,BLADDER,BRAIN,CANCERS,CONTEXT,EASTERN,ESOPHAGUS,LABEL,METHODS,OBJECTIVE,ORGAN,OROPHARYNX,OVARY,RAJASTHAN,RESULTS,THERE,WESTERN
233,252,ANTOINE,CAS,CHANGES,CHOLERA,FECAL,LAVOISIER,PETTERS,SALMONELLA,VIL,WILHELM
019,022,028,035,040,042,044,052,056,059,064,169,181,250,277,295,296,884,AGS,BACKGROUND,BRAZILIAN,CHACO,COPYRIGHT,IRELAND,J82,LABEL,LTD,MATERIALS,MES,METHODS,MRC,PARAGUAYAN,RELEVANCE,RESULTS,SOUTH,THESE,THREE,TOADS,UNDER
945,946,947,CDS,PCS,PDT,THREE
CD138,PUC
169,AMONG,AUSTRALIAN,PRESS,PUBLISHED,THREE,UNIVERSITY,USA,WHILE
015,085,214,814,845,COX
100,102,947,956,978,EXPRESSION,RT112,TAS,TFT,TPI
ABP,BTT,SINCE,THEIR,THESE,TOBACCO
BLADDER
286,ECM,NH2,PROGNOSCAN,SPARC
945,ALK,GISTS,IMT,KIT,THEREFORE
137,945,BACKGROUND,CON,HIF,III,LABEL,METHODS,RESULTS
001,004,005,012,027,032,169,347,417,459,ASA,BMI,CASES,CONCLUSION,CONVERSION,COPYRIGHT,FORTY,INC,INCREASING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PRIOR,RESULTS,WHITE
100,169,COPYRIGHT,COUNCIL,LTD,THESE
001,165,366,572,ABDOMEN,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
125,169,174,ASA,CLAVIEN,COPYRIGHT,CYSTECTOMY,EDUCATION,III,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,UROLOGICAL
169,AFTER,BACKGROUND,DLT,LABEL,MEDICAL,METHODS,MTD,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
000,169,INSTITUTE,LABORATORY,NATURALLY,PRESS,PUBLISHED,RESULTS,STUDIES,TCC,UNIVERSITY
169,757,990,ADHERENCE,AMONG,AOR,CONCLUSION,COPYRIGHT,DESPITE,END,III,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,RESULTS,UNIFORM
001,018,105,637,HOWEVER,KIT,T24
PAH,THESE
BAYES,BLADDER,LASSO,MAF,MARKERS,MMM,QTL,RESULTS,SIMULATED,SMR,SNP,SPANISH,THESE
169,BASAL,EXPRESSION,GSTP1,HOWEVER,RELATIVELY
CCAFU,COMMITTEE,DIAGNOSTIC,MRI,UROLOGY
169,290,383,387,BWS,CASES,COG,CONSISTENT,FAP,GROUP,INC,ORS,POPULATION,THERE,THESE,WIEDEMANN,WILEY
001,106,150,169,COPYRIGHT,DUPLICATE,EDUCATION,FGFR3,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
MEDLINE,SUBSEQUENT,THERE
118,169,AMONG,BLADDER,COPYRIGHT,GROUP,HOWEVER,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,RESULTS,SCIENCE,SOCIETY,SUO,THINK,WORKING
169,174,ABLATHERM,AFTER,AUTHORS,BCR,BETWEEN,BJU,CONCLUSION,CONTINENCE,DISEASE,EORTC,HSH,ICS,IMAGING,INCLUSION,INDEX,INTEGRATED,LABEL,METHODS,OBJECTIVE,PHOENIX,PSA,QLC,QLQ,RESULTS,SOCIETY,TREATMENT
169,20YEARS,AKT,BECAUSE,COPYRIGHT,DESPITE,INC,UROTHELIAL,VINFLUNINE
100,160,169,CLAVIEN,COPYRIGHT,CYSTECTOMY,EDUCATION,HOWEVER,INC,INDEX,INSTEAD,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,VANDERBILT
160,169,233,COPYRIGHT,EDUCATION,INC,INHIBITION,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T24,UROLOGICAL,USING
11014,14096,COX,KAPPA,LABEL,METHODS,OBJECTIVE,PREDICTIVE,RESULTS,ZEALAND
102,139,144,169,170,186,198,217,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SIX,SOCIETY
169,AMONG,COPYRIGHT,GATA3,INC,INTENSITY,NUCLEAR
115,119,169,177,COPYRIGHT,GLEASON,PUBLISHED,THERE
169,215,ABCD1,COPYRIGHT,GEM,NG0,NG1,NTUB1,PUBLISHED,RESISTANCE,TAKEN,THESE
007,111,124,250,295,361,386,387,CLAVIEN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
160,169,267,378,777,BACKGROUND,COLORECTAL,COPYRIGHT,LABEL,LTD,METHODS,RCC,RESULTS,RISKS,SIR,SWEDISH
000,007,100,169,227,242,400,500,906,956,AIM,ANTICANCER,BLADDER,CONCLUSION,COPYRIGHT,COX,CYSTECTOMY,INSTITUTE,LABEL,METHODS,OBJECTIVE,RADICAL,RATIO,RESULTS,UNIVARIATE
005,038,129,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,COX,INSTITUTE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
169,ANTICANCER,AVO,BACKGROUND,BAF,CONCLUSION,COPYRIGHT,FIP,INSTITUTE,LABEL,MATERIALS,METHODS,MTT,RESULTS,UROTHELIAL
169,AIM,ANTICANCER,BACKGROUND,BLADDER,CONCLUSION,COPYRIGHT,FURTHER,INSTITUTE,KNOWN,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SSTR1,SSTR2,SSTR3,SSTR4,SSTR5,SSTRS,THEREFORE
233,BCG,COMPARING,EARLY,HOWEVER,LABEL,NMIBC,OBJECTIVE,PURPOSE,RADICAL,RESULTS,SUMMARY,WHILE
DILIGENCE,LABEL,NMI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
AMACR,CK903,NAS,PIN,SIXTY
169,183,320,796,847,899,ANG,BACKGROUND,BECAUSE,CA9,ELISA,IL8,LABEL,METHODS,MMP10,RESULTS,ROC,URINARY,UTILIZING,VEGFA
BMJ,CNS,GROUP,LTD,METASTASIS,PUBLISHING,TCC,TREATMENT
000,169,500,FRUIT,NUTRITION,SOCIETY,THERE
001,005,16VAL,244,365,69C,GENOTYPING,GSTA1,GSTM1,GSTP1,GSTT1,ILE105VAL,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,VAL105VAL
BCG
TCC
COPYRIGHT,PROUS,SCIENCE,STOCKHOLM,UROLOGY
001,005,007,013,10878,424,AFTER,BACKGROUND,COX,CSS,LABEL,MEIER,METHODS,NEUTROPHIL,NLR,RESULTS,RFS,UCB
METASTASES,MMP,PCR,T24
002,169,AIMP3,III,PCR,PHASE,TMA
129,166,169,253,308,571,ACT,AMONG,BACKGROUND,COX,CSS,FEW,INITIATION,LABEL,MEDICAL,METHODS,ONTARIO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
HOWEVER,THEREFORE,THESE
001,002,032,067,114,143,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SERBIAN
169,COPYRIGHT,LTD,UROGENITAL
AFTER,OPERATING,THREE
1B1,881,890,937,942,996,997,ARTICLE,ASIAN,BACKGROUND,CAUCASIAN,CYTOCHROME,HOWEVER,L432V,LABEL,METHODS,RESULTS,STATA,THEREFORE,UNASSIGNED,VIRTUAL
196,215,356,BACKGROUND,CIVIL,CONCLUSION,COPDIFF,COPENHAGEN,COUNT,INDEX,LABEL,METHODS,PRIMARY,RESULTS,USING
169,BACKGROUND,C30,CONCLUSION,COPYRIGHT,ENGLISH,EORTC,LABEL,LTD,MEDLINE,METHODS,ORTHOTOPIC,QLQ,QOL,QUALITY,RADICAL,RESULTS,SIXTEEN
157,167,169,225,551,708,GLEASON,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPERATIVE,RESULTS,ROBOT,SEPTEMBER,THERE,UROLOGICAL
169,176,191,230,256,337,447,773,BACKGROUND,HGUCA,LABEL,METHODS,RESULTS,SOCIETY
THESE
169,CONCLUSION,COPYRIGHT,FDG,INC,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROUTINE,THERE
ACTIVATION,BACKGROUND,GTP,GTPASES,LABEL,LPA,METHODS,RESULTS,RHO,THESE
ACADEMY,BACKGROUND,BLADDER,DEPARTMENT,FORTY,LABEL,METHODS,NEPAL,PATAN,PATHOLOGY,RESULTS,TCC,THESE,UROTHELIAL
258,280,639,839,892,973,CONCLUSION,CUETO,DENMARK,EORTC,LABEL,METHODS,OBJECTIVE,RESULTS,SPAIN,SPANISH,TREATMENT,UROLOGICAL
001,002,003,007,011,015,046,047,095,105,166,169,254,295,308,364,391,423,450,488,492,585,670,769,895,955,964,AUTHORS,BJU,CONCLUSION,EARLY,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORTHOTOPIC,PREDICTORS,RESULTS,SEPTEMBER,UUO
005,169,874,AUTHORS,BJU,COMPETING,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,UCB,YOUNGER
017,019,026,169,BACKGROUND,CONCLUSION,JANUARY,LABEL,MAY,METHODS,POTENTIAL,RESULTS
BMJ,GROUP,LTD,PUBLISHING
1970S
169,945,HIF,JUN,RON,TAKEN,THESE
239,351,377,930,ASIAN,BACKGROUND,CENTRAL,EFFECTIVE,KOREA,LABEL,METHODS,PAF,RESULTS,SEX,SMOKING,STATISTICS,TOBACCO
BACKGROUND,BASED,CONCLUSION,LABEL,METHODS,OSSEOUS,PATHOLOGY,UBC
BACKGROUND,CONCLUSION,LABEL,METHODS,UROTHELIAL
BNC,DESPITE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE
018,019,038,337,400,418,500,INFECTION,JANUARY,LABEL,LRC,MATERIALS,MEIER,METHODS,OBJECTIVE,ORC,PURPOSE,RESULTS
010,100,132,173,323,BOO,BPH,CONCLUSION,FIFTY,HOLEP,LABEL,METHODS,OBJECTIVE,RESULTS,SCORE,SYMPTOM,VAS
CURCUMA,TRANSIENT,TRPV1,UROTHELIUM
BACKGROUND,CONCLUSION,DHULIKHEL,HISTORY,JANUARY,KATHMANDU,LABEL,METHODS,NEPAL,OBJECTIVE,RESULTS,SMOKING,TCC,TOBACCO,UNIVERSITY,URINARY
001,002,010,156,160,229,385,635,658,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UCB
AMONG,BLADDER,CADMIUM,DESPITE,FURTHER,HOWEVER,MECHANISMS,SPECIAL
159,BACKGROUND,BLADDER,LABEL,METHODS,NMIBC,NON,RESULTS,UII,UPG84,UTR
160,169,945,BASED,CAJAL,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PDGFR,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
160,169,188,628,727,788,BIPOLAR,COPYRIGHT,DIAGNOSIS,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROCEDURE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
120,169,240,954,CIS,COHEN,CONCLUSION,IMAGE,LABEL,MATERIALS,METASTASES,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHORT,WRITTEN
098,CLUSTER,CURRENTLY,HOWEVER,ISA,POISSON,SMR,SPANISH
319,375,667,AMONG,ARRAY,BIRC5,CRC,FINALLY,HELLS,KNOCK,MICRORNAS,MKI67,NOLC1,PARTICULAR,PHENOTYPIC,SET,USING
CGE,ECLIPSE,EUD,PTV,TPS,XIO
169,AUTHORS,HK2,HOWEVER,LTD,PTY,PUBLISHING,SCIENCE,STAT3,TAKEN,WARBURG,WILEY
CURRENTLY,DESPITE,SINCE
169,177,739,BASED,BECAUSE,FMR,INC,JANUARY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,ORTHOGONAL,PUBLISHED,PURPOSE,RESULTS,THESE,USING
142,156,FLOT1,FLOTILLIN,PCR,SAMPLES,TCC,THESE,WST
150,956,ARSENIC,BACKGROUND,BOOTSTRAP,CONCLUSION,FORTY,LABEL,METHODS,PREDICTED,RESULTS,SEVENTEEN,TEN
100,114,169,399,BACKGROUND,BLADDER,CONCLUSION,COPYRIGHT,DESPITE,HOWEVER,INC,LABEL,METHODS,RESULTS,THEREFORE
946,EMT,EPITHELIAL,FINALLY,GBC,PCBP1,TGF,USING
000,BLADDER,DESPITE,EVERY,LABEL,NMIBC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,USA
ASSESSMENT,CIGARETTE,CURRENT,CURRENTLY,LABEL,NMIBC,OBJECTIVE,PURPOSE,RESULTS,SMOKING,SUMMARY,THERE
946,CHINESE,E12,LABEL,MATERIALS,METHODS,OBJECTIVE,PAGET,RESULTS
100,954,BACKGROUND,DECREASED,EMT,J82,LABEL,METHODS,RESULTS,T24
BACKGROUND,CAUCASIAN,EXPRESSION,LABEL,LABORATORY,METHODS,UROTHELIAL
945,BACKGROUND,CONCLUSION,CXCR2,DIFFERENT,FURTHER,HIF,LABEL,METHODS,MMP,PAI,RESULTS,TAKEN,TMA,USING
BACKGROUND,CDX,CK7,CONCLUSION,LABEL,METHODS,MUCIN,PATHOLOGY,PSA,THESE,TURBT
BACKGROUND,CONCLUSION,LABEL,METHODS,THERE,THESE
001,009,013,040,100,104,110,233,342,442,BACKGROUND,COX,DSS,EZRIN,HR1,LABEL,MEIER,METHODS,PFS,REDUCED,RESULTS
956,ARSENIC,BACKGROUND,CURRENT,DISCUSSION,LABEL,LITERATURE,SUMMARY,TIGHTER
BACKGROUND,BETWEEN,FIFTY,JANUARY,LABEL,METHODS,RESULTS,UPPER,WESTERN
BACKGROUND,COLON,CONCLUSION,DUE,LABEL,METHODS
249,411,472,979,BACKGROUND,CONCLUSION,LABEL,METHODS,OVERALL,PAF,RESULTS,SIR,TAIWANESE
CONVERSELY,FGFR3,HOWEVER,INCREASED,PCR,THESE
CONCLUSION,CONVERSELY,LABEL,METHODS,MMP,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
001,017,022,169,CONCLUSION,COPYRIGHT,COX,EXPRESSION,INC,KDR,LABEL,METHODS,OBJECTIVE,RESULTS,THEREFORE
100,223,BRUNN,E12,GATA3,T2A,T2B,T3A,T3B,T4A,TYPICAL,UNIVARIATE
244,494,BIO,CLC,EXOME,HOWEVER,LIBRARIES,NGS,PEARSON,SEQ,WORKBENCH
ALTOGETHER,BIOMARKERS,DUE,MOLECULAR,SPECIAL

916,BASED,BEV,CTV,INTENSITY,LABEL,METHODS,MUS,OBJECTIVE,PURPOSE,RESULTS,TCP
935,956,AUC,LARGE,ROC,THESE,UMS
159,CYSTOSCOPY,UBC,UROVYSION
169,215,CARLO,DAP,INDUCED,MONTE,PCXMC,PRESS,PUBLISHED,RADIATION,SINCE,UNIVERSITY
169,2DE,941,946,AMONG,COPYRIGHT,ELISA,LABEL,MALDI,METHODS,OBJECTIVE,RESULTS,ROC,SERUM,TOF,WESTERN
DESPITE,HOWEVER,STILL,THROUGHOUT
BACKGROUND,DBCCC,LABEL,MARCH,METHODS,QUALITY,RESULTS,THERE,TREATMENT
ANY,CONTINENCE,FUNCTIONAL,QOL,THERE,UROLOGY
CHROMATIN,FURTHER,MTT,SINCE,TCC
100,225,BACKGROUND,CONCLUSION,CYSTECTOMY,CYSTOSCOPY,DIGITAL,GIANT,HOWEVER,LABEL,LOBES,METHODS,OBJECTIVE,PATIENT,RESULTS,THERE,TREATMENT,URINARY,URINE,UROGRAPHY
29C,AFTER,APOPTOSIS,BACKGROUND,BCL,BIU,DISEASE,EXOSOME,LABEL,MATERIALS,MCL,METHODS,PCR,QRT,RESULTS,WESTERN
490,BACKGROUND,CRP,CSS,FURTHER,JAN,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,RCC,RESULTS,RFS,SEP,STUDIES
HEMOLYTIC
TRPV1,TRPV4,WESTERN
000,001,044,074,169,702,719,733,COPYRIGHT,INC,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,OBJECTIVE,OBJECTIVES,RESULTS,STUDENT,USING,WHITNEY
169,ASSESSMENT,AUTHORS,BJU,CYSTECTOMY,FUNCTIONAL,HRQOL,INDEX,LABEL,METHODS,OBJECTIVE,ORC,RESULTS,THERAPY,THERE,UNIVARIATE,VANDERBILT
004,012,037,041,043,066,166,169,170,198,247,CSS,NEUROPILIN,RCT,THEREFORE,TURBT
226,270,349,449,818,CHINESE,IL23R,POLYMERASE
169,180,20P12,215,300,456,ICELANDERS,NOTCH,PRESS,PUBLISHED,SEVERAL,UBC,UNIVERSITY
001,020,031,169,177,180,BACKGROUND,CONCLUSION,ENDOSCOPIC,FORCE,JANUARY,JAPAN,LABEL,LOC,LTD,METHODS,OCTOBER,PTY,PUBLISHING,RESULTS,SOCIETY,SURGERY,UBS,USING,VUA,WILEY
233,CLASS,COLEY,CTL,MHC,THEREFORE,WHILE
000,001,100,110,160,169,221,508,800,956,BACKGROUND,CHILE,CONCLUSION,LABEL,METHODS,ORS,RESULTS
001,003,005,012,016,160,169,174,381,COPYRIGHT,EDUCATION,FEW,INC,LABEL,MATERIALS,METHODS,NMP22,OBJECTIVE,PREDICTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,UROTHELIAL
ABOUT,AMONGST,BCG,CARCINOMA,HOWEVER,IVC,IVT,RCT,RECURRENCE,SCREENING,TCC,THOSE,TURBT
FORCE,J82,MICROSCOPY,RT112,T24,USING
001,003,010,029,036,130,168,169,228,360,CD147,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TNM,UCB,UNIVARIATE,WORLD
001,009,139,169,233,257,327,383,599,884,AFTER,CLAVIEN,COPYRIGHT,III,INC,INDIANA,JANUARY,LABEL,LITERATURE,MATERIALS,METHODS,OBJECTIVE,OVERALL,PROGRAM,PURPOSE,QUALITY,RESULTS,UNIVERSITY,USING
010,028,046,167,169,205,226,306,309,355,439,453,548,589,661,705,743,876,965,981,CENTERS,CONCLUSION,COPYRIGHT,INC,LABEL,MAJOR,METHODS,OBJECTIVE,OLDER,RESULTS,RNU,UNIVERSITY
169,194,BACKGROUND,BLADDER,CIS,CONCLUSION,COPYRIGHT,COX,HAMPSHIRE,INC,JANUARY,LABEL,METHODS,ORS,PATHOLOGY,RESULTS,SIMILARLY,SOCIETY,STATE,TNM,UROLOGICAL,WORLD
001,121,COX,EMT,GRADE,LABEL,MATERIALS,MAY,METHODS,NMI,OBJECTIVE,PFS,RESULTS,SIXTY,STAGE,TWIST,UNIVARIATE
340,AFFAIRS,ATLANTA,AVAMC,CIS,INDEX,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VETERAN
177,5ML,BETWEEN,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,T2A,T3B,TEN,THERE,TURBT
112,175,191,198,199,222,AFFAIRS,AFRICAN,ATLANTA,AVAMC,BACKGROUND,BCG,CIS,FIFTY,INDUCTION,LABEL,MATERIALS,MEDICAL,METHODS,NMIBC,RECURRENCE,RESULTS,UNIVERSITY,USING,WHILE
947,AUTOPHAGIC,BLADDER,HOWEVER,LC3,OVERALL,SEVERAL,T24
001,132,160,169,237,257,266,459,560,686,COPYRIGHT,INC,LOW,MET
001,021,022,033,047,086,ABC,BACKGROUND,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SITES
ACUTE,ADVERSE,BACKGROUND,BLADDER,CTCAE,LABEL,METHODS,OABSS,OBJECTIVE,OVERACTIVE,RESULTS,SCORE,SYMPTOM,V20
001,117,EARLY,PCR,T24,TCC,URINARY,URINE,VUC
169,215,218,865,BLADDER,CBE,HOWEVER,PRESS,PUBLISHED,SALL1,SUBSEQUENT,UNIVERSITY,WNT9B
III,PHASE
001,002,007,623,701,CSS,PATHOLOGIC,RADICAL,RFS
185,209,BLADDER,CURRENTLY,FRESH,Q30,RIN
CONCLUSION,HOWEVER,IMPORTANT,LABEL,MRI,OBJECTIVE,THEREFORE,TREATMENT,URINARY
ARMED,CONCLUSION,FIFTY,IHC,INSTITUTE,JANUARY,LABEL,METHODS,OBJECTIVE,PATHOLOGY,PLACE,RAWALPINDI,RESULTS,TNM,UROTHELIAL
ANALYTICAL,BASED,BRT,CONCLUSION,HEALTHCARE,LABEL,MARCH,METHODS,MRI,OBJECTIVE,PLACE,RESULTS,SHAUKAT
169,INSTITUTE,NUTRITION,SOCIETY,THERE,WORLD
169,AMERICANS,BACKGROUND,BLADDER,COPYRIGHT,HOWEVER,INC,KINCAID,LABEL,METHODS,PATHOLOGY,REPORTS,RESULTS
CISPLATIN,FINALLY,HIPK2,HOWEVER,LABEL,RT4,THESE,UNLABELLED
114,16063,MICRORNAS,THESE
001,169,231,AFFYMETRIX,AUTHORS,FGFR3,GENOMIC,LTD,NANOSTRING,ONCOMAP,ONCOSCANTM,TARGETS,UCS,WHILE,WILEY
103,285,318,435,ANY,CLAVIEN,CYSTECTOMY,LABEL,METHODS,OBJECTIVE,RESULTS
169,441,504,BACKGROUND,CONVERSELY,END,LABEL,MEN,METHODS,PROGRAM,RESULTS,SIR,SIRBLADDER,SIRRECTAL,SOCIETY,THERE
169,241,243,CIRUJANOS,COPYRIGHT,IMAGING,INDICATION,PUBLISHED,RESONANCE
000,100,115,261,275,676,AFTER,BLADDER,THERE,THESE
GENERIC,HRQOL,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,UTERINE
BLADDER
BACKGROUND,BLADDER,EASTERN,GROUP,INC,LABEL,MAY,MEDONCS,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,OCTOBER,PUBLISHED,RESULTS,SOCIETY
026,169,AKT,CIS,CONCLUSION,COPYRIGHT,INC,LABEL,LOW,MARKERS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
003,004,007,135,141,169,205,BACKGROUND,CSS,EASTERN,GROUP,HRS,LABEL,MEIER,METHODS,RESULTS,SARCOPENIA,SARCOPENIC,SMI,SOCIETY,TNM,VARIABLES
223,HEMATURIA
APF,CCK,CKAP4,EGF,FURTHER,HCC,HOWEVER
131,169,427,461,473,852,CASES,INC,MEDICAL,URINE,WILEY
169,FOLLOWING,HOWEVER,PRESS,PUBLISHED,SIX,THERE,UNIVERSITY
045,169,BLADDER,CISPLATIN,COPYRIGHT,EXPRESSION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RT112,THESE
150,169,581,9TH,CONCLUSION,COPYRIGHT,EDITION,INC,LABEL,MARKETSCAN,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PROLONGED,RESULTS,VTE
002,169,ACG,AUTHORS,BLADDER,COPYRIGHT,INC,KDM6A,MUTATIONS,PUBLISHED,UCC,WHOLE
HARTUNG,JACKSON,LAIRD,MAKAMBI
BMJ,GROUP,LTD,PUBLISHING
001,004,006,ASA,BACKGROUND,BECAUSE,LABEL,LIBRARY,LRC,MAR,MEDLINE,METHODS,OBJECTIVE,ORC,RESULTS,SIXTEEN,THERE

160,169,377,646,COPYRIGHT,EDUCATION,END,HEMATURIA,HOWEVER,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL,USING,WOMEN
001,169,251,AFTER,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STRATEGIES,UROLOGICAL,USING
101,BACKGROUND,COX,HOWEVER,LABEL,LOW,METHODS,MIR,PCR,RESULTS
169,COPYRIGHT,LTD
174,3MM,915,CONCLUSION,KNOWLEDGE,LABEL,MEDICAL,METHODS,OBJECTIVE,OWING,PTV,PTV60,RADIATION,RESULTS,SYSTEMS
000,001,002,011,015,032,046,100,160,169,374,614,696,700,840,894,961,ADC,AUC,AUR,COPYRIGHT,HISTOGRAM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PARAMETERS,PUBLISHED,RATIONALE,RESULTS,ROC,THERE
169,176,177,1CM,377,COPYRIGHT,INC,MEDICAL,POTENTIAL,PUBLISHED,USING,VARIATIONS
AFTER,BECAUSE,SUPPOSING,TECHNICAL
BMJ,CIS,COX,GROUP,HRS,INDEX,INDUSTRIAL,LABEL,LIMITED,METHODS,MINNESOTA,MORTALITY,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SIMILARLY,WISCONSIN
CONTINUED,HOWEVER,NMIBC,PARTICULAR,THERE
AFTER,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUCCESSFUL,THREE
169,342,496,609,625,DENMARK,JOURNAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,POPULATION,RESULTS,SETTING,SIR
009,020,AFTER,AMONG,AZA,BACKGROUND,CARCINOMA,CONCLUSION,LABEL,METHODS,PCR,RESULTS,SELECTION,UCC,UROTHELIAL,VGF
002,028,AEG,ASTROCYTE,MEIER,NMIBC
BLADDER,BMJ,GROUP,LTD,METASTASIS,PUBLISHING
GLEASON,THREE
170,750,94INS,ASIAN,CAUCASIAN,NFKB1,OVERALL,STRATIFIED
OPINION,THERE
001,169,518,APART,AUTHORS,BJU,CONCLUSION,GLEASON,INCIDENCES,JANUARY,LABEL,METASTASIS,METHODS,OBJECTIVE,OVERALL,RCP,RESULTS,TNM
001,010,177,HRS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
AMERICANS,CALIFORNIA,DETROIT,END,HISPANICS,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,PROGRAM,RESULTS
169,AFTER,THERE,UROLOGICAL
000,001,033,047,091,112,159,160,169,177,215,276,403,772,945,960,995,ADC,AIM,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROC,ROYAL
946
169,946,EMT,FINALLY,HIPK2,HOWEVER,INC,PCR,SIRNA,THESE,WILEY,WNT
169,COPYRIGHT,GATA3,INC
126,ADAM9,BACKGROUND,DESPITE,LABEL,METHODS,NMI,NOTABLY,RESULTS,WHILE
HOWEVER,THESE,WHILE
009,169,4N1,APRIL,BETWEEN,CONCLUSION,DFS,ERCC1,LABEL,METHODS,OBJECTIVE,OVERALL,PAR,PURPOSE,RAR,RESULTS,SECONDARY,SIMON,SOCIETY
169,AMVAC,ANOTHER,CONCLUSION,FORTY,FURTHER,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,T4A,THERE
112,52E,947,AAPTAMINE,CISPT,DDR,NOTABLY,NRK,PROTECTION,S15,THEREFORE
HAEMATURIA,HOWEVER,POTENTIAL,YET
15D,947,HOWEVER,PGJ,ROS,STRATEGIES,T24,TAKEN
100,169,JAPAN,PRESS,PTV,PUBLISHED,RADIATION,SET,SOCIETY,THESE,UNIVERSITY,WHILE
160,CYSTOSCOPY,HISTORY
006,058,138,184,BACKGROUND,BASED,BLADDER,CASES,DISCUSSION,EPICURO,EUROPEANS,HOWEVER,IGF1R,LABEL,LASSO,LEAST,METHODS,P53AIP1,RESULTS,SELECTION,SHRINKAGE,SNP,SPANISH,UCB
ANTIBODIES,BLADDER,COX,STEAP,UROTHELIAL,WHILE
BAX,BCL,BID,CDK,FAS,FURTHER,T24
115,139,254,3RD,AFTER,APERT,FGF,FGFR2,MUTATIONAL,MUTATIONS,PRO253ARG,THESE
BASED,HOWEVER,PCR,SKI
169,CANCERS,CHALLENGES,HOWEVER,SOCIETY,THEREFORE,WHILE
001,027,101,844,844TC,BACKGROUND,CONCLUSION,EXTENSIVE,FAS,FATTY,GENOTYPES,LABEL,METHODS,RESULTS,TURKISH
211,212,213,225,227,945,DUE,INITIAL,THEREFORE
400,DOSES,EARLY,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PROTECTION,RESULTS,TEN
ADP,BECAUSE,CYTOX,J82,LC3,STATINS,T24
169,271,AUS,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RUA,THERE,THEREFORE,UROTHELIAL
169,COPYRIGHT,GLI,INC
014,022,037,039,045,101,120,125,154,169,755,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE,YKL
BLADDER
169,BALKANS,CONCLUSION,COPYRIGHT,HODGKIN,ITALIAN,LABEL,LTD,MEDIA,METHODS,NATIONS,NORWEGIAN,OBJECTIVE,RESULTS,SIR,SIXTY,SMR
169,DCMBQ,GPX,GSH,GST,HBQ,HOWEVER,PEARSON,PRESS,PUBLISHED,ROS,SOCIETY,T24,THESE,TOXICOLOGY,UNIVERSITY
BCG
CEVARIX,HOWEVER,HPV
169,CELLS,COPYRIGHT,DISRUPTION
100,360,BILATERAL,CONCLUSION,CONDUIT,LABEL,MATERIALS,METHODS,NEO,NUC,OBJECTIVE,OPERATIVE,PURPOSE,RESULTS,ROBOTIC,THERE,URETERO,URINARY
233,BCG,NMIBC
MRI
LABEL,OBJECTIVE,PURPOSE,RESULTS,SALVAGE,STRICTURE,SUMMARY
GASTRIC,MSI,MSS,SNP,THESE,TV1,ZAK
246,AFTER,HODGKIN,INCREASED,LABEL,LIMITED,METHODS,OBJECTIVE,RESULTS
128,303,BASED,RNASE
100,BASED,BRICKER,INSTRUMENT,LABEL,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SEVEN,STOMA
HOWEVER,RESULTS,SIMULATION,WEIBULL
NPC,PEG,PEGYLATION,USING
169,AUTHORS,BOWEL,CTC,DOSIMETRIC,GRADE,LTD,PATIENT,QOL,THREE,V40,V65,V70,WILEY
169,177,1CC,954,CIGEN,COPYRIGHT,DOSIMETRIC,GEOMETRIC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMALL,TOT
112,169,205,AUTHORS,BJU,BXT,CONCLUSION,LABEL,LDR,METHODS,OBJECTIVE,PVR,QOL,RESULTS,SCORE,SELECTION,SYMPTOM
169,500,BACKGROUND,CETUXIMAB,CIS,CTX,EPIDERMAL,LABEL,MEIER,METHODS,RESULTS,SOCIETY
169,COPYRIGHT,INC,LSI9P21,OVERALL,TARGETING,UTILIZING
001,117,185,809,862,914,NMIBC,NON,PDGFR,PPI,THEREFORE
001,173,177,CLASS,CTU,JACCARD,LCR,MGR,PREVIOUSLY
169,COPYRIGHT,III,THESE
143,168,311,483,CONCLUSION,LABEL,MATERIALS,METHODS,NEO,OBJECTIVE,RESULTS
024,025,026,046,089,137,155,239,818,BACKGROUND,BUC,CERTAIN,CHINESE,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,RRT,UCS,UPPER,UROTHELIAL,UUC,WHO1973,WHO2004
MOLECULAR,PRE
786,AKT,ASSAY,CCK,HEALING,HGF,MET,MMP,MVS,PCR,RCC,RNASE,TUNEL,WHARTON,WOUND
111,127,169,193,CIS,COPYRIGHT,HARRELL,INC,INDEX,MAI,MEIER,MITOTIC,WHO04,WHO73,WORLD
090,127,169,290,475,AFTER,AUC,AUCTEST,BLADDER,EPICURO,HOWEVER,INC,NONGENOMIC,ROC,SMOKING,SNP,SPANISH,THREE,UCB,WILEY
169,215,296,AUTHORS,CASES,CD163,CD3,CD8,CONCLUSION,COPYRIGHT,COX,FOXP3,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,TAM,THESE,TIL,UROTHELIAL
001,003,115,169,270,AFTER,COPYRIGHT,GLEASON,INC,LABEL,LOG,LOG10,MATERIALS,METHODS,NGF,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PATIENT,PCA,PERINEURAL,RESULTS,TOTAL,URINARY
015,110,119,121,129,169,176,442,729,844,ARSENIC,BACKGROUND,ESTIMATING,LABEL,METHODS,PROTECTION,RESULTS,THESE,WHILE,WORLD
001,023,024,332,509,COX,MEIER,PCR,PDCD6,PROGRAMMED
169,COPYRIGHT,INC
APRIL,CLINICALLY,CONCLUSION,DEDICATED,GYRUS,KETTERING,LABEL,METHODS,OBJECTIVE,RESULTS,SLOAN,THERE,ULTIMATELY
BCG,DESPITE
215,BCG,BRITISH,JANUARY,MRI
001,096,169,308,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
HOWEVER,HPV,PAP
279,558,603,AFTER,UCC
111,ANDALUSIA,ATNEA,FINALLY,LABEL,METHODS,NET,OBJECTIVE,PURPOSE,RESULTS,SEX
001,016,023,024,027,169,177,BACKGROUND,CONCLUSION,COPYRIGHT,COX,EASTERN,FDG,GROUP,INC,KLEIN,LABEL,MAY,MEIER,METHODS,MVA,OCTOBER,PET,PFS,RESULTS,TCC,UVA
DESPITE,SEVERAL
INHIBITION,JUN,NOTCH,PREVIOUSLY,THESE,USING
110ML,169,180,3CM,5CM,CONCLUSION,COPYRIGHT,FEDERATION,GYNECOLOGY,INDIA,INSTITUTE,IRELAND,LABEL,LTD,MAY,METHODS,OBJECTIVE,OBSTETRICS,PUBLISHED,RESULTS,ROBOT,SIX,THERE
EN2,ENGRAILED,HEK293T,HOWEVER,IHC,MAB2600,RESULTS,TAKEN
001,116,169,1ST,7TH,CONCLUSION,COPYRIGHT,GROUP,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TURBT
006,COX,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UCB
169,AAG,ACTIVATING,FGFR3,HOWEVER,HSP90,LABEL,MHG,RT112,RT4,SW480,SW780,TACC3,UDP,UGT1A,UNLABELLED
100,153,154,1CC,535,651,956,CARLO,GBQ,HDR,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
029,103,177,538,ADDITIONAL,BLOCKED,CARLO,LABEL,LAR,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TESTICULAR
050,128,250,285,300,768,801,838,AFRICAN,AFTER,AMERICANS,BACKGROUND,BASED,BECAUSE,CLL,GHANA,HOPKINS,JOHNS,LABEL,METHODS,MYC,PROJECT,RESULTS,UNIVERSITY,USING

138,199,973,CONCLUSION,LABEL,METASTATIC,METHODS,OBJECTIVE,RESULTS
009,183,213,AMONG,BACKGROUND,LABEL,MET,METHODS,ORDINAL,PFI,RESULTS,WALKING
100,130,169,CK7,COPYRIGHT,GATA3,III,INC
008,177,APRIL,FDG,PET,RECURRENCE,THEREFORE
BLADDER,MOLECULAR
103,ABDOMINAL,CHEST,DLP,LAR,ROUTINE,RUSSIAN
115,182,234,BACKGROUND,INTRA,LABEL,MATERIALS,METHODS,NPV,PPV,RESULTS,TUR,UNIVERSITY
BACKGROUND,CONCLUSION,ENGLISH,HOWEVER,LABEL,MEDLINE,METHODS,RESULTS
169,BRITISH,JOURNAL,OTHER,SOCIETY,THESE,TRP,TRPM3,TRPP2,TRPV1,TRPV3
AH109,BER,MGC5306,PLASMID,SAL,SMA,USING,WESTERN,XRCC1,Y2H
GRN,HOWEVER,STILL
018,169,373,390,391,878,BMI,COX,HAZARDS,NUTRITION,RESULTS
738,819,883,945,CTC,ELISA,PCR,ROC,SW780,TCC,WESTERN
282,289,744,DIAGNOSTIC,END,FACTORS,HRQOL,INTERVIEW,LABEL,MDD,METHODS,OBJECTIVE,POR,PROGRAM,PURPOSE,RESULTS,SURVIVORS,UNASSIGNED
169,946,COPYRIGHT,FERMENTED,FPP
169,946,AKT,ANG,C57BL,COPYRIGHT,GSK,HOWEVER,ILK,SAS
169,CONCLUSION,COPYRIGHT,FOLEY,IA1,IB1,INC,LABEL,METHODS,OBJECTIVE,ONCOLOGIC,PUBLISHED,RESULTS,THERE
169,COPYRIGHT,EFFECTS,EMT,EPITHELIAL,FINALLY,HOWEVER,ILK,INC,SNAIL,T24,THEREFORE,TWIST,WESTERN
169,BACKGROUND,COPYRIGHT,COX,CSS,EIGHT,FIFTY,LABEL,LNS,MEIER,METHODS,OBJECTIVE,OUTCOME,PATIENT,PRIMARY,PUBLISHED,RANDOMIZED,RESULTS,RFS,SUMMARY,UROLOGY
164,169,189,281,496,CONCLUSION,COPYRIGHT,INC,LABEL,LIMITED,METHODS,OBJECTIVE,RESULTS
000,160,169,200,499,533,791,AES,BETWEEN,BLC,CONCLUSION,COPYRIGHT,HAL,INC,LABEL,METHODS,OBJECTIVE,RESULTS
160,169,COPYRIGHT,DESPITE,INC
001,002,169,599,COPYRIGHT,LABEL,LIBRARY,LTD,MEDLINE,METHODS,OBJECTIVE,ORC,RESULTS,THERE,WMD
105,160,169,186,220,CONCLUSION,COPYRIGHT,LABEL,LSS,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,TAIWANESE,THEREFORE,WESTERN
169,COPYRIGHT,INC,PATHOLOGIC
169,COPYRIGHT,INC,KEY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE,VAGINAL
001,169,ADJUSTMENT,BACKGROUND,CALIFORNIA,COPYRIGHT,COX,LABEL,LTD,METHODS,OPTIMAL,PERMANENTE,RESULTS,WILEY
007,013,036,067,069,079,218,269,273,392,428,506,890,ARG,ARG213HIS,CAUCASIANS,CIS,HOWEVER,ORS,SEVERAL,SULT1A1,THEREFORE
169,AKT,BECAUSE,CONCLUSION,DEPLETION,HCC,LABEL,METHODS,OBJECTIVE,PURPOSE,RES,RESULTS,SENP6,WBSCR22,WNT
650,850,DUE,GLUT1,KNOCKDOWN,PCGAL16,PCS,PDT,PSS
5CC,BACKGROUND,CONCLUSION,DOSES,DOSIMETRIC,FIFTEEN,HDR,LABEL,MATERIALS,METHODS,OAR,RESULTS
181,533,5MM,683,CONCLUSION,DAILY,HOWEVER,LABEL,LEVEL,MATERIALS,METHODS,NAL,OBJECTIVE,OFFLINE,PTV,PURPOSE,RESULTS,USING
SLCO1B1,SLCO1B3,SLCO2B1,SLCOS,THEREFORE
EFFORTS,MEDLINE,SEVERAL
000,GIVEN,MTT,SELECTION,USING
8TH,GERMANY,LARGE,THESE,UCB

169,371,468,527,815,BACKGROUND,BCG,COSTS,ESTIMATES,LABEL,METHODS,RESULTS,SEQUENTIAL,SOCIETY
BACKGROUND,DESPITE,EXPRESSION,HPV,ISH,LABEL,MATERIALS,METHODS,NEITHER,PRIMARY,RESULTS,THESE
CRE,KERATIN,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE,USING
169,177,192,214,961,CARLO,COPYRIGHT,D90,HDR,INC,LABEL,MATERIALS,METHODS,MONTE,MRI,OBJECTIVE,PURPOSE,RESULTS
AVAILABLE,BACKGROUD,CHINESE,CONCLUSION,KNOWLEDGE,LABEL,LIBRARY,METHODS,NERVE,OBJECTIVE,RESULTS,THESE,UNASSIGNED
SHH,SONIC,THESE
169,201,231,COPYRIGHT,PUBLISHED,SAS,THERE
007,009,047,100,169,350,380,BCI,BIS,BLADDER,CONCLUSION,COPYRIGHT,IMAGE,INC,INDEX,KRUSKAL,LABEL,METHODS,OBJECTIVE,ORC,RESULTS,SOCIETY,TREATMENT
169,5CM,7MM,COPYRIGHT,CTV,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RADIATION,RESULTS,THERE
001,100,169,177,200,2MM,4MM,5ML,APRIL,BACKGROUND,BETWEEN,BMI,COPYRIGHT,GEL,HDR,IRELAND,LABEL,LTD,MANSFIELD,MATERIALS,METHODS,OBJECTIVE,PEG,PURPOSE,RESULTS,SEALANT,THERE

169,COPYRIGHT,INC
001,103,169,COPYRIGHT,HOWEVER,INC,UCS
169,BLADDER,CONSISTENT,MMC,MUTAGEN,OVERALL,PRESS,PUBLISHED,SOCIETY,THESE,UNIVERSITY,YET
147,160,331,338,460,550,945,AMONG,BACKGROUND,CASES,DDD,LABEL,METHODS,RESULTS
AMERICANS,BACKGROUND,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,STRATEGIES,THOUSANDS,USING
BECAUSE,FGFR3,SEVENTEEN,UNDER,UROTHELIAL,UROVYSION
BLADDER
109,AMONG,BECAUSE,RCC,UTUCS
ACCORDING,ATLAS,FURTHER,MMP,PROTEIN,THEREFORE,WESTERN
CELSIUS,HOWEVER,MRI,TME
393,BACKGROUND,CHANGES,END,INSTITUTE,LABEL,METHODS,RESULTS,SIR,THERE
021,036,066,120,128,140,152,ADR,ADULT,BMI,CONCLUSION,EASTERN,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILAR
169,DESPITE,DISCOIDIN,H1299,JM2,TAKEN
004,012,034,050,060,169,179,18Q12,215,306,404,507,763,ASIAN,CAUCASIANS,CHINESE,CIS,GSTM1,HOWEVER,ORS,OVERALL,THESE
100,120,177,AGE,BACKGROUND,LABEL,MATERIALS,METHODS,MUSCULARIS,PRESENTING,RESULTS,THESE,TURBT
BACKGROUND,CONCLUSION,LABEL,METHODS,SUBSEQUENT
00001,100,CONTINENCE,COX,LABEL,MEN,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,USING
169,ALTOGETHER,AUTHORS,HOWEVER,JOURNAL,OCT4A,PATHOLOGY,THESE
PCR,UNC5A,WESTERN
945,HIF,HRE,MTT,THESE,UNDER,UROTHELIAL
145,786,FOLLOWING,MMP,MTT,RCC,THESE
943,953,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,COLORECTAL,CONSORT,CONTROLLED,CURRENT,CURRENTLY,GBP,GRADE,HOWEVER,ISSUE,JANUARY,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SELECTION,THERE,THESE,TME
BACKGROUND,HOWEVER,LABEL,MARCH,METHODS,NMIBC,OBJECTIVE,PURPOSE,RESULTS,SERUM,T2A,TURBT

006,016,022,043,096,101,147,160,945,946,ALTOGETHER,CD8,COX,FOXP3,J82,OVERALL,TGF,TIL
001,169,ACT,BACKGROUND,COX,CSS,ELECTRONIC,HOWEVER,LABEL,METHODS,ONTARIO,RESULTS,SOCIETY
189,BLADDER,METHYLIGHT
120,169,181,366,405,502,BASEL,CONTINENCE,DAYTIME,H2O,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,PUBLISHED,THESE,UROLOGY
169,AUTHORS,BJU,CHRONIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
200,ALBUMIN,INHIBITION
126,ANNEXIN,DOC,DOCETAXEL,MCNCS,MESOPOROUS,MTT,PGA,T24
170,275,BCA,DEVELOPING,FUNCTIONAL,HRQOL,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,PSYCHINFO,PURPOSE,RESULTS
004,034,100,160,193,200,300,600,COLLEGE,COX,GRADE,MEDICAL,OMC,OSAKA,THERAPY
169,CHO,COPYRIGHT,ECD_FGFR1A,ECD_FGFR1B,ECD_FGFR2A,ECD_FGFR2B,ECD_FGFR3A,ECD_FGFR3B,ECD_FGFR4A,ECD_FGFR4B,FGFRS,FIBROBLAST,INC,WESTERN
169,316,CBCTS,COLLEGE,CONCLUSION,COPYRIGHT,CTV,D95,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,RESULTS,ROYAL,SET
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,T24,UROVYSION
177,BACKGROUND,BETWEEN,COLOR,CONCLUSION,DOPPLER,EARLY,INSTITUTES,LABEL,METHODS,RESULTS,SEPTEMBER,THYROID,TKI
109,183,201,726,ACCEPTANCE,COMPARISON,GREEN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SERBIAN
001,006,008,009,028,041,199,213,399,AAS,ARG,CAUCASIAN,HOWEVER,MNSOD,MPO,PBL,SEM,THEIR,THESE,XRCC1
177,504,CHINESE,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RCP,RESULTS,SPARING,THERE,WHOLE
126,ACTUARIAL,CCI,CISPLATIN,CKD,COCKCROFT,EPI,GAULT,OLDER
10878,ADVERSE,BACKGROUND,BEGINNING,FORTY,GYE,LABEL,MAY,METHODS,PHOENIX,RESULTS,T1B,T3BN0M0
121,138,937,AUC,BLADDER,SUCCESSIVE
BCG,CIS,CLOSE,COMPARING,INCIDENCE,JANUARY,MEDLINE,PAPILLARY,PSA,RCC,REPORTS,TCC,UPPER,UUT
ENDOSCOPIC,HOWEVER,THERE,THROUGH,UROTHELIAL
MINIMALLY,THERE
BLADDER,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
BCA,EMT,EXPRESSION,NMIBC,NOV,SILENCE,USING,WHETHER
109,ADHERENCE,AUA,END,FORTY,NMIBC,RESULTS,UROLOGICAL,YET
956,AAG,AKT,BAD,HSP,HSP70,HSP90,PCR,PFT,T24
OTHER,THERE
CD11C,EXCISIONAL,HLA,INCREASED,LEUKOCYTE,PERIPHERAL
001,125,169,215,233,AUTHORS,BCG,BJU,CONCLUSION,GRANULOMA,LABEL,MATERIALS,MEIER,METHODS,NMIBC,OBJECTIVE,OTHER,RESULTS
CTC,NON,THERE
007,014,128,158,1ST,239,2ND,3RD,BCG,INJECTION,RECURRENCE,RFI,RFR,WATER,WFI
001,090,105,139,147,150,199,213,279,283,367,444,AMONG,BACKGROUND,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,THESE,UCS,URINE
001,APOPTOSIS,MTT,TCC
001,002,007,013,032,039,159,ALDH1,ALDH1A1,BACKGROUND,CARCINOMAS,LABEL,MATERIALS,METHODS,RESULTS,TAKEN,THESE,TMA,UCS,UROTHELIAL
BACKGROUND,BLADDER,ENDOSCOPIC,LABEL,METHODS
DESPITE,SCARAMANGA
TEAMSTEPPS
786,FOLLOWING,MMP,RCC,THESE
009,102,169,302,594,658,CCNB1,COX,FANCONI,FINALLY,FOXM1,IVT,LABEL,METHODS,NMIBC,OBJECTIVE,PURPOSE,RESULTS,VARIOUS
946,AMP,DR4,DR5,FAS,FLICE,FLIPL,FURTHER,HOWEVER,METFORMIN,RT4,TAKEN,TRAIL
125,169,853,904,956,ANG,AUROC,BACKGROUND,CA9,ELISA,IL8,LABEL,METHODS,MMP10,NMIBC,RESULTS,ROC,UROVYSION,VEGFA
400,900,AFTER,BLADDER,COLOR,CSF,DIGITAL,GRADE,LABEL,LKR,PATIENT,RADICAL,RESULTS,UNLABELLED
010,030,039,211,FUDAN,LDH,PFS,PRIMARY,SCC,SERUM,UNIVERSITY
001,010,022,024,169,231,261,323,346,ADULT,BACKGROUND,BLADDER,CCS,CLAVIEN,CONCLUSION,COPYRIGHT,III,INC,LABEL,METHODS,PANEL,PROGRAM,RESULTS,THIRD,TREATMENT
001,006,100,169,212,CONCLUSION,COPYRIGHT,COX,HRS,IGF1R,INC,LABEL,MEMBRANOUS,METHODS,OBJECTIVE,RESULTS
125,240
165,169,APRIL,AUTHORS,BJU,CLAVIEN,DINDO,ERP,JANUARY,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,ORC,RESULTS
DBNRR,LCNRR,NRR
279,946,BACKGROUND,BECAUSE,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,THERE,THESE,USING
000,178,185,200,215,900,956,AFTER
AMONG,BACKGROUND,BLADDER,HOWEVER,IAC,LABEL,MAY,METHODS,RESULTS
023,042,ACCORDING,BACKGROUND,LABEL,MATERIALS,METHODS,QOL,QUALITY,RELATED,RESULTS,THERE
001,ATC,AUSTRALIA,AUSTRALIAN,BACKGROUND,BENEFIT,DAILY,DDD,DEFINED,EMA,FDA,HOWEVER,JANUARY,LABEL,MAY,MEDICINES,METHODS,MINOR,PBS,RESULTS,SEPTEMBER,TGA,WORLD
169,ALA,APOPTOTIC,COPYRIGHT,EMPLOYING,OVERALL,PDT,SILYBIN,SILYBUM,T24,TALALAY,THERAPY,USING
ESS,EWING,HPF,THREE
169,COPYRIGHT,IRELAND,LTD
100,177,APRIL,FUB,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TUR
169,185,515,840,BLADDER,CONCLUSION,COPYRIGHT,CYSTOSCOPY,DETECTION,INC,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,RESULTS
129,160,169,233,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,NONMUSCLE,OBJECTIVE,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,UROLOGICAL,USING
160,169,476,620,856,ANOVA,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
169,EPIDERMAL,HOWEVER,INC,WILEY
001,169,177,180,561,AGL,BACKGROUND,BLADDER,LABEL,MEIER,METHODS,PRESS,PUBLISHED,RESULTS,STUDENT,UMUC3,UNIVERSITY,USING
169,CONSISTENT,FURTHER,INC,MET,MTT,THESE,TUNEL,WILEY
160,AKT,BCL,HOWEVER,NAC,ROS,T24,TAKEN,THEREFORE,TREATMENT
100,150,363,APRIL,DFS,DSS,MARCH,MAY,PROPENSITY,SEVENTY,THESE
BLADDER,HOWEVER
112,177,248,274,432,982,AMONG,EXCEL,JANUARY,LNS,MICROSOFT,PARTICULAR,RESULTS,SEPTEMBER,SIMILARLY
119,174,176,BRS,GRADE,HIVEC,LABEL,MATERIALS,METHODS,MMC,NMIBC,OBJECTIVE,PURPOSE,RESULTS,THS,TREATMENT,TURBT,UTI
BLADDER,ELISA
002,023,024,028,031,138,144,149,156,172,177,193,241,291,810,NIMBC,NLR,NMIBC,PLR,TABLE,THERE
129,186,BACKGROUND,CIS,CONCLUSION,DOR,HOWEVER,LABEL,MEDICAL,METHODS,METHYLATED,RESULTS,SEPTEMBER,STUDIES,SUMMARY
169,AUTHORS,CSF,GIVEN,LTD,RAPID,SIMILARLY,WILEY
ARSENIC,SEVERAL,STUDIES
100,169,368,CHANGES,GIVEN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TIS
BECAUSE,EMAST,MSI
233,552,AFTER,BACKGROUND,LABEL,PCR,PRINCIPAL,RESULTS,UCC
AFTER,BACKGROUND,CONCLUSION,FAS,LABEL,MMC,PCR,RESULTS,TURBT,UNDER,UROTHELIAL
BLOOD,GIL,SOCIETY,THERE,WHILE
BASED,BLADDER,HOWEVER,MTT,T24
652,DESPITE,FDA,PDT,THERAPY,THEREFORE,WST
BACKGROUND,ENDOSCOPIC,GROSS,LABEL,METHODS,RECURRENT,TCC
946,CD105,GREATER,HOWEVER,HSP27,LABEL,MET,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
110,115,125,140,169,5CC,945,946,AUTHORS,COPYRIGHT,D50,DIL,INC,KUTCHER,LABEL,LYMAN,MARSDEN,MATERIALS,METHODS,OBJECTIVE,POISSON,PTV,PUBLISHED,PURPOSE,RESULTS,TCP,TEN
169,BOARD,CBCTS,COPYRIGHT,DIR,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,MLT,OBJECTIVE,PCT,PURPOSE,RESULTS,STUDENT
169,BACKGROUND,COPYRIGHT,ENGLAND,FIRSTLY,LABEL,LTD,METHODS,POPULATION,RESULTS
AUROC,BACKGROUND,BASED,CONCLUSION,ELISA,IL8,LABEL,QUANSYS,RESULTS,VEGFA
002,034,038,135,169,AKT,AUTHORS,DOC,ERK,KNOCKDOWN,LTD,MTT,PTY,PUBLISHING,RAS,SCIENCE,UCB,WILEY
012,038,049,169,AFTER,ASSESSMENT,FUNCTIONAL,LABEL,METHODS,NIGHT,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,THERAPY,TREATMENT,UROLOGICAL,WOMEN
000,100,110,183,698,743,ASSESSMENT,AUTHORS,BACKGROUND,CANCERLIT,CCMED,CENTRAL,COLLECTION,CONTROLLED,DENNERT,HOWEVER,ISSUE,LABEL,MEDLINE,METHODS,NEWCASTLE,OBJECTIVE,OBJECTIVES,PREVENTION,QUALITY,RCT,RESULTS,REVIEWS,SCALE,SELECTION,SYSTEMATIC,THESE,TRIAL,VITAMIN
101,233,241,4N0M0,BACKGROUND,CUMULATIVE,FEW,LABEL,METHODS,RESULTS,RNU
100,CROSS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,THERE,UROLOGISTS
160,169,233,AUA,CIS,COPYRIGHT,CURRENT,EDUCATION,EORTC,HOWEVER,INC,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,UROLOGICAL
111,125,169,186,CEA,COPYRIGHT,COX,FURTHER,INC,LABEL,LABORATORY,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RFS,UCB,USING
100,169,AFTER,BLADDER,CONCLUSION,COPYRIGHT,EIGHT,FERRC,ICG,INC,LABEL,LYMPHATIC,MESENTERIC,METHODS,OBJECTIVE,RESULTS,TEN
005,023,048,169,482,AFTER,BACKGROUND,BENEFIT,CENTRAL,CONTEXT,CONTROLLED,COPYRIGHT,DFS,DSS,LABEL,MEDLINE,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,SOCIETY,SUMMARY,SYNTHESIS,THERE,UROLOGY
111,113,148,159,169,307,388,AFTER,ARO,ART,BACKGROUND,COPYRIGHT,COX,HOWEVER,LABEL,LOCAL,METHODS,NEITHER,OBJECTIVE,OUTCOME,PATIENT,PCA,PFS,PUBLISHED,RESULTS,SETTING,SUMMARY,THREE,UROLOGY
221,ELECTRONIC,FURTHER,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCA,RESULTS
110,177,180,247,260,290,ABO,ACCORDING,CONCLUSION,DISEASE,HOWEVER,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PARAMETERS,PURPOSE,RESULTS,SEPTEMBER
004,016,020,200,286,294,BCG,BONFERRONI,HOWEVER,LABEL,NAD,PCR,UNASSIGNED,VARIANT
034,295,HOWEVER,HPV,KOREANS,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,P16,RESULTS
ABOUT,METASTATIC
BACKGROUND,BLADDER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,169,341,792,965,AUTHORS,BJU,CLAVIEN,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,RCS,RESULTS,USA
009,013,017,047,049,119,169,398,517,BACKGROUND,CONCLUSION,COPYRIGHT,COX,LABEL,LTD,METHODS,RESULTS,STAGE,UCB,VALIDATION,WOMEN
142,169,233,BACKGROUND,BCG,C57BL,CD8,COMPARABLE,COMPARISON,CONNAUGHT,COPYRIGHT,LABEL,MEIER,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,OUTCOME,PATIENT,PUBLISHED,RECURRENCE,RESULTS,SETTING,SUMMARY,TREATMENT,TRIAL,WHETHER
AFM,RT4,T24,WHILE,YOUNG
169,3BP,C155858,FINALLY,LACTATE,MCF,MCT,TCA
013,047,131,205,223,274,AFTER,CPG,EPIGENOME,HNSCC,SUBSEQUENT,THESE,USING
176,177,ANATOMICAL,AVERAGE,BSD,CEM43,ELLIPSE,LABEL,MATERIALS,METHODS,MMC,OBJECTIVE,PURPOSE,RESULTS,SIGMA,USING
BCG,CONNAUGHT,THERE
130,169,176,BACKGROUND,C000000093,COMMITTEE,IDENTIFIER,LABEL,MEDICAL,METHODS,MONITORING,NAC,PRESS,PUBLISHED,RESULTS,SECONDARY,SOCIETY,UNASSIGNED,UNIVERSITY
001,169,563,AFTER,ALDH2,AUTHORS,BJU,COX,HAMPSHIRE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,USA,VCAM1,XRCC4
EXPRESSION,GST,HOWEVER,LOCAL,NAT,UGT,XME
DESPITE,RADICAL,THEREFORE
300,500,946,956,CCND1,DAC,ELISA,MEANWHILE,MYC,PCR,T24,TSA,WIF,WNT,WST
169,ADDITIONAL,AFFAIRS,BACKGROUND,CENTRAL,COX,EPIGENETIC,LABEL,METHODS,RESULTS,SAS,SOCIETY,VPA
215,BLADDER,EZR,FOXF2,FURTHER,INSTITUTE,PRESS,PUBLISHED,RSPH3,SNP,TAGAP,UNIVERSITY
169,946,COPYRIGHT,EMT,FINALLY,IRELAND,LTD,TAKEN,WNT
169,379,APO,BLADDER,COPYRIGHT,FURTHER,INC,WESTERN
169,COPYRIGHT,GOVERNMENT,HOWEVER,INDIA,LTD,PUBLISHED
169,176,180,360,548,COPYRIGHT,CTV,CYBERKNIFE,FIXED,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLANNED,PURPOSE,RESULTS
016,101,102,169,6GY,CIMRT,COPYRIGHT,GROUP,HIMRT,INC,LABEL,MATERIALS,MEN,METHODS,MINIMIZING,OBJECTIVE,R64,RADIATION,RESULTS,THERAPY,THERE
014,022,048,169,177,198,214,CD4,CD8,COPYRIGHT,COX,FINALLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,V65
001,042,160,169,953,COPYRIGHT,COX,FACTORS,HISPANICS,III,INC,INSTITUTE,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RECEIPT,RESULTS,THESE,UPSTAGING
169,177,1KG,8CM,APRIL,BACKGROUND,CLAVIEN,COPYRIGHT,LABEL,LYMPH,METHODS,OBJECTIVE,OUTCOME,PATIENT,PROCEDURE,PUBLISHED,RESULTS,ROBOTIC,SETTING,SIX,SUMMARY,UROLOGY,VINCI
100,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UROTHELIAL
139,463,BACKGROUND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RELATIVELY,RESULTS
RAMAN,WHILE,WHITE
125,SEEDS,SUCCESSFUL
ADMISSION,BACKGROUND,CONCLUSION,CSF,DWI,EXTENSIVE,IMAGE,INPATIENT,LABEL,METHODS,MRI,OBJECTIVE,REPORTS,RESULTS,SETTING,T10
ADDITIONAL,ALTERATION,GATA4,THESE,UROMEDIUM
109,160,169,177,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVEN,THERE,UROLOGICAL
169,ATP,BBN,BESIDES,COPYRIGHT,CURIOUSLY,LIPIDOMIC,OVERALL
169,233,BCG,COPYRIGHT,IRELAND,LTD,NOS,SEVERAL
169,COPYRIGHT,LTD
160,169,945,947,BLADDER,CONSISTENT,COPYRIGHT,DCS,DESPITE,FEDERATION,FOXP3,IFN,MHC,OVERALL,PUBLISHED,SOCIETIES,ST6GALNAC1,STN,TH1,TNF
169,215,COPYRIGHT,INC,T24,UNDER
103,125,169,177,183,308,CONCLUSION,COPYRIGHT,INCIDENTAL,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
169,COPYRIGHT,ECM,INC,PERIOSTIN
160,169,COPYRIGHT,CTV,D2CM3,D90,IMAGE,INC,IVA,LABEL,LOCAL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THREE
001,011,034,119,169,176,213,519,BCS,COPYRIGHT,INC,LYMPH,MMP,RESULTS,SERUM
116,169,1990S,2000S,233,AUTHORS,BJU,CONCLUSION,FACTORS,FICHIER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,PREDICTORS,RESULTS,TURBT
169,BACKGROUND,CLOSE,COPYRIGHT,CYSTOSCOPY,CYTOLOGIC,INC,LABEL,METHODS,RENAL,SEPTEMBER,UROTHELIAL
CURRENTLY,DETAILS,SEVEN
208,ACCORDING,BACKGROUND,CLASS,DISCUSSION,DIVIDED,EARLY,FOLLOWS,III,LABEL,METHODS,OBJECTIVE,PERFORMED,PIVER,PRS,RATIONALE,RESULTS,SMITH,SURGERY,UNLABELLED
CURRENT,EARLY,FURTHER,NBI,QUESTIONS,TUR,WLI,WOULD
956,CYTOMETRY,HOWEVER,PCR,REDUCED,RT4,THEREFORE,TREATMENT
100,177,395,705,ATP,CA2,CB1,GPR55,HCV29,PCR,SEM
169,COPYRIGHT,PDT,T24
169,444,537,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,NSCLC,RESULTS
160,BACKGROUND,CONCLUSION,LABEL,METHODS,RADICAL,TURBT
236,BACKGROUND,BIVARIATE,COX,DSS,HOWEVER,LABEL,MEIER,METHODS,MTUS1,RESULTS,RT112,SEVENTY
CLINICALLY,EPIGENETIC,REVERSIBLE
042,BACKGROUND,CHRISTIAN,CONCLUSION,DEPARTMENT,IHC,LABEL,MAY,METHODS,RESULTS,UCB,UROLOGY
945,A231G,CCAAT,EBP,HOWEVER
080,230,232,2D6,374,464,582,AFTERNOON,BACKGROUND,CYP,LABEL,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,RESULTS,THM
450,750,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,THERE,V95,V99
EVALUATION,HWANG
003,005,447,709,784,849,BACKGROUND,CONCLUSION,CSS,LABEL,METHODS,NLR,RCC,RESULTS,RFS
001,004,005,015,256,ASA,BASEL,CLAVIEN,DINDO,III,LABEL,MATERIALS,MEDICAL,METHODS,MORBIDITY,OBJECTIVE,RESULTS,SOCIETY,URINARY
BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,RESULTS,THESE,VICRYLE,VINCI
111,160,169,954,COPYRIGHT,DIFFUSION,EDUCATION,FINAL,GLEASON,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCA,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SECONDARY,TESLA,THREE,UROLOGICAL
945,946,BACKGROUND,CTC,DISCUSSION,DUE,IDENTIFIER,III,IPI,LABEL,METHODS,NCI,PFS,PRIMARY,PSA,QOL,RADIATION,SECONDARY,TRIAL
954,956,AIM,BIU87,IGFBP,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,WESTERN
CTC,FDA,SINCE
LABEL,NMIBC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TOBACCO
AFTER,BCG
954,DCE,DYNAMIC,LABEL,MATERIALS,MCNEMAR,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,T2W
169,3T3,6MG,945,CISPLATIN,COMBO,COPYRIGHT,EVANS,GMP,NIH,SMA,TAF,TUNEL,UMUC3
169,BILIARY,COPYRIGHT,CURRENTLY,END,GIVEN,III,INC,RESULTS
169,BECAUSE,HOWEVER,MMP,MOLECULAR,UROLOGICAL
162,BETWEEN,COX,DFS,DSS,INDEX,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PREDICTORS,PURPOSE,RESULTS,UCB
BMJ,CASES,GROUP,LABEL,LIMITED,METHODS,NPV,OBJECTIVE,PPV,PUBLISHED,PUBLISHING,RESULTS,SEN,TURBT
1ST,2ND,BPV,THESE,VACCINE
145,266,357,363,405,496,561,688,773,779,845,948,FGFR3,HRS,MUTATIONS,NOTABLY,RRS,STUDIES
006,035,112,169,BACKGROUND,COX,DSS,LABEL,MEIER,METHODS,RESULTS,SOCIETY
108,160,ANOTHER,AVERAGE,BPT,FIFTEEN,HYPOTHESIS,LABEL,LOWER,METHODS,OBJECTIVE,PGS,PROLONGED,PRSGT,RESULTS,SIXTEEN,TUMOURS
001,004,014,023,042,045,395,453,623,726,763,BACKGROUND,BASED,COX,LABEL,METHODS,PROTEIN,RESULTS
169,COPYRIGHT,EGF,EPIREGULIN,ERBB1,ERBB2,ERBB3,ERBB4,LTD,NEU,THEREFORE
132,169,BCA,COPYRIGHT,EXPRESSION,FURTHER,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS
10878,116,131,169,247,2GY,5CC,5GY,7GY,AUC,BACKGROUND,COPYRIGHT,DSH,DUE01,DVH,IRELAND,LABEL,LTD,MATERIALS,METHODS,MVA,OBJECTIVE,PURPOSE,RESULTS,SCORE,SIMILAR
160,169,AUTHORS,CD4,CD8,COPYRIGHT,INC,JAK,PUBLISHED,S1PR1,STAT3
047,117,169,177,ACCEPTABLE,COPYRIGHT,DOSIMETRIC,INC,MCO,MEDICAL,MINIMIZING,NAVIGATED,NUCLETRON,PUBLISHED,RAYSEARCH,RAYSTATION
001,137,143,169,277,AES,ALVIMOPAN,BACKGROUND,COPYRIGHT,LABEL,LOS,METHODS,OBJECTIVE,OUTCOME,PATIENT,POI,RADICAL,RESULTS,SETTING,SUMMARY,TRIAL,UROLOGY
001,169,ANCTS,COPYRIGHT,EXPRESSION,IHC,LAK,NMIBC,PBK,PCR,PDZ,USING
151,169,301,BETWEEN,CHINESE,COPYRIGHT,EORTC,LABEL,LTD,METHODS,NMIBC,OBJECTIVE,OCTOBER,RESULTS,TURBT
001,100,102,169,177,390,AFTER,COPYRIGHT,FIFTY,INC,LABEL,MATERIALS,METHODS,NLR,NOC,OBJECTIVE,OVERALL,RESULTS,UNIVERSITY,WISCONSIN
169,177,AIM,BACKGROUND,CHANGES,CHINA,CONCLUSION,LABEL,METHODS,OBJECTIVE,OUTCOME,QUALITY,RADICAL,REDUCED,RESULTS,SHORTENED,SOCIETY,TREATMENT,VAGINAL,WHILE
1990S,450,CYP,DME,GST,HENCE,HOWEVER,LEBANON,NAT,PHASE,THERE
127,AMONG,BETWEEN,FOLLOWING,OCTOBER,T4AN0M0,THESE
970,AFP,CARCINO,SUBSEQUENT
001,016,139,COX,HOWEVER,MEIER,NEUROPILIN,NRP,PCR,STUDENT
ERK,HOECHST,HOWEVER,MEK,MTT,PKA,RAF,SER,T24,TCC,UO126,WESTERN
001,249,415,835,850,BP1,COX,RAPAMYCIN,RT4,TMA
005,125,169,956,ALLYL,BECAUSE,COPYRIGHT,DUE,HOWEVER,RT4,T24,THEREFORE
HIGGINS,OVERALL,SRR,THERE
064,MRE11,MRN,PCR,PREDICTIVE,RAD50,THERE
SEVENTY
023,135,141,161,169,184,276,278,583,782,861,BACKGROUND,CONCLUSION,INSURANCE,JANUARY,LABEL,MALIGNANCY,MATERIALS,METHODS,PHYSICIANS,PRESS,PUBLISHED,RESULTS,SPM,UNIVERSITY
001,009,186,256,BACKGROUND,CSS,LABEL,METHODS,MRE11,NGS,RESULTS,SNP
OCT
ALREADY,EP300,EPIGENETIC,KDM6A,ONCOGENIC,SIMILARLY,SMARCB1
215,AMONG,CLDN7,ECM,LPHN2,PDGFA,PTPRF,SEQ,UCB,UROTHELIAL,VEGFA
116,344,ADDITIONAL,AFTER,AIP,COX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
100,169,COPYRIGHT,ECLIPSE,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PLANS,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,SIXTY,SOCIETY,STUDIES,SYSTEMS,THERE
169,COMMISSION,COPYRIGHT,FRACTIONAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,UNITS
011,039,084,104,169,234,AIEOP,BACKGROUND,FIRST,GREATER,INC,IQR,ITALIAN,LABEL,METHODS,RESULTS,SEC,WILEY
DESPITE,KNOWLEDGE,MMC,NMIBC,STRATEGIES
215,BACKGROUND,LABEL,METHODS,MSC,PROTECTION,RESULTS,THESE
009,027,046,ACUTE,APRIL,BACKGROUND,BETWEEN,BOWEL,CONCLUSION,FAMOTIDINE,GRADE,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
MANAGEMENT,NMIBC
AAG,EPIGENETIC,HDAC6,HDACS,HOWEVER,HSP90,SINCE,TUBACIN,TUBASTATIN
184,202,632,BACKGROUND,BLOOD,CONVERSELY,CTC,FURTHER,HOWEVER,IRB,LABEL,METHODS,MRI,RESULTS
BLADDER,CIGARETTE,DELAYED,FATIGUE,FBC,FRANK,HAEMATURIA,HOWEVER,OTHER,PSA,SUGGESTED,UROTHELIAL
BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS
ASIAN,BACKGROUND,CONCLUSION,EBV,EPSTEIN,LABEL,LELBC,METHODS,WORLD
946,CONCLUSION,EXPRESSION,LABEL,METHODS,OBJECTIVE,RESULTS,RT4
001,006,007,018,020,038,043,106,118,254,COX,DGCR2,OVERALL,SIXTY,USP18
AFTER,BLI,NMIBC
169,BACKGROUND,BECAUSE,CONTEXT,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OPTIMAL,PATIENT,PUBLISHED,RESULTS,SUMMARY,SYNTHESIS,THERE,TMT,TREATMENT,UROLOGY
160,169,CONCLUSION,COPYRIGHT,CTV,D90,FORTY,GRADE,HDR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RELAPSE,RESULTS,SIXTEEN,SOCIETY,TEN
003,131,169,1ST,210,AEU,BCG,CIS,CONCLUSION,COPYRIGHT,HOWEVER,IQR,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,TUR
CUTANEOUS,HISTOLOGIC
001,BACKGROUND,LABEL,LOWER,METHODS,RESULTS,WHILE,WOMEN
169,AIM,BACKGROUND,IMS,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,RESULTS,THESE,WILEY
169,AIM,BACKGROUND,CARCINOMA,CHINA,CHRONIC,CURRENT,GIVEN,INDIA,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,RESULTS,SALMONELLA,SCHOLAR,SCIENCE,SOUTH,WEB,WILEY
169,754,ACCORDING,AUTHORS,BJU,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RNU,UNIVARIATE
169,581,AUTHORS,BJU,CONSOLE,GLEASON,LABEL,MATERIALS,METHODS,OBJECTIVE,PROPENSITY,RESULTS,RETZIUS,THERE
000,100,169,255,724,ABOUT,AFTER,ANALYSING,HOWEVER,THEREFORE,USA,VCH,WILEY
ALZHEIMER,CHASE,CHEVY,INCIDENCE,SMALL,WAR,WASHINGTON,WORLD
001,015,100,200,BLACK,CONCLUSION,HRQOL,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,PURPOSE,RESULTS,SCALE,THESE,UTILITY,WHITE
021,233,277,476,520,742,834,AMONG,BACKGROUND,KNOWLEDGE,LABEL,PCR,PRINCIPAL,RESULTS,TAIWANESE,UCC
169,954,BLADDER,COPYRIGHT,ERK,FURTHER,LTD,RT4,T24,UNCARIA
BLADDER
000,001,100,ASR,BACKGROUND,BLADDER,EDUCATION,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,UROLOGICAL
001,439,509,535,AMONG,BMI,FURTHER,HDL,HISTOLOGIC,LABEL,MARCH,MATERIALS,METABOLIC,METHODS,NON,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,TNM,TUR,UCB,WORLD
AIM,BACKGROUND,BLADDER,CTL,ERK,HOWEVER,LABEL,LPS,METHODS,MTT,OBJECTIVE,PD98059,RESULTS,T24,TARGETING,UBC
BRAIN,DIFFUSION
13527,19191,32718,ARMED,COMPARISON,CONCLUSION,DEPARTMENT,INSTITUTE,LABEL,METHODS,OBJECTIVE,PATHOLOGY,RAWALPINDI,RESULTS,TUMOURS
112,169,BACKGROUND,CAUTION,LABEL,METHODS,OTHER,RESULTS,SOCIETY,TETRASOMY,UROVYSION,USING
ANNEXIN,BLADDER,E1A,HOWEVER,REVERSE,SIMILARLY,T24,TRAIL,TUNEL,WESTERN
169,184,425,921,CHARLOTTE,COPYRIGHT,EDUCATION,EFFORTS,INC,LABEL,MATERIALS,METHODS,NORTH,OBJECTIVE,PREMIER,PUBLISHED,PURPOSE,RESULTS,SURGERY,UROLOGICAL
160,169,233,COPYRIGHT,EARLY,EDUCATION,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,USING
001,178,456,591,BACKGROUND,BECAUSE,CIS,HRS,INCREASED,LABEL,METHODS,RESULTS,THERE,WANFANG
169,ALA,AUTHORS,BLADDER,BTA,HOWEVER,LTD,NMP22,PTY,PUBLISHING,SCIENCE,THERE,THREE,URINE,WILEY
001,177,AREAS,CONCLUSION,DIL,INTENSITY,KNOWLEDGE,LABEL,METHODS,MRI,NTCPS,OBJECTIVE,RESULTS,TCP
DOX,SINOMENIUM
001,004,005,169,AIM,BCG,CELLSEARCH,COX,CTC,EORTC,FDA,MEIER,NMIBC,STAGE,TFR
BECAUSE,RANDOMIZED,THERE,THESE
133,169,199,253,AUSTRALIAN,BACKGROUND,BVI3000,BVI9400,COLLEGE,LABEL,METHODS,RESULTS,ROYAL,TREATMENT,ZEALAND
EXTENSIVE,LOCAL
RADIOLOGIC,THESE,TOTAL
038,CONCLUSION,KTP,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,PVB,RECURRENCE,RESULTS,TURBT
009,177,AMONG,CONCLUSION,EORTC,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,ONB,PURPOSE,RESULTS,TREATMENT,TUR
000,001,006,032,100,AGNOR,CONCLUSION,CUT,FIFTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC
001,500,956,CONCLUSION,HAASE,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TCC,THEREAFTER
138,CASPASE,CONVERSELY,COX,LABEL,LIVIN,MEIER,METHODS,NMIBC,OBJECTIVE,PURPOSE,RESULTS,RFS,TIS
892,952,BACKGROUND,BISULPHITE,CIS,CPG,LABEL,METHODS,ORS,RESULTS
001,108,369,374,402,535,657,784,BACKGROUND,ENGLISH,FURTHER,JANUARY,LABEL,METHODS,RESULTS
116,FINALLY,RESULTS
100,215,BACKGROUND,BETWEEN,BLADDER,DISCUSSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PLACEMENT,PURPOSE,RESULTS,SET,TUR
001,027,032,160,169,410,BLADDER,COPYRIGHT,COX,EDUCATION,GIVEN,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,TORONTO,UNIVERSITY,UROLOGICAL,WHILE
169,183,233,947,BCG,BRITISH,EFFECTIVE,IFN,IMMUNOLOGY,INDUCTION,LUC,PBS,REMARKABLY,S12,SOCIETY,TH1,THESE,TREATMENT
100,177,ART,CTS,CTV,DSC,LABEL,LARGE,METHODS,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS,SIEMENS,THREE,V45GY,V60GY
AFTER,BLAND,CBCTS,DSC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SDE
160,945,946,CRT,HOWEVER,THESE,TREATMENT,UEA,USING,UTR
169,898,AUC,CONCLUSION,DEPENDING,LABEL,METHODS,OBJECTIVE,PROTEASES,PURPOSE,RELEVANCE,RESULTS,ROC,SAMPLES,SOP,VCH,WILEY
169,APRIL,BACKGROUND,BETWEEN,GRADE,GYE,IIB,IVA,LABEL,METHODS,RESULTS,SOCIETY,TOTAL
169,CELLS,ILK,LIM,LIMD2,STRUCTURAL
008,104,160,196,686,BMI,BRICKER,FIFTY,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STRICTURES,THERE,WALLACE
147,409,ACM,BLADDER,COMMITTEE,CONSORTIUM,CSM,HOWEVER,JOINT,KOREA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOUTH,TABLE
000,220,469,479,791,838,BACKGROUND,COSTS,GBC,LABEL,LUS,METHODS,QALWS,RESULTS,ROUTINE,UNTIL
100,160,177,BACKGROUND,BTREF,BTRRS,CONCLUSION,DESPITE,DVH,ESTRO,FINALLY,GEC,IIB,LABEL,MATERIALS,METHODS,MRI,OAR,OBJECTIVE,PURPOSE,RESULTS,RRS,RRS25,RRS70
BMI,CIS,COX,FOLLOWING,HOWEVER,HRS,LITHUANIAN,SMOKING
ASM,ATLAS,DMR,FURTHER,USING
169,BCR,BRITAIN,COPYRIGHT,FGFR1,FGFR2,FGFR3,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
954,BACKGROUND,LABEL,METHODS,NUCLEAR,PAL,RESULTS,THESE
100,150,181,200,AG490,MCC,MYC,NON,SIRT1,STAT3,TCC
257,527,ADEQUATELY,CIS,FOLLOWING,HRS,LABEL,LIBRARY,LVI,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
000,001,007,088,210,443,818,842,BACKGROUND,DFS,HNSCC,LABEL,MIR,PFS,PRINCIPAL,RESULTS,RFS,WHILE
215,269,602,AMONG,BLADDER,COX,MEIER,NMIBC,PROGNOSTIC,UBC
AFTER,DFI,EORTC,FORTY,ICLMH,LABEL,METHODS,NMIBC,OBJECTIVE,PATIENT,PURPOSE,RESULTS,TREATMENT
945,GLUT1,HK2,HOWEVER,INHIBITION,KNOCKDOWN,SRC,STEROID,UBC,WARBURG
169,AKT,COPYRIGHT,CXCL5,INC,PCR,SNAIL,T24,THESE,WESTERN
00775,160,169,COPYRIGHT,CRYSTAL,CURRENTLY,EXCLUSION,INHIBITION,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,UNDER,USING,WITHOUT
001,169,457,510,BLADDER,CARCINOMA,CONCLUSION,COPYRIGHT,INC,INDIANA,LABEL,METHODS,MPV,OBJECTIVE,PCV,PEARSON,PSM,RESULTS,UNIVERSITY,USING
BLADDER,MICRORNAS,UBC
002,009,026,027,BNIP3,CACNA1A,CACNA1G,CCND2,COX,H2AFX,ID4,PRDM2,RECURRENCE,RUNX3,SFRP4,SFRP5,TIMP3,TSG,UNIVARIATE
AMNIS,BLADDER,FINALLY,IDEAS,PKH,USING
CDC20,CYTOSCAPE,DAVID,EXPRESSION,FINALLY,OMNIBUS,OVCAR,PCR,PPI,RAS,RASSF1A,STK
001,006,008,043,103,126,236,244,285,299,359,506,510,579,735,822,962,967,DISEASE,DSS,III,IVA,LABEL,METHODS,MFS,OBJECTIVE,PURPOSE,RESULTS
10B,INCREASED,LUCIFERASE,MEANWHILE,MMP14,PCR,SILENCING,TARGETING,THESE,TRANSWELL
BASED,IGG
169,967,EXPRESSION,HMGA2,HUC,KENDALL,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,WILEY
169,BIOMETRIC,QUIGLEY,SOCIETY,WHILE
000,100,ASR,BACKGROUND,CANCERS,CASABLANCA,CONCLUSION,FEW,HODGKIN,LABEL,METHODS,MOROCCO,RESULTS,STAGE,THESE,TUMOURS
ALDH1
945,954,BECAUSE,EBP,TAKEN
169,1970S,DESPITE,HOWEVER,INSTEAD,MEDICAL,PRESS,PUBLISHED,SOCIETY,THERE,UNIVERSITY
115,LABEL,METHODS,OBJECTIVE,RESULTS
DESPITE
188,188RE,AIM,CONCLUSION,DERMO,LABEL,METHODS,OBJECTIVE,PAGET,RESULTS
EARLY,FDG,METHODS,PET
DOTANOC,PET,URINARY
18FDG,LABORATORY,PET
160,169,448,COPYRIGHT,CTV,GIVEN,LIBRARY,LTD,MEDLINE,OAR,ORGAN,POPULATION,POTENTIAL,PTV,PUBLISHED,SCIENCE,THESE,UTERINE,WEB
181,956,AGS,DHA,HOWEVER,J82,MES,MRC,UNDER
HONEY,THESE
FURTHER,MCL,T24,TAKEN,TRAIL
108,169,400,956,ELONGATED,LABVIEW,SIX
CLINICIANS
138,586,DIFFICULTY
AIM,CONCLUSION,DFS,DISEASE,FIG,JANUARY,LABEL,MATERIALS,MEIER,METHODS,MRI,OBJECTIVE,RESULTS,STRUCTURES,THERE,UROLOGICAL

001,003,004,099,162,464,746,916,COX,LABEL,MEIER,METHODS,NMIUC,OBJECTIVE,PCR,PRIMARY,PURPOSE,RESULTS
INTRAMURAL,ORTHOTOPIC,PBS,UC1,UC3,USING
169,177,1CM,377,BACKGROUND,BLADDER,COPYRIGHT,CTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE,VARIATIONS
169,1CM,267,3MM,490,4MM,BMI,CONCLUSION,COPYRIGHT,DAILY,IRELAND,LABEL,LEVEL,LTD,METHODS,OBJECTIVE,PCA,PTV,PURPOSE,RCS,RESULTS,THESE,WITHOUT
165,169,BACKGROUND,CANDIDATES,CONCLUSION,COPYRIGHT,INC,LABEL,MAXIMAL,METHODS,RESULTS,TUR
169,COPYRIGHT,DUE,INC
124,4T1,AIM,CONCLUSION,F11,JAA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THESE,THOMSEN
AMONG,COX,FEW,INSURANCE,LABEL,METHODS,NHI,OBJECTIVE,OBJECTIVES,RESULTS,TAIWANESE
160,174,177,277,550,CONCLUSION,D30,D50,D60,HOWEVER,LABEL,MATERIALS,MEDICAL,METHODS,MUS,OAR,OBJECTIVE,PTV,PURPOSE,REGARDING,RESULTS,SMALL,SYSTEMS,TREATMENT,USA
169,BASEL,LABEL,METHODS,MORULES,MPC,OBJECTIVE,RESULTS
121,150,169,BACKGROUND,BASEL,BCA,EPIGENETIC,H3K27,H3K9ME1,H3K9ME2,H3K9ME3,HISTONE,LABEL,MET,METHODS,NMIBC,RESULTS
001,235,946,BACKGROUND,COX,LABEL,MEIER,METHODS,PROGNOSTIC,RESULTS,SERUM,TCC,TOTAL
240,BACKGROUND,CAUCASIAN,FOLLOWING,GLEASON,HEM,LABEL,METHODS,T1C,THERE
015,024,160,177,18F,881,898,932,AIM,EXACT,FDG,LABEL,METHODS,OBJECTIVE,PET,PHILIPS,RESULTS,SEM,SIEMENS,THESE,UNLABELLED,URINE
001,104,113,217,361,65308,65309,AMICO,BMI,COLLEGE,GLEASON,KHR,MAY,PSA,PSM,SEPTEMBER,THERE,UNIVERSITY
206,640,FINALLY
127,169,COPYRIGHT,COX,EXPRESSION,III,THERE,UPIII
CLUSTER,CONCLUSION,ENUGU,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
1910S,1940S,1960S,1970S,1990S,BOWEN,RESIDENTS,SEVERAL,THERE
001,005,009,034,1ST,2455A,3810T,CAUCASIANS,CBM,CIS,EBSCO,EIGHT,LIBRARY,ORS,SCHOLAR,SCIENCE,STATA,TEN,WEB
140,171,CAP,MEIER,UPPER,UUTUC
000,100,101,135,237,240,677,769,953,KOREA
BLADDER
189,340,LABEL,METHODS,POISSON,RESULTS,SIR,UNLABELLED
160,169,APRIL,CONCLUSION,COPYRIGHT,HEMOSTASIS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGY,RESULTS,SEPTEMBER
169,BARRINGTON,BRAIN,CONCLUSION,COPYRIGHT,DESPITE,GERMANY,INC,LABEL,LOWER,METHODS,OBJECTIVE,RESULTS,URODYNAMIC
169,CAREFUL,HOWEVER,INC,URINE,WILEY
169,EPISTASIS,HOWEVER,INC,NETWORK,SEN,WILEY
EXCESSIVE,ILLICIT,USA
232,684,CAUCASIANS,JANUARY,REVMAN4,STATA10,WANFANG,XRCC7
CAUCASIANS,GLN,LYS,LYS751GLN,OTHER,XPD
487,945,CA2,DAG,IL3,IP3,MYB,PKC,PLC,PROGNOSCAN
AKT,BCL,INSULIN,MTT,NOTABLY,PCR,T24
491,766,785,834,853,BACKGROUND,CHINESE,CURRENTLY,CYSTOSCOPY,ENGLISH,IMMUNOCYT,LABEL,LIBRARY,MEDLINE,METHODS,RESULTS
364,708,ACADEMY,AGE,BACKGROUND,CHINESE,CRH,FEDERATION,GYNECOLOGY,HOWEVER,IB1,JANUARY,LABEL,MEDICAL,METHODS,NERVE,NPSRH,OBSTETRICS,OCTOBER,RESULTS,SEVENTY,SINCE,THERE
169,AE105,CONCLUSION,COPYRIGHT,FAVORABLE,INC,LABEL,MBQ,METHODS,PET,RELATIVELY,RESULTS,UNLABELLED,VOI
001,116,139,BMI,CONCLUSION,LABEL,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,ROBOTIC,URINARY
BACKGROUND,DISCUSSION,EPA,HODGKIN,INTEGRATED,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCE,PROTECTION
160,169,COPYRIGHT,EDUCATION,HUC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SUP,TCC,UROLOGICAL,WESTERN
169,COPYRIGHT,ERASMUS,FULLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TPS,V95,VMATMAN
169,ABILITY,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,POD,RESULTS,RNU
HOWEVER,LEIOMYOMAS,MRI
041,042,BACKGROUND,BLADDER,CLAVIEN,DINDO,FIFTY,GIA,INTRA,LABEL,MATERIALS,METHODS,RESULTS,SST
BACKGROUND,COX,IRB,LABEL,MATERIALS,METHODS,NMIBC,RESULTS,RFS
120,945,BACKGROUND,CCK,HOWEVER,LABEL,METHODS,PKC,PMA,RESULTS,UNC5B
160,197,AMONG,BACKGROUND,BCI,BLADDER,CONSTRUCT,INDEX,LABEL,METHODS,RESULTS,SPANISH,THESE
493,BACKGROUND,CONCLUSION,CONTEXT,LABEL,METHODS,MMP40,OBJECTIVE,OBJECTIVES,RESULTS,RPP40
160,169,183,901,FINLAND,HODGKIN,LTD,NHL,POISSON,RRS,WILEY
001,BACKGROUND,DKK,ELISA,LABEL,MATERIALS,METHODS,RESULTS

001,007,075,68366,ENGLISH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR,SLE,STATA,SUMMARY
TAXANES
001,035,954,FIFTY,MEIER,TRG
169,AML,COPYRIGHT,MDS,PUBLISHED,SPECIALIST
169,947,BASAL,COPYRIGHT,FGFR3,INC,LUMINAL,MIBCS
169,COPYRIGHT,INC
C282T,CAUCASIANS,G191A,G590A,HOWEVER,PHASE,SNP,T341C
150,AIM,BACKGROUND,BUCHAREST,CELSIUS,CONCLUSION,FIRST,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY,TREATMENT
967,BACKGROUND,EDI,INDEX,LABEL,METHODS,PAF,POISSON,POPULATION,RESULTS
005,102,185,193,206,308,ALONE,BACKGROUND,CONCLUSION,ELISA,FURTHER,IHC,LABEL,METHODS,NMIBC,RESULTS,SDC
169,BACKGROUND,FEW,GREATER,HRR,HSA,LABEL,METHODS,REPORTING,RESULTS,SOCIETY,STATE,WASHINGTON
100,110,169,177,280,357,365,469,963,ARC,CDR,JAPAN,MUS,PHILIPS,PRESS,PUBLISHED,RADIATION,SMART,SOCIETY,UNIVERSITY,VOLUMETRIC
101,495,729,AFTER,CPG,METHYLATOR,NOTABLY,OTHER,PHENOTYPE
125,145,169,192,BLADDER,CONCLUSION,COPYRIGHT,DESPITE,HDR,INC,LABEL,LDR,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS,TEN
060,104,113,143,145,190,195,206,497,559,619,730,933,99A,AMONG,BCS,BIRC5,CURRENT,LUCIFERASE,NBE,REGARDING,T24,TARGETSCAN,WESTERN,WNT7A
CONSENSUS,PAM
121,169,AKT,ECD,EGF,ERK,FIRST,RAS
169,COLORECTAL,CRC,INC,MEIER,REDUCED,WILEY
DESPITE,MTT,PCR,SMALL,STAT3,T24,THESE,WESTERN
169,174,795,ACT,AFFORDABLE,ASA,COPYRIGHT,EDUCATION,GIVEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OUTPATIENT,PATIENT,PROGRAM,PROTECTION,PUBLISHED,PURPOSE,QUALITY,READMITTED,RESULTS,UROLOGICAL,USING
160,169,CISPLATIN,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THEREFORE,TUNEL,UNC5D,UROLOGICAL,WESTERN
127,169,215,AFTER,COPYRIGHT,DESPITE,EDUCATION,HOWEVER,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WHILE
110,126,169,956,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
160,169,174,971,COPYRIGHT,EDUCATION,ENGLISH,INC,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL,UROLOGISTS
ATP,BACKGROUND,CLASPIN,CONTEXT,GEFITINIB,LABEL,MATERIALS,METHODS,MOLECULAR,OBJECTIVE,RESULTS
100
169,27A,CANDIDATE,CONCLUSION,GSH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESISTANCE,RESISTANT,RESULTS,SLC7A11
001,169,297,AUDIT,AUTHORS,DIAGNOSIS,ENGLISH,INC,IQR,PRIMARY,PUBLISHED,ROUTINELY,THESE,USING,WILEY
PEARSON
169,PAI
BSA,CD104,HSA,YET
MOA,PROGRAMME,PROTECTION,USEPA
400,ABDOMINAL,BACKGROUND,EASTERN,GROUP,LABEL,MARCH,METHODS,OCTOBER,TOMOGRAPHY,TREATMENT
579,EASTERN,GROUP,MAXIMUM,PRT,RPA
BACKGROUND,CONCLUSION,EFFECTIVE,FRAGMENTS,HISTOLOGY,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,STN
100,BCG,CANCERS,TREATMENT
251,836,ASIAN,CAUCASIAN,GLN,HOWEVER,LYS,LYS751GLN,THERE,XPD
CARLO,CONCLUSION,LABEL,MATERIALS,METHODS,MONTE,MUS,OAR,OBJECTIVE,PURPOSE,RESULTS
001,156,183,200,219,350,500,800,ABT,ALLOGENIC,COX,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RADICAL,RESULTS,UCB
CAM,CAR,CD171,CE7,OVERALL
169,COPYRIGHT,DESPITE,INC
125,169,170,487,COLLEGE,COPYRIGHT,LABEL,LIMITED,LTD,MATERIALS,METHODS,MORTALITY,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,ROYAL,SERVICE,SIR,SPC,YORKSHIRE
AFTER,CD4,DESPITE,OVERALL,REGULATORY,SENEX,SILENCING,TREGS,UBC
062,832,ARG156ARG,ASN,ASP312ASN,ERCC2,FURTHER,GLN,LIBRARY,LYS,LYS751GLN,SCHOLAR,SCIENCE,WEB
5A2,946,BACKGROUND,EMT,KNOCKDOWN,LABEL,METHODS,RESULTS,STAT3,TGF
954,AMONG,INHIBITION,MMP,THESE,U0126
GEM,HOWEVER,KSI,MYC,THESE
125,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RADIATION,RESULTS,THERAPY,THREE
CK903,GATA3,GLEASON,PSA,THREE
003,233,945,IFN,M30,M65,THEREFORE
169,427,AMONG,CIS,COX,HOWEVER,RESULTS,RRS,USING
BLADDER,FURTHER,HUNDRED,OPERATION,RESECTION,SEVENTY,TURBT
004,008,037,060,338,359,378,468,479,750,982,998,RECURRENCE,RNU,UPPER,UTUCAND
AMONG,BASED,FINALLY,GADD45A,GLOBALTEST,HEPG2,PAM,RRM2B
ACCORDING,AWARENESS,HOWEVER,TYPICAL
001,100,169,BACKGROUND,GUIDELINES,LABEL,MARKETSCAN,METHODS,RESULTS,SOCIETY,WOMEN
169,196,600,COX,HBA1C,HRS,LABEL,METHODS,NETWORK,OBJECTIVE,RESULTS,SIMILAR,SUS
169,RAPHSON,VCH,WILEY
001,008,308,458,988,ASIAN,BACKGROUND,LABEL,METHODS,RENAL,RESULTS,SIR
001,011,115,386,388,3DCRT,503,BACKGROUND,CONCLUSION,IMAGE,LABEL,METHODS,PCA,PTV,RESULTS
008,010,020,026,169,532,728,748,888,906,ABO,AMONG,BLOOD,INC,LABEL,METHODS,MULTI,OBJECTIVE,PUBLISHED,RESULTS,UCB
169,AEG,CARCINOMA,CONCLUSION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,POTENTIAL,PUBLISHED,RESULTS,RT112
001,011,047,120,169,COX,FIFTY,FOLLOWING,FORTY,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,RECURRENCE,RESULTS,RFS,RNU,SIXTY,THESE,UNIVARIATE
169,HOWEVER,SIMILARLY,T24,WNT
CRK,EXPRESSION,FAK,ROS,SPECIES,THESE
233,AVAILABLE,BCG,BLADDER,CD4,CD8,DESPITE,SEVERAL,TRAIL
002,004,022,025,027,046,047,066,094,106,156,161,163,177,CONCLUSION,DOSIMETRY,EXM,FCH,LABEL,MBQ,METHODS,PET,RESULTS,THESE,UNLABELLED,WHOLE
169,ACE,AUTHORS,BACKGROUND,COMBINING,CONTEXT,COPYRIGHT,ELAC2,FEW,GSTM1,JANUARY,LABEL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,REVIEWERS,SUMMARY,SYNTHESIS,VDR
004,008,169,279,672,BACKGROUND,CLAVIEN,COPYRIGHT,LABEL,LIMITED,LOS,MAJOR,METHODS,MORBIDITY,OBJECTIVE,ORC,OUTCOME,PATIENT,PUBLISHED,RADICAL,RESULTS,SETTING,SUMMARY,UROLOGY,USING
BACKGROUND,CONCLUSION,D35,D99,LABEL,MAR,METHODS,PTV,RESULTS,TREATMENT
160,BACKGROUND,CD44S,EXTRACTED,FURTHER,INCREASED,LABEL,METHODS,MFS,RESULTS,THESE
338,608,818,824,APRIL,CBM,FIFTEEN,FURTHER,INCREASING,LIBRARY,SCIENCE,STATA,WEB
101,169,33258,BACKGROUND,BRITISH,CONCLUSION,CONVERSELY,HOECHST,KEY,LABEL,METHODS,MICROARRAY,OBJECTIVE,PCR,PROTEIN,PURPOSE,RESULTS,SOCIETY
176,233,ADVERSE,BCG,BSD,EFFECTIVE,EORTC,FIFTEEN,FOLEY,HEATING,LABEL,MATERIALS,METHODS,MMC,NMIBC,OBJECTIVE,PURPOSE,RESULTS,TREATMENT,TREATMENTS
102,242,AMONG,DRE,GLEASON,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RCP,RESULTS
8TH,AUSTRALIA,AUSTRALIAN,BLADDER,COUNCIL,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,STATE,WELFARE
169,16S,COPYRIGHT,LTD,MALDI,NMIBC,TOF
001,169,COX,LABEL,METASTATIC,METHODS,NANOSTRING,OBJECTIVE,PFDN2,PURPOSE,RESULTS,SCNAS,USP21
001,028,036,169,180,BACKGROUND,COPYRIGHT,EVALUATION,HEMATURIA,INC,LABEL,METHODS,PRIMARY,RESULTS,UROLOGICAL
169,416,BACKGROUND,COPYRIGHT,END,FOLLOWING,HBT,LABEL,LOS,METHODS,OBJECTIVE,OUTCOME,OVERALL,PATIENT,PUBLISHED,RELYING,RESULTS,SETTING,SUMMARY,THESE,UROLOGY
007,108,169,465,890,CONCLUSION,COPYRIGHT,DISEASE,IMPORTANT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
102,169,AFTER,CAMEY,CONCLUSION,COPYRIGHT,EARLY,ICP,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,SIXTY,SSC
106,112,113,118,169,BACKGROUND,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,MEDICAL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SAMSUNG,THERE
AFM,GIVEN,T24
HOWEVER,PATIENT
231,4T1,946,AKT,ANOIKIS,BIM,ERK,HOWEVER,MDA,RESISTANCE,SRC,STILL,T24
104,169,BACKGROUND,BLADDER,COPYRIGHT,GREATER,LABEL,LTD,METHODS,OTHER,PREVALENCE,RESULTS,SURVIVORS,WILEY
954,BACKGROUND,BASEL,CONCLUSION,LABEL,METHODS,RESULTS
123,CLOSO,LNCAP,THERE
101,131,166,176,200,233,407,BASEL,LABEL,METHODS,OBJECTIVE,RESULTS,TUMOURS
169,183,COPYRIGHT,LTD,OPIUM
001,006,114,160,169,240,241,269,283,377,COMMISSION,COPYRIGHT,CROWN,CTV,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POINT,PREDICTORS,PUBLISHED,PURPOSE,RADIATION,RESULTS,STUDENT,TREATMENT,UNITS
ANNEXIN,ANX,AREAS,BACKGROUND,CCC,COVERED,LABEL,METHODS,OPINION
AIM,CONCLUSION,FOLLOWING,GELFOAM,HAEMATURIA,INITIAL,LABEL,METHODS,OBJECTIVE,RESULTS,T3A,THREE
169,HOWEVER,INC,INTUITIVE,USING,UTILIZING,WEB,WGS,WHOLE,WILEY
001,169,BACKGROUND,END,LABEL,METHODS,READMITTED,RESULTS,SOCIETY,USING
000,131,150,AKT,ATLAS,CHROMATIN,ERBB2,FGFR3,HPV16,RTK,TACC3,THERE,UROTHELIAL,WHOLE
169,APMIS,DESPITE,DIAGNOSIS,LTD,MANAGEMENT,PUBLISHED,URACHAL,WILEY
AFTER,CANCERS,IRELAND,OTHER,RISKS,VARIATIONS
177,198,615,ACCORDING,AUC,BACKGROUND,CHI,DISCUSSION,LABEL,METHODS,NLR,NMIBC,RESULTS,ROC,TUR,WHETHER,WHITNEY
183,806,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,VARIOUS
IIA,OWING,SEVERAL,STAGE
CAM,CDS,GEN,GENISTEIN,RESULTS
169,ADDITIONAL,ANOTHER,BACKGROUND,CONTEXT,COPYRIGHT,DUE,LABEL,MEDICAL,MEDLINE,METHODS,NMIBC,OBJECTIVE,OPTIMIZING,PUBLISHED,REGARDLESS,RESULTS,ROUTINE,STUDIES,SUBJECT,SYNTHESIS,UROLOGY
001,005,169,BACKGROUND,COPYRIGHT,DESPITE,FACTORS,LABEL,METHODS,NAC,OBJECTIVE,OUTCOME,PATIENT,PEARSON,POC,PUBLISHED,RESULTS,SETTING,SUMMARY,UROLOGY
APL,HALOMONAS,HOWEVER,JANUS
677,967,BETWEEN,COX,IQR,LABEL,LRC,MEIER,METHODS,OBJECTIVE,ORC,PURPOSE,REGARDING,RESULTS
039,332,CONCLUSION,LABEL,METHODS,OBJECTIVE,ORC,PATIENT,PURPOSE,RESULTS,THERE,THESE
SVS,TCC,THERE,USING
107,130,327,BLOOD,CONCLUSION,EXCLUSION,HLA,INCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
001,003,010,036,100,AFFAIRS,AGENT,BACKGROUND,FIFTY,FURTHER,HOWEVER,JANUARY,LABEL,LEVEL,METHODS,RESULTS,WASHINGTON
EPIGENETIC,H3K27,HOWEVER,USING
169,174,CONCLUSION,COPYRIGHT,ERG,EXPRESSION,HBP,INC,LABEL,METHODS,OBJECTIVE,PCA,RESULTS,SIMILAR,TMPRSS2
001,113,169,211,CONCLUSION,COPYRIGHT,COX,DSS,FDG,INC,LABEL,MEIER,METHODS,OBJECTIVE,PET,RESULTS
ANTICANCER,BACKGROUND,BCG,CHO,CIS,CYSTECTOMY,FORTY,GROUP,LABEL,METHODS,NMIBC,RECURRENCE,RES,RESULTS,SIXTY,SOUTH,THERE,TURBT
004,169,488,AUTHORS,BJU,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
001,002,017,133,169,APRIL,AUTHORS,BJU,BMI,CLAVIEN,ERP,JANUARY,LABEL,LOS,METHODS,OBJECTIVE,OCTOBER,PRIMARY,RESULTS,SECONDARY,SOCIETY,THERE,UNIVERSITY
169,ARYLAMINE,ASP,AUTHORS,BRITISH,COA,CYS,JOURNAL,LTD,NAT,SALMONELLA,SOCIETY,WILEY
000,063,100,120,122,187,234,238,294,330,366,454,697,785,940,951,BACKGROUND,COX,INCIDENCES,INSURANCE,JANUARY,LABEL,METHODS,RESULTS,TAIWANESE,THERE,USERS,WHETHER
290,350,580,660,946,954,FGFR3,TGF
001,105,BLADDER,HOWEVER,MNC,THEREFORE,UCC
CCP,FEW
004,027,039,144,177,299,336,383,498,701,877,988,AGE,EFFICIENT,HOLEP,HOLMIUM,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,RESULTS,USING
EPCAM,EPICD,LABEL,MEMBRANOUS,METHODS,MOC,OBJECTIVE,REGULATED,RESULTS,TMA
FINALLY,HOWEVER,LABEL,PAI,T24,TARGETING,UNLABELLED
169,174,ANNEXIN,AUTOPHAGY,BACKGROUND,BECLIN1,CONCLUSION,DETECTION,GREEN,INC,KIT,LABEL,LC3,MATERIALS,MDC,METHODS,OBJECTIVE,OBJECTIVES,PDT,RESULTS,T24,TEM,THESE,WESTERN,WILEY
THEIR
018,088,135,271,AZIENDA,BACKGROUND,CLINICIANS,DEPARTMENT,EVERY,FORTY,GYNECOLOGY,ITALIAN,LABEL,MAURIZIANO,METHODS,OBJECTIVE,OBJECTIVES,OBSTETRICS,RESULTS,SEVERAL,TURIN,UMBERTO
169,COPYRIGHT,III,SAS,THESE
169,215,27A,AGGF1,COPYRIGHT,HYPOXIA,TAKEN,UNDER,VEGFA
034,100,169,181,200,543,915,ADDITIONAL,AUTHORS,COPYRIGHT,IRELAND,LTD,PUBLISHED,WHILE
169,343,BASED,COPYRIGHT,COX,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
169,CCR,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100NM,169,B42,COPYRIGHT,EXOSOME,LABEL,LTD,METHODS,NANOSIGHT,OBJECTIVE,PURPOSE,RESULTS,THESE
169,BASED,COPYRIGHT,DIFFERENT,FIRST,INDIVIDUAL,IRELAND,LTD,SNS,TOT,TVT,URINARY,VAGINAL
120,171,204,ACTOS,ADDITIONAL,AMONG,APRIL,BACKGROUND,DIABETICS,LABEL,LYMPH,METHODS,OCTOBER,PATHOLOGIC,PATHOLOGY,PATIENT,RESULTS
000,100,801,ASR,BACKGROUND,BASED,CHICAGO,ICD,KHUZESTAN,LABEL,MATERIALS,METHODS,RESULTS,THERE
ARG,ASP,DRY,ERRAT,FUNCTIONAL,GPR87,MOLECULAR,PROSA,SVM,TYR
10Q,CCND1,FGFR3,PTPN1,RB1,SEVERAL,T24,THESE,UBC
177,844,AIM,APRIL,JANUARY,LABEL,LNS,METHODS,OBJECTIVE,OVERALL,PET,RESULTS,SEVEN
AFTER,INITIAL,IRB,JANUARY,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,THREE
AFTER,BASED,EASTERN,GROUP,HEMOSTATIC,LABEL,METHODS,OBJECTIVE,RESULTS
025,026,035,100,103,105,108,117,126,142,145,147,170,1CC,212,260,2CC,4CC,5CC,6CC,8CC,AMONG,BACKGROUND,D90,HDR,LABEL,METHODS,PURPOSE,RECORDS,RESULTS,ROC,THREE
002,007,024,034,100,BACKGROUND,CONTINENCE,LABEL,LRP,METHODS,OBJECTIVE,PVR,RESULTS,SCORE,SEVERAL,SYMPTOM,THREE,URINARY
000,169,510,PEMETREXED,SEVERAL,SOCIETY,UROLOGICAL,VAC
DESPITE,FDA,HBA1C,III,SGLT2,THEREFORE,TREATMENT,UNDER
002,041,053,064,073,154,1B1,238,432,504,783,853,942,981,EGGER,HOWEVER,LEU,LEU432VAL,VAL
001,002,270,AMU,BPW,EUS,FOV,FUNCTIONAL,LABEL,METHODS,MRI,MUL,OBJECTIVE,PURPOSE,RESULTS
169,AMERICA,AMONG,BACKGROUND,BCA,CENTRAL,CONTEXT,CONTINENTS,COPYRIGHT,EGYPT,ESTIMATED,INCIDENCE,LABEL,METHODS,MORTALITY,NORTH,OBJECTIVE,PUBLISHED,RESULTS,ROMANIA,SAHARAN,SOUTH,SYNTHESIS,THESE,UROLOGY,WESTERN,WORLD
FURTHER,SP1,TAKEN,YHL
169,946,CONCLUSION,EMT,FINALLY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TGF,THESE
002,38E,399,536,660,71E,780,803,816,946,949,954,984,ACTIVATION,GIVEN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAT3,TGF,UROTHELIAL,VEGFA
946,CONSISTENT,GATA3,HOWEVER,J82,KNOCKDOWN,MMP,SUP,SVHUC,TCC,THESE,UMUC3
108,169,240,712,AUTHORS,BJU,BRITISH,FINAL,LABEL,METASTASIS,METHODS,NON,OBJECTIVE,OBTAINING,RESULTS,SECTION,TCC,TNM,UROLOGICAL,WORLD
001,169,175,279,AFTER,AHV,ALV,AUTHORS,BJU,CHV,CLV,HOSPITALS,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,USING,WHILE
AFTER,CFM,PAM,VIEWING
129,169,AUTHORS,BJU,ENGLISH,FURTHER,HOWEVER,JANUARY,MEDLINE,METHODS,OBS,RENAL,RFN,STUDIES,THERE,UIA,URINARY,WHICH
BACKGROUND,CONCLUSION,DESPITE,FIRST,HOLMIUM,LABEL,MEDLINE,METHODS,RANDOMIZED,RESULTS,THULIUM,TURBT
160,400
100,169,HOWEVER,UROLOGICAL
ABDOMINAL,ART,EARLY,HISTOLOGIC,IA2,IB1,IB2,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,ROMANIA,THERE,THESE,THREE

106,169,BACKGROUND,DESPITE,LABEL,METHODS,RENAL,RESULTS,SPECIAL
LABEL,LDN,LND,LYMPH,OBJECTIVE,PURPOSE,RESULTS,ROUTINE,SUMMARY,THERE
001,013,018,061,069,083,169,CONCLUSION,COPYRIGHT,COX,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM,TEK,WHITNEY
000,100,169,200,215,680,942,BLADDER,COPYRIGHT,EVALUATING,HOWEVER,INC,PRS,SIX
001,002,052,169,243,413,897,AMONG,BETWEEN,INC,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,SMS,THERAPY,UNLABELLED,USING
160,169,259,CASES,COPYRIGHT,FURTHER,INSURANCE,PUBLISHED
027,081,954,BCL,CASPASE,FURTHER,LUCIFERASE,T24,USING
ITGB3,LUCIFERASE,MECHANISM,PCR,T24,TARGETSCAN,TCC,TRANSWELL
0325901,AKT,AXL,BACKGROUND,CONCLUSION,ERK,INHIBITION,LABEL,MEK,METASTATIC,METHODS,MUTATIONAL,PDX,RAS,RESULTS,STAT1,STAT3,TAKEN
174,176,400,LABEL,METHODS,MMC,OBJECTIVE,PURPOSE,RESULTS,UNITHERMIA
DDM,DIR,ICE,PEARSON,THEREFORE
160,169,AUTOPHAGIC,AUTOPHAGY,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T24,UROLOGICAL,WESTERN
001,003,038,047,125,160,169,4CM,5CM,7KG,BMI,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,THREE,WOMEN
100,169,ANORECTAL,ENROLLMENT,FORTY,LABEL,METHODS,MRI,OBJECTIVE,POSTNATAL,PPV,PURPOSE,RESULTS,SCT,WHITNEY
00012,038,10A,169,INC,LABEL,LOWER,MATERIALS,METHODS,OBJECTIVE,PROFILING,PUBLISHED,RESULTS
001,100,105,118,123,125,127,12M,177,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SILODOSIN,URINARY
169,AKT,CLINICALLY,COPYRIGHT,DISRUPTION,IRELAND,JNK,LTD,NSCLC,STAT3,TAKEN
231,4T1,BCL,CAM,HOWEVER,JNK,JUN,MCL,MDA,SCF,T24,TRAIL,TUBULIN,UNRAVELING
001,002,007,169,3DCRT,COPYRIGHT,INC,MEDICAL,MLC,MODULATOR,OAR,PUBLISHED,V50,V60,V65,V70
001,128,169,177,190,227,283,588,740,741,779,780,783,786,COX,CURRENT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SMOKING,UCB
000,140,ACADEMY,AMERICANS,EARLY,MAJOR,MANAGEMENT,PHYSICIANS,RENAL,STAGING,TNM,TREATMENT,URINARY,UROTHELIAL,WRITTEN
CUTANEOUS,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RELEVANCE,SERPENTINE,THESE,WHILE
001,003,009,028,200,CHEMOKINES,GENOTYPING,HOWEVER,INDIANS
CIS,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SIR,SLE
031,034,042,110,133,139,160,169,COPYRIGHT,COX,LABEL,LTD,MEIER,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS
ARGONAUTE,COX,DISTANT,FURTHER,HOWEVER,ICH,LABEL,MEIER,METHODS,NOTABLY,PCR,RESULTS,THESE,UCB,UNLABELLED,WESTERN
245,473,497,500,663,967,970,AMONG,COX,INSURANCE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
160,AMONG,FABP4,FABPS,FATTY,SCC,THESE
010,039,1377G,160,171,175,404,585,607,844TT,878,956,AFTER,BACKGROUND,EORTC,FAS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,UNIVARIATE
CONCLUSION,HOUNSFIELD,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,THEREFORE
019,028,100,116,295,754,886,BASED,CAPRI,DHI,DNR,DVH,EUD,HOWEVER,TCP
169,200,224,523,571,712,AUC,BASED,COPYRIGHT,EDUCATION,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,SARCOPENIA,THERE,TOTAL,UROLOGICAL
34A,BACKGROUND,CISPLATIN,HOWEVER,INCREASED,LABEL,MASSARRAY,METHODS,RESULTS,SYNTHETIC
020,029,042,072,160,180,BACKGROUND,BCG,BLADDER,COMPARING,DFS,LABEL,MEIER,METHODS,NMIBC,RESECTION,RESULTS,TRANS,WHITNEY
125,178,204,247,BACKGROUND,BMI,CLAVIEN,DINDO,EARLY,III,LABEL,METHODS,RADICAL,RESULTS,SMI
217,BACKGROUND,CLAVIEN,LABEL,METHODS,OBJECTIVE,POP,PURPOSE,RESULTS,SPECIMENS,TEN,THERE
ADULT,ANTIGEN,IMAGING,PROSTATIC
169,BACKGROUND,GATA3,GCDFP,LABEL,METHODS,RESULTS,SOCIETY
001,002,675,AFTER,IQR,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,445,COX,EINDHOVEN,SES,THEREFORE
100,BLADDER,CYSTOSCOPY,DESPITE,NMIBC,THERE
015,384,631,APRIL,BORDERLINE,CENTRAL,DESPITE,EGGER,HOWEVER,THEREFORE,WEB,WHILE
EMA,LABEL,OPINION,STATEMENT,UNASSIGNED,UROTHELIAL,VAC,VINFLUNINE,WHILE
013,HOWEVER,IMMUNOBLOT,MEIER,NSCLC,RING1,TNM
041NG,15MIN,169,17MIN,1ML,5ML,997,9NG,AQUASIL,C18,COPYRIGHT,EIGHT,FINALLY,HILIC,PTERINS,RSD,SEPARATION
004,052,148,169,196,588,664,847,AMONG,BMI,HOWEVER,INC,INCREASED,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RFS,RNU,VARIOUS
001,012,014,130,146,160,169,BIOLOGY,COLOR,COPYRIGHT,DOPPLER,FEDERATION,INC,PRE,PUBLISHED,TEN,THERE,ULTRASOUND,WORLD
169,BECAUSE,HOWEVER,INC,LABEL,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,THERE
038,135,169,233,AFTER,BACKGROUND,BCG,GST,GSTM1,GSTT1,INC,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,THESE
105,169,192,BETWEEN,COPYRIGHT,GROUP,INC,IRT,LABEL,MATERIALS,MAY,MEIER,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RADIATION,RESULTS,SALVAGE,THERAPY
001,056,100,169,307,315,441,499,740,865,978,AMONG,COPYRIGHT,CTV,INC,LABEL,LVI,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,003,005,006,009,160,169,268,AFTER,COPYRIGHT,COX,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,REDUCTION,RESULTS,SCORE,SEVENTY,SYMPTOM,UNIVARIATE,V90
160,169,ACUTE,AFTER,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TMT
169,ASSOCIATED,BACKGROUND,BCG,CIS,CONCLUSION,COPYRIGHT,DEC,FSH,HOWEVER,HPE,INC,INDUCTION,JAN,LABEL,METHODS,RESULTS,SEMEN,SERUM,SEVEN,TOTAL,TURBT
169,947,COPYRIGHT,DSB,INC,INDUCTION,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RAD51,RESULTS
169,AUTHORS,BJU,CURRENT,MEDLINE,THERE,UNTIL
BACKGROUND,FORTY,HDL,HOWEVER,LABEL,MEDCALC,METHODS,OUTPATIENT,RESULTS,TAS,TTL,UROLOGY
000,060,119,120,260,338,361,399,518,536,553,635,699,754,807,813,880,881,979,AMONG,CONFIDENCE,DISCUSSION,EAR,FIRST,HODGKIN,HOWEVER,ICD,INCIDENCE,INCREASED,ISLANDS,ITALIAN,LABEL,LIFESTYLE,METHODS,MPS,NON,NORTH,OBJECTIVE,OBJECTIVES,OVERALL,RATIO,RESULTS,SIR,SOUTH,WOMEN
003,004,127,BACKGROUND,CONCLUSION,HARRELL,KAPPA,LABEL,METHODS,OBJECTIVE,RATIO,RESULTS,USING,WHO04,WHO1973,WHO2004,WHO73
138,590,AIM,COLORECTAL,CONCLUSION,CUMULATIVE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SPANISH
001,002,076,129,AIM,BTC,CONCLUSION,ID1,ID4,LABEL,METHODS,OBJECTIVE,RESULTS,THEIR
177,511,773,BACKGROUND,CONCLUSION,EBL,HOWEVER,LABEL,LRC,METHODS,ORC,RESULTS
169,AFM,COPYRIGHT,HUC,INC,LTD,MATERIALIA,MGH,MRS,PUBLISHED,RAMAN
BACKGROUND,CONCLUSION,D98,DVH,HOWEVER,LABEL,METHODS,MRI,PTV,RESULTS
169,SIX,UROLOGICAL
025,050,131,199,1ST,358,439,620,ASIAN,CAUCASIAN,CBM,CRUDE,LIBRARY,MAY,PB0,SCIENCE,STATA,TEN,THERE,UNIVARIATE,WEB
127,AFTER,AIM,CONCLUSION,COX,FURTHER,III,LABEL,METHODS,OBJECTIVE,RESULTS,THREE,WHILE
ANAPLASTIC,APC,BACKGROUND,CONCLUSION,LABEL,LOW,METHODS
169,AUTHORS,GERMANY,HODGKIN,LTD,SPC,SWEDISH,WILEY
160,AG490,IGF,MSM,RECURRENCE,STAT3,THEREFORE,THESE
ABDOMINAL,AFTER,BAKER,FACES,LABEL,METHODS,MSE,OBJECTIVE,PURPOSE,RESULTS,THERE,WHILE
001,101,190,AFTER,BACKGROUND,CIS,IVI,LABEL,METHODS,RESULTS,THERE,TIS,UTR
160,BAX,BCL,CASPASE,HOWEVER,KANK1
173,LABEL,MALIZIA,MATERIALS,METHODS,OBJECTIVE,RESULTS
233,BACILLE,BCG,COUNT,DCS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIX
169,ASIAN,BECAUSE,BIOMARKERS,CLCA2,DESPITE,FEW,GABRE,INC,LABEL,METHODS,NOVEL,OBJECTIVE,OBJECTIVES,PRACTICAL,RESULTS,SUBMITTED,UPPER,WESTERN
169,BACKGROUND,CONCLUSION,COPYRIGHT,EIGHT,INC,LABEL,METHODS,TECHNICAL,THERE
RADICAL,VARIOUS
001,131,177,190,BLOOD,CATEGORIC,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,STUDENT
BACKGROUND,CAMEY,CONCLUSION,HISTOLOGY,LABEL,METHODS,SECONDARY,STAGE,SURGERY,T2B,TCC,THERE
BINDING,HSA,MICRORNAS,SIRT7,THESE
169,1ST,2ND,BLOOD,COPYRIGHT,FOURIER,MTP,UBC,VCH,WILEY
450,689,BACKGROUND,CONCLUSION,DIAGNOSIS,LABEL,METHODS,ORDINAL,PROCEDURE,RESULTS,TNM
002,157,161,169,AFTER,ALTOGETHER,BACKGROUND,CHANGES,CONCLUSION,COPYRIGHT,GRADE,INC,KETTERING,LABEL,MAY,METHODS,MODIFYING,MVAC1,OVERALL,RESPONSES,RESULTS,SEPTEMBER,SLOAN
169,24H,946,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PCR,POKEMON,RESULTS,T24,THESE,WESTERN,WHILE
047,886,988,AUC,BLADDER,BTL,EPICURO,LASSO,SBC,SNP,SPANISH,TEXAS,THESE,THRESHOLD,USING
169,BACKGROUND,GROUP,LABEL,METHODS,REGRESSION,RESULTS,SOCIETY,SOUTHWEST
022,053,069,103,141,775,839,AMONG,BIOMEDICAL,CBM,CHINESE,CIS,LITERATURE,MMP,ORS,SCIENCE,WANFANG,WEB
223,680,CAUCASIANS,HOWEVER,USING
160,200,49A,AGT,BCG,CT60A,CTLA4,CYTOTOXIC,GAC,HAPLOTYPE,LYMPHOCYTE,NORTH,PCR,SNP,WHILE
166NM,169,956,BACILLE,BCG,COPYRIGHT,CWS,HOWEVER,MBT,TH1
001,169,945,AIM,BUC,COPYRIGHT,HOWEVER,IHC,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SHORT,SHRNA,T24,THESE
160,169,1CC,COPYRIGHT,DMEAN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THREE,VBT
165,169,191,622,BACKGROUND,COPYRIGHT,COX,INSULIN,IQR,LABEL,MAJOR,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,RNU,SETTING,UNASSIGNED,UNI,UPPER,UROLOGY
052,111,169,274,597,679,788,982,BACKGROUND,BCA,COPYRIGHT,DESPITE,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RESULTS,SETTING,SOCIETY,SUMMARY,UROLOGY
001,160,169,APRIL,BLADDER,COMPOSITE,CONCLUSION,COPYRIGHT,FIFTY,INC,INDEX,LABEL,METHODS,OBJECTIVE,RESULTS,SCORE,SHORT,SYMPTOM
000,097,452,648,668,ADC,BACKGROUND,BCL,CONCLUSION,COX,FINALLY,JIANGSU,LABEL,METHODS,PATHOLOGY,RESULTS,THERE,UNIVERSITY,ZHENJIANG
213,517,945,946,CD4,CDCA1,CDCA155,CFA,DEPDC1191,DR4,DRA,FINALLY,HLA,KIF20A494,NOTABLY,PBMCS,REPORTS,TAA,TGM,WILMS
169,ADP,BAX,BCL,C57BL,COPYRIGHT,LCB,LTD,T24,THESE
160,169,COPYRIGHT,EDUCATION,ERECTIONS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PADUA,PUBLISHED,PURPOSE,RESULTS,SURVIVORS,THEREFORE,UROLOGICAL
011,148,267,654,ACCORDION,BACKGROUND,GRADING,INDEX,JANUARY,LABEL,METHODS,MORBIDITY,PMI,RESULTS,THESE,USING
CD133,EBV,EPSTEIN,HCV,HPV,INFECTION,RNS,ROS,THEREFORE,UNDER
KNOWLEDGE,NEUROKININ,TAC
001,003,004,008,021,034,169,632,988,ANGELES,BER,BLADDER,BONFERRONI,CHINESE,CIS,HHR,LOS,NER,ORS,SNP,TOBACCO,USING,XPC,XRCC6
001,BACKGROUND,COMPOSITE,FURTHER,GRADE,INDEX,LABEL,METHODS,OVERALL,PSA,QUALITY,RESULTS,THERAPY
001,BACKGROUND,CONTILIFE,DAYTIME,HRQOL,LABEL,METHODS,ONB,RESULTS,UNADJUSTED
150,ASIAN,BETWEEN,GRADE,LABEL,MARCH,MEIER,METHODS,OBJECTIVE,RESULTS,SALVAGE,T1C,THERE,THREE
100,116,145,160,172,181,231,2OS,500,549,786,872,A2058,CA2,ECM,FBS,HCC,HCT,HEP,MCF,MDA,MIA,MMP,PMA
001,004,140,181,351,522,ACUTE,ASSESSMENT,BCG,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS,URINARY,UROTHELIAL
169,ACUTE,ADT,BACKGROUND,CONCLUSION,COPYRIGHT,DLT,GNRHA,INC,LABEL,MEN,METHODS,MTD,RESULTS
323,ABOUT,ACUTE,AIM,CARCINOMA,DEPARTMENT,HEPATITIS,KARACHI,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PATHOLOGY,RESULTS,SECTION,SOUTH
180,210,BACKGROUND,GST,GSTP1,HOWEVER,LABEL,MATERIALS,METHODS,PCR,RESULTS,SNP,UBC,USING
325,HAEMATURIA,ROC
169,945,FL3,T24,VCH,WILEY
169,AFTER,BIOLOGY,CK8,EPHA4,EPHA7,FEDERATION,FGF,FGF10,MEANWHILE,NANOG,OCT,SOX,TIE
160,211,344,DETECTION,SEROLOGIC
001,144,233,ACCORDING,AFTER,BCG,UNIVARIATE
019,BIU,ERK,FURTHER,HOWEVER,USING
002,005,100,169,AFTER,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIMILAR,UROLOGICAL
001,009,130,169,359,COPYRIGHT,EDUCATION,INC,KINGDOM,LABEL,MATERIALS,METHODS,METICULOUS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,VALIDATED
169,BACKGROUND,CONTEXT,COPYRIGHT,ENGLISH,GENOMIC,INCREASED,LABEL,LNCRNAS,MEDICAL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,SUBJECT,SUMMARY,SYNTHESIS,UROLOGY
169,BACKGROUND,BCA,CONTEXT,COPYRIGHT,EAU,LABEL,LND,METASTATIC,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,SMOKING,SUMMARY,SYNTHESIS,T4AN0M0,UROLOGY
160,169,175,291,493,679,ADJUSTING,IMPAIRMENT,LABEL,LTD,METHODS,MUI,OAB,OBJECTIVE,OUTCOME,QUESTIONS,RESULTS,THESE,UUI,WILEY
169,315,348,409,COMMITTEE,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
SMALL
CONTINENT
111,148,150,242,868,AVERAGE,BACKGROUND,BILATERAL,BLADDER,CLEVELAND,CONCLUSION,DENMARK,LABEL,METHODS,NEPHRON,NSS,RADICAL,RCC,RENAL,RESULTS,SAD,SURGERY,THERE,UROLOGY,USA,VHL
001,004,256,337,626,727,779,992,DOT,SERUM
233,BACILLE,BCG,GUIDELINES,JAPAN,NON,PUBLISHED,TUR,WESTERN
169,BIS,COPYRIGHT,NPGDE
110,169,221,COPYRIGHT,INC,MEASURING,PERCENTAGE,PREDICTIVE,RECURRENCE,THERE,TURBT,UROTHELIAL
956,AUTOPHAGY,CELLS,T24,TALALAY,TREATMENT
BACKGROUND,BLADDER,COX,DESPITE,LABEL,METHODS,RESIDENCY,RESULTS,SIR,SMOKING,STATE
300,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PET,RESULTS,SIX,THREE,WHOLE
169,177,BLADDER,COPYRIGHT,INC,PFS,THERE
169,178,AFTER,AMONG,BLADDER,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,WORLD

945,AKT,BLADDER,EXPRESSION
004,177,215,CISPLATIN,H1975,LCL,NSCLC,SNP,THEREFORE
BCA,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAGE,UROTHELIAL,WGA,WHEAT
151,LABEL,METHODS,OBJECTIVE,RESULTS
001,012,015,019,020,047,HGF,INCREASED,SHORTER,SOMATIC
001,002,006,112,156,535,588,BACKGROUND,CONCLUSION,DIAGNOSTIC,GENERAL,GUIDELINE,GUIDELINES,LABEL,METHODS,RESULTS,SUSPECTED,TESTS,THERE,USING
024,030,177,BACKGROUND,BLADDER,INDEX,LABEL,METHODS,PROSTATIC,RESULTS,SCORE,SYMPTOM,URINARY
308,905,AMONG,COX,ELISA,HOWEVER,MEIER,URINE
100,181,CASPASE,CC531,ERUFOSINE,INCUBATION,MTT,RAT,SW480
DYSMORPHIC,HOWEVER,UROLOGICAL
316,407,COX,MEIER,NAMPT,PCR,STRATIFIED
GALVESTON,LABEL,LOCAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPHINCTER,THERE
088,120,128,ACM,CONCLUSION,COX,INSTEAD,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PROGNOSIS,PURPOSE,RESULTS,WOMEN
008,CLAVIEN,EARLY,LABEL,METHODS,MORTALITY,OBJECTIVE,PURPOSE,RESULTS
001,200,740,BLADDER,CONCLUSION,IA1,IB1,IIB,LABEL,LARVH,METHODS,OBJECTIVE,PREVALENCE,PURPOSE,RESULTS,THERE,VALRH
169,COPYRIGHT,DUE,INC,PRIMARY
169,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OVERALL,RESULTS
135,144,169,438,BACKGROUND,BEIJING,CHINA,CHINESE,CIS,CONCLUSION,COPYRIGHT,COX,FIRST,LABEL,LOWER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UNIVARIATE,UNIVERSITY
001,002,008,009,032,043,049,119,169,CONCLUSION,DSS,INC,LABEL,LVI,LYMPH,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RFS,THESE,UCB,VEGFR
005,010,013,122,169,CSS,HOWEVER,INC,IVR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RNU,THERE
111,169,BACKGROUND,INC,LABEL,METHODS,PUBLISHED,RESULTS
035,067,169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FGFR3,HOWEVER,III,INC,LABEL,MATERIALS,METHODS,MIBCS,OBJECTIVE,OBJECTIVES,RESULTS,TNM
004,108,119,124,169,332,CIS,COPYRIGHT,EORTC,INC,LABEL,MEIER,METHODS,NMIBC,OBJECTIVE,OCTOBER,PFS,RESULTS,TREATMENT
169,BLADDER,CISPLATIN,HOWEVER,INC,PUBLISHED
169,ACUTE,AKI,CKD,COPYRIGHT,FOUNDATION,INC,PUBLISHED
005,034,169,ASA,COPYRIGHT,EIGHT,HDR,INC,LABEL,METHODS,NEBLETT,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,USING,V75
BACKGROUND,BAX,BCL,BESIDES,BIP,J82,LABEL,METHODS,PEE,RESULTS,T24,TAIWANESE
544,CENTRAL,ELIZABETH,JANUARY,PERFORMING,QUEEN,THERE,WITHOUT
177,BACKGROUND,HOWEVER,LABEL,PCR,RESULTS,TNM
BYSTANDER,CD154,CD40L,FAS,RAD,WHEREAS
169,874,COO,CSC,DPC,FGFR3,HOWEVER,KDM6A,NMI,PRESS,SINCE,THERE
001,178,64257,751,967,PCR,RHOBTB2
ASA,FIFTEEN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SOCIETY,T2A,THERE
300,500,BACKGROUND,CONCLUSION,HOWEVER,INCLUSION,LABEL,METHODS,RAH,RESULTS,SINGAPORE,TLRHS
035,101,169,600,CAC,MSI,UAC,URACHAL
169,651,AMONG,COLLEGE,CONCLUSION,FURTHER,LABEL,LTD,MDS,MEDICAL,METHODS,OBJECTIVE,OLDER,PACIFIC,PTY,PUBLISHING,RESULTS,UNION,WILEY
CYSTOSCOPY,RAL
014,020,039,BACKGROUND,CAREFUL,DISEASE,HOWEVER,LABEL,METHODS,RESULTS,SEVERAL,SNAIL
BLADDER,DUTCH,EDUCATION,FELLOWSHIP,SCALE
2AX,947,BECLIN1,COMET,EXPRESSION,FAS,FLICE,KNOCK,RAS,TREATMENT
233,BBN,BCA,BCG,HOWEVER,THESE,THP,VITAMIN
CONCLUSION,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PCA,PET,PURPOSE,RESULTS,SUVMEAN
AMP,FURTHER,HOWEVER,METFORMIN,T24
BACKGROUND,LABEL,OBJECTIVE,OBJECTIVES,OTHER,THESE
000,100,185,265,455,INCIDENCE,JANUARY,KOREA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,VIETNAM,WAR
CELECOXIB,COX,GFP,INHIBITION,JNK,JUN,TAKEN
002,042,125,BACKGROUND,FURTHER,HUMORAL,LABEL,RESULTS,SPAG9,SPERM,TCC,THEREFORE
001,108,186,AFTER,FINALLY,PCR,USP28,WESTERN
094,360,797,894,ASN,ASP,ASP312ASN,CAUCASIANS,CBM,CIS,CRUDE,DESPITE,LYS751GLN,ORS,OVERALL,THESE,XERODERMA,XPD
169,AKT,BLADDER,FGFR3,HOWEVER,INC,NMIBC,THESE,WILEY
BLADDER,CANCERS,MMR
233,BCG,CAROTID,FINAL,MYCOTIC,RADICAL
WORLD
39351,3RD,CANCERS,CHILDHOOD,CONCLUSION,DEC,EDITION,GENERAL,HACETTEPE,HOSPITALS,JAN,LABEL,MEDICAL,METHODS,OBJECTIVE,PEDIATRICS,PURPOSE,RADIATION,RESULTS,SURGERY,UNIVERSITY,UROLOGY
037,065,2N0,3DCRT,BETWEEN,EORTC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS,VAS
169,INC,MOLECULAR,PUBLISHED
160,169,819,ADVERSE,COPYRIGHT,EDUCATION,H19,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROLONGED,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
000,001,005,068,169,177,340,640,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
102,160,169,617,937,BASED,CIS,COPYRIGHT,DESPITE,FIFTEEN,INC,JANUARY,RRS,SIMILAR
169,207,233,AUTHORS,BJU,FDG,HENCE,HOWEVER,LABEL,LNS,METHODS,OBJECTIVE,PET,RESULTS,THERE,THESE,USING
169,BACKGROUND,BCA,BLACK,DATABASES,ELIXHAUSER,FLORIDA,HEALTHCARE,INPATIENT,LABEL,METHODS,PROJECT,QUALITY,RESULTS,SOCIETY,STATE,THESE
120,250,AMONG,III,LOW,PROLONGED
33342,CSC,HOECHST,KNOCKDOWN,MOLONEY,NSP,PCR
HOWEVER,RANDOMIZED
BASEL,EIGHT,GERMANY,LABEL,METHODS,OBJECTIVE,RESULTS
169,277,280,BASEL,CD138,CYTOL,SAHIN,SINCE,WHILE
169,954,AKT,CDK,COPYRIGHT,FINALLY,LTD,MMP,SIMILAR,THESE
147,169,257,AFTER,BIPOLAR,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SECONDARY,THERE,THOSE,UROLOGICAL
004,015,031,075,103,169,360,414,931,ABO,COPYRIGHT,DISEASE,EDUCATION,INC,INCLUDING,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SINCE,THOSE,UROLOGICAL
018,169,19Q13,AKT,COPYRIGHT,CROSSTALK,EDUCATION,ERBB2,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UPPER,UROLOGICAL
169,233,947,CONNAUGHT,COPYRIGHT,EDUCATION,INC,IRRADIATED,J82,LABEL,MATERIALS,METHODS,OBJECTIVE,PERIPHERAL,PUBLISHED,PURPOSE,RESULTS,RT4,T24,UROLOGICAL
001,003,091,169,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,YOUNGER
006,011,125,169,199,516,COPYRIGHT,EDUCATION,INC,INDIANA,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PRIOR,PUBLISHED,PURPOSE,RESULTS,UNIVERSITY,UROLOGICAL
169,BIOMARKERS,COPYRIGHT,ENGLISH,HOWEVER,INC,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UCB,UROTHELIAL
001,100,169,198,CONCLUSION,DIAGNOSTIC,ELISA,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OMEGA,OPTIMAL,POC,PUBLISHED,RESULTS,SEVERAL,UBC,URINE
100,169,233,AE1,AE3,BASED,BCG,COPYRIGHT,CYSTOSCOPY,DENSE,HMB,LANGERHANS,LCH,SEVEN,THERE
005,169,223,245,BACKGROUND,CONCLUSION,COPYRIGHT,ENE,INC,JANUARY,LABEL,LNS,METHODS,RADICAL,RESULTS,RFS,UBC,VARIABLES
130,169,677,AUA,BACKGROUND,BASED,BECAUSE,CONCLUSION,COPYRIGHT,DESPITE,EAU,END,GREATER,INC,IVP,LABEL,METHODS,MRI,NETWORK,RESULTS,RPG,STAGING,THERE,UROLOGICAL,UROLOGY
BCG,COMMITTEE,CONCLUSION,DIEGO,DRUGS,FDA,INC,INVITED,LABEL,MAY,METHODS,NMIBC,OBJECTIVE,ONCOLOGIC,PANEL,PUBLISHED,RESULTS,SAN,THERE,UROLOGICAL
169,176,1FA,1PA,210,360,6MM,8MM,AGILITY,ARC,AUTHORS,BACKGROUND,COPYRIGHT,CTV,INCLUDING,IRELAND,LABEL,LTD,MATERIALS,METHODS,MLC,MODULATED,OAR,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SEVEN,THERAPY,USING,VOLUMETRIC
169,3MM,CONCERNING,COPYRIGHT,CTV,GTV,IMAGE,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE
169,215,AFTER,AMONG,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,048,122,169,399,521,BACKGROUND,CONCLUSION,COPYRIGHT,CSM,EORTC,INC,LABEL,LVI,METHODS,RESULTS,SG1,SG2,TREATMENT,TURBT
1980S,KEY,SBR,THESE,VIDEO,WHILE
001,004,022,033,169,BACKGROUND,COPYRIGHT,CSM,HOWEVER,LABEL,LVI,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,UCB,UROLOGY
160,169,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VINCI
169,BACKGROUND,BJU,CONTEXT,ENGLISH,HOWEVER,ILEAL,LABEL,MEDLINE,METHODS,OBJECTIVE,ORTHOTOPIC,RESULTS,SYNTHESIS
169,946,BLACKWELL,DHT,EMT,LOW,PCR,T24,TGF
GREEN
RES,SEVEN
945,AKT,BAX,BCL,COX,HOWEVER,WESTERN
BACKGROUND,BETWEEN,LABEL,LOW,MARCH,METHODS,OBJECTIVE,PRIOR,RESULTS
169,945,946,ABH,COPYRIGHT,ENDOGENOUS,GALECTINS,GM3,HNK,K176L,KEY,LNT,LTD,THESE
AMERICA,AUTOLOGOUS,BACKGROUND,DESPITE,DISCUSSION,LABEL,METHODS,NORTH,OPIOIDS,QUALITY,TRIAL
258,635,637,956,BACKGROUND,BASED,DOVITINIB,EMT,EXPRESSION,LABEL,METHODS,PCR,PROTEIN,RESULTS,RTK,TKI,WESTERN,XTT
169,469,AUTHORS,BJU,COX,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RADICAL,RESULTS,UNADJUSTED
169,230,BRITISH,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,SOCIETY
000,100,676,811,AGE,CHINESE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILARLY
AZA,BACKGROUND,BIU,CDR,CONCLUSION,CPG,EPIGENETIC,LABEL,METHODS,OTHERWISE,PCR,RESULTS,T24,WESTERN
270,AIM,AMH,BASED,CONCLUSION,IGA,IVU,LABEL,LOW,METHODS,NEWLY,OBJECTIVE,RESULTS,THREE,UUT
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
765GC,765GG,AIM,AMONG,BLADDER,CONCLUSION,COX,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SIX
31G,57G,BACKGROUND,CENTRAL,CONCLUSION,HOWEVER,LABEL,MATERIALS,MEANWHILE,METHODS,NON,RESULTS,XRCC6
001,003,016,131,212,678,AIM,ALTERED,AMONG,CONCLUSION,DEFECTS,LABEL,METHODS,OBJECTIVE,RESULTS,UCB
THESE
001,020,022,178,BACKGROUND,FURTHER,LABEL,METHODS,ORC,RESULTS,TSF
169,CISPLATIN,COPYRIGHT,HOWEVER,L02,NMR,THEREFORE,THESE
169,CD138,CIS,CK5,COPYRIGHT,HOWEVER,IHC,INC,NEU,P53,USING,WHEREAS
100,160,169,548,FOCAL,GATA3,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,UNIVARIATE,WILEY
176,180,192,945,946,CTV,D90,HDR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
956,BECAUSE,DEVIATION,FEM,LABEL,METHODS,MHZ,OBJECTIVE,OCT,OPTICAL,PURPOSE,RESULTS,SINCE,YOUNG
177,BOARD,CLASS,CTU,IRB,JACCARD,LABEL,LEVEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
177,CTS,CTV,D99,DAILY,DSC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,THESE
HODGKIN,NHL,PRIMARY
169,244,632,AMONG,BACKGROUND,CHINA,CIGARETTE,CIS,CONCLUSION,COX,HRS,LABEL,METHODS,RESULTS,THESE
CARLO,CONCLUSION,KNOWLEDGE,LABEL,LOWER,METHODS,MONTE,MRI,MUS,OBJECTIVE,PTV,PTV78,PTV86,RESULTS,SIB,V30,V50,V60,V80
900,D52,PCR,STRONGEST,THESE,TPD52
038,BLADDER,CALIFORNIA,CONCLUSION,FIFTY,HOWEVER,HRQOL,INDEX,KRUSKAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE,UNIVERSITY
945,946,954,HAF,HIF,HOWEVER,HYPOXIA,P65,T24
215,299,391,580,676,778,AFTER,ALPHA,CIS,COLORECTAL,FINNISH,LINE1,ORS,OVARIAN,PREVENTION,SCREENING,THESE,TOCOPHEROL,TRIAL
169,945,946,949,BIU,COPYRIGHT,FURTHER,HOWEVER,INC,PKC,PLC,PROTEIN,PUBLISHED,T24,THESE
156,167,169,252,454,642,679,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,MIXED,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIMILARLY,UROLOGICAL,WHILE
169,BACKGROUND,COPYRIGHT,CZECH,HOWEVER,LABEL,LTD,METHODS,RESULTS
169,AEU,ALTERATION,CONCLUSION,CONTEXT,COPYRIGHT,DETERMINE,EVIDENCES,HLA,LABEL,OBJECTIVE,PUBLISHED,SYNTHESIS,THERE,THOSE,UNASSIGNED
150,159,169,AMONG,BACKGROUND,CCTTT,CONCLUSION,COPYRIGHT,GENOTYPING,INDUCIBLE,LABEL,METHODS,NAD,PUBLISHED,RESULTS,UNASSIGNED
169,945,946,ARG,ASP,AXDADB3,CAR,CONCLUSION,COPYRIGHT,E1A,E1B,EXPRESSION,GLY,HCV29,INC,LABEL,METHODS,OBJECTIVE,RESULTS,RGD
169,412,999,CLEVELAND,CONCLUSION,COPYRIGHT,FOLLOWING,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PVP,RESULTS,SIXTY
100,169,196,AMONG,CDC,GATA3,GIVEN,INTENSITY,RCC,SEVERAL
169,175,179,AUTHORS,BCR,BJU,CLAVIEN,GRADE,III,LABEL,MEIER,METHODS,OBJECTIVE,PFS,POTENCY,PSA,RESULTS,SALVAGE
AKT,BACKGROUND,CONCLUSION,LABEL,LRIG1,MEANWHILE,METHODS,PCR,RESULTS,T24,TAKEN
006,018,27A,27B,685,730,CHINESE,DICER,III,LABEL,LUCIFERASE,METHODS,OBJECTIVE,PURPOSE,RESULTS,RNASE,STRATIFIED,TAKEN,UTR
AKT,BLADDER,HU1,J82,RT4,T24,THESE
151,169,COPYRIGHT,HOWEVER,INC,INSTITUTE,KIT,OUTSIDE,PATHOLOGY,THEREFORE,USING,WILEY
178,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,CRANBERRY,GIVEN,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OTHER,OVERALL,PRIOR,QUALITY,RESULTS,SELECTION,TEN,THERE,UTI
169,ADP,AKT,BAX,BCL,COPYRIGHT,DIALLYL,ERK,JNK,JUN,MAPKS,T24,TREATMENT
000,ITALY

169,600,831,ENDOSCOPIC,FORCE,JAPAN,LTD,PTY,PUBLISHING,SOCIETY,SURGERY,T4BN0M0,TOTAL,TPE,WILEY
100,120,145,160,205,870,992,997,AUC,MIR,PCR
117,125,BLADDER,CONCLUSION,DUE,INDEX,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SCORE,SYMPTOM,TME,WJD
CD154,CD40L,HOWEVER,ONCOLYSIS,ONCOLYTIC,TH1,THEREFORE
HOWEVER,METASTATIC,USING
169,241,243,728,AUA,AUTHORS,BJU,CONCLUSION,CUETO,DUTCH,EAU,EORTC,IPS,LABEL,METHODS,OBJECTIVE,ONCOLOGICO,RESULTS,THERE,TREATMENT,UROLOGICAL
LC3,MTT,WESTERN
NEOPLASTIC,SEVERAL,SPECIAL,THEIR,THESE
129,169,175,353,493,668,CLAVIEN,KETTERING,LABEL,METHODS,OBJECTIVE,RESULTS,SLOAN,THERE,UROLOGICAL
000,ADULT,BACKGROUND,BLADDER,CONCLUSION,LABEL,METHODS
177,AMONG,GRADE,IMAGE,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS
101,117,119,169,171,216,BACKGROUND,INK4A,LABEL,METHODS,RESULTS,SOCIETY
127,JANUARY,PRIMARY,THREE
169,COPYRIGHT,COUNCIL,EDUCATION,FINALLY,HOWEVER,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,THEREFORE,THESE,UROLOGICAL
947,BBN,C57BL,ELISPOT,IFN,MULTIPLEX,SCC,TCC,TH1
CURRENTLY,NUR77,THESE
BFTC905,BFTC909,IC50S,III,MOLECULAR,T24,TCC,THESE,YM155
100,181,420,DIETARY,THERE,UVA
BCG,SCC
001,117,169,200,347,956,CHILE,COPYRIGHT,DMA,INC,MMA,OVERALL
169,ADP,COPYRIGHT,HOWEVER,LTD,OVERALL,ROS
145,169,175,250,300,360,400,420,612,ACTUARIAL,CLAVIEN,CONCLUSION,COPYRIGHT,EARLY,INC,IQR,LABEL,MARCH,MATERIALS,MEIER,METHODS,OBJECTIVE,RECURRENCE,RESULTS
169,HDAC3,HDACS,INC,INCREASED,SIRNA,WILEY
123,243,ARGENTINA,BACKGROUND,BLADDER,LABEL,METHODS,OBJECTIVE,RESULTS
607,ALONGSIDE,BACKGROUND,CONCLUSION,ELISA,EPCAM,EPITHELIAL,FURTHER,LABEL,MEIER,METHODS,RESULTS,ROC,URINARY,WHITNEY
017,043,169,210,945,946,947,COPYRIGHT,CXCR4,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SDF,UROLOGICAL,USING,WHILE
169,24H,AMONG,ARSENIC,COPYRIGHT,FURTHER,H2A,HOWEVER,THESE,USING
169,COPYRIGHT,DPP,EARLY,FDA,GLP,LTD,PUBLISHED,THERE,THESE
BACKGROUND,LABEL,METHODS,OCT,OPTICAL
CURRENTLY,FIRST,HOWEVER,INCREASED,RASSF1A,RT4,TCC,THEREFORE
110,116,120,169,177,4N0,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
145,169,250,750,ASSESSMENT,AVP,COPYRIGHT,CURRENT,FIFTEEN,MRI,SAS,TRANSIENT
120,160,177,224,596,BACKGROUND,LABEL,METHODS,PVP,RESULTS,RUV,SCORING,SYMPTOM,THERE
100,150,200,403,478,668,768,CIS,COX,HRS,LABEL,METHODS,OBJECTIVE,RECURRENCE,RESULTS,SURGERY,TURBT
CARCINOMAS,ENGLISH,SHELDON,STAGING,SYSTEMS
183,295,ADI,ASIAN,CAUCASIAN,FLT,NOTABLY,PEG20,PET,TAKEN
AKT,KAE,KAEMPFEROL
001,169,177,275,APRIL,BACKGROUND,BMI,CCS,CLAVIEN,COPYRIGHT,FIFTY,ITALIAN,LABEL,LTD,MARCH,MATERIALS,METHODS,OVERALL,RESULTS,SIX
169,24H,ALA,COPYRIGHT,FINALLY,PUBLISHED,THESE
100,169,ALA,BACKGROUND,CONCLUSION,COPYRIGHT,CPI,CPIII,III,LABEL,METHODS,PDS,RESULTS,THESE,UPI,UPIII
BACKGROUND,CASES,CONCLUSION,INITIAL,LABEL,MELANOSIS,METHODS
BACKGROUND,CONCLUSION,ENGLISH,LABEL,METHODS
177,BACKGROUND,BCG,BCGTHERAPY,BLADDER,CONCLUSION,INITIAL,LABEL,METHODS,PARAMETERS,RADICAL,RESULTS,SIX,TCC,TUR,UNIVARIATE
001,012,027,038,108,138,169,177,380,546,BASEL,DESPITE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RNU,THERE,UCC,UUT
149,196A2,27A,499,CRUDE,FINALLY,FURTHER,HOWEVER,MICRORNAS,SCCHN
169,177,200,300,BACKGROUND,BLADDER,CMP,CONCLUSION,CTU,FIFTY,FOUNDATION,HOUNSFIELD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROI
155,262,264,277,419,449,507,925,CONCLUSION,EXCELLENCE,INSTITUTE,IUC,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RECURRENT,RESULTS,SPC,THEATER
160,169,CLINICALLY,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
169,414,457,642,800,878,AUTHORS,BIVARIABLE,BJU,COLLEGE,EXCLUDING,LABEL,LOS,METHODS,NAC,NSQIP,OBJECTIVE,PROGRAM,QUALITY,RESULTS,USING
AAV,BACKGROUND,ENDOSTATIN,GIVEN,HSV,LABEL,METHODS,PREVIOUSLY,RESULTS,THREE,TIE,VP1,VP2,VP3
AAV,BACKGROUND,ENDOSTATIN,GFP,GIVEN,HSV,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREVIOUSLY,RESULTS,THREE,TIE,VP1,VP2,VP3
169,210,281,APPROACHES,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TRANS,WILEY
169,300,527,936,GROUP,INC,SPECIMENS,THESE,WILEY
EVALUATION,KIT,PATIENT
22RV1,954,ARRAY,BPH,DU145,LIMITED,LNCAP,METHODS,OBESITY,PCR,SIMILAR,WESTERN,ZFP91
001,042,307,REGIONS,STAG2,STRIKINGLY,THERE
169,2CC,797CC,BLADDER,COPYRIGHT,CROWN,HDR,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE
169,177,198,COPYRIGHT,D90,DOSIMETRIC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RIGID,SOCIETY
160,169,COPYRIGHT,DOSIMETRIC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SIMILAR,SOCIETY,V95
169,COPYRIGHT,FOUNDATION,PUBLISHED,UROLOGY
BACKGROUND,HOWEVER,IHC,LABEL,METHODS,PCR,PINX1,RESULTS,THESE,UCB
169,COPYRIGHT,INC,LIVER,PANCREATIC
ELISA,HGTCC,LABEL,LGTCC,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC
001,004,AGE,BACKGROUND,COX,CUMULATIVE,IQR,LABEL,METHODS,RESULTS,THERE,TUR,UNI
169,ADDITIONAL,BACKGROUND,COPYRIGHT,DEGRADABLE,ECM,EGD,INC,LABEL,METHODS,PRIMARY,PUBLISHED,RESULTS,SOCIETY
APRIL,ARG194TRP,ARG280HIS,ASIAN,CIS,HOWEVER,ORS,OVERALL,SCIENCE,SUMMARY,WEB,XRCC1
001,129,256,326,353,399,669,681,956,HOUSEHOLD,NICOSIA,THM
AAM,AGGRESSIVE,CLOSE
29B,29C,BUC,CONCLUSION,HU609,KNOCKDOWN,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,T24
001,048,120,945,EXPRESSION,HENCE,HOWEVER,INTER,ITIH5,RT112,THEREFORE,UCS
169,COPYRIGHT,DWI,INC,MRI,TREATMENT,WILEY
160,ATP,OTHER,PURINERGIC
674,823,ALA499VAL,CAUCASIAN,CCND1,CIS,G870A,ORS,RESULTS,SCIENCE,WEB,XPC
169,AFTER,BACKGROUND,CONTEXT,COPYRIGHT,INC,LABEL,METHODS,MRI,OBJECTIVE,OUTCOME,PATIENT,PURPOSE,RESULTS,T11,T12
160,169,5A2,AUTHORS,BIU,EMT,GC7,J82,KNOCKDOWN,LTD,PTY,PUBLISHING,SCIENCE,WILEY
MASSIVE,SERUM,THESE
005,023,032,043,177,201,400,559,603,725,800,804,902,ADC,AUC,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,WHITNEY
III,KEY,KRT15,P63
181,ADDUCTS,FINALLY,HEPG2,POLYCYCLIC,T24,THESE
013,016,025,028,539,627,ASIAN,BACKGROUND,CAUCASIANS,CHINESE,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,RESULTS
954,ACT,HIPAA,INSURANCE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,RESULTS,USING
DOPPLER,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,USING
005,008,013,017,150,169,197,233,340,343,587,627,945,BCG,CD163,EFFECTIVE,HIF,HOWEVER,HYPOXIA,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
APC,ATM,BACKGROUND,BRCA1,BRCA2,CASP8,CDH13,DAPK1,GSTP1,IGSF4,LABEL,METHODS,NMIBC,RESULTS,TIMP3,VHL
ACTIVATED,BASED,EPIDERMAL,FGFR3,FIBROBLAST,FINALLY,MITOGEN,PROTEIN
010,013,031,109,119,122,177,ASSESSMENT,HOWEVER,HRQOL,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,TEN,TRIAL,UNIVERSITY
121,122,169,CONTINENCE,FLOOR,INC,KHQ,LABEL,MATERIALS,METHODS,OBJECTIVE,QOL,RESULTS,SCORE,SUI,SYMPTOM,THERE,VALIDATED,WILEY
169,945,ADVERSE,BACKGROUND,INSTITUTE,LABEL,METHODS,PFS,RESULTS,SECONDARY,SIXTEEN,SOCIETY,THERE
130,202,HAL,LABEL,METHODS,NMIBC,OBJECTIVE,PURPOSE,RESULTS
160,470,AIM,CONCLUSION,ENGLISH,JANUARY,LABEL,MEDLINE,METHODS,MULTIMODAL,MVR,OBJECTIVE,RECURRENT,RESULTS
160,BLC,HAL,WLC
001,013,128,133,174,206,274,300,584,900,BACKGROUND,IQR,JANUARY,LABEL,LARGE,METHODS,OVERALL,RESULTS,THERE
038,177,956,BPE,CONCLUSION,ELISA,HOWEVER,LABEL,METHODS,ONFFN,RESULTS,TCC,UNLABELLED,URINE
129,239,AIM,CONCLUSION,DIAGNOSTIC,LABEL,METHODS,OBJECTIVE,PRIMARY,PROSTATIC,RESULTS,TUR
175,BASEL,EASTERN,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS
127,160,169,CARBO,CIS,CONCLUSION,COPYRIGHT,CSS,GEM,INC,INDUCTION,LABEL,METHODS,OBJECTIVE,PROGNOSIS,RESULTS
270,313,BCA,EXPRESSION,HOWEVER,NMIBC,TNM,TURBT
CONCLUSION,GIVEN,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNTIL
CAGGS,CRE,FTI,LASER,RAS,THESE,TPA,TREATMENT
945,946,947,DDT,GAMMA,GAS,GST,GSTM1,GSTT1,HCH,OCP,PCR,THESE,UBC,URINARY
001,162,177,331,399,485,ALAIN,ALG,AVERAGE,COMMISSION,CONCLUSION,GERBAULET,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,UNITS
169,956,AUNPS,HAASE
169,COPYRIGHT,HIV,HOWEVER,RETINOIDS,THERE
001,006,032,049,166,169,414,567,CASES,COPYRIGHT,COX,FEMALES,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RECURRENCE,RESULTS,SOCIETY,UCB
169,COPYRIGHT,COX,CUMULATIVE,INC,INPATIENT,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,ORTHOTOPIC,RESULTS,UNIVARIATE,UTI
001,004,169,BRITISH,CONCLUSION,COPYRIGHT,DELEGATES,EXCELLENCE,FIFTEEN,GROUP,INC,INSTITUTE,KINGDOM,LABEL,MATERIALS,METHODS,MTB,OBJECTIVE,OBJECTIVES,OPTIMIZING,RESULTS,SEPTEMBER,SEVEN,URO
169,195,417,780,BACKGROUND,COPYRIGHT,IHM,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,PARTIAL,RESULTS
169,956,BP1,CELLS,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,T24,THESE
169,946,AKT,BLADDER,BOLDINE,COPYRIGHT,CYTOMETRY,DESPITE,ERK,GSK,INC,LABEL,METHODS,OBJECTIVE,RESULTS,T24,WESTERN
169,401,COPYRIGHT,FURTHER,INC,INCIDENCE,INSURANCE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SCI
169,2PF,332,946,947,AKT,AUTHORS,ERK,HOWEVER,HUVEC,LAMININ,LTD,PTY,PUBLISHING,SCIENCE,THESE,WILEY
169,8505C,8505CBRAF,956,AZA,BACKGROUND,BCPAP,BRAFV600E,CONCLUSION,COPYRIGHT,CPG,DAC,EXPRESSION,INC,LABEL,LATER,MAGEA,MEK,METHODS,MOSBY,PLX,PLX4720,RESULTS,TPC,TREATMENT
100,169,AFTER,BACKGROUND,COPYRIGHT,FURTHER,HOWEVER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SMALL,TECHNICAL,UNCOVERED
120,160,852,956,AMONG,BACKGROUND,FOODS,HOWEVER,LABEL,LIMITED,METHODS,RESULTS
946,CEREALS,PROBIOTIC,PROBIOTICS
BLADDER
105,963,CDC25,HOWEVER,MTT,PCR,THERE,WESTERN
001,169,233,250,945,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
120,165,177,232,397,739,795,852,CONCLUSION,KETTERING,LABEL,MEIER,METHODS,MSKCC,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,ROC,SLOAN
180,257,420,875,BRICKER,CAMEY,EARLY,EVERY,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,THERE,UNIVERSITY
BCG,INF,NMIBC,TREATMENT
AFRICAN,TCC,USING
169,COPYRIGHT,INC,MALIGNANT,URACHAL
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,MALECOT,METHODS,TECHNICAL
160,169,962,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,NAC,OBJECTIVE,RESULTS,THESE,THOSE,UNIVARIATE,USING
120,BACKGROUND,BIU,GSIXX,JAGGED2,LABEL,METHODS,MTT,NOTCH,PROGNOSTIC,RESULTS,T24,THERE,WESTERN
043,169,312,425,477,BMI,COX,HOWEVER,NUTRITION,STRATIFIED,THERE,UCC
100,128,135,945,AMACR,CASES,CD44S,CIS,COA,HOWEVER,IUN,METHYLACYL,UROTHELIAL,VARIOUS
107,916,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCC,THERE,UCS
160,AVERAGE,BACKGROUND,D2CCS,EBT,ESTRO,GEC,GGE,GYN,IMAGE,LABEL,METHODS,RESULTS

169,AUTHORS,BJU,RADICAL,THERE
BACKGROUND,CONCLUSION,DESPITE,DISCOVERY,J82,LABEL,MEIER,METHODS,RESULTS,THEREFORE,UROTHELIAL
BPB,CH2,NPS
169,AUTHORS,ENDOGENOUS,INC,KNOCKDOWN,MBT,PUBLISHED,THESE,WILEY
014,023,037,BACKGROUND,CONCLUSION,HOWEVER,IVA,LABEL,LCR,METHODS,PFS,PROGNOSTIC,RESULTS
218,580,AIM,C521A,CONCLUSION,G14713A,G21985A,G32124A,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,T28608A,T29107A,TAIWANESE,UPPER,WESTERN
661,ABOUT,CONCLUSION,LABEL,METHODS,ONCOLOGIC,PET,PLANNED,RESULTS,UNLABELLED
100,120,174,181,200,344,400,GROSS,MMC,MOLECULAR,POLYPHENON,SIXTY
169,490,COPYRIGHT,FOS,FURTHER,INC,LUCIFERASE,MICRORNAS,THESE
169,COPYRIGHT,III,INC,LABEL,METHODS,OBJECTIVE,PEARSON,PFS,RESULTS,TEN,YATES
EGYPT,LABEL,NAD,UNASSIGNED,UNLABELLED
106,NMR,ROC
001,118,169,350,386,396,AUTHORS,BJU,BMI,CONSORTIUM,CYSTECTOMY,LABEL,LOS,MEANWHILE,METHODS,OBJECTIVE,RADICAL,RESULTS,SOCIETY
055,169,AUTHORS,BJU,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,THESE,UNADJUSTED
ALT
016,023,111,113,140,169,203,369,ACCORDING,BASEL,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL,SNP,THERE,THESE
FDG,HOWEVER,PET,THESE,URACHAL
169,302,ACTIVATION,COPYRIGHT,HENCE,PUBLISHED,RB1,UROLOGY
056,179,BACKGROUND,COX,HRS,LABEL,METHODS,REGISTERS,RESULTS,TZD
BACKGROUND,BIBLIOTEK,LABEL,MEDLINE,METHODS,NEOPLASMS,OBJECTIVE,PHYSICIANS,RESULTS,SCIENCE,SOURCES,WEB
968,CIS,COLLECTED,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
022,026,040,045,FINALLY,FURTHER,GRADE,III,PAPILLARY,USING
169,BACKGROUND,BECAUSE,CHEMISTRY,CONTENT,LABEL,LARGE,SEVERAL,SUMMARY
956,BSO,DHE,GSH,H2DCFDA,LCA,NAC,ROS,SRB,T24
169,CAPSAICIN,TRPV1,VARIOUS
169,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,BLADDER,COPYRIGHT,INC,USING
169,BACKGROUND,BYM,CLASSIC,CONCLUSION,COPYRIGHT,DIC,ISERE,LABEL,MAPPING,METHODS,MORAN,POISSON,RESULTS,SAS
001,169,500,ACUTE,AUR,BRITISH,COPYRIGHT,CROWN,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADIATION,RESULTS,THERAPY
767,FDG,IULIT,PET
001,ABDOMINAL,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PNEUMATIC,PURPOSE,RESULTS
155,165,726,HRS,LABEL,LIBRARY,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
111,377,ASA,BACKGROUND,END,FIFTY,LABEL,MEIER,METHODS,NSQIP,PUF,RESULTS
112,244,249,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RNU
100,AGREEMENTS,AIM,AREAS,BLAND,COMPARISON,CONTENT,DENMARK,EDUCATION,INSTRUMENT,LABEL,METHODS,OBJECTIVE,PLOTS,RESULTS,SCALE,UNIVERSITY
169,956,ACTIN,HENCE,LABEL,METHODS,OBJECTIVE,OKABAYASHI,RADICAL,RESULTS,SCHWANN,VUL,WHILE
169,AFTER,CSF,DUE,ISCMS,MRI,PATHOLOGY,SDC
169,233,COPYRIGHT,PUBLISHED,THESE
100,417,ACCORDING,BACKGROUND,BLADDER,CGH,CONCLUSION,LABEL,METHODS,RESULTS,TCC
AREAS,BACKGROUND,CONTINUED,COVERED,DESPITE,LABEL,MAJOR,METHODS,OPINION,THERE
001,159,182,230,956,ERBB2,LABEL,METHODS,MUTATIONS,NGS,OBJECTIVE,PURPOSE,R157W,RESULTS,S310F,S310Y,SEQUENCING
AIR,EASTERN,GOF,GWR,HOWEVER,NO2,OVERALL,SAUDI,THESE
117,171,176,232,243,403,BACKGROUND,BASEL,BETWEEN,CIS,FSA,LABEL,METHODS,OVERALL,RESULTS,UCB
005,006,181,194,239,247,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TUR,VARIATIONS
169,804,BOWEL,COPYRIGHT,DOPPLER,EARLY,FIFTEEN,GRADE,LABEL,LTD,MEDLINE,METABOLISM,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,OVERALL,PURPOSE,RESULTS,SOCIETY,SYNTHESIS
A13,B13,C13,D13,HOWEVER,HOX,MOLECULAR,PCR,SEVERAL
160,169,945,946,COPYRIGHT,FEDERATION,GYNECOLOGY,IB2,INC,IVA,LABEL,MATERIALS,METHODS,OBJECTIVE,OBSTETRICS,POINT,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TOTAL,USING
AFTER,AMGEN,FGF,FGFR2,KGF,THERE
000,044,051,614,806,967,AFFILIATED,AIM,AMONG,CONCLUSION,COX,FIFTH,HOWEVER,LABEL,MALIGNANT,METHODS,OBJECTIVE,PCR,RESULTS,SEN,SUN,UNIVERSITY,YAT
100,COX,ERBB2,PATHOLOGIC,UNIVARIATE
169,AFTER,BRIEF,COPYRIGHT,EDUCATION,FATIGUE,INC,INVENTORY,LABEL,MATERIALS,METHODS,NEITHER,OBJECTIVE,OTHERWISE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SECONDARY,THERE,UROLOGICAL
004,024,169,307,COLLEGE,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,METHODS,NSQIP,OBJECTIVE,PROGRAM,PUBLISHED,PURPOSE,QUALITY,RESULTS,THEREFORE,UNIVARIATE,UROLOGICAL
169,300,688,800,AGE,CONDITIONS,COPYRIGHT,EDUCATION,HOWEVER,INC,KRIMPEN,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,LABEL,METHODS,OBJECTIVE,PCR,RESULTS
012,169,240,242,245,267,295,577,773,904,AUSTRALIA,BACKGROUND,COPYRIGHT,HODGKIN,LABEL,LTD,METHODS,OTHER,RESULTS,THERE
001,086,106,167,169,198,414,570,768,817,935,BACKGROUND,CONSORTIUM,COPYRIGHT,CYSTECTOMY,KRUSKAL,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,ROBOT,ROBOTIC,SETTING,SOCIETY,THERE
169,COPYRIGHT,DISCUSSION,DOPPLER,INC
169,BLADDER,COPYRIGHT,INC
100,169,500,800,CONCLUSION,COPYRIGHT,CSA,III,INC,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,SEVEN,THERE
124,BACKGROUND,DAB,EXOGENETIC,HOWEVER,INCREASING,J82,LABEL,MET,METHODS,MTT,PCR,RESULTS,ROCK1,T24,THREE
001,BACKGROUND,CIS,FURTHER,INCREASING,LABEL,MATERIALS,MEDLINE,METHODS,RESULTS,RRS,SUMMARY,THERE
160,162,BCS,BHE,BMI,BPA,CORRELATES,FACTORS,SEVERAL,THESE
005,008,018,075,077,091,110,167,169,180,210,788,823,890,942,990,ARG399GLN,ASIAN,HOWEVER,XRCC1
113,160,169,BETWEEN,COPYRIGHT,DFS,GRADE,III,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PUBLISHED,PURPOSE,RESULTS,SOCIETY,UNIVERSAL
823,BACKGROUND,LABEL,METHODS,MUS,PTV,RESULTS,THREE,V40
463,AMONG,BACKGROUND,DUZCE,EXCLUSION,FACULTY,LABEL,MATERIALS,METHODS,RESULTS,UNIVERSITY
ENGLISH
DIAGNOSIS,ORGAN,SLAUGHTER

106,123,229,DUTCH,LABEL,METHODS,NERVE,OBJECTIVE,RADIATION,RESULTS,RHL
160,AFTER,ANOTHER,DEFORMABLE,DIR,FURTHER,HOWEVER,JAC,ORGAN,REDUNDANT,SEMINAL,THREE
HOWEVER,THESE
129,149,299,575,931,AFTER,AMONG,GLEASON,JANUARY,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RCP,RESULTS
ALA,BCS,BLADDER,HENCE,THESE
169,326,597,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,COX,CSM,FEW,INC,LABEL,METHODS,NMIBC,REPORTS,RESULTS,TURBT,VARIABLES,VUC
169,215,BACKGROUND,COPYRIGHT,D10,D25,LABEL,LTD,METHODS,MRI,PUBLISHED,RESULTS,SIMILAR,THEREBY
734,BACKGROUND,CENTRAL,EFFORTS,EXCLUDING,LABEL,MEASURING,METHODS,NORTH,OBJECTIVE,RESULTS,USING,WORKFORCE
DESPITE,NON,THEREFORE
SCCUB,SMALL
CELLS,ERK,EVALUATION,FURTHER,MEMBERS,NOD,THESE
203,BECAUSE,CINPT,DAVINCI,GLEASON,JANUARY,LABEL,METHODS,MONTSOURIS,NVB,OBJECTIVE,PSM,PURPOSE,RESULTS,SEPTEMBER
003,006,108,127,141,327,457,528,565,926,BETWEEN,BLADDER,CONCLUSION,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
CIS,FINALLY,IMMUNOCYT,MAJOR,NMIBC,NON,STAGE,TURBT,URINE,URO
169,AUSTRALIA,AUTHORS,BJU,COX,FOLLOWING,LABEL,MEIER,MELBOURNE,METHODS,OBJECTIVE,PATHOLOGIC,PATIENT,RESULTS,USING
169,ADD,AUTHORS,BJU,KNOWN,METAPLASIA,SUBJECT,UROLOGISTS,USUALLY
11P15,20P12,215,801,814,CANDIDATE
100,118,122,133,164,169,945,946,DFS,GRADE,HDR,LABEL,METHODS,OBJECTIVE,RESULTS
10B,946,BASED,FM4,PC3,WNT,WNT11
185
284,511,534,909,CONCLUSION,JANUARY,LABEL,LRC,METHODS,MINOR,OBJECTIVE,ORC,PURPOSE,RESULTS
III,PHASE,VINFLUNINE,WHILE
001,005,114,885,BACKGROUND,HOWEVER,LABEL,MEDLINE,METHODS,RESULTS,URO,WHILE
CPT,DPD,ELISA,FINALLY,FIRST,HOWEVER,MEANWHILE,THEREFORE
001,008,02E,03E,169,210,CHINA,CHINESE,CONFIDENCE,COPYRIGHT,INC,MYC,TACC3,THREE,TIS,WILEY
285,300,COLORECTAL,CONCLUSION,ENDOSCOPY,LABEL,METHODS,PATIENT,RESULTS,TNM,UNLABELLED
945,946,BBN,BCA,J82,KNOCKDOWN,MECHANISM,PHTPP,RESTORING,T24,TARGETING,USING
160,KEY,RELAPSE,SMOKERS,SMOKING,SUCCESSFUL,TOBACCO
169,177,THERE,UROLOGICAL
CONCLUSION,LABEL,MRI,OBJECTIVE
001,248,454,761,967,LEN,MYC,NDRG2,T24,TRANSWELL
199,DECORIN,HOWEVER,INSTEAD
100,CK7,FORTY,PSA,THESE,THREE
CTV,D95,DOSIMETRIC,EMT,OAR,PDF,PTV
281,286,423,512,588,696,954,CURRENT,HOWEVER,MPVTI,THERE,THESE
114,139,233,945,AMONG,BACKGROUND,BCG,BRIGHAM,INF,LABEL,METHODS,OBJECTIVE,OVERALL,RANDOMIZED,RESULTS,WOMEN
110,169,233,BACKGROUND,BCG,COPYRIGHT,COX,LABEL,METHODS,NMIBC,OBJECTIVE,OUTCOME,PATTERN,PREDICTORS,PRIMARY,PUBLISHED,RESULTS,SECONDARY,SETTING,TIS,UUT,VARIOUS
115,169,307,AUC,BACKGROUND,FURTHER,LABEL,MEIS1,METHODS,ONECUT2,RESULTS,URINE,USING
169,AUTHORS,FINALLY,FINDING,LTD,PUBLISHED,WILEY
160,APOA1,ELISA,THEREFORE
169,ASSOCIATED,CONCLUSION,COPYRIGHT,INC,INHIBITING,LABEL,MATERIALS,METHODS,OBJECTIVE,PKA,PROTEIN,RESULTS,T24
169,COPYRIGHT,HENCE,HPV,INC,INFECTION,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,120,169,177,181,240,AFTER,CELLS,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PDT,RESULTS,RT112,RT4,T24
169,CONCLUSION,COPYRIGHT,CROWN,FINALLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEVERAL
002,003,007,169,200,402,502,509,551,COPYRIGHT,COX,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UCB
001,117,169,302,COPYRIGHT,EXPRESSION,HOWEVER,LABEL,LTD,MATERIALS,MEANWHILE,METHODS,OBJECTIVE,PURPOSE,RESULTS,UCB,WHILE
CASES
007,160,169,216,865,BMI,CONCLUSION,COPYRIGHT,EASTERN,GROUP,INC,LABEL,METHODS,NON,OBJECTIVE,RESULTS,THESE,VTE
169,COPYRIGHT,IDENTIFIED,PRE,USING
CUTANEOUS
169,BACKGROUND,COPYRIGHT,COX,CSS,GIVEN,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RADICAL,RESULTS,SETTING
169,215,226,ARGON,CLINICALLY,COMPOSITE,CONCLUSION,COPYRIGHT,CUMULATIVE,GROUP,INC,INDEX,LABEL,MATERIALS,MEIER,MEN,METHODS,OBJECTIVE,PURPOSE,QOL,RADIATION,RESULTS,THERAPY,THERE
BACKGROUND,DEPARTING,DISCUSSION,LABEL,METHODS,SWEDISH
007,169,CAPRI,COPYRIGHT,CTV,D90,DMEAN,DOSES,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,OPTIMAL,PURPOSE,R12,R13,R23,RESULTS,THREE,TREATMENT
001,169,180,192,372,AMONG,COMMITTEE,COPYRIGHT,CTC,INC,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
130,135,142,170,177,18S,21S,24S,27S,30S,536,555,956,BLOOD,CONCLUSION,EXM,F18,LABEL,MBQ,METHODS,PET,RELATIVELY,RESULTS,SUCCESSIVE,UNLABELLED
370,CONCLUSION,GIVEN,LABEL,METHODS,OBJECTIVE,RESULTS
001,049,100,933,AFTER,CIS,COX,LABEL,LYMPH,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,TUR,UNIVARIATE
169,CARLO,COPYRIGHT,CTV,D90,DICOM,DVH,EXCLUSION,HDR,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MONTE,NEBLETT,OBJECTIVE,PURPOSE,RESULTS
137,155,503,AFFYMETRIX,BACKGROUND,BLADDER,CLARA,LABEL,METHODS,RESULTS,SANTA,SUPERVISED,THESE,UCA
LYMPH,MOLECULAR
108,169,PARTIAL,UROLOGICAL
001,100,BACKGROUND,ELISA,GROUP,HAASE,LABEL,METHODS,PCR,RESULTS,URINARY
001,100,BACKGROUND,ELISA,GROUP,HIF,HOWEVER,HYPOXIA,LABEL,METHODS,MVD,RESULTS,SECONDARY,THERE,URINARY
CRANIOTOMY,FCD,FOCAL,III,MRI,THERE,THESE
002,007,032,188,215,332,603,ALLELIC,CAUCASIAN,HSA,OVERALL,POTENTIAL,SFRP1,SNP
169,251,521,AUTHORS,BJU,CALIFORNIA,COX,LABEL,LNS,MEIER,METHODS,OBJECTIVE,PREDICTORS,RESULTS,RFS,UNIVERSITY
091,160,174,609,ABOUT,CURRENTLY,FIFTEEN,INSURANCE,LABEL,LEUKOCYTES,METHODS,NMP22,OBJECTIVE,PURPOSE,RESULTS,UROSCREEN,UROVYSION
357,BACKGROUND,BSC,III,LABEL,MEIER,METHODS,PRIOR,RESULTS,VINFLUNINE
001,169,243,500,AUTHORS,BETWEEN,BJU,COX,HOWEVER,LABEL,MARCH,METHODS,NMIBC,OBJECTIVE,PREDICTORS,RESULTS,UROVYSION
001,002,102,169,99M,AUTHORS,BETWEEN,BJU,COMPARISON,LABEL,MAG,METHODS,OBJECTIVE,RENAL,RESULTS,THERE
169,AUTHORS,BJU,CONCLUSION,COX,HRS,LABEL,METHODS,NSW,OBJECTIVE,RESULTS,WOMEN
AKT,BBN,BCA,CASODEX,EGF,EPIDERMAL
177,25411,AAA,ALGORITHM,ANALYTICAL,ARIZONA,AXB,CONCLUSION,ECLIPSE,FINALLY,LABEL,MATERIALS,METHODS,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS
104,148,169,242,284,ABOUT,CONCLUSION,COPYRIGHT,INC,LABEL,MEDICAL,METHODS,NAC,OBJECTIVE,PHASE,RESULTS
169,177,228,239,BETWEEN,CONCLUSION,DESPITE,EARLY,JANUARY,LABEL,LTD,MARCH,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SCC,THEIR,WILEY
169,183,185,AMONG,BACKGROUND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,WILEY
169,BLADDER,BUC,COPYRIGHT,GATA3,HOWEVER,INC,PCR,REDUCED,WILEY
177,3DCRT,3DRCT,ACUTE,AFTER,BETWEEN,CONCLUSION,FORTY,GRADE,GROUP,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,THERAPY,TREATMENT,V70GY,V95
BACKGROUND,CONCLUSION,COX,HOWEVER,LABEL,METHODS,RESULTS,T4A,VAC
2YL,956,BACKGROUND,CONCLUSION,FINALLY,LABEL,MATERIALS,METHODS,RESULTS,RT4
150,303,352,374,398,412,CONCLUSION,EVALUATION,LABEL,LUT,MARCH,METHODS,NIGERIA,OBJECTIVE,PSA,PVR,RESULTS,SCORE,SEVENTY,SYMPTOM,THERE,WHILE
001,002,129,169,19A,222,AKT,ARRAY,EXPRESSION,FGFR3,PROTEIN,RIBOSOMAL
000,100,169,AMONG,BACKGROUND,BLADDER,END,GIVEN,JOINPOINT,LABEL,METHODS,RESULTS,SOCIETY,TIS
169,726,BACKGROUND,CIGARETTE,COX,EFFORTS,HAMPSHIRE,LABEL,METHODS,RESULTS,SMOKERS,SOCIETY,THESE,WESTERN
BLADDER,ESPL1,FGFR3,NOTABLY,OVERALL,STAG2,TACC3,TCC
ASXL2,ATM,ERCC2,FANCA,SMC1A,SMC1B,STAG2,UBC,UROTHELIAL
STAG2,THESE
001,169,ACTIVATING,TCC,THESE
100,191,208,CK7,GATA3,HOWEVER,III,REMAINING,THEREFORE,UCS
177,234,318,93M,956,AIN,DR5,FKA,GENOTYPED,SV40T,THESE,TUNEL,UCC
169,ANNEXIN,ANXA5
169,194,864,COMPOSITE,CONCLUSION,COPYRIGHT,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,QOL,RESULTS
169,COPYRIGHT,INC,INCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THESE
169,177,2GY,945,946,CONCLUSION,COPYRIGHT,D98,DVH,EQUIVALENT,ESTRO,GEC,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PTV,PURPOSE,REFERENCE,RESULTS
001,002,169,201,AMONG,AUTHORS,BJU,CONCURRENT,COX,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
169,282,ACS,AUTHORS,BJU,BLADDER,CONSORTIUM,CSS,HOWEVER,IBCNC,LABEL,LUGHEZZANI,METHODS,OBJECTIVE,OCM,PFS,RESULTS,USING
15201,160,169,AUSTRIA,BACKGROUND,BETWEEN,BTC,GBC,LABEL,LTD,METHODS,OBJECTIVE,OTHER,PUBLISHED,RESULTS,STATISTICS,WHILE,WILEY
001,017,156,169,177,240,396,HOWEVER,JANUARY,LABEL,METHODS,NON,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UROLOGICAL
181,AFTER,HERNIARIN,MTT,RESULTS,TCC
169,FABP4,H3K27,H3S10,HBP17,INC,MICROARRAY,REVERSING,TIMP3,URB,WILEY,WNT5B
BCG
001,005,034,039,099,169,257,491,748,763,ACUTE,COPYRIGHT,CRT,GROUP,INC,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,THERE,TREATMENT,UNIVARIATE,V70
001,004,005,078,122,169,383,AUTHORS,BCI,BCR,BGTIS,BJU,JANUARY,LABEL,MEIER,METHODS,NSS,OBJECTIVE,PSM,RESULTS,THERE
BACKGROUND,CLINICALLY,FINALLY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,100,1000I,134,174,ANALYTICAL,BACKGROUND,CONCLUSION,DETECTION,ISOMORPHIC,JAPAN,LABEL,LTD,METHODS,RBC,RESULTS
CENTRAL,DEFINITION,ELONGATION,GATA3,GRN,RET,THESE
012,013,014,017,020,022,025,033,036,144,147,174,178,285,287,290,335,339,631,A17893G,APRIL,BIOMEDICAL,C18067T,CHINESE,CIS,FURTHER,HARDY,HOWEVER,HRR,LITERATURE,ORS,XRCC3
169,AFTER,DIGITIZED,LABEL,LTD,METHODS,NMIBC,OBJECTIVE,REASONS,RESULTS,WILEY
169,BRITISH,SOCIETY,THERE,TRANSIENT,TRP,TRPA1,TRPV1,TRPV3
AGE,AGING,BECAUSE,THERAPIES
124,146,327,ATG,ETS,ORIGINALLY,TCF,TIS
004,008,009,035,092,190,344,416,477,641,721,750,753,816,831,963,987,DSS,EGGER,HOWEVER,MEDLINE,PUBLISHED,RFS,THERE
FINALLY,THERE,WHILE
100,169,ART,BLADDER,CONCLUSION,COPYRIGHT,DIR,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLANSELECT,PURPOSE,REOPT,RESULTS,SEVEN
000,001,022,100,169,923,AIM,COPYRIGHT,GDF15,LABEL,LOW,LTD,METHODS,MSP,NUTUS,OBJECTIVE,RESULTS,ROC,UPPER,VIM
010,014,024,028,122,132,169,177,4MM,702,802,810,817,BETWEEN,DMEAN,JANUARY,MEDICAL,MLC,MUS,OAR,PTV,THERE,TPS,V10,V20,V30,V40
169,174,209,ASA,CONTINENT,COPYRIGHT,EDUCATION,INC,INDIANA,LABEL,MATERIALS,METHODS,MINIMALLY,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,URINARY,UROLOGICAL
000,254,726,AFTER,CHINESE,DEPRESSION,GDS,GERIATRIC,SCALE,SYMPTOM
001,002,007,009,012,020,029,039,040,BACKGROUND,BESIDES,LABEL,RESULTS,SNP
BPH,GREENLIGHT,LABEL,METHODS,OBJECTIVE,PURPOSE,PVP,RESULTS,SIXTY
001,041,567,ASIAN,BIRC5,CAUCASIANS,CIS,FURTHER,ORS,OVERALL,STRATIFIED
108,130,131,150,BACKGROUND,CONCLUSION,DUE,INITIAL,LABEL,MBQ,RAI,SUMMARY
001,002,126,CSS,HOWEVER,IHC,UCB,WESTERN
169,607,695,754,833,BACKGROUND,HOWEVER,LABEL,METHODS,NUTRITION,PAH,RESULTS,THESE,USING
000,100,596,856,ADDITIONAL,AFTER,MOOSE
001,045,153,COX,HOWEVER,IHC,MEIER,PCR,RESULTS,SPHK1
CLEVELAND,COMBINING,FNA,HOPKINS,JOHNS,MEDICAL,THEREFORE,TODAY,URINE,VOLPE
001,005,COX,HOWEVER,MEIER,OVERALL,THESE
1980S,EXPANSION,OUTCOME
AIM,BLADDER,CONCLUSION,LABEL,METHODS,OBJECTIVE,ORTHOTOPIC,RESULTS,SYSTEMATIC,WHERE
169,233,COPYRIGHT,CURIETH,DOSIMETRIC,EUROP,INC,INTER,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SOCIETY,THESE,VARIATION
100,106,177,183,C30,CHINESE,CONCLUSION,EORTC,LABEL,LOCAL,LOWER,METHODS,OBJECTIVE,QLQ,QOL,QUALITY,RESULTS,SCORE,SYMPTOM,TRACT,TREATMENT,URINARY
455,APRIL,BACKGROUND,GLEASON,LABEL,METHODS,MRI,PCA,PSA,RESULTS,SERUM
945,946,EXP,GIVEN,LABEL,LIN,METHODS,MIX,OBJECTIVE,PURPOSE,RESULTS,THREE
003,110,113,146,215,372,541,564,741,837,BLOCKED,CARLO,HIP,LABEL,METHODS,MONTE,OBJECTIVE,ORGAN,PURPOSE,RESULTS
000,100,124,133,149,169,259,392,542,746,759,ABC,AGE,BACKGROUND,COLORECTAL,CONCLUSION,COX,EFFECTIVE,LABEL,METHODS,NOMOGRAMS,OVARIAN,RESULTS,USING
HOWEVER
ANALYZING,SIMULATION
138,180,325,400,800,AUTHORS,BACKGROUND,BLADDER,CENTRAL,COLLECTION,CONTROLLED,GROUP,IQR,ISSUE,LABEL,LARVH,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RAH,RANDOMISED,RCT,RESULTS,SELECTION,THERE,THEREFORE,WOMEN
609,667,AUG,CAUCASIANS,HOWEVER,MEDLINE,SCIENCE,STATA,THR241MET,WEB,XRCC3
DIALLYL,HOWEVER,MMP
001,149,177,698,920,AGE,BACKGROUND,BLADDER,LABEL,MATERIALS,MEDICAL,METHODS,OPIUM,RESULTS
221,AFTER,BINGO,C1QBP,CONCLUSION,CYTOSCAPE,EXPRESSION,FINALLY,FIRSTLY,GESTALT,GSE3167,LABEL,MCODE,METHODS,OBJECTIVE,OMNIBUS,PRDX2,RESULTS,THESE,YWHAZ
001,008,015,039,BACKGROUND,COX,HOWEVER,LABEL,MATERIALS,METHODS,PATHOLOGY,RESULTS,TCC,TUR
000,169,337,BACKGROUND,BASEL,CONCLUSION,III,LABEL,METHODS,PFS,RESULTS,T4B,THERE
002,105,BASEL,COX,LABEL,METHODS,NMIBC,OBJECTIVE,PATHOLOGY,RESULTS,SOCIETY,TEN,TUR,UROLOGICAL
005,008,015,0GY,169,177,1GY,2CC,2GY,4GY,5GY,6GY,7GY,8GY,9GY,CONCLUSION,COPYRIGHT,CTV,D90,HDR,INC,LABEL,MATERIALS,METHODS,MVC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIMILARLY,SOCIETY,SVC
BACKGROUND,BECAUSE,CONCLUSION,CONTEXT,LABEL,METHODS,OBJECTIVE,RESULTS,UROTHELIAL
000,100,200,THERE
946,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,TGF,USING
100,120,131,133,177,205,BETWEEN,CONCLUSION,LABEL,MARCH,METHODS,NABOTHIAN,OBJECTIVE,RESULTS,SPECT,SUBSEQUENT,THESE,THREE,USING
001,122,123,169,201,COPYRIGHT,GST,GSTA1,GSTM1,GSTP1,GSTT1,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,POTENTIAL,PUBLISHED,RESULTS,SMOKERS
132,169,CONCLUSION,COPYRIGHT,FOCAL,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
100,169,177,231,CONCLUSION,COPYRIGHT,DIR,DSC,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,UNDER
169,DIAGNOSIS,METAPLASIA
169,4EBP1,AKT,DESPITE,MYC,UPPER,UTUCS
175,208,253,365,650,AFTER,APRIL,ASA,AVERAGE,BACKGROUND,BOARD,INDEX,INDICATION,LABEL,LONGEST,METHODS,MORBIDITY,OBJECTIVE,OCTOBER,PURPOSE,RADICAL,RESULTS,SEVEN,SOCIETY
169,BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS,SPANISH,WEB
CONCURRENT,CURRENT,NONMUSCLE
169,CANCERS,PAI,REDUCTION,SIMILAR,T24,TREATMENT
181,233,AST,MIC,PCR,VITEK
236,ATP,HCV29,P70,PKA,TSC
019,100,143,160,177,219,697,DCE,DWI,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THERE,USING
169,177,415,577,578,AMERICA,BACKGROUND,COPYRIGHT,COX,LABEL,METHODS,MMC,NORTH,OBJECTIVE,OUTCOME,PREDICTIVE,PUBLISHED,RESULTS,RNU,SETTING,UNASSIGNED
002,006,016,140,231,409,491,523,708,895,ADULT,DISCUSSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
233,BCG
120,227,389,651,CONCLUSION,ESSEN,HYALURONAN,J82,LABEL,LENTIVIRAL,MEIER,METHODS,PCR,RESULTS,RHAMM,UNIVERSITY,UNLABELLED
EXPECTEDLY,HOWEVER,KNOCKDOWN,LABEL,UNLABELLED
AKT,DESPITE,ETS,FURTHER,PREVIOUSLY,UROTHELIAL
FDG,PET
HOWEVER,METABOLIC
001,005,024,031,033,040,065,126,148,233,246,254,296,344,480,594,668,936,BACKGROUND,BCG,CONCLUSION,LABEL,METHODS,RESULTS,TREATMENT
BCG
169,BCSCS,BLADDER,COPYRIGHT,LTD
500,ABRUZZO,ADMISSIONS,BACKGROUND,COMMITTEE,COX,DISCUSSION,LABEL,METHODS,MIXED,SECONDARY,TRIAL,UNIVERSITY,WHILE
613,934,ASIAN,ASP1104HIS,CIS,ORS,OVERALL,PUBLISHED,SCIENCE,SUMMARY,WEB,XPG
169,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,JANUARY,LABEL,LRC,MATERIALS,METHODS,RESULTS,SEPTEMBER,TNM
005,100,DIFFUSE,HOWEVER,NUCLEAR,SRC,THREE
BACKGROUND,CONTEXT,HOWEVER,LABEL,MATERIALS,METHODS,MUSASHI,OBJECTIVE,PCR,RESULTS,TBP,USING
159,169,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SECONDARY,THERE,THESE,UPPER,UROLOGICAL
169,CLAVIEN,CONCLUSION,COPYRIGHT,DINDO,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIX,THERE
001,002,005,024,10878,125,169,175GY,225,3MONTHS,5CC,5CM,BACKGROUND,COPYRIGHT,ENDPOINTS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PRE,PURPOSE,RESULTS,SCORE,SYMPTOM,VPR
00001,HOWEVER,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS,RFS,THERE,TUR,WLC
001,002,005,006,038,235,BLADDER,COX,CSS,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS
169,17Y,561,AFTER,BCA,COPYRIGHT,INC,LABEL,LIMMA,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SEQ,SIGNATURE,T1P
001,169,177,233,BASED,BCG,BLADDER,CONCLUSION,COPYRIGHT,CURRENTLY,EOSINOPHIL,IHC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RATIO,RESULTS,TH1,TH2,TIS
169,BACKGROUND,CONCLUSION,COPYRIGHT,DISCUSSION,DUKES,LABEL,METASTASIS,METHODS,MILES,OTHER,SAS,TREATMENT
027,169,181,COPYRIGHT,EXPRESSION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OSI,PP242,RESULTS,T24,THREE,WESTERN
001,047,169,625,687,708,850,COPYRIGHT,GIA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RADICAL,RESULTS,STAPLER,THERE,TOTAL,WELCH
1400W,169,233,ACTIVATION,BCG,CCL20,COPYRIGHT,CXCL1,CXCL3,IL6,IL8,INC,INHIBITION,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,BLADDER,COPYRIGHT,ENGLISH,HOWEVER,INC,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,URINARY,URINE
006,AFTER,AMONG,CONCLUSION,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,RCP,RESULTS
001,103,106,125,169,249,469,AUTHORS,BJU,CONCLUSION,COX,LABEL,METHODS,NMIBC,OBJECTIVE,RESULTS
002,008,047,099,169,358,441,4N0M0,828,AMONG,AUTHORS,BETWEEN,BJU,CONCLUSION,LABEL,MEIER,METHODS,NAC,OBJECTIVE,ORS,OVERALL,RESULTS,THESE,UNADJUSTED
001,011,029,034,100,169,AUTHORS,BJU,CLAVIEN,DESPITE,DINDO,LABEL,MAJOR,METHODS,OBJECTIVE,OCTOBER,ORC,OVERALL,RESULTS
001,007,169,AUTHORS,BJU,LABEL,LIBRARY,METHODS,OBJECTIVE,OVERALL,RESULTS,RFS,SEPTEMBER,SIX,THROUGH
001,169,345,385,413,565,AUTHORS,BETWEEN,BJU,KAROLINSKA,LABEL,LOS,METHODS,OBJECTIVE,OCTOBER,OVERALL,PATIENT,RARCS,RESULTS,THERE,TOTALLY,UNIVERSITY
001,002,003,005,169,227,AUTHORS,BETWEEN,BJU,C30,JANUARY,LABEL,METHODS,OBJECTIVE,ONB,QOL,RESULTS,TREATMENT
001,002,003,004,010,017,047,169,AUTHORS,BJU,COX,IQR,LABEL,METHODS,OBJECTIVE,PBT,RESULTS,UCB
169,AUTHORS,BJU,LABEL,LOW,METHODS,OBJECTIVE,RCS,RESULTS,SERUM
004,007,014,066,660,CIS,GOVERNMENT,LABEL,METHODS,OBJECTIVE,PATHOLOGY,PUBLISHED,RESULTS,USA
003,009,028,169,ACCORDING,AUTHORS,BJU,BOO,BPE,EXCLUSION,INCLUSION,LABEL,METHODS,OBJECTIVE,PSA,RESULTS,SCORE,SYMPTOM,URODYNAMIC
024,169,AUTHORS,BJU,EXPRESSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UCB
001,169,190,310,481,981,AUTHORS,BJU,COX,DESPITE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,THESE
132,169,400,AUTHORS,BETWEEN,BJU,CONCLUSION,DIARRRHOEA,LABEL,METHODS,OBJECTIVE,OCTOBER,ORR,PFS,RESULTS,SECONDARY,THERE,TREATMENT
108,169,215,44K,AGILENT,AMONG,AUTHORS,BIOMETRIC,BJU,CLARA,LABEL,MAY,METHODS,MICROARRAY,OBJECTIVE,PCR,RESULTS,SANTA,SEPTEMBER,USA,WHOLE
169,AFTER,AUTHORS,BJU,DETAILS,INITIAL,JANUARY,LABEL,METHODS,MITOMYCIN,MMC,OBJECTIVE,OBJECTIVES,RESULTS,TURBT
004,134,169,279,APRIL,AUTHORS,BJU,DESPITE,LABEL,METHODS,NMIBC,OBJECTIVE,RESULTS,TURBT
119,161,169,192,588,AREAS,AUTHORS,BJU,EVERY,JANUARY,LABEL,METHODS,MITOMYCIN,NEWLY,NMIBC,OBJECTIVE,OBJECTIVES,RESPONSES,RESULTS,THERE,TURBT,UROLOGIST,UROLOGY
081,169,192,247,251,376,AUTHORS,BJU,LABEL,METHODS,OBJECTIVE,OVERALL,RALNU,RESULTS,THERE
169,185,209,249,APRIL,AUTHORS,BJU,CIS,DESPITE,GUY,HAL,LABEL,MARCH,METHODS,NMIBC,OBJECTIVE,PDD,RESULTS,SECONDARY,THERE,TURBT
001,169,274,605,AFTER,AGE,BACKGROUND,BASEL,COPYRIGHT,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,NIS,PROPENSITY,RCS,RESULTS
169,177,240,BASEL,CONCLUSION,COPYRIGHT,EUL,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
169,ACCORDING,ASSESSMENT,BASEL,CLAVIEN,CONCLUSION,COPYRIGHT,ERP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SHORT,SOCIETY,VIP
BASEL,VESICAL
CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,008,028,163,341,ACCORDING,ADA,CIS,CRT,CTCAE,DMEAN,HIR,LABEL,METHODS,OBJECTIVE,RESULTS,SIB,V15,V40
006,018,019,022,023,037,040,043,053,061,064,300,ABOUT,AIM,CONCLUSION,FIFTY,ITALY,LABEL,LOCAL,METHODS,NEVER,OBJECTIVE,RELATIVELY,RESULTS,RIETI,SECONDHAND,SHS,SMOKERS,WORKERS
181,183,GEORG,HRESIMS,NMR,STUTTGART
017,020,041,536,AFTER,BACKGROUND,LABEL,METHODS,RESULTS,RNU,USING,UUT,WBC
056,682,841,945,C111A,CHINA,FURTHER,HIF,HOWEVER,KNOWLEDGE,OVERALL,THEREFORE
160,169,1970S,COPYRIGHT,CURRENT,EDUCATION,EMETINE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TALALAY,UROLOGICAL
001,169,504,531,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NMP22,OBJECTIVE,RESULTS
169,AUTHORS,BACKGROUND,COPYRIGHT,DESPITE,IRELAND,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,QOL,RESULTS,STUDIES,SYSTEMATIC,THERE
003,104,169,177,916,COPYRIGHT,COV,CTV,D95,ERB,EUD,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,WHILE
BLADDER,EARLY,IDEALLY
191,ABDULAZIZ,CONCLUSION,DEPARTMENT,FACULTY,JANUARY,KINGDOM,LABEL,METHODS,OBJECTIVE,PACKAGE,PATHOLOGY,RESULTS,SAUDI,SEVEN,UNIVERSITY,URINE
BCG,HOWEVER,THESE
BACKGROUND,CENTRAL,CONCLUSION,CONFERENCE,CONTROLLED,EXTRACTION,FUNDING,HEALTHCARE,INDEX,LABEL,MEDLINE,METHODS,MINOR,OBJECTIVE,PRIMARY,PURPOSE,QUALITY,RESULTS,SCI,SELECTION,SERIOUS,SOURCES,SYNTHESIS
100,150,181,INORGANIC,METABOLISM,MOA,PROGRAMME,PROTECTION,USEPA
001,006,022,028,105,ASP140ASP,ASP142ASP,CONCLUSION,COX,GST,GSTA1,GSTM1,GSTO1,GSTO2,GSTP1,GSTT1,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,THERE
006,007,008,015,086,094,211,327,515,621,622,680,693,898,932,BACKGROUND,BER,BIOMEDICAL,CBM,CHINESE,CIS,FURTHER,HOWEVER,LABEL,LITERATURE,METHODS,OBJECTIVE,ORS,R194W,R280H,R399Q,RESULTS,XRCC1
233,947,AMONG,BACILLE,BCG,CD4,DECREASED,FIFTY,HOWEVER,IFN,INTERFERON,PPD
001,005,167,169,801,BER,CUMULATIVE,INC,SMUG1,SNP,WILEY
001,011,015,020,038,111,239,368,377,390,480,754,782,876,966,ALA,CHINA,CIS,KNOWLEDGE,LEU,MNSOD,ORS,PRO,PRO198LEU,SINOMED,VLA
EXPRESSION,LIN28,MYC,NMIBC,PCR,TCC,USING
CYBERKNIFE,EIV,THERE,TODAY,TREATMENT,V75
181,335,538,640,BACKGROUND,CHILE,INDICES,LABEL,METHODS,ORS,RESULTS,ROTHMAN,SYNERGY,THESE
169,174,333,625,BECAUSE,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,TREATMENT,UROLOGICAL
001,008,044,112,129,169,282,COPYRIGHT,COX,EASTERN,EDUCATION,GROUP,HEMOGLOBIN,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,241,390,631,COPYRIGHT,DECREASED,EDUCATION,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
100,169,233,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WHILE
169,BACKGROUND,BLADDER,COMPANY,COPYRIGHT,DIAGNOSIS,JOURNAL,LABEL,LTD,METHODS,OBJECTIVE,PEDIATRIC,PUBLISHED,RESULTS,THERE,UROLOGY
169,CHALLENGES,COPYRIGHT,IHC,INC,PATHOLOGY,PUBLISHED,SOCIETY
169,804,902,BACKGROUND,BLADDER,CONCLUSION,CONVERSELY,COPYRIGHT,EGYPT,EGYPTIANS,INC,LABEL,METHODS,NAD,RESULTS,UNASSIGNED,WATER
169,COPYRIGHT,FINALLY,INC,MICRO
000,100,169,181,500,AKT,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,T24,THEREFORE
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,SURGERY,TECHNICAL,TEN
001,100,100ML,169,BACKGROUND,CONCLUSION,COPYRIGHT,DCE,EFF,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,REGIONS,RESULTS,STUDENT,TREATMENT
177,189,AVERAGE,BACKGROUND,BENEFIT,CALYPSO,D99,DMEAN,DOSIMETRIC,DVH,HOWEVER,INITIAL,IRB,LABEL,LARGEST,MATERIALS,MEDICAL,METHODS,MRI,OAR,OBI,OBJECTIVE,PER,PRECISE,PRIOR,PTV,PURPOSE,RESULTS,RIGID,T2C,UNIVERSITY,V50,VAN
100,104,169,CIS,COPYRIGHT,HODGKIN,INC,ITALIAN,ITALY,LABEL,METHODS,NHL,OBJECTIVE,OLT,PYS,RESULTS,SIR,THESE
169,891,COMMITTEE,END,FOLLOWING,JOINT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,POISSON,RELYING,RESULTS,TNM,UROLOGICAL
AUC,INCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PCA,PHS,POSTERIOR,PURPOSE,RESULTS,SEPTEMBER
PATHOLOGIC
029,204,206,218,415,BMI,CHINA,HOWEVER,TAIXING,THESE
100,169,945,III,PROEX,SIXTY
169,BIOMARKERS,BLADDER,COPYRIGHT,IRELAND,LTD,NOMOGRAMS,THESE
598,INDEX,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,TRAIT,UNTIL
232,A1C,APRIL,ASSESSMENT,BACKGROUND,CONCLUSION,EVALUATION,EXTRACTION,FUNDING,GRADING,LABEL,LIBRARY,LIMITATION,MEDLINE,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RANDOMIZED,RESULTS,SELECTION,SGLT2,SOURCES,SYNTHESIS,THREE,URINARY
169,DC1,OTHER,RECURRENCE
101,225,531,537,569,577,ASSOC,ROC,RUEDA
000,004,138,218,356,734,ERCC1,REFERENCES,STATA,SYSTEMATIC
13Q14,ATP7B,BACKGROUND,CONCLUSION,LABEL,LOH,MATERIALS,METHODS,RESULTS
946,BACKGROUND,CGB,EXPRESSION,LABEL,LENTIVIRAL,METHODS,RESULTS
169,177,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,MUL,OBJECTIVE,PRM,PURPOSE,RESULTS,WILEY
215,HPC,SFT,THERE
001,887,CHINESE,EIGHT,GSTM1,HAN,OVERALL,THERE
101,122,159,179,213,559,561,AMONG,CONCLUSION,COX,CSS,LABEL,LNU,MEIER,METHODS,OBJECTIVE,ONU,RESULTS,RNU,SEVERAL,THERE,UUT
169,BACKGROUND,CES,CHORDOMAS,CONTEXT,COPYRIGHT,CROWN,ENGLISH,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
BACKGROUND,DLEC1,HISTONE,HMCAN,LABEL,MOTIVATION,RESULTS
322,399,406,ANOTHER,AUTHORS,CONCLUSION,FIG,JANUARY,LABEL,METHODS,OBJECTIVE,PATHOLOGY,PURPOSE,REF,RESULTS,TAB,THESE
DIO,RT4,T24
001,606,623,HRQOL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURVIVORS,SYMPTOM,USING,WHILE,YOUNGER
310,376
169,174,COPYRIGHT,COX,EDUCATION,INC,LABEL,LENTIVIRUS,MASSARRAY,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,UROLOGICAL
169,CKB,HOWEVER,ONCONEURAL,PCD,PNS
111,169,173,174,184,194,283,357,BACKGROUND,C228T,COPYRIGHT,FGFR3,HOTSPOT,LABEL,METHODS,MUTATIONS,OBJECTIVE,OBJECTIVES,OUTCOME,PUBLISHED,RESULTS,SETTING,SOMATIC,THERE,UBC,UROLOGY
010,014,049,169,945,BACKGROUND,CENTRAL,CONTEXT,CONTROLLED,COPYRIGHT,LABEL,MAY,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,SYNTHESIS,UROLOGY
100,102,121,169,BACKGROUND,BCA,CONTINUED,COPYRIGHT,CSS,EIGHT,IQR,LABEL,LNS,LRC,MEIER,METHODS,OBJECTIVE,OUTCOME,PRIMARY,PUBLISHED,RESULTS,RFS,SECONDARY,SEPTEMBER,SETTING
169,COPYRIGHT,FURTHER,HOWEVER,LOCAL,MANAGEMENT,PRESENTLY,PUBLISHED,SAS,T1SM1,T1SM2,T1SM3,THERE,TRANSANAL
041,100,10877,169,239,ACUTE,AFTER,COPYRIGHT,END,FORTY,INCIDENCE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
004,897,945,BLADDER,EXPRESSION,RT4,T24
300,49A,ADDITIONAL,CYTOTOXIC,HOWEVER
AGE,AMERICANS,ARA,DETROIT,FOREIGN,LABEL,METHODS,MIGRANT,NHW,OBJECTIVE,OTHER,PURPOSE,RESULTS,STOMACH,USA
10X80,10X95,14X40,16X40,ADVENTA,ANGIO,CARDIATIS,CIA,DUE,GIVEN,MEDTRONIC,RELIANT
001,LTR,LUCIFERASE,MYB,TAKEN,UCC
169,COPYRIGHT,GIVEN,LTD,PUBLISHED
169,COPYRIGHT,HOWEVER,LTD
169,211,299,415,471,513,926,COPYRIGHT,EDUCATION,END,FURTHER,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PARTIAL,PUBLISHED,PURPOSE,RESULTS,SECONDARY,UROLOGICAL
169,177,COG,DESPITE,KEY,LABEL,METHODS,OBJECTIVE,RESULTS
169,946,EMT,OVERALL,SILIBININ,T24
169,176,24H,489,ANTIBIOTIC,BACKGROUND,COPYRIGHT,FEBRILE,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,UROLOGY,UTI
166,169,177,300,400,800,956,BACKGROUND,CONTINUOUS,COPYRIGHT,EXCLUSION,LABEL,METHODS,OBJECTIVE,ORC,OUTCOME,PRBCS,PUBLISHED,RESULTS,SETTING,STRATEGIES,TOTAL,UROLOGY
102,120,308,606,BACKGROUND,BCA,CCL18,ELISA,FURTHER,IHC,LABEL,METHODS,RESULTS
109,169,897,ADDITIONAL,AREVA,BACKGROUND,BASED,CONCLUSION,COX,HRS,INC,LABEL,METHODS,MORTALITY,NUCLEAR,RESULTS,WILEY
107,140,239,642,AGE,AMONG,ASIAN,CANCERS,COX,FURTHER,ICD,INCREASED,INSURANCE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,USING
169,954,BACKGROUND,BASEL,CONCLUSION,FURTHER,HOWEVER,LABEL,METHODS,MMP13,PCR,RESULTS,SENP2,SMALL,T24,WESTERN,WNT
169,250,400MG,AFTER,BILIARY,CONCLUSION,COPYRIGHT,INOPERABLE,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS
000,100,160,BACKGROUND,BLADDER,CAUCASIAN,CYSTOSCOPY,LABEL,METHODS,URINALYSIS,URINE,UROTHELIAL
001,ARSENIC,BCP,CRM,EXR,HYDERABAD,INORGANIC,LCP,NER
956,APRIL,ARGENTINA,ASSESSING,BANGLADESH,CHILE,CORDOBA,EIGHT,FLORIDA,FURTHER,IDAHO,JANUARY,USA
166,169,AUTHORS,BJU,CONCLUSION,INPATIENT,LABEL,METHODS,NATIONWIDE,OBJECTIVE,RESULTS,USA
LNCRNAS
001,011,169,209,363,387,405,768,ABOUT,AMONG,AUTHORS,BJU,CERTAIN,CHRONIC,CKD,CYSTECTOMY,DISEASE,EPI,FACTORS,GFR,GLOMERULAR,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,USING
004,018,036,AMONG,BASED,GROUP,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS,USING
112,160,945,946,VPA,WESTERN
100,169,COPYRIGHT,DECOY,HOWEVER,INC,URINE,WILEY
001,COX,CRP,MEIER,PFS,ROC,SERUM,UNTIL,WHITNEY
ENDOSCOPIC,HOLMIUM,LABEL,NEITHER,OBJECTIVE,RESULTS,YAG
127,BACKGROUND,GENOMES,KYOTO,LABEL,METHODS,RESULTS,THERE,THESE
169,4G2,4G3,686,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WILEY
169,POISSON,VCH,WEIBULL,WILEY
100,105,108,242,ASA,BACKGROUND,CONCLUSION,GROUP,LABEL,METHODS,RESULTS,THREE,UROLOGISTS,VARIABLES
000,001,008,149,232,239,300,AMONG,BACKGROUND,CLAVIEN,CONCLUSION,DAVINCI,DINDO,FINAL,FUNDING,LABEL,METHODS,OVERALL,RESULTS,ROBOT,TRIAL
233,CRANBERRY,DESPITE,MESNA,THERE
169,177,6CM,AMACR,CDC,CK5,CK7,COPYRIGHT,GATA3,IHC,MSA,RCC,RENAL,SEVEN,SIMILAR,SIX,TEN
001,169,177,601,835,ADVANCING,BACKGROUND,COPYRIGHT,COX,EAU,FEW,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,UCB,UROLOGY
BETWEEN,DEFINITIVE,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
119,138,169,172,AGE,BACKGROUND,CONCLUSION,FIFTY,FURTHER,INC,LABEL,METHODS,MMT,MMT84,MMT95,OVERALL,PROCEDURE,RESULTS,RMS,WILEY
174,CONCLUSION,ECLIPSE,KNOWLEDGE,LABEL,MEDICAL,METHODS,MUS,OAR,OBJECTIVE,PTV,RESULTS,SYSTEMS,TREATMENT
001,007,008,010,032,042,173,200,339,ANEUPLOIDY,CDC20,HOWEVER,RFS,SAC,SIMILARLY,UCB
000,100,146,169,177,285,476,534,539,809,ACCORDING,AEU,CARCINOMA,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGY,PUBLISHED,PURPOSE,RESULTS,SOCIETY,SPAIN,SPANISH,UROLOGICAL,UROLOGY,USING
001,004,128,169,175,176,384,COPYRIGHT,COX,EDUCATION,EXPRESSION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ONCOFETAL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
138,169,ANNEXIN,BIOSS,EUPHORBIA,MTT,NMR,OVCAR
169,ABCG2,ALA,ATP,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PCR,PDD,PEPT1,RESULTS,THESE,USING
169,418,ADVERSE,ANXIETY,BLADDER,C30,COLLEGE,COPYRIGHT,DEPRESSION,EFFECTS,LABEL,LTD,MANAGEMENT,MATERIALS,MEASURE,METHODS,OBJECTIVE,PUBLISHED,QUALITY,RESULTS,ROYAL,SCALE,SUBJECTIVE,SYMPTOM,THEREFORE,TISSUES,TREATMENT
THEREFORE
001,177,1ST,34U,37U,BACKGROUND,CONCLUSION,DEPARTMENT,ELISA,INSTITUTE,LABEL,MATERIALS,METHODS,RESULTS,SERUM,SIMILARLY,THERE
BACKGROUND,LABEL,MATERIALS,METHODS,NPV,PPV,RESULTS,UROVYSION
169,233,JANUARY,MAY,OCTOBER,UROLOGICAL
122,CONCLUSION,DETERMINE,FGFR3,HOWEVER,LABEL,METHODS,OBJECTIVE,R248C,RESULTS,S249C,SIXTY,TCC,THREE,Y375C
000,003,100,171,177,185,AFTER,BRITISH,INCIDENCE,LABEL,METHODS,OBJECTIVE,RESULTS
LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WESTERN
AKT,BACKGROUND,CONCLUSION,INHIBITION,LABEL,METHODS,RAPAMYCIN,RESULTS,TCC,THESE
004,142,143,159,BASEL,HISTOLOGY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TURBS
169,LABEL,LIGHT,MTP,PDN,ROS,UNASSIGNED,UNLABELLED
169,BASEL,CONCLUSION,COPYRIGHT,CXCR4,LABEL,LVD,METHODS,OBJECTIVE,RESULTS
004,AFTER,BASEL,CLAVIEN,CONCLUSION,DIFFERENT,ERP,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,VESCICA,VIP

HOWEVER,SUPPORT,SVM
523,554,576,591,597,616,645,662,BACKGROUND,BCG,CONCLUSION,CONVERSELY,COX,CUETO,EORTC,HOWEVER,LABEL,METHODS,NMIBC,RESULTS,SPANISH,THESE,TREATMENT,UROLOGICAL
MUTATIONS
169,654,879,ADDITIONAL,AIM,BACKGROUND,COVARIATES,FIFTY,FLORIDA,INCREASED,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY
001,002,006,009,030,043,048,064,411,541,584,599,771,898,946,AFTER,BNP,DIL,LABEL,METHODS,OBJECTIVE,PSM,PURPOSE,RESULTS,SIMILAR,THERE
001,020,029,031,100,116,153,BASED,BETWEEN,GRADE,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,T1E,T1M,THERE,WORLD
BCG,HOWEVER,PROMISING,THESE,TLR
BLADDER,DESPITE,USA
169,COPYRIGHT,CTV,D95,ESTIMATION,INC,LABEL,LEVEL,MATERIALS,METHODS,NTCPS,OBJECTIVE,PURPOSE,RESULTS,TRUTH,USING,V70GY
FINALLY,FIRST,GIVEN,GPI,PIG
945,946,EGF,FAT,GLOBULE,INHIBITING,MFGE8,USING
BASED,COPII,COQ10,GOLGI,L02,PARKINSON,SCD,SINCE,T24,USING
609,640,BACKGROUND,CHINESE,LABEL,MATERIALS,METHODS,NFKB1,RESULTS
137,164,176,181,183,AMAZONIAN,GEORG,HOWEVER,PDA,RT4,SAMPLES,STUTTGART,T24,UNCARIA
BACKGROUND,CONCLUSION,ELECTRICAL,LABEL,METHODS
011,020,053,086,111,194,368,411,459,480,876,891,962,CHINA,DATABASES,EGGER,GPX,KNOWLEDGE,ORS,PCA
BLADDER
CONCLUSION,CONFERENCE,CONSENSUS,HODGKIN,INSULIN,LABEL,METFORMIN,METHODS,OBJECTIVE,OTHER,RESULTS,SEPTEMBER,THERE,USA
945,AIF,ANNEXIN,BAD,BAX,BCL,FMK,GRP78,GRP94,HA22T,HCC,MCL,SINULARIA,TUNEL,VAD
169,BLADDER,CIS,COPYRIGHT,DESPITE,EDUCATION,GROUP,INC,LABEL,MAJOR,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,021,169,233,496,894,COPYRIGHT,EDUCATION,FAILURE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESTAGING,RESULTS,THEREFORE,UNIVARIATE,UROLOGICAL
169,179,COMMISSION,DOSES,HDR,INCREASED,MEDICAL,OAR,RADIATION,UNITS
169,954,COPYRIGHT,CRT,DIFFERENT,DVH,III,INC,LABEL,MAJOR,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
160,169,233,AFTER,BCG,COPYRIGHT,INC,POLYMERASE
AREAS,BACKGROUND,BTC,COVERED,HOWEVER,LABEL,METHODS,OPINION
087,BLAND,COMPARISON,CONCLUSION,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PERCENTAGE,RESULTS,SOLID
ENGLISH,PECOMAS
127,404,946,967,CLINICALLY,COMPARING,CUTL1,HOWEVER,LYS,RII,SMAD2,T24,TGF,THESE
AKT,ANNEXIN,BAX,BCL,ERK,INHIBITION,KIT,T24
GPR,GPR54,KISSPEPTIN,METASTASIS,THESE
169,223,25R,304,945,946,COPYRIGHT,DIOSCOREA,ECV,LTD,NMR,THEIR
001,004,006,027,101,169,COPYRIGHT,EARLY,EDUCATION,EORTC,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,QLQ,QUALITY,RESULTS,THERE,TREATMENT,UROLOGICAL
169,24H,945,956,AKT,ARSENIC,COPYRIGHT,COX,HIF,HUC,IRELAND,JNK,LTD,ROS
174,ART,BACKGROUND,CONCLUSION,DEX,LABEL,METHODS,RESULTS,SIN
BLADDER,CONCLUSION,GROUP,KHQ,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PRE,PURPOSE,QUALITY,RADICAL,RESULTS
131,APRIL,BACKGROUND,BETWEEN,CLINICALLY,CONCLUSION,CTA,INCIDENTAL,INCREASED,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
001,161,393,880,BACKGROUND,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,ACA,AUTHORS,BLADDER,COMET,INC,PREVIOUSLY,PUBLISHED,WILEY
ARRAY,DETECTION,INITIAL,LIVERMORE,MICROBIAL,PCR
145,3T3,956,AMONG,FRIEDEL,T24
169,215,219,COPYRIGHT,GROUP,HOWEVER,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RADIATION,RESULTS,THERAPY
217,BACKGROUND,CELSIUS,DUE,LABEL,METHODS,MUNICIPAL,RESULTS
001,013,045,139,213,271,CHINA,CHINESE,COX,CSS,FEW,THESE,UNIVARIATE
IMT
169,BACKGROUND,BASED,CONTEXT,COPYRIGHT,FURTHER,IDEAL,ITEMS,LABEL,METHODS,MOLECULAR,OBJECTIVE,PREFERRED,PUBLISHED,REPORTING,RESULTS,REUTERS,REVIEWS,SCIENCE,SYNTHESIS,SYSTEMATIC,THOMSON,UROLOGY,WEB
BACKGROUND,BLADDER,CONCLUSION,FOLEY,LABEL,METHODS,TUR
233,AREAS,AWARENESS,BACKGROUND,BCG,CIS,COVERED,DIFFERENT,HOWEVER,INCREASED,LABEL,METHODS,NMIBC,OPINION,SPI,TURBT
BACKGROUND,CONCLUSION,EXHALED,LABEL,METHODS,RESULTS
H2A,HIST1H2AC,HOWEVER,REDUCED,SIMILAR,TAKEN
3T3,4T1,CATHEPSIN,DOX,FABRICATED,GELATIN,RESULTS,THESE,VIABILITY
1075553,22RV1,BAY,CONCLUSION,LABEL,LNCAP,MBQ,METHODS,NON,OBJECTIVE,PET,PURPOSE,RESULTS
116,145,197,200,310,600,750,800,956,HCT,HOWEVER,III,MRI
017,119,169,177,COPYRIGHT,EDUCATION,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,COLLEGE,CONCLUSION,COPYRIGHT,DMEAN,FIFTEEN,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,RESULTS,ROYAL,SEQUENTIAL,V20,V30,V40
160,169,BECAUSE,COPYRIGHT,DIGITAL,IMAGING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POINT,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THESE
004,022,025,027,154,159,161,177,CONCLUSION,DOSIMETRY,EFFECTIVE,EXM,INJECTION,LABEL,MBQ,METHODS,PET,RESULTS,THESE,UNLABELLED,WHOLE
CURRENT,EXOGENOUS,FGF10,FIBROBLAST,III,MEK,PCR,UROTHELIAL,WESTERN
BACKGROUND,CONCLUSION,FORTY,GP5,GP6,HPV,HPV16,LABEL,METHODS,PCR,RESULTS,SUBSEQUENT
000,015,128,169,250,403,BASEL,COPYRIGHT,COX,EORTC,EXPRESSION,FAS,LABEL,MEIER,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,TREATMENT
127,169,268,346,614,BACKGROUND,BASEL,LABEL,METHODS,RESULTS,UCS,UUT,WHILE
169,ASSAY,CCK,COPYRIGHT,HOWEVER,HUC,INC,KIT,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,T24,WESTERN
012,030,047,064,125,169,233,471,670,833,844,922,929,AMONG,BCG,CHAIN,CONFIDENCE,COPYRIGHT,FAS,INC,LABEL,METHODS,OBJECTIVE,POLYMERASE,RATIO,RESULTS,THEREFORE
BACKGROUND,BLADDER,J82,LABEL,METHODS,MIGRATION,RESULTS,SLIDE,T24,UNASSIGNED,VIRTUAL,WNT,WNT5A
ALLYL,CELECOXIB,COX,HOWEVER,THESE
174,177,215,947,FURTHER,PBL
BLADDER,GUIDELINES,SALVAGE,UROLOGICAL,UROLOGY
139,141,BACKGROUND,BRAIN,CONCLUSION,DISEASE,EPSCC,IRELAND,LABEL,MANAGEMENT,METHODS,PATIENT,PCI,RESULTS
100,139,141,145,169,205,20A,214,222,723,BLADDER,COPYRIGHT,INC,MOLECULAR,PATHOLOGY,PCR,PUBLISHED,SEVEN,SOCIETY,WESTERN
169,945,GLEASON,HOLMIUM,SERUM,UROLOGICAL
CK7,CLASSICAL,FIG,FINALLY,HMWCK,INK4A,REF,TAB,UCS
CAM,CONCLUSIVE,INITIAL,VITAMIN,ZYFLAMEND
098,147,173,202,262,307,326,364,414,432,519,555,668,717,748,951,BCA,BMI,CONVERSELY,HDL,LABEL,LVI,METABOLIC,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,177,BASEL,BESIDES,CONCLUSION,COPYRIGHT,FDG,LABEL,MEDLINE,METHODS,MRI,OBJECTIVE,PET,RESULTS,SIX
001,003,386,418,BACKGROUND,CSS,III,IQR,LABEL,METHODS,OCTOBER,PFS,RESULTS,SEPTEMBER
068,134,644,678,863,ASIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SPM,THERE,THYROID,USA,WESTERN
169,BECAUSE,CHRISTIAN,EDITORS,EISENACHER,ERA,GUEST,HOWEVER,ISSUE,PROTEOMICS,SPECIAL,STEPHAN,TECHNICAL
GATA3,OWING
008,169,AUTHORS,BJU,CALIFORNIA,CIS,DIFFERENT,ESTIMATED,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,RFS,UNIVERSITY,WHILE
118,169,337,551,748,946,956,ARS,AUTHORS,BJU,CGP,EFS,FORCE,ICI,KCL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
153,ADP,BESIDES,EBP,GADD153,GRP,LCA,ROS,T24
029,248,25307,312,365,389,410,561,595,742,836,847,871,APRIL,HYPOTHESIS,JANUARY,LABEL,MEDLINE,METFORMIN,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,THERE
134,164,600,818,COLLEGE,MEDICAL,OMC,OSAKA
178,INSTITUTES,OBESITY,THESE
169,COPYRIGHT,HOWEVER,INC,OCT4A,PATHOLOGY,PUBLISHED,SOCIETY
169,947,AUTHORS,BACKGROUND,CLONOGENIC,COPYRIGHT,HISTONE,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRE11,OBJECTIVE,PAN,PUBLISHED,PURPOSE,RAD51,RAD51KD,RESOLUTION,RESULTS,RT112
069,315,525,547,AOR,CIS,EGYPTIANS,MEN,SCC,WOMEN
316,359,443,AGE,APRIL,BACKGROUND,CLAVIEN,CVA,HOWEVER,JANUARY,LABEL,MATERIALS,METHODS,RADICAL,RESULTS,THERE,THEREFORE,THOSE
COX,HODGKIN,HRS,MEIER,NHL,WHILE
946,ALTOGETHER,FINALLY
117,956,AGE,CONCLUSION,HISTORICAL,INDEX,LABEL,METHODS,NON,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,THERE
AIM,BACKGROUND,CHI,CONCLUSION,HGPUC,HOWEVER,LABEL,LGPUC,MATERIALS,METHODS,OBJECTIVE,RESULTS,TOTALLY,UROTHELIAL
042,047,174,193,210,403,AMONG,BACKGROUND,CHINA,CONCLUSION,IMMEDIATE,LABEL,METHODS,RESULTS,THP,TUR,TURBT
100,169,AUTHORS,BJU,CONCLUSION,CT1,LABEL,METHODS,OBJECTIVE,PST,RESULTS
BACKGROUND,FACTORS,FEW,HISTORY,HRQOL,LABEL,MCS,METHODS,PCS,RESULTS
335,638,ELISA,H2B,HOXA1,NIF,PROTEOMIC,URINARY
HOWEVER
756,GATA3,III,S100P,SIX,THEIR,UROTHELIAL
953,ATR,HOWEVER,JNK,JUN,XERODERMA,XPC
120,169,APRIL,ASIAN,BETWEEN,COPYRIGHT,HOWEVER,IIB,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,TEN,TREATMENT
003,048,113,249,269,834,934,ALA,ALA499VAL,ASIAN,BIOMEDICAL,CAUCASIAN,CHINESE,CIS,DESPITE,GLN,LYS,LYS939GLN,MEDLINE,ORS,PAT,VAL,XERODERMA,XPC

169,INC,SIX,STEAP,THESE,USING
169,BH3,BIM,COPYRIGHT,INC,MCL,PRO,THESE
169,BACKGROUND,COPYRIGHT,LABEL,LNS,METHODS,MRI,OBJECTIVE,OUTCOME,PER,PUBLISHED,RESULTS,SETTING,TESLA,UROLOGY,USPIO
001,022,036,038,047,049,053,169,305,699,953,ABC,AEU,BACKGROUND,COPYRIGHT,DIAGNOSTIC,ELISA,KRUSKAL,LABEL,METHODS,MMP,PUBLISHED,RESULTS,ROC,THERE,WHITNEY
160,AFTER,BACKGROUND,CA125,CA724,CEA,CONCLUSION,EPI,HOWEVER,IFO,LABEL,MAY,METHODS,SURGERY,TAXOL,THEREFORE,URACHAL
002,011,013,023,10P,11P,181,44K,ARRAY,BACKGROUND,CGH,GENOMIC,LABEL,METHODS,MOLECULAR,PFND2,PREFOLDIN,QUALITY,RESULTS,SUPERVISED,URINARY,VALIDATION
THESE,URACHAL
CONCLUSION,END,EXCEPTIONS,HOWEVER,LABEL,METHODS,NON,OBJECTIVE,OVERALL,PROGRAM,RESULTS,SETTING
160,177,AREAS,BCG,CK5,DESPITE,GROUP,IHC,THERE
100,101,133,145,169,373,99A,COPYRIGHT,ENGLISH,INC,INDIVIDUAL,LABEL,MARCH,MATERIALS,METHODS,MICRO,OBJECTIVE,PURPOSE,RESULTS,ZEB
100,600,650,BACKGROUND,CURRENT,INC,LABEL,MATERIALS,METHODS,MODEL,PUBLISHED,RESULTS,SOCIETY,SUO,UOS
169,265,332,ABSENCE,COPYRIGHT,HISTORY,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIO,RESULTS,TURBT
001,169,199,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T4A,UROLOGICAL
169,BLADDER,COPYRIGHT,DEPARTMENT,EDUCATION,INC,LABEL,MATERIALS,MEETING,METHODS,MOUNT,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,SINAI,UNMET,UROLOGICAL,UROLOGY
100,169,177,ADC,BACKGROUND,CONCLUSION,COPYRIGHT,DIFFUSION,FIFTY,FOLLOWING,FSE,INC,LABEL,METHODS,MRI,RESULTS,THESE
103,169,204,233,403,460,653,826,914,AFTER,BACKGROUND,BCG,COPYRIGHT,LABEL,LOCAL,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,OUTCOME,PUBLISHED,RESULTS,SETTING,UROLOGY
160,169,AUS,CONCLUSION,COPYRIGHT,FORTY,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RECORDS,RESULTS,STENT,THERE,UROLUME
169,183,946,CONCLUSION,CURRENT,DISCUSSION,HBA1C,KNOWN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SGLT2,THESE,WILEY
169,BLADDER,INDEX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROSTATIC,RESULTS,SCORE,UROLOGICAL
100,140,150,300,31398,76A,ABOUT,AFTER,AIN,ANNEXIN,BAX,MOLECULAR,SV40T,TCC,THERE,THESE
AFTER,GLEASON
169,175,954,BACKGROUND,COHEN,COPYRIGHT,LABEL,METHODS,RESULTS,SOCIETY,THERE,THESE,TIS,URINE,USING
324,413,771,954,CIS,GERMANY,GUIDELINES,IPOIC,ITALY,KINGDOM,LABEL,METHODS,NMIBC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIXTY,SPAIN,TURBT,UNION,UROLOGISTS,UROLOGY,VARIABLES
DESPITE,EFFORTS,LABEL,OBJECTIVE,ONGOING,PURPOSE,RESULTS,SUMMARY,THERAPIES
AFTER,DOPPLER,LABEL,MORBIDITY,OBJECTIVE,PRIOR,PURPOSE,RESULTS,SUMMARY,VARIOUS
001,500,AUSTRALIA,DESPITE,DOPPLER,HOWEVER,LTD,SEVERAL,SUPRA,THEIR,USCOM
100,105,124,169,ART,CONCLUSION,COPYRIGHT,D99,INC,LABEL,MATERIALS,METHODS,MLC,OBJECTIVE,PLN,PURPOSE,RESULTS
AMERICANS,METFORMIN,THERE
169,ALA,BACKGROUND,CIS,CONSORT,CONTEXT,COPYRIGHT,DIAGNOSTIC,FORTY,FURTHER,HAL,IDENTIFIED,ITEMS,LABEL,LIBRARY,MEDLINE,METHODS,MODERATELY,NMIBC,OBJECTIVE,OCTOBER,PDD,PREFERRED,PUBLISHED,REPORTING,RESULTS,RFS,STANDARDS,STARD,STUDIES,SYNTHESIS,SYSTEMATIC,TURBT,UROLOGY,WLC
169,186,349,535,CLAVIEN,DINDO,III,INDEX,INFECTIONS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADICAL,RESULTS,SCORE,SOCIETY,UNI,UROLOGICAL,USING
001,169,332,947,COPYRIGHT,KRUSKAL,MEIER,NBT,PUBLISHED
BLADDER,NUMERICAL
001,005,169,197,740,ASA,AUTHORS,BJU,CONCLUSION,ENDPOINTS,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,RFS,SOCIETY,THESE,UBC
000,169,AUTHORS,BJU,COMPARISON,COX,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,RESULTS,SIMILARLY,SWEDISH,THERE,UBC,URINARY,WILEY
169,COPYRIGHT,INC
169,BLADDER,COPYRIGHT,INC,SHORT
BACKGROUND,BIPOLAR,CIS,LABEL,METHODS,MONOPOLAR,NBI,NMIBC,RESULTS,SMALL,TURBT
008,BLADDER,CTV,DVH,LABEL,METHODS,MOD,OBJECTIVE,PTV,PURPOSE,RESULTS
112,ACCORDING,BETWEEN,EORTC,HOWEVER,NMIBC,SEVENTY,THERE,TREATMENT,TURBT
AFTER,ALK,BACKGROUND,BASED,BECAUSE,CONTEXT,LABEL,MALIGNANT,METHODS,OBJECTIVE,OBJECTIVES,SINCE,SOURCES,TEXTBOOKS,THESE
BACKGROUND,BASED,CONTEXT,DETECTION,HOWEVER,HPV,IDENTIFIED,INVADER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SAMPLES,SCC
ALA,ASP,DDX39,FINDING,GLU,HOWEVER,HSP27,INTRINSIC,PROTEOMIC,STUDENT,THESE
001,003,AKT,CNA,CONCLUSION,GIVEN,LABEL,METHODS,OBJECTIVE,PURPOSE,RAF,RAS,RB1,RESULTS,RTK,SIXTY
AUSTRIA,BLADDER,FOURIER
BAX,BCL,FURTHER,HOWEVER,ROS,T24,THEREFORE,THESE,WESTERN
618,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,SEVERAL
004,AFTER,CAUCASIANS,CCND1,G870A,HOWEVER,LIBRARY,MANAGER,PUBLISHED,STATA
AFTER,BLADDER,NON,TRANS
001,160,APRIL,ASSESSMENT,CONCLUSION,HRQOL,LABEL,METHODS,OBJECTIVE,PATIENT,PHYSICIANS,PURPOSE,RESULTS,SIX,SURVIVORS,THERE,UNADJUSTED,WHILE
169,214,302,CAUCASIAN,CBM,DESPITE,FURTHER,LABEL,MEDLINE,PAT,THEREFORE,UNASSIGNED,UNLABELLED,XPC
160,169,177,192,AL13122005,APPLICATOR,BOLTZMANN,CARLO,COMMISSION,COPYRIGHT,HDR,INC,LABEL,MATERIALS,MCNPX,METHODS,MONTE,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,TPS
169,800,BACKGROUND,COPYRIGHT,EVALUATION,INC,LABEL,METHODS,PAZOPANIB,RESULTS,SOLID
135,138,148,169,177,207,259,351,956,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,048,118,169,174,AUTHORS,BJU,LABEL,MAFFEZZINI,METHODS,NMIBC,OBJECTIVE,RESULTS,THERE,UROVYSION
169,AIM,BACKGROUND,CYSTOSCOPY,EROSION,IPP,LABEL,MANAGEMENT,METHODS,OBJECTIVE,PATIENT,POTENTIAL,RESULTS,SIX,SOCIETY
181,AMONG,APRIL,BASED,COX,LABEL,LIVER,MEIER,METHODS,OBJECTIVE,RESULTS
945,AMC,ARG,AUTOPHAGY,BACKGROUND,CA074,CATHEPSIN,CONCLUSION,DCFDA,FINALLY,HOWEVER,J82,LABEL,LC3,METHODS,MTT,PCR,RESULTS,TKI
ALK,APART,BREAK,COLOR,PCR,Q24,VYSIS
139,182,215,956,ACTIONABLE,CCND1,CCND3,ERBB2,FGFR1,FGFR3,GAS,KDM6A,NF1,NGS,NOTABLE,RB1,UCS
001,152,CCND1
169,BASEL,COPYRIGHT,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPANNER,STENT
006,114,119,1A1,432,CYP,GENOTYPES,GST,GSTM1,GSTT1,HOWEVER,PCR,TURKISH
CXCR4,HOWEVER,SRC,THEREFORE
CELLS,INCREASED,PCR,ROS,RUNX3
626,BACKGROUND,HOWEVER,LABEL,MATERIALS,METHODS,NHL,RESULTS,THERE
100,215,278,398,904,AMONG,CYSTOSCOPY,Q2Y,R2X,R2Y,ROC,SUBSEQUENT,THEREFORE,TOFMS
BACKGROUND,CONCLUSION,EARLY,GUTMANN,LABEL,METHODS,MICHAELIS,URINARY
DESPITE,LND,LYMPH,UCB
000,BACKGROUND,HOWEVER,INCREASED,ITALIAN,LABEL,METHODS,ORS,RESULTS,SWISS
ATTENTION,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS
AFTER,BACKGROUND,BLADDER,CASES,CONCLUSION,LABEL,METHODS
956,AGS,COMPOUNDS,J82,MES,MRC
DESPITE,FIRST,THIRD
157,192,614,930,CONCLUSION,CYSTOSCOPY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,UNIVARIATE,UUTTS
058,536,588,948,BACKGROUND,CONCLUSION,COX,HRS,KEY,LABEL,MAY,MEIER,METHODS,MODELLING,OBJECTIVE,RESULTS,WHILE
105,111,225,229,234,404,CONCLUSION,CTU,HIPAA,IRB,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UTT
BCA,LABEL,OBJECTIVE,ORC,PURPOSE,RESULTS,SUMMARY,THERE
CARCINOMA,HOWEVER,INSTEAD,LABEL,NMIBC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE,THEREFORE
LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
160,169,219,AFTER,CONFORMAL,COPYRIGHT,FIFTY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS
128,131,169,247,390,500,BETWEEN,BJU,LABEL,LYMPH,MAY,METHODS,OBJECTIVE,PARTICULAR,PATHOLOGY,RESULTS,THERE,UUTUC
001,007,169,263,AUSTRALIA,BJU,LABEL,LOCAL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,PRIMARY,RESULTS,RRP
963,BACKGROUND,COM,COV,INTER,LABEL,METHODS,PROSTATES,REGARDING,RESULTS,RMS
HOWEVER,ICP,INCREASED,LABEL,MATERIALS,METHODS,MYC,OBJECTIVE,PURPOSE,RESULTS,USING
BACKGROUND,CONCLUSION,CTS,DEFORMABLE,DIR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VMANUAL,VPROP
47HM4,HOWEVER,THESE
METASTASIS
EXTRA,FDG,PET,PRIMARY
1255B,144,26B,374,618,754,BLOOD,FURTHER,SINCE,THREE,USING
169,1T1,956,AFFYMETRIX,CELLS,COPYRIGHT,DMA,HBE,III,INCREASING,INORGANIC,IRELAND,LTD,MMA,THESE
253JB,437,BORTEZOMIB,FINALLY,HSP70,HSP72,KNK,PCR,SW780,VELCADE
169,COPYRIGHT,GAUSS,LTD,THERE,WILEY
187,661,738,EUROPEANS,FURTHER,LABEL,NAD,PRO,PRO187SER,SER,UNASSIGNED
001,022,BESIDES,FURTHER,HOWEVER,INCREASING,J82,RT4,T24,TAKEN
GENERATION,HOWEVER
169,BLADDER,COPYRIGHT,INC,ONGOING
169,COMPANY,COPYRIGHT,JOURNAL,LTD,PEDIATRIC,POSTERIOR,PUBLISHED,PUV,UROLOGY
ANY,BACKGROUND,BCG,CK7,CONCLUSION,HOWEVER,LABEL,METHODS,MRI,THERE,THEREFORE,THREE,TUR,VILLOUS
001,002,003,004,005,013,046,113,213,BACKGROUND,COX,HIPPO,HOWEVER,IHC,LABEL,MEIER,METHODS,PCR,RESULTS,UCB,WESTERN,YAP,YES
100,169,AUSTRALIAN,AUTHORS,BACKGROUND,BLADDER,COLLEGE,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,NON,OAR,OVERALL,RADIATION,RESULTS,ROYAL,SEVENTY,SUGGESTED,THERE,V40GY,V50GY,V60GY,V65GY,ZEALAND

945,AFM,EGF,FURTHER,MEANWHILE,T24,TGF
BACKGROUND,HOWEVER,LABEL,METHODS,OBTURATOR,RESULTS,TRANS
001,009,556,845,BACKGROUND,CONCLUSION,LABEL,METHODS,QRESEARCH,RESULTS,THERE
10A,152,169,AZA,BECAUSE,COPYRIGHT,FINALLY,HUEPC,INC,J82,PCR,RT4,URINARY
169,241,BAT,COPYRIGHT,FDG,PET
001,002,007,945,AFTER,ITC,OUTCOME,SKYPE,THESE
001,043,5GY,CRT,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RCI,RESULTS
102,177,INCLUDING,TESTS
DUE,FINALLY,SMALL,THESE
001,033,COLONIC,COMPLIANCE,GOLDWASSER,LABEL,METHODS,OBJECTIVE,RESULTS,URINE
100,PRESENTLY,SAMPLES,THERE,THESE,UNDER
ANOTHER,ERG,FAF,IHC,LABEL,METHODS,OBJECTIVE,OCT,PURPOSE,RESULTS,SDOCT,THREE,WESTERN
002,003,005,006,157,178,ASIAN,BACKGROUND,C609T,CAUCASIAN,CONCLUSION,LABEL,METHODS,NAD,PRO187SER,RESULTS,STRATIFIED
009,048,141,169,241,BACKGROUND,BASEL,BLADDER,LABEL,MATERIALS,METHODS,RESULTS,RISKCHECK,ROC
169,365,ANY,COX,FURTHER,LABEL,LTD,METHODS,OBJECTIVE,PROACTIVE,RESULTS,THERE,THESE,WILEY
233,AMONG,COCHRAN,COMPLETED,CONNAUGHT,GROSS,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS
169,CD4,CD8,FURTHER,USING,VCH,WILEY
ACUTE,AUR,CONTINENCE,CONTRARILY,ICS,NEUROLOGIC,SOCIETY
CLEAR,CONCERNING,DOSES,HOWEVER,LOOKING,OAR,PTV,SIMILAR
WHY
947,C7ORF24,CHROMATIN,CPG,IMR,MCF,THESE
ANALOGOUS,ARF,DDR,HOWEVER,INK4A,ONCOGENIC
247,680,954,ATLAS
000,800,NOTABLY,THOUSANDS
027,029,197,359,487,710,FURTHER,OVERALL,TZD,WHILE
150,DUE,HOWEVER,LABEL,MINIMALLY,OBJECTIVE,ORTHOTOPIC,PURPOSE,RESULTS,SUMMARY,URETHRA
HOWEVER,III,LABEL,OBJECTIVE,ONGOING,PURPOSE,RESULTS,SUMMARY,THERE
APART,BCL,LABEL,OBJECTIVE,PREDICTIVE,PURPOSE,REGARDING,RESULTS,SUMMARY
233,BIOMARKERS,LABEL,NMIBC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
169,COPYRIGHT,EDUCATION,INC,INITIAL,LABEL,MATERIALS,METHODS,NUCLEOSIDE,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,004,008,009,015,045,169,306,BACKGROUND,BIOMARKERS,CONCLUSION,COPYRIGHT,COX,CSS,CXCR4,IHC,INC,LABEL,MEIER,METHODS,PFS,RESULTS,RFS,STK15,UBC
169,COPYRIGHT,ERG,HOWEVER,INC,SMALL,THEREFORE,TMPRSS2,URINARY
169,COPYRIGHT,DOSES,DPO,HIGHEST,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,TREATMENT
00001,169,886,BACKGROUND,BCA,CENTRAL,CONTEXT,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,RFS,SCIENCE,SECONDARY,SYNTHESIS,UROLOGY,WEB
001,100,169,954,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,UCB
169,CALYPSO,COPYRIGHT,FIRST,INC,LABEL,LILLIEFORS,MATERIALS,METHODS,OBJECTIVE,PEARSON,PURPOSE,RESULTS,THERE
169,BLADDER,COPYRIGHT,FOLEY,IA2,INC,NERVE,ONCOLOGIC,PUBLISHED
FIFTY,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THOSE
IMAGING,RESONANCE
DESPITE,HOWEVER
177,ECLIPSE,PTV,VARIOUS
23B,EMT,FURTHER,LUCIFERASE,MEIER,MICRORNAS,PCR,ROC,THESE
139,COX,HOWEVER,LABEL,METHODS,OBJECTIVE,PREVALENCE,PURPOSE,RESULTS,SIMILARLY,SMOKING,THERE
101,130,169,CGI,CONCLUSION,CPG,FGFR3,LABEL,LOW,METHODS,NMIBC,OBJECTIVE,PURPOSE,RESULTS
169,HOWEVER,ROBOT,THEREFORE,UROLOGICAL
102,BACKGROUND,BLAND,HOWEVER,LABEL,MARCH,METHODS,RESULTS
000,002,044,169,199,975,984,990,994,995,BACKGROUND,COPYRIGHT,COX,EXCLUDING,FURTHER,LABEL,METHODS,ONTARIO,RESULTS,SOCIETY,USING
ATTENTION,BACKGROUND,CCI,CIVIL,DENMARK,EARLY,IBC,LABEL,LOS,METABOLISM,METHODS,NRS,NUTRITION,OBJECTIVE,OBJECTIVES,PATIENT,PROLONGED,RESULTS,SOCIETY,UNDER,UNIVERSITY
160,177,ACROMEGALY,AGE,IGF,MALIGNANCY,RENAL,THEREFORE,THYROID
AML,INDUCTION,MONITORING,PULMONARY,SIR,THESE,TYPICAL
160,PLANS,SIO,TPS
946,BLADDER,BUC,HUC,III,KNOCKDOWN,PCR,SIMILARLY,T24
002,006,037,177,6GY,CONCURRENT,DOSES,OAR,PTV,RA1,RA2,SLIDING,TEN,V30,VOLUMETRIC
169,ATTENTION,CAS,COPYRIGHT,HOWEVER,INC,IST,MALIGNANCY,PUBLISHED
BIOMETRIKA,COX,SIMULATION
169,174,207,404,855,906,913,914,941,944,949,AFTER,AUC,COPYRIGHT,DIAGNOSTIC,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,COPYRIGHT,GSE,HOWEVER,LC3,LTD,SINCE,T24,THROUGH
169,AMONG,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MIR,OBJECTIVE,OBJECTIVES,RESULTS
154,160,169,178,ACCORDING,BCR,CONCLUSION,COPYRIGHT,FURTHER,III,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,PHOENIX,PRIOR,PSA,RESULTS,STUTTGART,THREE,UNIVERSITY
169,COPYRIGHT,CTC,EMT,IRELAND,LTD
169,AUR,CONCLUSION,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,REGIONS,RESULTS,SVM
169,COPYRIGHT,FGF,FGFRS,FIBROBLAST,LTD,STUDIES
001,169,ARR,ASSESSMENT,BACKGROUND,CONTEXT,COPYRIGHT,DESPITE,ERS,EVALUATION,GRADING,HOWEVER,IVC,LABEL,MARCH,MEDLINE,METHODS,NMIBC,NON,OBJECTIVE,PUBLISHED,QUALITY,RESULTS,RFI,SYNTHESIS,THERE,TURBT,UROLOGY
001,020,021,030,102,128,146,236,364,395,561,834,CCND3,COX,RR3,RR5
001,169,177,AFTER,BACKGROUND,COPYRIGHT,D35,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
169,COPYRIGHT,EVALUATION,INC,INDIANA,MRT,PEDIATRIC
HOWEVER,MB231,MDA,NEL,NELL2,THEREFORE,UC5
233,945,BACKGROUND,BCA,BCG,LABEL,LIBRARY,METHODS,MITOMYCIN,PFS,RCT,RESULTS,RFS
169,237,CAD,CCNB1,COPYRIGHT,ERBB2,IHC,INC,KRT14,PATHOLOGY,PUBLISHED,SOCIETY,THESE,URO
169,233,BACKGROUND,BCG,BLADDER,CIS,CONTEXT,COPYRIGHT,CURRENT,CYSTECTOMY,DIAGNOSIS,EAU,EORTC,LABEL,LITERATURE,METHODS,NMIBC,NON,OBJECTIVE,PANEL,PATIENT,PUBLISHED,RESULTS,SINCE,SUMMARY,SYNTHESIS,THESE,TUMOURS,TUR,UROLOGY,WEB,WHERE
001,169,17A,947,BLADDER,CD4,COPYRIGHT,FURTHER,INC,PBMCS,PUBLISHED,ROR,SOCIETY,THEREFORE,THESE
BACKGROUND,CLAVIEN,ERP,ICU,LABEL,METHODS,OTHER,PRIMARY,RESULTS,SECONDARY,THERE
CRUCIALLY
E2C,HOWEVER,SMALL,TAKEN,UBE2C
BLCAP,BLCAP_V2A,CCCTC,H19,HOWEVER,WILMS
HOWEVER,MODULATED,NOISE,RAMAN,RATIO,SNR,WAVELENGTH
AVERAGE,BBN,C57BL,ERK,MACROPHAGE,MIF,PCR,TDR,TREATMENT,USING
169,183,BACKGROUND,BETWEEN,COPYRIGHT,DEC,FUNDING,INSTITUTE,IQR,JAN,LABEL,LTD,METHODS,RESULTS,SIX,USA
100,945,946,D95,D97,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,V95
177,244,376,817,BECAUSE,EPI,FMS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE
012,036,177,ESPECIALLY,EXCLUDING,FURTHER,IMRTCUT,LABEL,LARGE,METHODS,OAR,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,V60
409,FURTHER,MET,SILENCING,THERE,THESE
HOWEVER,T24
103,DFS,DISEASE,FORTY,LABEL,LOG,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPECIMENS,TURBT
009,100,157,169,185,ARCON,CON,CONCLUSION,CUSTOMIZED,III,LABEL,LARYNGEAL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SAMPLES,T4A,THESE,YET
160,169,COPYRIGHT,EDUCATION,FRESH,HGF,INC,KRUSKAL,LABEL,MATERIALS,MET,METHODS,OBJECTIVE,PHA,PRIMARY,PUBLISHED,PURPOSE,RESULTS,TECHNIQUES,TREATMENT,UROLOGICAL,USING,XENOGRAFT
169,233,946,AUTHORS,BCG,BJU,BLADDER,CONCLUSION,HBD,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,REVERSE,T24
013,085,088,109,214,352,354,681,688,BACKGROUND,BIOMEDICAL,CBM,CHINA,CIS,CONCLUSION,CRUDE,HOWEVER,KNOWLEDGE,LABEL,LITERATURE,LYS939GLN,MEDLINE,METHODS,ORS,OVERALL,RESULTS,SCIENCE,UNASSIGNED,VIRTUAL,WEB,XERODERMA,XPC
100,106,177,BACKGROUND,CARCINOMA,CIS,HGPCA,LABEL,METHODS,OBJECTIVE,RESULTS,UNASSIGNED,VIRTUAL
019,022,042,1306C,1562C,169,199,241,AUTHORS,BJU,GENOMIC,LABEL,METHODS,MMP12,OBJECTIVE,OBJECTIVES,RESULTS,THERE,TIMP1,TIMP3,TIMPS
000,059,147,163,169,538,912,ADDITIONAL,AUTHORS,BJU,EXCELLENCE,G1PTA,INSTITUTE,LABEL,MARCH,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,OLA,PDD,RESULTS,THERE
779,DECLINE,IDIOPATHIC,MORTALITY,PENDING,SERIOUS,THERE,UNION
280,CONCLUSION,EXPRESSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHO1973
CONCLUSION,D50,EORTC,FORTY,GRADE,III,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS,THERE,VAS
CONCLUSION,DIFFERENT,DUE,HOWEVER,HYPOTHESIS,III,LABEL,LOWER,LUT,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTY,VOIDING
001,216,232,283,733,CSS,END,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TURBT
177,330,410,BETWEEN,CIS,CLAVIEN,DAYTIME,III,IQR,LABEL,LRC,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OIN,RESULTS,UCB
160,212,331,603,660,738,ALTERED,CONCLUSION,EXPRESSION,HOWEVER,LABEL,LSCCS,METHODS,OBJECTIVE,PURPOSE,RESULTS
945,ACTN4,AKT,ERK,STAT3,T24,TUR
100,169,786,956,BASEL,COPYRIGHT,DU145,H2052,H2452,H28,HEPG2,HUH,LNCAP,MKN,NCI,SBC,T24,VHL
169,947,ARF,INK4A,LABEL,REG,UNLABELLED
112,169,6MONTHS,AMONG,ARTHRITIS,B27,BCG,HLA,HOWEVER,LABEL,METHODS,NOTEWORTHY,OBJECTIVE,OVERALL,REA,RESULTS,SEVENTY
012,142,152,BACKGROUND,BCA,CHEMOKINES,CONCLUSION,CXCL1,FURTHER,LABEL,METHODS,RESULTS,SIMILARLY,STUDIES
001,019,100,169,BJU,CLAVIEN,CONCLUSION,DEFINITIVE,LABEL,METHODS,OBJECTIVE,ORC,RESULTS,THERE,UNIVERSITY
NF1
144,169,946,HOWEVER,THESE,WNT
233,932,AGE,BCG,CONCLUSION,COX,DESPITE,END,LABEL,METHODS,NMIBC,OBJECTIVE,PREDICTORS,PURPOSE,RESULTS,TIS
CONVERSELY,EGF,HOWEVER,MET,RT4,SRC,STAT3,T24,UROTHELIAL,USING
030,126,169,171,200,222,327,336,532,873,BBC,CONCLUSION,COPYRIGHT,GREENLIGHT,INC,IQR,LABEL,LASER,METHODS,OBJECTIVE,OCTOBER,PRIOR,PVP,PVR,QOL,RESULTS,SIMILARLY,SIX,THERE,URINARY,WILEY
METASTASES,TCC
CHINESE,EMT,MULTI,WESTERN
LABEL,METHODS,RESULTS,UNLABELLED
BACKGROUND,CURRENT,FIRST,LABEL,METHODS,RADICAL,RESULTS
BACKGROUND,CURRENT,HOWEVER,LABEL,MAXIMAL,METHODS,RESULTS,TURBT
169,947,956,AFTER,CASPASE,COPYRIGHT,HOWEVER,JUN,LTD,MDA,MEKK1,OME,PHOSPHO,ROS,SOD,T24,UROLITHINS
003,100,169,257,295,AIR,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,STUDENT,UROLOGICAL,WATER
031,150,160,169,COPYRIGHT,FIFTEEN,LABEL,LTD,METHODS,NEWLY,OBJECTIVE,PUBLISHED,RESULTS,TME,UROGENITAL
110,169,220,BACKGROUND,COPYRIGHT,COX,CSS,GSTM1,GSTT1,LABEL,LTD,MEIER,METHODS,PCR,PFS,RESULTS
169,BACKGROUND,CIGARETTE,CONTEXT,COPYRIGHT,ENGLISH,FINALLY,HOWEVER,ITEMS,JANUARY,LABEL,MARCH,MEDLINE,METHODS,OBJECTIVE,PREFERRED,PUBLISHED,REPORTING,RESULTS,REVIEWS,RNU,SMOKING,SYNTHESIS,SYSTEMATIC,THERE,UCB,UROLOGY,WHILE
169,177,6MM,717,COPYRIGHT,CROWN,CYBERKNIFE,D10,D80,D98,HDR,HOWEVER,INC,MEDICAL,OAR,PUBLISHED

BACKGROUND,CONTEXT,E26,ETS,LABEL,LITERATURE,METHODS,OBJECTIVE,SEVERAL,SOURCES,UROVYSION
169,183,GEORG,RADICAL,STUTTGART
001,005,009,153,CHD1L,HOWEVER,MEIER
004,005,010,013,160,164,206,BACKGROUND,COX,DSS,IRS,LABEL,MEIER,METHODS,MOLECULAR,PFS,RESULTS,SNAI1
001,411,441,776,ASIAN,BACKGROUND,BLACK,CHINESE,CLUSTERING,CONCLUSION,EFFORTS,ENGLAND,ENGLISH,EXPERIENCE,EXPLORING,LABEL,METHODS,ORS,PATIENT,RESULTS,WHITE,YOUNGER
100,169,COPYRIGHT,DESMOGLEIN,INC,THEREFORE,URINARY,UROTHELIAL
028,089,180,LABEL,MENOPAUSE,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SCALE
GROUP,HODGKIN,NHL,THEREAFTER
CHINESE,EARLY,GENERAL,LABEL,LIBERATION,METHODS,OBJECTIVE,OBJECTIVES,PLA,RESULTS
001,005,BACKGROUND,CIS,INCREASING,JANUARY,LABEL,MEDLINE,METHODS,NOTEWORTHY,RESULTS,RRS,SUMMARY,THESE
115,DETECTION,INDIA
177,6TH,ANOVA,ARITHMETIC,BIRMINGHAM,BON,BONFIRE,BRISTOL,CPI,EPAQS,GENERALLY,HOWEVER,IND,JANUARY,NIGHT,PAH,SINCE,SVOCS
105,BACKGROUND,BLADDER,BLOOD,CASES,LABEL,LEBANON,METHODS,PCR,RESULTS
956,AA8,CHINESE,CHO,COL,FURTHER,ISOLATE,MCF,MTT,T24,TLC,TUNEL
131,215,244,AMONG,CIS,EGGER,FURTHER,HOWEVER,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,STRATIFIED,STUDIES,SUMMARY,WANFANG
177,ADJ,BACKGROUND,FORTY,FURTHER,IMA,LABEL,MATERIALS,METHODS,OSI,RESULTS,SERUM,TAS,THERE,TOS
018,029,169,CONTINENCE,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UROLOGICAL
CPG,MAFUCCI,TET,THESE
169,296,790,BACKGROUND,LABEL,METHODS,RESULTS,SOCIETY,UCC,URINE,UROVYSION
100,108,COMBINING,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,T2A,TESLA
AMS,AREAS,BACKGROUND,COVERED,FURTHER,LABEL,METHODS,OAB,OPINION
946,BACKGROUND,BTM,CONCLUSION,COX,CTX,LABEL,METHODS,RCC,RESULTS,SERUM,SRE,ZOL
AKT,CSTP1,EXPRESSION,MEIER,S473D
215,253,3GY,9GY,AKT,CLONOGENIC,KU7,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RAPAMYCIN,RESULTS,TREATMENT,UC3,UC5,UC6
484,HIS447ARG,SDH,SEQUENCING,THEREFORE
HMB45,LIGHT,PECOMAS
060,180,412,BACKGROUND,CI0,INSURANCE,LABEL,METHODS,NHIRD,OBJECTIVE,RESULTS,USING
ANY,ARTIFICIAL,THERE,THESE
169,26A,COPYRIGHT,FEDERATION,HMGA1,PUBLISHED,SOCIETIES,T24,THESE
169,417,AFTER,BPT,COPYRIGHT,END,INC,ISPOR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RADICAL,RESULTS,SIMULATION,SOCIETY,USING
152,169,COPYRIGHT,HISTOLOGY,INC,LABEL,MATERIALS,METHODS,NATIONWIDE,NETWORK,OBJECTIVE,PALGA,PATHOLOGY,PRIMARY,PROGNOSTIC,PURPOSE,RESULTS,SHELDON,URACHAL
169,250,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
002,004,036,047,169,555,ACE,ADULT,AGE,ASA,AUC,CCI,COPYRIGHT,EASTERN,EVALUATION,GROUP,INC,INDEX,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCORE,SOCIETY,UNLABELLED
001,169,192,825,ACCORDING,COPYRIGHT,INC,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,OWING,PROGNOSIS,PUBLISHED,RADICAL,RESULTS,RFS,SIMILARLY,UNLABELLED
111,169,316,357,764,BACKGROUND,COLON,CONCLUSION,COPYRIGHT,FOLLOWING,INC,LABEL,LYNCH,MEIER,METHODS,MMR,PUBLISHED,RESULTS,SIR
045,106,124,126,167,169,808,COPYRIGHT,DISEASE,EVALUATION,INC,INDUCTION,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADICAL,RESULTS,SOLID
107,125,137,169,174,180,233,738,740,970,COPYRIGHT,CUMULATIVE,CYSTOSCOPY,INC,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROUTINE,SCIENCE,WEB
169,856,945,946,BACKGROUND,BIOMARKERS,COPYRIGHT,INC,INCIDENCE,IRR,LABEL,METHODS,NUTRITION,OBJECTIVE,PUBLISHED,RESULTS,UCC
169,233,274,408,845,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THESE,VB4
169,521,ANY,BERNE,BJU,CALIFORNIA,LABEL,MEIER,METHODS,OBJECTIVE,RADICAL,RESULTS,UNIVERSITY,USC,YET
103,110,169,233,299,341,469,776,BCG,BJU,CONCLUSION,COX,LABEL,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
001,008,014,016,029,045,169,740,972,992,BCA,BJU,CONVERSELY,FTR,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,OBJECTIVE,OLDER,OVERALL,RESULTS,WHEREAS
AES,LABEL,METHODS,OBJECTIVE,PAP,RESULTS,TTO,USING,UTILITY
AFM,RT4,SMC,T24,UCC,YOUNG
BCG,HOWEVER,NMIBC,REGARDING
EVENTUALLY,SINCE,WILMS
FIFTY,OPERATIVE,THERE,UUT
COMPARABLY,DESPITE,GSK461364,GW843682X,HOWEVER,RT4,T24
BAX,BCL,BCLXL,CISPLATIN,HOWEVER,IAP,RT4V6,USING
169,794,CASES,COPYRIGHT,EDUCATION,HOWEVER,INC,JUDICIOUS,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
143,169,AUTHORS,CHEMICALLY,COPYRIGHT,LTD,PUBLISHED,T24
169,182,183,AMONG,BLADDER,COPYRIGHT,FURTHER,MIR,THEREFORE
014,120,169,322,329,502,877,925,939,BACKGROUND,COPYRIGHT,COX,INC,INSULIN,LABEL,MATERIALS,METHODS,RESULTS,WHETHER
026,120,150,169,BLOOD,CONCLUSION,COPYRIGHT,INC,LABEL,LOW,MAXIMAL,METHODS,MMC,OBJECTIVE,RESULTS,TURBT
109,169,200,532,AFTER,APRIL,BETWEEN,BNC,CAD,CONCLUSION,COPYRIGHT,HOLAP,INC,INDEX,LABEL,MARCH,METHODS,OBJECTIVE,PROCEDURE,PVP,REGARDLESS,RESULTS,SCORE,SMALLER,SYMPTOM
169,AFTER,COPYRIGHT,INC,SEVERAL
001,169,AEU,BMI,COPYRIGHT,EHS,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SCORE,VARIABLES
115,169,BCA,BCL2L12,COPYRIGHT,FINALLY,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
029,169,BASED,BJU,FDG,LABEL,METHODS,OBJECTIVE,PATIENT,PET,RESULTS,UPSTAGING
ADDITIONAL,AIC,BACKGROUND,BCG,CONCLUSION,COX,EORTC,HOWEVER,INDUCTION,LABEL,MANAGEMENT,METHODS,NMIBC,RESULTS
173,282,BLADDER,CIS,ORS,THERE,TOBACCO
AFTER,ALONG,CLINICALLY,DUE,EAU,RECURRENCE
116,169,CHI,CONFIDENCE,CONTINUED,COPYRIGHT,INC,LABEL,MAJOR,MATERIALS,METHODS,MMC,OBJECTIVE,OBJECTIVES,RATIO,RESULTS,USING
127,393,494,BACKGROUND,DNT,INCIDENCE,ITALIAN,LABEL,METHODS,RATIO,RESULTS,SIR,THERE
133,160,ACCORDING,H1299,HOWEVER,MMP,NCI
169,APMIS,BKPYV,DESPITE,DIAGNOSIS,LTD,OTHER,PCR,PUBLISHED,PYVAN,PYVHC,WILEY
048,137,BETWEEN,GBM,NEUTROPHIL,NLR,THESE
100,945,BACKGROUND,BLADDER,CONCLUSION,FGFR3,FINALLY,HIF,HYPOXIA,INCREASED,KNOCKDOWN,LABEL,METHODS,NMI,NON,PCR,PKB,RESULTS
039,169,BACKGROUND,BROWN,COPYRIGHT,CSF,DEFINITION,ERASMUS,FACTORS,IMAGING,IMBCM,LABEL,MED,MEDLINE,METHODS,OBJECTIVE,PUB,RESONANCE,RESULTS,SEQUARD,TREATMENT
169,BACKGROUND,CONCLUSION,COPYRIGHT,III,INC,LABEL,METHODS,NGB,RESULTS,SCT,VUR,WILEY
169,586,660,ANGELES,BLADDER,DIETARY,LOS,NITROSO,NOC,PERHAPS,RESULTS
016,031,047,FUNCTIONAL,LABEL,METHODS,MRI,MUL,OBJECTIVE,OBJECTIVES,PAD,PCL,QOL,RESULTS,SURGERY,VISIBILITY
169,COPYRIGHT,EPIGENETIC,FGFR3,HOWEVER,INC,LOH,OVERALL,WILEY
GLEASON,OVERALL,PCA,PROSTATIC,USUAL
169,AEU,BACKGROUND,BCG,CONNAUGHT,CONTEXT,COPYRIGHT,DUE,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SINCE,SPANISH,SPECIAL,SYNTHESIS,UROLOGY
169,ADC,AEU,BACKGROUND,COPYRIGHT,EVALUATION,LABEL,METHODS,MRI,NPV,OMS1987,PPV,PUBLISHED,RESULTS,ROC,THERE,WHITNEY
001,006,018,024,169,BASED,BCI,BIS,BJU,BLADDER,CLAVIEN,EORTC,IMAGE,INDEX,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,THERE,TREATMENT
169,COPYRIGHT,LEVEL,PUBLISHED,UROLOGY
001,002,004,169,231,AUTHORS,BACKGROUND,CON,COPYRIGHT,HYPOXIA,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAMPLES,THERE
279,427,570,731,926,967,975,ALA,ALA222VAL,BACKGROUND,BIOMEDICAL,CBM,CHINESE,CONCLUSION,EGGER,LABEL,METHODS,MTHFR,RESULTS,SCIENCE,SLIDE,STATA,UNASSIGNED,VAL,VIRTUAL,WEB
AVAILABLE,MINIMALLY,ROBOTIC,UNTIL
ENGLISH,MEDLINE,PDD
160,BLADDER,USA
100,110,129,945,946,BACKGROUND,BOARD,CONTEXT,CTV,FIFTY,IRB,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,PTV,RESULTS,THERE
169,945,946,954,COPYRIGHT,ERK,HOWEVER,INC,JAK,MMP,SIMILAR,THESE,TREATMENT,U0126
169,403,610,776,946,AFTER,COPYRIGHT,CYSTECTOMY,EASTERN,EDUCATION,GROUP,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PENDING,PREDICTION,PUBLISHED,PURPOSE,RADICAL,RESULTS,SPARC,UROLOGICAL,WHILE
169,181,250,256,308,780,945,AFTER,AUA,COPYRIGHT,EDUCATION,INC,LABEL,LOWER,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,PURPOSE,RESULTS,STORAGE,THESE,UROLOGICAL
107,113,169,BACKGROUND,BETWEEN,CLAVIEN,COPYRIGHT,CSS,FORTY,LABEL,MEIER,METHODS,OBJECTIVE,OCTOBER,ORC,OUTCOME,PROCEDURE,RESULTS,SETTING,TOTALLY,UROLOGY,USING
169,BACKGROUND,BETWEEN,CLAVIEN,COPYRIGHT,DAYTIME,DINDO,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,ROBOT,SETTING,UROLOGY
005,AMONG,ANOTHER,ANXA5,BLADDER,COL18A1,FN1,GEM,IL13RA1,ITGA5,POSTN,RAPGEF3,RIPK1,SIX,THESE,VIM
EVIDENTLY,JANUS,KALLIKREIN,KLK,REGARDING
000,001,122,181,300,400,640,860,CASES,CHILE,HOWEVER
169,BEL,BPB,COPYRIGHT,INC,LABEL,NPS,OVERCOMING,THESE,UNASSIGNED,UNLABELLED,USING,XENOGRAFT
102,169,174,206,ANG,AUROC,CA9,COPYRIGHT,DIAGNOSTIC,EDUCATION,INC,LABEL,MATERIALS,METHODS,MMP,OBJECTIVE,PAI,PUBLISHED,PURPOSE,RESULTS,SEVEN,THROUGH,UROLOGICAL,UROVYSION
000,100,112,160,169,178,197,269,288,423,494,734,922,981,ADVERSE,AGE,COPYRIGHT,DEPARTMENT,DUE,EDUCATION,EMERGENCY,INC,LABEL,MATERIALS,METHODS,NATIONWIDE,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL
169,COPYRIGHT,INC,OVERALL
HOWEVER,NDRG1,PCR,T24,XENOGRAFT
339,352,691,ADDITIONAL,BACKGROUND,CONCLUSION,HENCE,LABEL,LAR,METHODS,NORMALIZED,OBJECTIVE,PURPOSE,RESULTS,SUMMATION,USING,VII
120,181,INTRA,LABEL,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THREE,TURBT
169,363,663,711,741,768,CHINESE,CONCLUSION,COPYRIGHT,CUETO,EORTC,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,NMIBC,OBJECTIVE,RESULTS,SEPTEMBER,SPANISH,TREATMENT,UROLOGICAL
169,COLLEGE,COPYRIGHT,FOCAL,LTD,PUBLISHED,ROYAL,THERE
148,234,ASA,CCI,CCS,COX,CSS,INDEX,JANUARY,KARNOFSKY,KPS,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PFS,RADICAL,RESULTS,SOCIETY,THESE,WHETHER
011,024,169,275,BLADDER,COPYRIGHT,ENGLAND,OVERNIGHT,SLC14A1,SLC14A2,USG
169,BASEL,CLAVIEN,COPYRIGHT,CSTEA,DINDO,LABEL,MATERIALS,METHODS,NAS,OBJECTIVE,OUTCOME,RESULTS,UNDER,VAS
010,041,056,GPR87,LPA,THESE
DESPITE,UBC,UGT1A
233,BCG,LOCAL
SPECT
001,132,169,177,BASEL,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,TURBT
020,022,029,150,169,521,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,CSS,EORTC,LABEL,MATERIALS,METHODS,MIBCS,NMIBC,OBJECTIVE,RESULTS,SECONDARY,WHILE
945,AREAS,BACKGROUND,BPH,COVERED,LABEL,MEDICAL,MEDLINE,METHODS,OPINION
500,AIM,CONCLUSION,III,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PFS,RESULTS,SIXTY
024,351,887,ALA,ASP,DDX39,GLU,H2052,H2452,H28,MALIGNANT,MET,MPM,NCI,SINCE,THESE
001,131,212,AIM,CONCLUSION,FURTHER,LABEL,MATERIALS,METHODS,NMIBC,OBJECTIVE,RESULTS
EFFORTS,PERSONHOOD
003,006,008,036,069,100,112,304,937,AFTER,C609T,NAD,OVERALL,SINCE,THERE,THEREFORE
BCL,J82,THEREFORE
152,195,462,687,AFTER,AMPLATZER,AVP,LABEL,MAINZ,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,SINCE,THERE,TRANSRENAL
174,AIM,BASED,BCG,BCS,CONCLUSION,DESPITE,LABEL,MEDLINE,METHODS,NMIBC,OBJECTIVE,PARTICULAR,RESULTS,TUR,TURBT
JANUARY,KEY,LND,MARCH,RCC,THERE,UCUUT,UTUUC
CASES,END,GIVEN,LABEL,METHODS,OBJECTIVE,PROGRAM,RESULTS,SEVENTY,USING,UTERINE,WOMEN
HOWEVER
169,5MM,COPYRIGHT,CTV,INC,MFO,PUBLISHED,ROTATIONAL,TEN,V45,V70
169,177,AMONG,CHINA,CHINESE,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RENAL,RESULTS,THERE,WESTERN
100,169,406,AES,CONCLUSION,COPYRIGHT,CURRENT,INC,LABEL,METHODS,MINNESOTA,OBJECTIVE,PROCEDURAL,RESULTS,THESE,UNIVERSITY
100,169,362,AUC,AUR,COPYRIGHT,DWI,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,THREE,TIS
001,002,003,021,162,169,BJU,COX,JANUARY,LABEL,METHODS,NON,OBJECTIVE,OBJECTIVES,RESULTS
560,AFTER,BETWEEN,CONCLUSION,FOLEY,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS
169,CISPLATIN,COPYRIGHT,ERK,FK228,HENCE,INC,NOX
BCG,DIAGNOSIS,PCR,THESE
POTENTIAL,TRANSIENT,TRPV2
007,021,042,088,160,238,258,527,673,734,842,882,907,AMONG,ASIRS,CATALAN,CATALONIA,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPAIN,TARRAGONA,THESE
152,185,429,581,885,945,946,CIS,COX,HRS,LATINOS
001,183,215,BAX,BCL,COMPARING,FERULIC,SOD,T24
169,981,BACKGROUND,COPYRIGHT,END,INCREASING,LABEL,METHODS,RESULTS,SOCIETY,STAGE,TIS,USING,WOMEN
124,160,383,449,506,AFFAIRS,CONCLUSION,FURTHER,JANUARY,LABEL,MEDICAL,METHODS,MPM,OBJECTIVE,PURPOSE,RESULTS
483,CSM,LABEL,LND,LNS,LYMPH,METHODS,OBJECTIVE,PRIOR,PURPOSE,RADICAL,RESULTS
169,291,649,AUC,BLADDER,BTF,CHINA,CHONGQING,CONCLUSION,COPYRIGHT,INC,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,ROC,SOCIETY,STATA,SUMMARY,TECHNOLOGY,VIP,WAN
169,AFTER,BASEL,COPYRIGHT,EXTRA
169,BASEL,COPYRIGHT,ENGLISH,EXPERIENCE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
135,169,333,408,702,BASEL,CONCLUSION,COPYRIGHT,GLEASON,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PCA,PSA,PSM,RESULTS,USING
100,158,356,BACKGROUND,BASED,CONCLUSION,CPG,EARLY,FIRST,LABEL,METHODS,RESULTS,ROC,SIMILARLY,URINE
157,176,177,550,99M,CIM,CONCLUSION,LABEL,LNCAP,METHODS,MIP,PC3,RESULTS,SPECT,THESE,TIM,UNLABELLED
CTV,D90,ESPECIALLY,IMAGE,THERE
143,DU145,FOLLOWING,MICRORN,MMP,THESE
001,BCA,CROSS,EFFECTIVE,MAS,NMR,NOTICEABLY,PC1,PCA,PLS
BACKGROUND,EXPRESSION,GROUP,HISTORX,LABEL,METHODS,RADIATION,RESULTS,THERAPY,TREATMENT,TURBT
221,400,ADVERSE,BACKGROUND,BASED,GRADE,HDR,LABEL,LOCAL,METHODS,RESULTS,THEIR
105,113,119,150,177,335,408,452,483,485,487,513,583,677,681,CTV,D90,ESTRO,GEC,GROUP,MANCHESTER,WORKING
169,174,251,300,308,594,945,CHRONIC,COPYRIGHT,DMA,INC,MMA,TNF,URINARY
169,COPYRIGHT,DUE,EDUCATION,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIAN,PUBLISHED,PURPOSE,RECEIVING,RESULTS,UROLOGICAL,USING
160,169,174,ASIC1,BLADDER,COPYRIGHT,CXCL9,EDUCATION,INC,INCREASED,LABEL,MATERIALS,METHODS,NGF,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TRP,TRPA1,TRPM2,TRPV1,TRPV2,TRPV4,ULCERATIVE,UPK3A,UROLOGICAL
169,CIS,COPYRIGHT,GRAFT,GROSS,INC,LABEL,METHODS,METICULOUS,OBJECTIVE,OBJECTIVES,RADICAL,RESULTS
AAP,COV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,V70
100,145,162,205,BACKGROUND,COLPOSCOPY,LABEL,LUV,MARCH,METHODS,RESULTS,THREE
643,656,683,819,AMERICA,BLADDER,CAUCASIAN,LABEL,METHODS,NORTH,OBJECTIVE,PURPOSE,RESULTS,SCHOLAR,STUDIES,SUMMARY,THERE
001,954,ADR,BCL,BIU87,RESISTANCE,THESE
35S,ACUTE,BPH,EPIDIDYMO,STI,UTI
APOPTOSIS,BACKGROUND,BCL,LABEL,METHODS,RESULTS,THEREFORE,THESE,WHILE
001,100,410,ACCORDING,BACKGROUND,COMBINING,ELISA,EXPRESSION,LABEL,METHODS,PCR,POSITIVITY,RESULTS,SCATTER
BISULFITE,CIGARETTE,CSE,H19,PCR,PRSS8,RUNX3,TRANSIENT
BACKGROUND,CIN,EMT,FINALLY,HPV,INK4A,LABEL,MATERIALS,METHODS,RAS,RESULTS,SORAFENIB,THERE,THESE
CHINESE,FURTHER,GFP,ISO,RT112,SP1,UMUC3
945,946,AKT,BCS,GSK,PCR,RAB,RAB25,SNAIL,T24
169,924,ALONG,BACKGROUND,COPYRIGHT,INCOMPLETE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RESULTS,TREATMENT
001,009,012,026,055,169,210,243,284,361,491,ACCORDING,COPYRIGHT,TMA
101,120,169,3N0M0,AMONG,COPYRIGHT,COX,CSS,LABEL,LTD,LVI,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS
34A,MTT,PCR,T24,THESE
169,399,626,634,BACKGROUND,BASED,COPYRIGHT,COX,EASTERN,GROUP,INDIVIDUAL,LABEL,METHODS,RESULTS,SOCIETY,VARIABLES
169,364,BACKGROUND,COPYRIGHT,FLEISCHER,LABEL,METHODS,PFS,RESULTS,SOCIETY
BACKGROUND,EXPRESSION,FURTHER,LABEL,MICRORNAS,PRINCIPAL,RESULTS,THEIR,USING
120,250,CELLS,ECM,ILK,INTESTINE,J82,PHASE,PROTEIN,REVERSE,SIS,SMALL,SUBMUCOSA
BAX,BID,EGR,JNK,JUN,NAC,ROS,T24,TAKEN
043,102,DIVERSITY,PANEL
140,146,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SSN
909,COX,EXPRESSION,HOWEVER,MMP,UUT,UUTUC
160,ADM,HOWEVER,T24,THESE,UNDER
GREEN,GTP,THERE
169,BLADDER,COPYRIGHT,HTRA1
135,177,BLOOD,FORESTS,FOURIER,LDA,OBVIOUSLY,PARTICULAR,RFS,UBC,USING
143,145,183,20A,BASED,MICRORNAS,SEVERAL
169,233,BACKGROUND,BCG,CONTEXT,COPYRIGHT,DESPITE,LABEL,MEDLINE,METHODS,NIMBC,NMIBC,OBJECTIVE,PUBLISHED,RESULTS,SEVEN,SYNTHESIS
169,249,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,PROGNOSTIC,RESULTS,UROLOGICAL
275,527,CONCLUSION,LABEL,LRC,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
65308,AGE,BACKGROUND,CANCERS,COX,END,HRS,LABEL,LIFESTYLE,MEN,METHODS,RESULTS,VITAL
169,176,180,200,270,COPYRIGHT,LTD,USING
151,169,211,406,564,976,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,NOTABLY,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TEN,THESE,UROLOGICAL,VARIANT
001,149,163,169,312,476,753,COPYRIGHT,EDUCATION,HGPIN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROSTATIC,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,TEN,UNIVARIATE,UROLOGICAL
169,183,260,ABRAXIS,BACKGROUND,BIOSCIENCE,CELGENE,COPYRIGHT,EVALUATION,FUNDING,LABEL,LTD,METHODS,NAB,OCT,PRS,RESULTS,SOLID,TAXANES,THESE,TREATMENT
100,169,260,800,CONCLUSION,COPYRIGHT,INC,ITT,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
FUNCTIONAL,HENCE,HOWEVER,MODULAR,THESE
956,ATP,BACKGROUND,COX,EXPERIMENT,FINALLY,HOWEVER,INHIBITION,LABEL,MDR,METHODS,MITOMYCIN,MMC,MTT,RESULTS,SUBSTRATE,THREE,TRANSPORT
011,021,054,057,107,199,200,205,362,372,408,748,869,898,900,ARG194TRP,ARG280HIS,ARG399GLN,ASIAN,BACKGROUND,CHINA,CIS,CONCLUSION,INDIA,JAPAN,LABEL,ORS,PRINCIPAL,RESULTS,THERE,XRCC1
946,AKT,EMT,EPITHELIAL,FINALLY,ILK,MMP,RNASE,SNAIL,T24,TWIST
225,BACKGROUND,CONCLUSION,EFFECTS,LABEL,MANAGEMENT,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SUBJECTIVE
154,160,270,517,816,CAUCASIAN,ERG,GLEASON,SEVENTY,SPANISH,THREE

169,297,BNI,COPYRIGHT,COX,HARRELL,INC,LABEL,METHODS,NMIBC,OBJECTIVE,PURPOSE,RCS,RESULTS
945,BCL,BP1,RT4,SOUTHEAST,T24
177,AFTER,AIM,BACKGROUND,COMPLETING,LABEL,METHODS,OBJECTIVE,RESULTS,SINCE,THERE,THEREFORE
EGF,PANCREATIC,R18,RT4,SIMILAR,USING,V19
945,954,955,AE1,BRUNN,CD138,CEA,CK5,CK6,CK7,CK8,CYSTOSCOPY,EMA,EXPRESSION,KIT,LCC,MUCIN,NSE,OTHER,PCR,SIG,TUR,VARIOUS
169,946,AKT,AZD4547,BECAUSE,DOVITINIB,EMT,FGF,FGFR1,FGFR2,FGFR3,FGFR4,FGFRS,FIBROBLAST,INC,KI23057,NOTCH,RAS,TACC1,TACC3,TGF,WHOLE,WILEY,WNT
002,027,FURTHER,HOWEVER,SATB1,SPECIAL,T24
CONCLUSION,HPS,KTP,LABEL,MATERIALS,METHODS,OBJECTIVE,RECURRENCE,RESULTS,TUR,TURBT
000,100,116,142,181,AMONG,ARSENIC,BACKGROUND,CESSATION,COOKING,INORGANIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROXARSONE
BACKGROUND,C1QTNF6,CHROMOSOME,FINALLY,HEPG2,HOWEVER,LABEL,LINE1,METHODS,PCR,PGR,PTGS2,RESULTS,RT4,SOCS3,STR,T24,THEREFORE,UNUSUAL
138,186,ALCOHOL,EXPLOSIVES,MEDICAL,ORS,SIX,TOBACCO
300,500,CIS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,ORS,RESULTS,THERE
215,INTRA,LAPAROTOMY
001,006,140,169,177,207,214,482,APC,BACKGROUND,BASEL,BCD,CONCLUSION,COPYRIGHT,LABEL,METHODS,RESULTS
102,169,CHROMATIN,COPYRIGHT,EXPRESSION,FREQUENTLY,FURTHER,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RIP,SUZ12
00001,211,216,BACKGROUND,CONCLUSION,LABEL,LRC,MATERIALS,METHODS,OBJECTIVE,ORC,PURPOSE,RADICAL,RESULTS,THERE
DESPITE,IGF1R,NOTABLY,UROTHELIAL,VEGFR,WHILE
169,637,AMONG,BRICKER,COLOPLAST,COPYRIGHT,INC,MAY,SENSURA,WILEY
169,277,ARRAY,AUC,COPYRIGHT,CURRENT,LNA,UCC
169,ACUTE,BACKGROUND,CONCLUSION,COPYRIGHT,GRADE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,ORS,PURPOSE,RESULTS,THESE,VARIATION
169,AUS,CONCLUSION,COPYRIGHT,HOLMIUM,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,USING,YAG
177,2ND,340,375,3RD,FIRST,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,RESULTS
CONCLUSION,DESPITE,LABEL,MATERIALS,METHODS,RESULTS,UNLABELLED
108,168,174,AFTER,BPH,CD3,CD8,FIRST,IIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PIN,PSA,RESULTS,SERENOA,SPECIMENS
BLADDER,FIFTY,MSP,TWIST
000,7TH,BACKGROUND,CONCLUSION,FOLEY,HEMOSTASIS,HOWEVER,LABEL,METHODS,OBJECTIVE,RADICAL
107,117,121,247,312,CONCLUSION,EARLY,IIA,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,RAJAVITHI,RESULTS,THESE
100,108,150,169,350,400,750,ASPIRIN,NSAID,SKH,UVB
160,342,740,HODGKIN,HUNGARIAN,INCIDENCE,NON,SEMMELWEIS,SIR,THESE,UNIVERSITY
293,945,947,CD4,CD8,DC2,HISTONE,HOWEVER,IDO,III,MBT,OSU
EXPRESSION,HPV,ISH,THEREFORE,THESE
946,947,CONSISTENT,DESPITE,THESE,TRIAL
160,176,180,215,945,946,CTV,D90
074,169,935,BLADDER,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UPPER,UROLOGICAL
BLADDER,GOVERNMENT,PUBLISHED,THERE,USA,UTI
ASSESSMENT,BACKGROUND,FURTHER,HEART,LABEL,MATERIALS,METHODS,RESULTS,SEP,URBAN,VARIATION
MRI
172,563,BACKGROUND,HRS,LABEL,METHODS,RESULTS,SIR,SMOKING,THESE,VAT
160,430,CXCR7,ERK,FURTHER,HOWEVER,MICRORNAS,MMP,THESE
CHANGES,EPIGENETIC,J82,RT4,T24,THERE,UMUC3,WESTERN
169,BCL,KEAP1,NADPH,PGAM5,ROS,THESE,TRX
001,067,169,257,364,BACKGROUND,BCC,COPYRIGHT,COX,CSS,END,LABEL,METHODS,NCC,PARTIAL,RCC,RESULTS,SOCIETY,USING
956,ADJUSTMENT,AFTER,PRIOR,SMOKING,TUNISIA
100,169,543,ADVERSE,BACKGROUND,CONCLUSION,COPYRIGHT,III,INC,INDIVIDUAL,LABEL,METHODS,RESULTS,THERE
BACKGROUND,HMW,LABEL,METHODS,MMP,RESULTS,THERE
427,BCG,HSP,HSP27,OGX
002,169,533,COPYRIGHT,DISEASE,EDUCATION,INC,LABEL,MATERIALS,METHODS,MYC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TREATMENT,UROLOGICAL,WESTERN,WST
169,3MM,628,CDR,COPYRIGHT,IBA,INC,MATRIXX,MEDICAL,MUS,PTV,PUBLISHED,V20,VDR
001,169,ADT,BACKGROUND,COPYRIGHT,INDEX,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PCA,PHOENIX,PRIMARY,PSA,PUBLISHED,RESULTS,SALVAGE,SECONDARY,SETTING,SIXTY,UROLOGY,WHOLE
014,125,150,160,169,916,AUR,CONCLUSION,COPYRIGHT,DELTA,EXPERIENCE,GRADE,GROUP,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SCORE,SOCIETY,SYMPTOM,THERAPY,URINARY
000
169,AUTHORS,CAESAREAN,COLLEGE,JOURNAL,PHYSICIANS,ROYAL
112,BLADDER,CRL,CULLINS,KNOCKDOWN,NMIBC,REGULATOR
177,282,COX,EXCLUSION,LABEL,LNS,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
137,EFFECTIVE,EIGHT,LABEL,METHODS,OBJECTIVE,PCN,PURPOSE,RENAL,RESULTS,THEREFORE
BACKGROUND,CRC,ENGLISH,LABEL,MEDLINE,METHODS,MVR,RESULTS,RETRIEVED,SURGERY,WHERE
096,169,233,COPYRIGHT,CYSTECTOMY,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THERE,THOSE,UROLOGICAL
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,RESULTS,THERE,THEREFORE
169,946,CK7,COPYRIGHT,GATA3,INC,TUBULAR
100,160,169,503,AGE,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CPE,DVH,INC,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,THERE
169,805,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,EORTC,HPF,INC,LABEL,MEDICAL,METHODS,NMIBC,RESULTS,SIMILARLY,TOKYO,TREATMENT
169,AEU,BLADDER,CANCERLIT,CAUCASIANS,COPYRIGHT,INDEX,LABEL,LITERATURE,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCIENCE,WESTERN
LARGE,THERE,THEREFORE,TUMORAL
001,016,115,272,281,446,743,BACKGROUND,COX,DIAGNOSTIC,HOWEVER,LABEL,METHODS,RESULTS
MMC,TWEEN
184,727,ADDITIONAL,AMERICA,HOWEVER,NORTH,OVERALL,SOUTH
170,ACTIVATING,FGFR3,R3MAB,THEREFORE
945,946,DIFFERENCE,IIB,NMR,NOE,RGD,SATURATION,WHILE
114,760,BACKGROUND,BCG,BETWEEN,CONCLUSION,FORTY,LABEL,MEIER,METHODS,METICULOUS,NMIBC,PRIMARY,RESULTS,TIS
AUSTRALIAN,HOWEVER,MEN
BCL
100,954,AREAS,CONCLUSION,DIAGNOSTIC,INTER,JANUARY,KEY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
100,343,BACKGROUND,CONCLUSION,DSS,LABEL,MEMBRANOUS,METHODS,PFS,PODXL,RESULTS
256,530,866,AFTER,BACKGROUND,CONCLUSION,HODGKIN,INSURANCE,LABEL,METHODS,RESULTS,SIR
176,177,ACCORDING,CBCTS,CMD,CTS,CTV,D99,FORTY,ROT_C
018,028,AMONG,DOSIMETRIC,ECLIPSE,INTENSITY,MUS,OAR,OPTIMIZED,PLANS,PTV,SEVEN,TPS
D30,D50,D99,DOSIMETRY,KUTCHER,LYMAN,PTV,TCP,THEREFORE,V17GY,V35GY
00001,001,004,009,BACKGROUND,LABEL,LASER,LIBRARY,MEDLINE,METHODS,NMIBC,RESULTS,SCIENCE,TNM,TURBT,WEB,WMD
169,235,AVO,BEZ,COPYRIGHT,GFP,INHIBITION,IRELAND,LABEL,LC3,LTD,MATERIALS,METHODS,NTUB1,NVP,OBJECTIVE,PURPOSE,RESULTS,WESTERN
BACKGROUND,LABEL,METHODS,RESULTS,THREE
EXOME,FGFR3,UBC,UROTHELIAL
022,060,067,069,145,209,227,570,763,794,795,852,857,869,918,921,926,957,961,998,ALA,ALA222VAL,HENCE,MTHFR,OVERALL,VAL
686,750,956,DBP,SEVERAL,SPAIN,THM,TOTAL
169,177,233,662,AFTER,AVERAGE,BETWEEN,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,UROLOGICAL
169,BACKGROUND,BCA,BILATERAL,CONTEXT,COPYRIGHT,LABEL,LNS,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SELECTIVE,SYNTHESIS,UROLOGY
215,AFTER,AIM,COMPARISON,CONCLUSION,LABEL,LITHUANIA,MATERIALS,METHODS,NMIBC,OBJECTIVE,RESULTS,TAA,TUR,VILNIUS
007,BACKGROUND,BMP,BMP10,CONCLUSION,EXPRESSION,HOWEVER,LABEL,MATERIALS,METHODS,PCR,RESULTS,T24
BAK,BAX,BLADDER,BRAZILIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PRIMA,RESULTS,RT4,T24
169,AEU,COPYRIGHT,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SYNTHESIS,VALIDATION
169,946,COPYRIGHT,GONORRHEA,LTD,NEISSERIA,PUBLISHED,TGF,TH1,TH2,THEREFORE,VITAMIN
197,AES,AFRICAN,AMS,AREAS,ASIAN,BACKGROUND,CAUCASIAN,COVERED,FURTHER,JAPAN,KRP,LABEL,METHODS,OAB,ONO,OPINION
954,AMONG,BETWEEN,EUA,FEDERATION,FINAL,GYNECOLOGY,ITEMS,LABEL,METHODS,OBJECTIVE,OBSTETRICS,RESULTS,SUBSEQUENT
006,069,072,114,153,160,244,302,328,449,489,656,836,899,BLADDER,HOWEVER,JANUARY,MARCH,SIX,SMD
024,234,366,BCR,CML,CRC,HOWEVER,MUTATIONS,THESE
169,COPYRIGHT,LTD,NLS
100,174,ACUTE,AFTER,CYBERKNIFE,DVH,GRADE,IIB,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PTV,PURPOSE,RESULTS,THERE
EMT,THEREFORE
169,AFTER,BACKGROUND,COPYRIGHT,DESPITE,INC,LABEL,METHODS,OTHER,PANCREATIC,RENAL,RESULTS,THERE,WILEY
192,931,ARG194TRP,ARG280HIS,ARG399GLN,ASIAN,CHINA,CIS,JANUARY,KNOWLEDGE,ORS,XRCC1
100,178,200,CISPLATIN,GEMOX,GFR,THESE
100,176,180,270,D90,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,TREATMENT,UNIFORM
BLADDER,FIRST,FRE,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE,THESE
BIOLOGICAL,CARLO,EUD,FTP,HOWEVER,IFD,INCREASED,INVERSE,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RBE,RESULTS,STP,TCP
006,008,010,012,BACKGROUND,BCG,CIGARETTE,CONCLUSION,COX,LABEL,MEIER,METHODS,NMIBC,PT1,RESULTS,THESE,UNIVARIATE
112,BACKGROUND,BCG,BLADDER,LABEL,METHODS,NMIBC,PROGNOSTIC,RESULTS,UNIVARIATE
AFTER,AMONG,BACKGROUND,FEW,FLUID,LABEL,METHODS,ORS,RESULTS,THESE,TOTAL,UDP,UGT,WHETHER
113,BACKGROUND,LABEL,METHODS,RADAR,RESULTS,SIMILAR,THERE
001,111,169,203,APOA1,APOA2,APOC2,APOC3,AUC,AUTHORS,BIOLOGICAL,COPYRIGHT,LABEL,PUBLISHED,SEVERAL,SIX,TIM,UNASSIGNED,UNLABELLED,USING,WESTERN
100,116,169,177,1FMOL,956,ACH,CCH,COPYRIGHT,ERK,HDSMC,LTD,PCR,QNB,SAMPLES,WHILE
BCG,FGFR3,FURTHER,GIVEN,INCREASING,LAMC2,NMIBC,RASSF1A,RUNX3,SFRP1,TIMP3,URINARY,VALIDATED,WESTERN
004,013,014,024,169,1ST,420,993,ASIAN,BACKGROUND,BIOMEDICAL,CAUCASIAN,CHINESE,COPYRIGHT,CROWN,FORTY,FURTHER,HOWEVER,LABEL,METHODS,PUBLISHED,RESULTS,SCIENCE,SEPTEMBER,STATA,WEB
169,BCA,C18,COPYRIGHT,DOX,GEM,HOWEVER,MMC,OWING,WGA
169,COPYRIGHT,INC
006,037,060,169,212,915,AMONG,COPYRIGHT,COX,HOWEVER,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,MULTIFOCAL,OBJECTIVE,OCTOBER,RESULTS,UNIVARIATE,UUT
165,169,946,947,BIU,COPYRIGHT,HUC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRESENILIN,PSS,RESULTS,SW780,T24,UCB,WESTERN
169,233,945,BCG,COPYRIGHT,CURRENT,HOWEVER,IFN,INC,LABEL,METHODS,NETWORK,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS,THERE
186,ACCORDING,APRIL,BACKGROUND,CAUCASIANS,JANUARY,LABEL,METHODS,RESULTS
169,AFTER,ANTIGEN,BLOOD,CHANGES,ELISPOT,FIFTY,MUC20,REGULATORY,TAA,TREGS
139,146,152,162,166,960,COLLEGE,III,MEDICAL,OMC,OSAKA,THREE
956,981,COMPLEXES,DMF,N3O,ROS
129,174,945,AKT,CHROMOSOME,FOLLOWING,INGENUITY,IPA,LABEL,MATERIALS,METHODS,MYC,OBJECTIVE,PATHWAY,RESULTS,THEIR,WEBGESTALT
142,169,AKT,COPYRIGHT,COX,EXPRESSION,INC,LOW,MOLECULAR,NMIBC,RFS,VARIOUS
132,169,COPYRIGHT,INC,INTENSITY,KNOWLEDGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,708,745,COPYRIGHT,INC,PLANS,PTV,PUBLISHED,TEN,THERE,V20,V40,V65
ADR,APOPTOSIS,BCL,BIU87,CAT,MTT,RESISTANCE,ROS,SOD
001,ALTERATION,MMP,SERUM
105,168,173,177,192,1ST,251,ALT,ANOVA,AST,BACKGROUND,DEPARTMENT,JANUARY,LABEL,LFT,LSD,MANIPAL,MATERIALS,METHODS,NEPAL,POKHARA,RESULTS,THERE
001,002,GENOTYPES,GLU298ASP,THERE,TURKISH
000,003,018,052,221,231,255,285,498,562,759,787,843,996,AFTER,CONCLUSION,DFS,DSS,EGGER,HRS,LABEL,METHODS,NEWCASTLE,OBJECTIVE,RESULTS,SCALE
100,ATATURK,BACKGROUND,BETWEEN,CONCLUSION,III,LABEL,MARCH,MEDICAL,METHODS,RESULTS,SIX,TCC,UPPER,UROLOGY,WHILE
ABC,BETWEEN,CISPLATIN,CONCLUSION,EASTERN,GRADE,GROUP,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,PS0,PS1,RESULTS,THERE
946,954,ELISA,FIREFLY,RENILLA,UTR
000,082,098,100,101,102,104,169,236,310,356,782,867,870,880,885,926,969,980,983,BACKGROUND,COPYRIGHT,COX,INCIDENCES,INSURANCE,JANUARY,LABEL,LTD,METHODS,NEITHER,RESULTS,TAIWANESE,THERE,WHETHER
PEDIATRIC
101,169,COPYRIGHT,INC,MET,MICRORNAS,T24,UTR
001,004,123,169,174,ADM,AFTER,BIU,BLADDER,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RHODAMINE,TRANSWELL,UROLOGICAL,WESTERN
CELSIUS,PULMONARY
169,AEU,BACKGROUND,BLADDER,CONTEXT,COPYRIGHT,INDEX,INFECTIOUS,LABEL,MEDLINE,METHODS,PUBLISHED,RADIATION,RESULTS,SCIENCE,SMOKERS,SMOKING,SYNTHESIS,TOBACCO
001,BLADDER,OVERALL,TUR
BCG,HISTOLOGY
COPYRIGHT,MILAN,PROUS,SCIENCE,UROLOGY
118,160,CONCURRENT,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS
ZOLEDRONIC
BLADDER,DESPITE,HOWEVER,SPAIN,WHILE
001,169,BASED,BASEL,CONCLUSION,DIAGNOSIS,GROSS,LABEL,METASTASES,METHODS,OBJECTIVE,PEARSON,RESULTS,THERE,VISIBLE
7TH,8TH,ACCORDING,ADDITIONAL,CENTRAL,CONCLUSION,CONTROLLED,FURTHER,LABEL,MEDLINE,METHODS,OBJECTIVE,PCI,PREVIOUSLY,PURPOSE,RESULTS,SCC,SMALL
BUC,CONCLUSION,HOWEVER,IHC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFQ,RTPCR,TNM
283
BCL,PCR
ACTIVATION,ELISA,ERK,JNK,JUN,LPS,MAP,NH2,PCR,STAT3,T24,WESTERN
001,005,006,008,009,022,038,946,ACTIVATION,UCB
169,BACKGROUND,CONCLUSION,COPYRIGHT,ELECTRONIC,EUROPEANS,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SIXTEEN,THEREFORE
169,AEU,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,FOLLOWING,ISC,LABEL,METHODS,OBJECTIVE,PUBLISHED,SUMMARY,TUMOURS,UNASSIGNED
001,169,ALTERED,BACKGROUND,COPYRIGHT,CULLIN1,INC,LABEL,METHODS,NMIBC,OBJECTIVE,RESULTS,WILEY
1960S,BLADDER,CONCLUSION,HOWEVER,LABEL,LITERATURE,METHODS,OBJECTIVE,OBJECTIVES,PHYSICIANS,PRESENTING,PSYCHINFO,RESULTS,SCI,SCREENING,SEVERAL
FDG,HOWEVER,PET
169,AFTER,APMIS,HPV,HPV16,HPV52,INK4A,ISH,LTD,PUBLISHED,WILEY
004,015,177,201,336,501,702,922,BASED,CONCLUSION,LABEL,METHODS,NLR,OBJECTIVE,RESULTS,THERE
160,BETWEEN,LABEL,MAY,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
100,954,99M,AIM,LABEL,MDP,METHODS,MRI,OBJECTIVE,PET,RESULTS,SPECT
169,215,COPYRIGHT,CRT,CTV,ESTRO,GEC,INC,LABEL,MAI,METHODS,OBJECTIVE,RESULTS,UNIVERSITY
169,288,403,COPYRIGHT,IRELAND,JUMONJI,LTD,PCR
169,255,AEU,COMPARISON,COPYRIGHT,DESPITE,ICS,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,STUDENT,THERE,USG,WHITNEY
001,003,004,006,029,040,050,052,133,169,343,372,390,482,627,634,653,696,761,804,831,898,924,937,991,BACKGROUND,CIS,COPYRIGHT,HAL,HOWEVER,ITT,LABEL,LAIRD,METHODS,NMIBC,OBJECTIVE,OUTCOME,PUBLISHED,RECURRENCE,RESULTS,RRS,SETTING,STUDIES,THERE,UROLOGY
120,169,177,1SD,2CM,363,BACKGROUND,COPYRIGHT,CTV,D90,DVH,HDR,IRELAND,LABEL,LTD,METHODS,OAR,OBJECTIVE,PURPOSE,RESULTS,USING,VARIATIONS
169,946,COPYRIGHT,DIAMOND,EDX,FOURIER,ION,MALDI,METAL,PHASE,RESULTS,SEM,TOF
100,AMONGST,FEW,FIFTEEN,GATA3,HOPKINS,OVERALL,PATHOLOGY

100,169,215,233,COPYRIGHT,CYSTOSCOPY,EDUCATION,GROUP,HOWEVER,INC,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIOR,PUBLISHED,PURPOSE,RESULTS,SOUTHWEST,TIS,UROLOGICAL
CK7,MUC,P504S,PAX,SIMILAR,THESE
120,132,169,AUS,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,ONB,PRE,PRIOR,RESULTS,SUI,TCC,THERE,VARIABLES,WILEY
00001,155,169,BACKGROUND,BASEL,BETWEEN,CONCLUSION,COPYRIGHT,LABEL,LRC,METHODS,ORC,RESULTS
114,160,271,366,DEPENDING,NORWEGIAN,SIR,USING
BACKGROUND,HAITIAN,LABEL,METHODS,THROUGH
001,002,010,016,030,169,APMIS,BLACKWELL,HOWEVER,LTD,NOTCH,OCT,PUBLISHED,PUBLISHING,THERE
169,DISORDERS,HOWEVER,THEREFORE,UROLOGICAL
72H,AKT,CASPASE,CCK,MVS,SEVERAL,T24,THESE,TUNEL,WESTERN,WHARTON
001,164,CCND1,ERBB2,MIP,MULTIPLEX,THESE
AMONG,BLADDER,FDG,MAY,OCTOBER,PET
100,177,BCI,BNC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RRP,STUDENT,T2A,T2C
956,ERK,HOWEVER,HUC,JNK,NAASO,ROS,TAKEN
642,ALTERED,BACKGROUND,ELISA,HAI,LABEL,METHODS,MIDKINE,PROTEOMIC,RESULTS
113,123,132,160,177,191,193,203,222,242,245,363,516,610,827,BLADDER,COX,DISTANT,HVH,LABEL,LOCAL,LVH,METHODS,OBJECTIVE,RESULTS,THESE,TNM
308,802,BACKGROUND,LABEL,MALIGNANT,MARCH,METHODS,MUO,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE
500,550,744,AFTER,CHRONIC,CONCLUSION,EGE,EIGHT,ICD,LABEL,METHODS,OBJECTIVE,PERIPHERAL,RESULTS,SEVEN,SEVENTEEN,THREE
AFTER,EARLY,LABEL,METHODS,OBJECTIVE,RESULTS
CONCLUSION,LABEL,METHODS,OBJECTIVE,PLAIN,RESULTS,SPANISH,WORLDWIDE
132,169,500,961,ADC,CONCLUSION,COPYRIGHT,DIFFUSION,INC,LABEL,LIS,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,TESLA,WILEY
BACKGROUND,CONCLUSION,HOWEVER,LABEL,LND,LYMPH,METHODS,RESULTS
160,169,BKV,COPYRIGHT,INC,PCR,VP1,WILEY
945,946,AKT,EARLY,GPR30,HOWEVER,PHTPP,RESULTS,TARGETING,THESE
120,169,COPYRIGHT,GEM,HOWEVER,HSA,HUC,WGA,XTT
048,132,195,BACKGROUND,BETWEEN,COX,ENDPOINTS,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,PRIOR,RESULTS,UCB
581,921,BACKGROUND,III,LABEL,MATERIALS,METHODS,PRO,RESULTS,SEVERAL,THOSE,TREEAGE
BLADDER,DESPITE
IVC,NMIBC,SEVERAL,TUR
BLADDER,GUIDELINES,THESE,UROTHELIAL
169,BASED,COPYRIGHT,HOWEVER,INC,RRP,URINARY
169,295,AMBULATORY,ASSURANCE,COMMITTEE,COPYRIGHT,EDUCATION,FINALLY,HOPES,INC,LABEL,MATERIALS,MEDICAL,METHODS,NAMCS,OBJECTIVE,OFF,PUBLISHED,PURPOSE,QUALITY,RESULTS,SUCCESSFUL,UROLOGICAL,UROLOGY,WHILE
167,169,201,216,241,263,267,527,740,AMONG,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,UROVYSION
169,945,BACKGROUND,COPYRIGHT,ESC,IPSCS,KRUPPEL,LABEL,METHODS,MYC,OBJECTIVE,OUTCOME,POU,PRIMARY,PRO,PUBLISHED,RESULTS,SETTING,SIMILARLY,SRY,SUCCESSFUL,THESE,UROLOGY
001,006,169,945,BBN,COPYRIGHT,CRP,HOWEVER,HSD,ICR,MELOXICAM,MTT,NSAID,RENAL,SAS,T24,THESE,TNF
169,233,BACKGROUND,BCG,BLADDER,CONTEXT,COPYRIGHT,EAU,GROUP,GUIDELINES,LABEL,MEDICAL,MEDLINE,METASTATIC,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SUBJECT,SYNTHESIS,UROLOGY
160,169,177,APPLICATOR,COPYRIGHT,CTV,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,V75
160,169,CENTRAL,COLLEGE,CONCLUSION,CONTROLLED,COPYRIGHT,ENROLMENT,III,LABEL,LTD,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,REGRESSION,RESULTS,ROYAL,SEPTEMBER,SRE
025,049,169,ADVERSE,AMONG,COPYRIGHT,EVALUATION,GROUP,INC,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,V40
ATP,CPS,CRT,DAMPS,FEW,GOLGI,HSP70,HSP90,ICD
ADJUSTMENT,CML,DETERMINE,LABEL,METHODS,OBJECTIVE,PROTECTIVE,REMAINING,RESULTS,RRS,ZEALAND
101,18F,90Y,BECAUSE,FDG,MAY,MBQ,MRI,PET,TREATMENT
INCIDENTAL
KDM5B,T24,TAKEN
010,016,043,102,123,7TH,FINALLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,T4BN0M0,THERE
BLADDER,BOWEL,DAVINCI,HISTORICAL,ILEAL
169,COPYRIGHT,INC,MEDICAL,MPD,PBS,PEARSON,PUBLISHED,STUDIES
002,C677T,CIS,EUROPEANS,MTHFR,ORS,RESULTS
945,HENCE,NAP,ROS
233,AFB,AFTER,BCG,OWING,PCR
169,COLLEGE,CONCLUSION,COPYRIGHT,CUMULATIVE,HODGKIN,INDEX,JANUARY,LABEL,LITERATURE,MAY,MEDLINE,MEN,METHODS,NURSING,OBJECTIVE,POPULATION,RESULTS,SCIENCE,SIR,SIX,SSC,THERE,WEB
143,169,317,566,945,CONCLUSION,DISCOVERY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
DUE,SMALL
BURKITT,HODGKIN,IMAGING
100,434,AIM,AUC,BACKGROUND,BIOMARKERS,CALBIOTECH,ELISA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROC,SIMILARLY,TOBACCO,USA
ANNEXIN,APOPTOSIS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,P21,P53,RESULTS,T24,WESTERN
FURTHER,MRI,PET
169,253,967,COMPARISON,COPYRIGHT,COX,INC,MEIER,PEARSON,THESE,TIDCS

001,174,ANGIOTECH,ETHICON,FORCE,INC,LABEL,METHODS,OBJECTIVE,QUILL,RESULTS,SOMERVILLE,TLH,VANCOUVER
000,100,169,790,AUSTRALIA,AUSTRALIAN,AUTHORS,BJU,CIS,INSTITUTE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,RESULTS,THERE,WELFARE
945,AE1,BECAUSE,CD5,CEA,CK7,CK8,EMA,MRI
PRESENTING,TUR
III,LARGE,LCNEC
169,216,BACKGROUND,BETWEEN,COPYRIGHT,COX,CSM,CTX,EVERY,EXPRESSION,JANUARY,LABEL,LNI,LVI,METHODS,MKI67,MOLECULAR,OBJECTIVE,OUTCOME,PATHOLOGIC,PUBLISHED,RESULTS,SETTING,THERE,UCB,UROLOGY
956,AFTER,AZA,BACKGROUND,BAX,BCL,CDR,LABEL,METHODS,MIGRATION,MMP,PCR,RESULTS,T24,THESE,USING,VEGFR
135,LABEL,METHODS,OBJECTIVE,PCDH8,RESULTS
105,571,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
174,CAUCASIANS,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS
708,BLADDER,CASPASE,FURTHER,LABEL,LUCIFERASE,METHODS,MIR,OBJECTIVE,PURPOSE,RESULTS,T24,UTR
305,AMBIENT,BACKGROUND,CHINA,CONCLUSION,ECOLOGICAL,HRS,KRIGING,LABEL,METHODS,MIR,RESULTS,SIMILAR,SOLAR,UVB
005,BACKGROUND,CONCLUSION,JANUARY,LABEL,MEDLINE,METHODS,RESPECTIVE,RESULTS,WHILE
011,012,015,020,030,032,058,077,177,240,299,300,ASSESSMENT,BAY,BECAUSE,CONCLUSION,FDG,IMAGE,LABEL,MBQ,METHODS,PET,RADAR,RADIATION,RESULTS,UNLABELLED
169,ALTOGETHER,COPYRIGHT,FEDERATION,HENCE,HOWEVER,MCR,PUBLISHED,SOCIETIES,ST6GALNAC,STN
200,945,BACKGROUND,BPH,GIANT,GPH,HOWEVER,LABEL,METHODS,PROSTATIC,TURPS
001,004,006,048,343,BACKGROUND,CHI,CONCLUSION,COX,DSS,LABEL,LOW,MEIER,METHODS,PFS,REDUCED,RESULTS
HOWEVER,PROSTATIC
124,946,CISPLATIN,ELEMENE,SIMILARLY
SEVERAL
169,COPYRIGHT,COQ10,ECTOPIC,INC,RNS,ROS,SXR,TERE1,VITAMIN,WILEY
FINALLY,FINDR,FOURIER,RAMAN,SVM
157,169,584,861,CAUCASIANS,COPYRIGHT,HENCE,OVERALL,T241M,XRCC3
002,005,007,109,112,138,169,217,220,302,415,467,APRIL,BACKGROUND,CCS,CLAVIEN,COPYRIGHT,III,ITALY,LABEL,LTD,MARCH,MATERIALS,METHODS,RESULTS,UNIVARIATE
HOWEVER,RABBITS
215,226,294,946,956,INCREASING,MIRABEGRON,OATP1A2,OATP2B1,PEPT1,THESE,XENOPUS
946,BIP,GLCNAC2,INCREASED,T24,TAKEN,UDP
AFTER,BECAUSE,FGFR2,FGFR3,THROUGH
E14,E15,EMT,HOWEVER,ID1,INHIBITOR,MAMMARY,MYC,TMA
CONCLUSION,DIFFERENT,END,HOWEVER,LABEL,METHODS,OBJECTIVE,PROGRAM,PURPOSE,REGISTRIES,RESULTS
AFTER,CSI,HOWEVER,LABEL,METHODS,MIM,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,THREE,VARIOUS
D10,FOLLOWING,HDR,INVERSE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
7OG,7OM,7OP,CLONOGENIC,DHS,DSS,FURTHER,HTB,ISOMERS,OVERALL,PC3,SILYBIN
CURRENT,ORTHOTOPIC,PBS,THREE,UC1,UC3,ULTRASOUND,VSV,XENOGRAFT
169,916,936,AIF,BAD,COPYRIGHT,INC,RESULTS,ROS,WESTERN,WILEY
169,456,AMONG,COPYRIGHT,SEVERAL,SNP,XRCC1
001,002,003,004,008,009,215,515,892,946,ALTERED,ARSENIC,AS3MT,BACKGROUND,BLADDER,EPICURO,INDIVIDUAL,LABEL,METHODS,MTHFS,OBJECTIVE,PERSONS,RESULTS,SLC19A1,SPANISH,WOMEN
169,BACKGROUND,BRAIN,CNS,COPYRIGHT,LABEL,METHODS,MRI,MRS,NAA,OBJECTIVE,PATHOLOGY,PURPOSE,RESECTION,RESULTS,SOCIETY
169,BCG,CIS,CONCLUSION,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE,UCC,WILEY
169,BJU,EVEROLIMUS,KETTERING,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SIMON,SLOAN,STUDIES,THERE,UNLABELLED
169,BACKGROUND,BKV,CONCLUSION,FURTHER,HOWEVER,LABEL,METHODS,RESULTS,WILEY
108,119,146,177,484,ANOTHER,CONCERNING,CONCLUSION,HOWEVER,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PURPOSE,RADICAL,RESULTS,SEVEN
GEFITINIB
001,009,103,128,160,177,221,280,565,721,BNS,EHS,INDEX,JANUARY,ROBOTIC,RRP,SHORTER
000,002,120,169,233,ANOVA,BLADDER,BLS24,C30,CONNAUGHT,COPYRIGHT,EDUCATION,EORTC,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,QLQ,QUALITY,RESULTS,TREATMENT,UROLOGICAL,WHILE
001,169,COPYRIGHT,EDUCATION,FURTHER,HOWEVER,INC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RETROVIRAL,UROLOGICAL
200,945,946,BED,HDR,HOWEVER,INDICATION,T3A
AIM,BACKGROUND,DIFFERENT,INTRIGUING,LABEL,OBJECTIVE,PROSPECTS
000,0006397,0034621,0034622,115,261,AIM,BACKGROUND,BLADDER,CMC,CYTOSCAPE,LABEL,MATERIALS,METHODS,OBJECTIVE,PPI,PROTEIN,RESULTS
MALIGNANT
169,177,1SD,2CM,945,946,AFTER,COPYRIGHT,CTV,HDR,INDIVIDUAL,IRELAND,LABEL,LTD,METHODS,MRI,OAR,OBJECTIVE,PRIOR,PURPOSE,RESULTS
100,102,169,3MM,CONCERNING,COPYRIGHT,D99,DIL,EXCEPTING,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT,V95
002,018,047,169,AUC,COPYRIGHT,FURTHER,HOWEVER,MARCH,PATHOLOGIC,PFS,PUBLISHED,RADICAL,THERE
135,169,BACKGROUND,CONTEXT,COPYRIGHT,EAU,LABEL,MEDLINE,METHODS,OBJECTIVE,OVERALL,PHYSICIANS,PUBLISHED,REFERENCES,RESULTS,SYNTHESIS,THERE,THESE,TNM,UROLOGY,UTUCS
108,169,CONCLUSION,CONCURRENT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PRIMARY,RESULTS
169,BLADDER,CONSENSUS,COPYRIGHT,INC,NETWORK,NMIBC,NON,UROLOGICAL,UROLOGY
169,COPYRIGHT,INC,NMIBC,TUR
169,COPYRIGHT,INC
169,COPYRIGHT,INC,NMBIC,NMIBC,THESE,TREATMENT,WLC
000,169,ADJUNCTIVE,AMERICANS,BECAUSE,BLADDER,COPYRIGHT,INC
169,COPYRIGHT,INC
169,COPYRIGHT,INC,RADICAL
169,233,COPYRIGHT,INC
169,BCG,COPYRIGHT,HOWEVER,INC
169,COPYRIGHT,INC,THERE
169,COPYRIGHT,INC
169,COPYRIGHT,DISCUSSION,INC
169,COPYRIGHT,INC,URINARY
169,COPYRIGHT,INC,NMIBC,TREATMENT
169,BACKGROUND,COPYRIGHT,CTV,D90,FORTY,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PDR,PURPOSE,RESULTS,THERE
169,COPYRIGHT,INC,MAXIMUM,MCO,MEDICAL,PUBLISHED,RAYSTATION,TREATMENT,V50,V70
001,091,AIM,BACKGROUND,CASES,CONCLUSION,FIFTEEN,GENERAL,LABEL,METHODS,OBJECTIVE,RESULTS,VISIBLE
001,003,004,006,021,023,034,035,295,340,BACKGROUND,HUC,IGFBP,LABEL,METHODS,RESULTS,UCS,UROTHELIAL,USING,WESTERN
001,009,581,604,ABP,AMONG,ANGELES,BACKGROUND,BLADDER,CALIFORNIA,CHINA,CIS,CONCLUSION,DMA,HEMOGLOBIN,LABEL,LOS,METHODS,ORS,OTHER,RED,RESULTS,SIMILARLY,URINE
001,041,087,169,193,210,310,328,342,803,ANOVA,COPYRIGHT,EARLY,EDUCATION,H2O,HOWEVER,INC,JANUARY,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,UROLOGICAL,YOUNGER
100,151,444,HOLMIUM,LABEL,LOCAL,METHODS,NMIBC,OBJECTIVE,PURPOSE,RESULTS,TREATMENT,UNIVERSITY,YAG,YTTRIUM
000,100,169,200,215,680,942,BLADDER,EVALUATING,HOWEVER,PRS,SIX
169,BLADDER,CONVERSELY,CRITICALLY,GSN,TAKEN,THESE
118,121,155,169,271,299,387,391,851,BACKGROUND,CYTOPATHOL,JANUARY,LABEL,METHODS,OVERALL,RESULTS,SOCIETY,THEREFORE
233,BACKGROUND,BCG,FORTY,HOWEVER,LABEL,MATERIALS,METHODS,NMIBC,RESULTS,SOLID,TEN,THERE,UROLOGISTS
117,BACKGROUND,EARLY,ELISA,IAP,LABEL,MATERIALS,METHODS,RESULTS,TCC,URINARY
000,120,CANAL,CD117,DEPARTMENT,EGYPT,HOWEVER,IHC,KIT,PATHOLOGY,SBSCC,SCC,UNIVERSITY,URINARY
169,HOWEVER,PROTEOMICS,VCH,WILEY
005,COX,K9TCC,TAKEN,TCC,USING
169,AE1,AE3,AUTHORS,CK7,LIPOBLAST,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
001,10759,169,803,BACKGROUND,COPYRIGHT,CUMULATIVE,LABEL,MEIER,METHODS,NMIBC,REFERENCE,RESULTS,RGS,SNP,SOCIETY
DIAGNOSIS

031,058,160,169,224,233,BCG,BOARD,CONCLUSION,COPYRIGHT,FCI,INC,LABEL,MATERIALS,MEIER,METHODS,NEITHER,OBJECTIVE,RECURRENCE,RESULTS,RFS
169,BACKGROUND,BLADDER,COPYRIGHT,DUE,GENERAL,LABEL,METAL,METHODS,RESULTS,TPP,TYR,USING
169,333,598,COPYRIGHT,HIERARCHAL,HOWEVER,INC,URACHAL
BECAUSE,CALIF,HOWEVER,INC,INTUITIVE,MINIMALLY,SUNNYVALE,VINCI
015,022,023,032,946,ARF,AUC,EXACT,FISHERS,LABEL,MATERIALS,METHODS,OBJECTIVE,P16,PCR,PURPOSE,RAR,RASSF1A,REGRESSION,RESULTS,ROC,RUNX3,TIMP3
CXCR4,STAT3,STATTIC,T24,TAKEN
169,ADP,BFTC905,COPYRIGHT,GEFITINIB,GPF,IRELAND,LTD,RKO,TAKEN,TREATMENT
169,ASC,BECAUSE,COPYRIGHT,INC,QUINONE,ROS,T24
169,218,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
169,947,ALTERATION,BCA,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
160,169,COPYRIGHT,INC,INITIAL,NMIBC,REASONABLE
169,177,AMONG,EXCLUSION,UNIVARIATE,UROLOGICAL
005,075,169,237,BLADDER,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
DESPITE
BACKGROUND,BLADDER,INC,LABEL,LOW,METHODS,NMIBC,PUBLISHED,RESULTS,TURBT
169,ARM,COMMISSION,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERE,UNITS
169,COPYRIGHT,DPP,EARLY,FDA,GLP,INDIA,LTD,PUBLISHED,THERE,THESE
169,233,ADD,BCG,BJU,CIS,KNOWN,NETWORK,NMIBC,SIMILAR,SUBJECT,TIS,WHILE
APRIL,COX,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SERUM,THESE
001,028,122,BACKGROUND,BBN,BUTYL,COX,HOWEVER,HUR,LABEL,LVD,METHODS,MVD,NUCLEAR,RESULTS,VEGFS
111,BOARD,CONCLUSION,DOSIMETRY,DOTANOC,DOTATOC,LABEL,METHODS,ORGAN,PET,REPORTING,RESULTS,THERE,UNLABELLED
SFT
CONCLUSION,CONSORTIUM,CYSTECTOMY,EARLY,JANUARY,LABEL,LITERATURE,METHODS,OBJECTIVE,RESULTS,ROBOTIC,STUDIES
004,011,AFTER,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THERE,THESE
THEREFORE
146,AKT,BACKGROUND,CONCLUSION,LABEL,LENTIVIRUS,METHODS,RESULTS
233,99M,FDG,MDP,PET
169,APART,CONCLUSION,COPYRIGHT,FORTY,FURTHER,INC,LABEL,METHODS,MMC,NMIBC,OBJECTIVE,RESULTS,SEQUENTIAL,TEN
100,125,150,169,200,COPYRIGHT,D90,GREATER,INC,MEDICAL,PUBLISHED,USING,V20,V50
ADVERSE,C30,CONCLUSION,EORTC,HOWEVER,LABEL,METHODS,OBJECTIVE,PATIENT,PHYSICIANS,QLQ,QOL,RESULTS,THERE
169,215,233,945,COPYRIGHT,EDUCATION,HOWEVER,IFN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SCH,SECONDARY,URGENCY,UROLOGICAL
169,290,COPYRIGHT,COVARIATES,COX,CSS,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RFS,RNU
169,385,719,AMONG,CIGARETTE,COPYRIGHT,HOWEVER,HRS,INC,LABEL,LIFESTYLE,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMOKING,STATE,VITAL,WASHINGTON
CYSTOSCOPY
BACKGROUND,CASES,CURRENTLY,LABEL,METHODS,PRIMARY,SUS,THEREFORE
111,155,178,228,CONCLUSION,CONFIDENCE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RATIO,RESULTS
126,ANAEROBIC,HOWEVER,RADICAL,THEREFORE,VARIOUS
100,169,215,5TH,BACKGROUND,CHEMISTRY,COPENHAGEN,DECREASING,HEART,LABEL,LOWER,METHODS,RESULTS,TOBACCO
169,AGILENT,CALIFORNIA,CLARA,COPYRIGHT,EDUCATION,GENOMIC,HOPKINS,IBARAKI,INC,JAPAN,JOHNS,KU7,KYOTO,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RIKEN,SANTA,TOKYO,UNIVERSITY,UROLOGICAL,VANCOUVER
169,AGA,AMONG,BACKGROUND,BASED,BECAUSE,COPYRIGHT,FINLAND,INC,INSTITUTE,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIC,SIR,SMALL,STUDIES
169,565,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THESE,URINARY,UROLOGICAL,USING
169,ASC,BBN,BCA,COPYRIGHT,HOWEVER,IHC,INC,PATHOLOGY,PUBLISHED,SOCIETY,SV40T,TARGETING,URO
001,076,100,169,AIM,BETWEEN,CONCLUSION,COPYRIGHT,EFFECTIVE,INDIANA,JANUARY,LABEL,METHODS,OBJECTIVE,PRODUCTION,RESULTS,SOMETIMES,UNLABELLED
001,044,117,169,177,30MIN,469,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,HIGHEST,LABEL,METHODS,OBJECTIVE,PRODUCTION,RESULTS,SSI
169,347,380,BETWEEN,BLADDER,CALIFORNIA,COPYRIGHT,COX,HISTOLOGIC,INC,LABEL,LOG,MATERIALS,MEIER,METHODS,MUC,OBJECTIVE,OBJECTIVES,RESULTS,RFS,TNM,UNIVERSITY,USC
008,122,ASSESSMENT,BLADDER,BLM30,BRICKER,C30,CUS,EORTC,FUNCTIONAL,HOWEVER,HRQOL,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,ONB,ORTHOTOPIC,PURPOSE,QLQ,RESULTS,THERAPY,TREATMENT,VIP,WOMEN
086,105,430,AMONG,BACKGROUND,BLADDER,LABEL,METHODS,RESULTS,THESE
001,008,AFTER,ARG194TRP,ARG399GLN,BACKGROUND,CRUDE,HARDY,LABEL,METHODS,REGROUPING,RESULTS,SEPTEMBER,WANFANG,XRCC1
169,174,ADD,AFTER,BJU,ENDOSEW,KNOWN,LABEL,METHODS,OBJECTIVE,RESULTS,SECONDARY,SUBJECT,THERE,UNLABELLED
044,106,108,177,DISCOMFORT,LABEL,LEAKAGE,METHODS,OBJECTIVE,RESULTS
123,169,954,960,ADM,ADRAMYCIN,AKT,COPYRIGHT,GST,INC,JNK,PEITC,RHODAMINE,T24,TWIST,WILEY
121,169,392,397,578,728,BACKGROUND,BETWEEN,CYTOPATHOL,IMMUNOCYT,JANUARY,LABEL,LESIONS,MARCH,METHODS,OVERALL,RESULTS,SOCIETY,WORLD
149,169,502,CONCLUSION,COPYRIGHT,DSM,FEW,LABEL,LTD,METHODS,OBJECTIVE,PREVALENCE,RESULTS,THERE,WILEY
215,946,CURRENT,DESPITE,HGF,HOWEVER,MSC,SMC,TGF,THERE,THESE
169,4CM,6GY,7GY,8GY,9GY,ACTUARIAL,COPYRIGHT,D90,DURABLE,HDR,INC,LABEL,MATERIALS,MAY,MEIER,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RECORDS,RESULTS,SEPTEMBER,SOCIETY,THERE
169,AUTOMATED,COPYRIGHT,EXPRESSION,GENOTYPING,HPV,IMAGE,LABEL,METHODS,OBJECTIVE,RESULTS,SAS,TCC,TEN
169,COPYRIGHT,INC,MUCIN
169,CONCLUSION,COPYRIGHT,CXS,INC,LABEL,MATERIALS,METHODS,NDO,OBJECTIVE,OVERALL,RESULTS,SELECTIVE
169,177,1CM,2CM,945,946,BACKGROUND,CONCLUSION,COPYRIGHT,DIR,DVH,FORTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VARIATIONS
169,946,COPYRIGHT,FURTHER,LTD,TGF,UROTHELIAL
145,BLADDER,BPH,CONCLUSION,FSCN1,LABEL,MATERIALS,METHODS,MICRORNAS,MUC,MYC,OBJECTIVE,PCR,PURPOSE,RESULTS,RNU,THERE
2N0,3DCRT,AIM,BETWEEN,EORTC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
176,255,259,266,ESTIMATES,FACTORS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,URINE,VISCOSITY
169,AUTHORS,FEDERATION,GYNECOLOGY,LLOYD,OBSTETRICS,POTENTIAL,SEVERAL,SOCIETIES
AFTER,BLOOD,SIX,T2AN0M0,THESE
COX,INSURANCE,NSAID
120,128,169,170,BNIP3,CACNA1A,CACNA1G,CCND2,CHANGES,COPYRIGHT,COX,DIAGNOSTIC,EDUCATION,H2AFX,ID4,INC,LABEL,METHODS,OBJECTIVE,PRDM2,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,ROC,RUNX3,SCGB3A1,URINE,UROLOGICAL
000,001,005,100,148,169,315,BCA,COPYRIGHT,DISCUSSION,END,INCIDENCE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAGE
603,BIU,FCM,GTPASES,PLC,RAP,RAS,SILENCE,T24,WESTERN
ADP,BIU,HOWEVER,IGG,PCR,T24,WESTERN
360,CIS,GSTP1,ILE105VAL,ORS,WANFANG
150,180,945,946,IPT,PROGNOSCAN,PSI,RECEPTEUR,RON,RTK,SIX
160,181,945,954,AKT,BCL,PCR,T24,URSOLIC
001,005,021,025,030,BACKGROUND,CONCLUSION,COX,FURTHER,HOWEVER,LABEL,METHODS,RESULTS
227,APC,BACKGROUND,BCA,CONCLUSION,GSTP1,HPAII,LABEL,MATERIALS,METHODS,PTGS2,RASSF1A,RESULTS,TIMP3
169,BKV,CK7,CK903,COPYRIGHT,GLEASON
617,629,BACKGROUND,BLADDER,CLINICIANS,COMPETING,CONCLUSION,CSM,FEW,LABEL,METHODS,OCM,RESULTS
954,AGREEMENT,AMONG,BACKGROUND,CONSENTING,LABEL,METHODS,OBJECTIVE,ONCOLOGIC,PET,RESULTS
THERE,URINARY
169,ALA,DFX,HUVEC,PDT,THESE
ARG,ARG399GLN,FURTHER,GLN,MAY,PUBLISHED,UPDATED,XRCC1
BLADDER,IDEALLY
186,203,358,AMONG,BASED,GENOMES,KYOTO,THREE
99MTC,BLADDER,FDG,PET
169,295,409,998,BACKGROUND,BCA,BLADDER,BLU,COPYRIGHT,CURRENT,DUTCH,FGFR3,LABEL,METHODS,NMP22,OBJECTIVE,OUTCOME,OVERALL,PROJECT,PUBLISHED,RESULTS,SETTING,SEVENTY,URINE,UROLOGY
004,005,141,169,244,444,CASES,COPYRIGHT,COX,FOLLOWING,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGIC,RECURRENCE,RESULTS,UCB
001,386,AFTER
160,3DCRT,DSH,DVH,DVH10,DWH,INC,MRI,MSS,VODCA
100,169,956,BLADDER,COPYRIGHT,ESPECIALLY,HOWEVER,PCR,TYPICAL,WORLDWIDE
169,325,COPYRIGHT,DFS,DSS,GENERAL,HARRELL,INC,INDIVIDUAL,LABEL,MATERIALS,METHODS,MGH,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,SELECTIVE,TREATMENT
001,143,148,169,291,AFTER,AWARENESS,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
001,APRIL,CHINESE,CIS,EGGER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,RRS,SCIENCE,STUDIES,SUMMARY,THERE,WEB
EMA,GASTRIC,HIGHEST,JAPAN,KOREA,LYMPHATIC
A20,BLADDER,FIFTY,PCR,WESTERN
AGVMAT1,AGVMAT2,BRT,DOSES,DOSIMETRIC,DVH,EUD,HDR,HOWEVER,PTV
BACKGROUND,INCIDENCE,LABEL,METHODS,MONITORING,MORTALITY,RESULTS,WHILE
001,025,169,344,945,946,ADD,ATLAS,BJU,EXPRESSION,FGB,INCREASED,KNOWN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROTEIN,RESULTS,SUBJECT,TOP2A,UNLABELLED,URINARY,URINE,WESTERN
169,BJU,BRITISH,DESPITE,DIAGNOSES,FURTHER,HES,INCREASING,LABEL,METHODS,MORTALITY,OBJECTIVE,ONS,REPOSITORY,RESULTS,STATISTICS,UROLOGICAL,UTUCS
101,169,178,221,231,348,BJU,CLAVIEN,CONVERSION,DESPITE,DISEASE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIX,THERE
398,BCS,BGJ,EMT,FGFR1,FGFR3,FGFRS,FIBROBLAST,HOWEVER,SIMILARLY,UC3
000,169,AFTER,BACKGROUND,BON,COPYRIGHT,HOWEVER,LABEL,METHODS,RESULTS,UMB,WESTERN
BLADDER,WOC
CONCLUSION,HRQOL,JAPAN,LABEL,MEDICAL,METHODS,OBJECTIVE,OSAKA,PURPOSE,RESULTS,SHORT,WOC
125,169,1CM,961,COMPOSITE,COPYRIGHT,DOSES,EUS,INC,INDEX,IUS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,URINARY,V35
001,169,488,492,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,UCB,VARIANT,WHILE
169,177,ALA,BACKGROUND,CONCLUSION,COPYRIGHT,DIAGNOSIS,DIAGNOSTIC,LABEL,MAP,METHODS,PDD,PRE,RESULTS,SEPTEMBER,THREE
001,007,169,247,ACD,AGE,AIM,ANN,COPYRIGHT,COX,CSM,ENDPOINTS,IQR,LABEL,LTD,LYMPH,METHODS,OBJECTIVE,RESULTS,UCB
169,556,804,BACKGROUND,CONCLUSION,FOUNDATION,FOV,LABEL,LIMITED,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIMILARLY
BLADDER,BPS,IBD,MICRORNAS,USING
LOW,LVI,RAF,UBC,UROTHELIAL,USING
169,COPYRIGHT,ECTOPIC,INC
169,177,BACKGROUND,BOWEL,COPYRIGHT,HDR,IRELAND,LABEL,LTD,MATERIALS,METHODS,OAR,OBJECTIVE,PRE,PURPOSE,RESULTS
169,177,1SD,2CC,945,946,BACKGROUND,CONSENSUS,COPYRIGHT,CTV,DVH,ESTIMATION,GTV,IRELAND,LABEL,LEVEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,OPTIMISED,PURPOSE,RESULTS,THESE,TRUTH
FPC,NORTH,REGISTRIES,SPC
000,004,018,122,CASES,DELHI,EPI,FACTORS,GBC,INDIA,INSTITUTE,KEEPING,MEDICAL,OCTOBER,PREVENTION,THERE
139,160,169,174,177,185,221,469,513,534,AMONG,AUC,CONCLUSION,LABEL,LTD,METHODS,NUCLEAR,OBJECTIVE,RESULTS,THERE,WILEY
024,025,035,BASED,CONCLUSION,CYSTOSCOPY,GROUP,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,THP,UROLOGICAL,UUT
169,1980S,831,BACKGROUND,COPYRIGHT,DOE,INC,JANUARY,LABEL,LABORATORY,METHODS,OAK,RESULTS,RIDGE,SMR,TENNESSEE,VITAL,WILEY,WORKERS
CTV,D90,EIGHT,FINALLY,MANCHESTER,NMS
293,3T3,ATPDS,NIH,T24
000,181,ARSENIC,BACKGROUND,BANGLADESH,CHILE,CHRONIC,DISCUSSION,KNOWLEDGE,LABEL,LOCATIONS,MCL,METHODS,OBJECTIVE,OBJECTIVES,PROTECTION,TESTING,THESE
109,120,169,AMONG,BACKGROUND,COPYRIGHT,LABEL,METHODS,RESULTS,SOCIETY,THERE,THESE
CONCLUSION,CURRENT,EXTENDING,LABEL,MATERIALS,METHODS,OBJECTIVE,PROLONGED,REGARDING,RESULTS,T1A,TURBT
FDG,PET,THESE
169,229,331,COPYRIGHT,COSTS,COUNTRY,FIGURES,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,OSAKIDETZA,PUBLISHED,RESULTS,SCIENTIFIC,SPAIN,SPANISH
109,120,123,132,149,169,174,213,258,266,289,293,351,352,417,497,719,CLAVIEN,COPYRIGHT,EDUCATION,INC,IQR,JANUARY,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UNIVARIATE,UROLOGICAL
169,218,786,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RCC,RESULTS,UROLOGICAL
0GY,169,1CM,1GY,2GY,4GY,5GY,7GY,8GY,9GY,COPYRIGHT,D90,DOSES,EQD2D90,HDR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THOSE
161,169,COPYRIGHT,EWING,GATA3,HOWEVER,IMT,INC,SARCRCC,SARCUCS
169,177,2CM,CONCLUSION,COPYRIGHT,ECLIPSE,EMBRACE,EVALUATION,EVERY,INTER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,BLADDER,COPYRIGHT,INC,RADICAL
169,338,AEU,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THREE
169,COPYRIGHT,CROWN,INC,PRIMARY,PUBLISHED
001,008,021,169,APRIL,BJU,COCHRAN,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RESULTS,THERE,THESE,UBC,UCB
AFTER,ANXA1,ARHGEF4,GENESPRING,GNE,INITIAL,NINJ1,PLOD2,PSAT1,THESE,TNFSF15,WDR34,WDR72
102,169,197,233,774,971,AMERICA,APRIL,AUA,BCG,BJU,EAU,HOWEVER,LABEL,METHODS,NMIBC,NORTH,NOTABLY,OBJECTIVE,OBJECTIVES,PHYSICIANS,RESULTS,THERE,UROLOGICAL,UROLOGY
169,BJU,LABEL,LYNCH,METHODS,MSH,OBJECTIVE,OBJECTIVES,RENAL,RESULTS,TUMOURS,WORLD,YAG
001,002,169,55635,BJU,HOWEVER,INPATIENT,LABEL,METHODS,NATIONWIDE,OBJECTIVE,OVERALL,PREDICTED,RECEIPT,RESULTS,UNLABELLED,USA,USING,VARIATIONS
BACKGROUND,BRUNN,CONTEXT,GLANDULAR,LABEL,LIBRARY,MALIGNANT,METHODS,OBJECTIVE,SOURCES,WORLD
001,037,500,608,900,ASIAN,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,THESE
BMI,CRC,PLA2S,SAMPLES
233,BASED,BCG
412,430,ANALGESIC,AUTHORS,BACKGROUND,BIOMEDICAL,CBM,CENTRAL,CHINESE,COLLECTION,CONTROLLED,CSF,CURRENT,ISSUE,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCS,SELECTION,SINCE,THERE,VAS
BLADDER,TOBACCO
FINALLY,STRA6
DESPITE,THESE
946,ACTIVATION,FINALLY,HOWEVER,MEIER,R1881,TCF,THERE,USING,WNT
008,DISCUSSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SELECTING,SHP,THOSE
142,169,233,254,877,AMONG,BASED,BCG,BETWEEN,BJU,COX,LABEL,MARCH,METHODS,NMIBC,OBJECTIVE,OCTOBER,RESULTS,THESE,UNIVARIATE
169,COPYRIGHT,LTD,NORMFINDER,SAS,WILEY
001,004,016,021,022,104,119,138,149,169,175,683,COPYRIGHT,INC,LBC,NMP22,WILEY
BCG,LABEL,METHODS,OBJECTIVE,RECURRENCE,RESULTS
BACKGROUND,COX,DETECTING,DISCUSSION,LABEL,LCS,MATERIALS,METHODS,OBJECTIVE,RESULTS,SUBSEQUENT,THESE,WHEREAS
169,COPYRIGHT,FAS,FURTHER,INC,MIGRATION,RT112,T24,WILEY,YOUNG
012,FURTHER,INDUCED,KNOCKDOWN,MAMMALIAN,PCR
012,035,160,177,CONCLUSION,CRT,DMEAN,EWING,HOWEVER,LABEL,METHODS,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,V30,V50,V60,V95,WHEREAS
160,273,ALIGNMENT,CONCLUSION,DAILY,LABEL,MARGINS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,RSE
DESPITE,MAJOR,URINE
133,218,BACKGROUND,BLADDER,ELISA,EXPRESSION,FINALLY,HOWEVER,LABEL,LUCIFERASE,METHODS,MRE,RESULTS,TRAIL
145,480,548,COX,HOWEVER,INITIATIVE,NEITHER,WOMEN
000,ACTOS,ALABAMA,AVANDIA,BACKGROUND,BIRMINGHAM,CHF,CLINICIANS,FDA,GLITAZONES,GREEN,INITIAL,LABEL,MEDLINE,MERCY,METHODS,OBJECTIVE,RESULTS,THERE
25F,BACKGROUND,CONCLUSION,CYSTOSCOPY,LABEL,METHODS,OBJECTIVE,PURPOSE,RENAL,USING
001,100,169,445,765,ADD,AMONG,BJU,CONSORTIUM,CYSTECTOMY,KNOWN,LABEL,LND,LNS,LYMPH,METHODS,OBJECTIVE,RESULTS,ROBOT,ROBOTIC,SUBJECT,UNLABELLED
100,119,336,780,891,EMG,IAS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,URINARY
169,COPYRIGHT,EMBRYONIC,LTD,RT4
002,036,146,169,183,CD138,ISS,LTD,NOTABLY,STAGING,WILEY
001,002,BACKGROUND,CIS,CONCLUSION,INCREASING,LABEL,MARCH,MEDLINE,METHODS,RESULTS,RRS,SUMMARY,THESE
169,181,187,ALDH1A3,COPYRIGHT,HOXA9,ISL,LIM,NMIBC,PSQ
26S,946,FINALLY,HSP27,ILK,KNOCKDOWN,MG132,QLT,SIGNALING,USING
AKT,AMONG,ANCHORAGE,CSE,DCC,FOXO1,HOWEVER,MAPK1,MOLECULAR,P53,PCR,RAS,THEREFORE,UCC,UROTHELIAL,USA,VALIDATION
169,BECAUSE,CHRONIC,COPYRIGHT,IGG,INC,IPT,UNDER
169,COPYRIGHT,DESPITE,EN2,ENGRAILED,LTD,NMIBC,TIS
001,006,012,102,123,136,160,169,816,AFTER,AMONG,ANY,APRIL,BETWEEN,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TCC
169,178,946,ADV,BMA,CMV,COMBINING,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PR1,RESULTS,TSU
169,BLADDER,COPYRIGHT,INC,WESTERN
169,72H,CISPLATIN,COPYRIGHT,HOWEVER,SAS,TREATMENT
FLUID,MRI,URINARY,WHILE
168,177,314,390,946,ANOVA,ASSESSMENT,BACKGROUND,CYSTECTOMY,FUNCTIONAL,HOWEVER,INDEX,JANUARY,LABEL,MATERIALS,METHODS,QOL,RANDOMIZED,RESULTS,THERAPY,VANDERBILT,VCI
BACKGROUND,COLLECTED,INCIDENTAL,LABEL,MATERIALS,METHODS,RESULTS
905,BACKGROUND,CCK,CHINESE,GFW,LABEL,METHODS,P21,RESULTS,WAN,WESTERN
AAV,APOPTIN,BLADDER,CAV,HCV29,HOWEVER,PCR,T24
018,032,1001G,200,250,2549I,2578C,NORTH,PCR
177,932,CONCLUSION,IBD,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OLDER,PATIENT,POUCHITIS,RESULTS,THERE
001,024,169,AFTER,BACKGROUND,BASEL,BIU87,HOWEVER,LABEL,MATERIALS,METHODS,PCR,RESULTS,WESTERN
169,COLON,CONCLUSION,COPYRIGHT,ENDEMIC,HEREDITARY,HNPCC,INC,LABEL,LIBRARY,METHODS,NON,OBJECTIVE,OBJECTIVES,POLYPOSIS,PRIMARY,RESULTS
169,CONCLUSION,COPYRIGHT,CYP,INC,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES
162,169,543,ADVERSE,CISPLATIN,COPYRIGHT,FIT,GRADE,HOWEVER,III,INC,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
945,946,AKI,FOLLOWING,THESE
AWARENESS,CK7,THESE
BLADDER,CAREFUL,DESPITE,LABEL,OBJECTIVE,ONGOING,PURPOSE,RESULTS,SUMMARY,TOBACCO,WHILE
169,744,BLACKWELL,HSP27,HSP60,HSP70,HSP90,LABEL,LOW,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS
SEARCHING,SEN
PREDICTIVE,THESE
AFTER,BACKGROUND,DISCUSSION,LABEL,METHODS,PAPILLARY,RESULTS,THERE,ULTRASOUND,URINARY
197,BACKGROUND,CONCLUSION,CROSS,DIPHTHERIA,GLU,GLY52,LABEL,LEVEL,METHODS,RESULTS,TEN
100,169,305,AMONG,BETWEEN,CHRONIC,COPYRIGHT,CYSTECTOMY,DEFINITIVE,GENITAL,INCLUSION,INDEX,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,T2B
169,COPYRIGHT,OCT,VCH,WILEY
160,169,ASSOCIATES,BACKGROUND,BPS,CHRONIC,CLINICIANS,CONCLUSION,CONTINENCE,COPYRIGHT,CPP,LABEL,LARGE,LIBRARY,LTD,MARCH,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PSYCHINFO,PUBLISHED,RESULTS,SELECTION,SIGLE,SOCIETY,SOURCES,WEB
280,320,570,719,906,BACKGROUND,BSC,COX,III,ITT,LABEL,METHODS,ONCOL,PHASE,RESULTS,THESE,THREE
0058MSV,0124MSV,169,CONCLUSION,COPYRIGHT,ESTIMATED,EXM,FIFTEEN,LABEL,LTD,MBQ,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEQUENTIAL
169,945,AKT,COPYRIGHT,HIF,HOWEVER,INC,T24
169,180,ACTUARIAL,COPYRIGHT,INC,LABEL,MATERIALS,MEIER,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
169,COPYRIGHT,FIFTY,INC,INJECTION,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,REDUCTIONS,RESULTS,THERE,V70
001,004,013,121,122,177,17A,AIM,CONCLUSION,III,LABEL,METHODS,OBJECTIVE,RESULTS
ASPEN,BEATSON,CHIEF,COMPARZ,FRANCESCA,GLASGOW,III,INSTITUTE,JONES,PHASE,PHD,PLUTO,STUDIES,UNIVERSITY
BKV,HOWEVER,PRIOR,SIX
001,003,004,005,007,469,487,BACKGROUND,CHINA,CHINESE,CONCLUSION,LABEL,METHODS,ORS,RESULTS
142,151,152,AIM,BACKGROUND,HEART,HOWEVER,HTX,INCIDENCE,LABEL,METHODS,OBJECTIVE,REGULAR,RESULTS,TEN,WHILE
114,169,251,272,979,COLLECTED,CONCLUSION,COPYRIGHT,DEPENDING,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OTHER,RESULTS,SUBSEQUENT,WHETHER
BCG,DESPITE,LTD,PMN,PUBLISHED,SINCE,STUDIES,TNF,TRAIL,UROTHELIAL
139,142,169,221,AGAIN,CIS,COPYRIGHT,FINALLY,INC,NOTABLY,OVERALL,PATHOLOGY,PUBLISHED,SOCIETY,STRIKINGLY
100,HOWEVER,KENNARD,PCA,PLS,STONE,WHITNEY
CTS,CTV,GYE,INTENSITY,LABEL,METHODS,RESULTS,SIB,SIMULATION,UNLABELLED
SEQ
946,947,BACKGROUND,CONCLUSION,DIM,INDUCTION,LABEL,MTT,PRINCIPAL,RESULTS,THESE
199,276,295,591,AFTER,BACKGROUND,CIS,CONCLUSION,CONTEXT,COX,HOWEVER,HRS,INSTITUTES,LABEL,METHODS,NIH,OBJECTIVE,OUTCOME,PERSONS,RESULTS,RETIRED,SETTING,YET
234,272,282,285,319,433,681,740,762,818,COMPARISON,COX,CSS,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS,RFS,RNU,THEREFORE,UBC,USING
001,006,008,126,177,CONCLUSION,COX,ESPECIALLY,EXPRESSION,HOWEVER,LABEL,MEIER,METHODS,MIR,OBJECTIVE,PCR,PFS,PURPOSE,RESULTS,THESE
169,BASEL,CONCLUSION,COPYRIGHT,CYTOLOGIC,HISTOLOGIC,HOPKINS,JOHNS,LABEL,METHODS,OBJECTIVE,PDA,RESULTS,SINCE,THERE
108,112,160,169,215,COPYRIGHT,D90,EVALUATED,HGS,INC,LABEL,MASTERPLAN,MATERIALS,METHODS,NUCLETRON,OAR,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,VEENENDAAL
169,177,AIM,BASEL,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
169,AIM,BACKGROUND,CONCLUSION,DESPITE,FEW,FOLLOWING,HOWEVER,LABEL,LITERATURE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY
946,EMT,FOXQ1,PCR,T24,TGF
000,169,DESPITE,EFFECTS,FINALLY,GIVEN,LABEL,METHODS,MILLENNIUM,MITOTIC,MLN8237,OBJECTIVE,PCR,PURPOSE,RESULTS,RT4,T24
025,048,137,169,16974,200,607,BCG,COPYRIGHT,ELISA,NORTH,PCR,SERUM,VARIATION,WHILE
013,024,169,662,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,RNU,USING,UUT
169,956,BFTC905,CASPASE,CHANGES,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MMC,OBJECTIVE,OBJECTIVES,REDUCED,RESULTS,UROTHELIAL
001,030,041,042,169,COPYRIGHT,CROWN,GROUP,INC,INPATIENT,LABEL,LVT,MATERIALS,METHODS,NATIONWIDE,OBJECTIVE,OVERALL,PATIENT,PROJECT,PUBLISHED,RCS,RESULTS,THESE,THRESHOLD
127,132,149,174,177,185,217,289,486,ADVERSE,PTV,TPS
169,AKT,BRITAIN,COPYRIGHT,ERK,G469V,GREAT,HCV29,HOWEVER,HSP90,IRELAND,LAPATINIB,LTD,NVP,PUBLISHED,SOCIETY,WILEY
001,003,015,169,270,432,708,877,888,ALA,ALA499VAL,ASIAN,COPYRIGHT,DESPITE,GLN,LYS,LYS939GLN,MEDLINE,OVERALL,VAL,XPC
169,AUTHORS,H19,HOWEVER,ID2,INHIBITOR,JOURNAL,PCR
112,169,AEU,COPYRIGHT,CYSTOSCOPY,JANUARY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEVEN
215,2NG,3N0M0,ARM,BACKGROUND,BCF,BCFFS,CGE,LABEL,METHODS,NADIR,RADIOLOGY,RESULTS,SOCIETY
120,180,CENTERS,CLAVIEN,EXPERIENCE,IQR,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SOCIETY,STAGE,SURGERY,THERE
BLADDER,CONCLUSION,GROUP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHORT,THERE,UISFS,URODYNAMIC
CONCLUSION,LABEL,LOCALIZED,METHODS,MIBCS,OBJECTIVE,PURPOSE,RESULTS,SNP
100,744,CIS,LCP,LPC,OTHER,PATIENT,UROTHELIAL
001,003,169,402,502,509,642,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STATINS,THESE,UROLOGICAL
169,233,BACKGROUND,BCA,COPYRIGHT,INTUITIVE,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PARAMETERS,PUBLISHED,RESULTS,SETTING,SIX,THESE,THREE,URINARY,UROLOGY,USA,VINCI
114,169,637,AFTER,COPYRIGHT,INCLUSION,LABEL,LND,LNM,LTD,LYMPH,MATERIALS,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,RFS,ROUTINE,STRATIFIED,TIS,WHETHER
001,002,006,007,029,040,169,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,THESE
160,169,AD5,CONCLUSION,COPYRIGHT,COXSACKIE,F35,HOWEVER,INC,LABEL,MATERIALS,METHODS,MKP,OBJECTIVE,RESULTS,REVERSE,T24
169,ADRIAMYCIN,COPYRIGHT,INC
BIOMARKERS
013,045,178,180,205,AUO,BACKGROUND,COX,LABEL,MEIER,METHODS,MPC,PUC,RESULTS,SINCE,WORLD
001,018,043,044,945,GSTA1,GSTM1,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TCC,URINARY
164,221,233,ACCORDING,AMONG,BCG,EAU,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,TUR,UROLOGY
CLEAR,EARLY
HOWEVER,IMAGING,PET
BIU,CCK,LIRG3,LRIG3,PCR,T24,TRANSWELL,WESTERN
145,946,AKT,EXOGENOUS,EXPECTEDLY,IFN,PIC,RNASE,SOCS7,STAT3,T24,TRAIL
001,047,389,DESPITE,GROUP,JANUARY,LABEL,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,THERE
100,169,BACKGROUND,BASEL,LABEL,MATERIALS,METHODS,RESULTS,THEREFORE,UNIVARIATE,UUT
100,169,308,360,450,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,005,037,120,121,169,ADD,AFTER,BJU,BRITISH,COMPLEX,ENGLAND,ENGLISH,EPISODE,EXAMINING,KNOWN,LABEL,MEN,METHODS,OBJECTIVE,OPERATIONS,RESULTS,STATISTICS,SUBJECT,THERE,THREE,UNLABELLED,UROLOGICAL,WHETHER
169,949,COPYRIGHT,DOX,GLYCINE,NMR,PCL,PEO,RGDFK,U87MG
169,DESPITE,SEPTEMBER,THESE,UROLOGICAL,VARIOUS
177,INSIGHT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,TOOLKIT
CTS,IGART,LABEL,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,RDE,RESULTS,RPM,TPS
108,169,29C,ADD,BJU,EXPRESSION,KNOWN,LABEL,METHODS,MICRORNAS,MOLECULAR,NMI,OBJECTIVE,PATIENT,RECURRENCE,RESULTS,ROSETTA,SUBJECT,THESE,UNLABELLED,USING
127,BACKGROUND,COLON,FOLLOWING,LABEL,LYNCH,MEIER,METHODS,MMR,RESULTS,SIR,WOMEN
132,160,169,420,AFTER,COMPANY,CONCLUSION,COPYRIGHT,III,JOURNAL,LABEL,LTD,MAINZ,METHODS,OBJECTIVE,PEDIATRIC,PUBLISHED,PURPOSE,RESULTS,RMS,URINARY,UROLOGY
169,233,AIM,BCG,COLLEGE,CONCLUSION,COPYRIGHT,DWI,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,POLYGONAL,PUBLISHED,RESULTS,ROYAL,TEN,THREE
043T_P2,048T_P2,169,ARRAY,CGH,PASSAGABLE,STR,XENOGRAFT,XENOGRAFTS
144,174,BACKGROUND,BLADDER,CONCLUSION,LABEL,LITHOCLAST,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLM,STONE,SWISS,UNDER,WESTERN
049,169,AFTER,BJU,FINAL,LABEL,METHODS,OBJECTIVE,RESULTS
LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RECURRENT,RESULTS,THOSE
CARCINOMA,COL11A1,ERBB3,FN1,FURTHER,RAS,T24,TCC,THESE,TRANSITION,USING,WHILE
ABP,BACKGROUND,ELISA,LABEL,PRINCIPAL,RESULTS,STRUCTURAL
169,945,AUTHORS,COPYRIGHT,GIVEN,GLUT1,LTD,PUBLISHED,SW620,WILEY
AGE,INITIAL,INTEGRATED,LABEL,METHODS,MONITORING,NETWORK,OBJECTIVE,OBJECTIVES,OCTOBER,RESULTS,SERVICE
169,387,448,939,BACKGROUND,CONSORTIUM,COPYRIGHT,CYSTECTOMY,FORTY,KETTERING,LABEL,METHODS,MSKCC,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,ROBOTIC,SECONDARY,SETTING,SLOAN,THEREFORE,UROLOGY,USING
169,COMPANY,COPYRIGHT,DUE,JOURNAL,LTD,NF1,PEDIATRIC,PUBLISHED,UROLOGY
001,011,028,045,169,177,200,AFTER,COX,END,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,UROLOGICAL
001,160,169,BLACKWELL,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS,TELOMERIC
LABEL,LCNEC,UNASSIGNED,UNLABELLED,VIRTUAL
AKT,BACILLE,BCG,CDC42,DESPITE,RAS,SIMILARLY,THESE
233,BCG,HOWEVER,NMIBC
DIFFERENT,E2F1S,HOWEVER
18F,FDG,PET
001,169,892,COPYRIGHT,DISEASE,EDUCATION,FURTHER,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,24H,947,956,ARSENIC,BLADDER,BSO,COPYRIGHT,COX,ERK,GCS,GSH,HOWEVER,HUC,INDUCTION,JNK,LTD,ROS,THESE
169,172,233,855,896,ADVERSE,BETWEEN,CONNAUGHT,COPYRIGHT,EDUCATION,INC,JANUARY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,OVERALL,PATIENT,PUBLISHED,PURPOSE,RESULTS,THEREFORE,TOKYO,UROLOGICAL
125,152,169,187,AIM,COPYRIGHT,FIFTEEN,INDUCTION,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PPV,RESULTS
133,169,174,COPYRIGHT,INC,SEVEN
169,AFTER,BECAUSE,COPYRIGHT,DEPENDING,INC,MRI,TESLA
001,169,177,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SUPER,THESE,USING
127,151,CLAVIEN,CONCLUSION,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGEON
001,108,169,200,CLAVIEN,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
117,169,298,395,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,RFR,RFS,SMOKING,TEN,TUR
954,963,BACKGROUND,COFILIN,EGF,EPIDERMAL,KNOCKDOWN,LABEL,METHODS,MIBCS,RESULTS,T24,THESE
1BETA,945,946,947,BACKGROUND,BAL,IFN,LABEL,METHODS,RESULTS,TCI,TH1,THEREFORE,TNF,TREGS
162,AFTER,CONCLUSION,EASTERN,GROUP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
001,169,56YEARS,604,652,AREAS,CONCLUSION,COPYRIGHT,FDG,ICC,INC,INTER,JANUARY,LABEL,MEIER,METHODS,MTV,OBJECTIVE,PET,PFS,RESULTS,THERE,TLG
001,167,169,BLADDER,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,MEIS1,METHODS,OBJECTIVE,ONECUT2,PCDH7,PUBLISHED,PURPOSE,RESULTS,SOX21,THEREFORE,THREE,UROLOGICAL
110,142,151,956,DCMBQ,HBQ,HOWEVER,MDA,NAC,PROTEIN,ROS,T24,THESE
BACKGROUND,BLADDER,CONCLUSION,DIFFERENT,FINALLY,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UROLOGICAL
954,ATM,BLADDER,CHINA,GENISTEIN
002,009,076,169,BACKGROUND,ELECTRONIC,LABEL,METHODS,RESULTS,SOCIETY,THESE
169,CD11B,CHEMOKINES,FOXP3,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,STAT3
159,169,765,APRIL,BASEL,BETWEEN,CLAVIEN,COPYRIGHT,DINDO,LABEL,METHODS,MORTALITY,OBJECTIVE,PRIMARY,RADICAL,RESULTS,SOCIETY
00007,KUB,PRIOR,RATES
CIS,FIXED,HOWEVER,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OCTOBER,POTENTIAL,PURPOSE,RESULTS,THERE
100,382,ASSESSMENT,BACKGROUND,CONCLUSION,FLORIDA,FORTY,INSTITUTE,LABEL,METHODS,PER,RESULTS,THERAPY,THERE,THREE,UFPTI,UNIVARIATE,UNIVERSITY
650,956,ALA,DLS,LABEL,METHODS,OBJECTIVE,RESULTS,T24
THEREFORE
169,ADD,AGE,BJU,KNOWN,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SEVERAL,SUBJECT,TEN,THESE,UNLABELLED
002,004,013,017,018,019,025,089,116,143,160,276,310,370,567,734,945,946,950,ACUTE,EORTC,LABEL,MATERIALS,METHODS,MINIMUM,OBJECTIVE,PURPOSE,RESULTS
000,105,156,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,THEREFORE
FURTHER,HOWEVER,LABEL,LOS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY
483,AFTER,BACKGROUND,EARLY,LABEL,METHODS,OBJECTIVE,RESULTS,URINE
169,538,ADD,BJU,FACTORS,GRADE,III,KNOWN,LABEL,METASTATIC,METHODS,OBJECTIVE,PCA,PHOENIX,PRESERVED,RESULTS,SEPTEMBER,SEVENTY,SUBJECT,THERE,UNLABELLED
002,169,215,639,706,785,894,ADD,BJU,COMMITTEE,EFS,KNOWN,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SUBJECT,THERE,UNLABELLED
038,141,AFTER,ANY,BACKGROUND,HOWEVER,LABEL,MEIER,METHODS,RESULTS,URINARY
169,ADD,ASIDE,BJU,BLADDER,HOWEVER,KNOWN,RADICAL,SUBJECT,THERE,WHILE
BACKGROUND,LABEL,METHODS,MTT,RESULTS,T24,THESE,USING
000,232,250,306,335,640,956,BACKGROUND,BECAUSE,BLADDER,CHILE,LABEL,METHODS,OCTOBER,ORS,RESULTS
BCG,FURTHER
001,009,135,169,982,BKV,COPYRIGHT,HOWEVER,INCREASED,JCV,MCV,PARTICLES,SPANISH,THEREFORE,VIRUS
169,946,COPYRIGHT,H19,HOWEVER,IRELAND,LTD,THESE,WNT
488,AUSTRALIA,CELLVIZIO,CLE,GIVEN,IMAGING,KEA,MAUNA,PROBE
AKT,ATG,CHINESE,III,INHIBITION,LC3,MDC,MTT,T24,TUNEL
233,588,BCG,MIYAIRI,MMP,PBMCS,TAKEN,TRAIL
JANUARY,MARCH,STUDIES
169,AMONG,BLADDER,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS
000,169,500,COPYRIGHT,EPIGENETIC,INC,UROLOGICAL
169,233,954,COPYRIGHT,EDUCATION,EXOGENOUS,HMGB1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIOR,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,UROTHELIAL
169,COLLEGE,CONCLUSION,COPYRIGHT,FORTY,GRADE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PRIMARIES,PUBLISHED,RESULTS,ROYAL,THERE
014,156,169,187,238,ALBUMIN,CONCLUSION,COPYRIGHT,COX,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS,SERUM
008,169,233,ADD,BCG,BJU,END,KNOWN,LABEL,METHODS,OBJECTIVE,RELAPSING,RESULTS,SUBJECT,THEREFORE,TRANSPLANT,UNLABELLED
160,169,AUTHORS,DECORIN,IGF,JOURNAL
000,100,142,169,178,215,AUTHORS,ELECTRONIC,HOWEVER,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SIX,THEREFORE
001,119,124,132,169,191,434,AUC,BJU,CNV,COX,ESTIMATES,HRS,LABEL,METHODS,OBJECTIVE,PIS,RESULTS,ROC,THERE,UNLABELLED,UROSCREEN,UROVYSION
916,968,BAX,BCL,DESPITE,NAC,ROS,T24,THESE,TREATMENT
001,100,946,GATA3,GLANDULAR,HOWEVER,NUCLEAR,UROTHELIAL
001,008,012,663,CENTERS,CONCLUSION,CROSS,DISCHARGE,INPATIENT,LABEL,METHODS,NATIONWIDE,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,URINARY,UTI
150,ETS,SYSTEMATIC,THESE
945,ACSL1,ACSL5,ACSLS,COA,FURTHER,HOWEVER,III,METABOLIC,PCR,SINCE,THESE,UROPLAKIN
CRK,DISRUPTION,ENDOGENOUS,ROS,THESE
000,ENGLISH,HOWEVER,INVERSE,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,RRS,SEVENTEEN,TZD
UPPER
ANTENATAL,ANTIBIOTIC,BMI,CAESAREAN,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PRETERM,RECURRENT,RESULTS,THERE,VAGINAL,WOMEN
100,169,360,520,720,AFTER,CONCLUSION,COPYRIGHT,DAYTIME,EARLY,H2O,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SINCE,TURIN,URODYNAMIC
06040,100,215,CYSTOSCOPY,FIG,GCS,NETWORK,PET,SUNITINIB,TCC,THERE
DIAGNOSIS,PDD,TURBT,WHILE

160,CISPLATIN
169,COPYRIGHT,FEW,INC,TERATOMAS,WILEY
088,177,459,460,539,554,710,CONCLUSION,LABEL,METHODS,OBJECTIVE,PATHOLOGIC,RESULTS
NON
123,150MG,169,177,264,947,ARTEMISIA,COPYRIGHT,CROWN,EXCEPTING,GAE,IFN,LPS,LTD,PEGANUM,PUBLISHED,RAW,RESULTS,RT112,THESE,TUNISIA
169,COPYRIGHT,ERBB1,ERBB2,ERBB3,ERBB4,EXPRESSION,PCR,THERE,URINARY
005,169,177,BASED,COPYRIGHT,CTV,D90,DOSIMETRY,HDR,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,REPLANNING,RESULTS,TEN,THERE
169,177,2CM,BT1,BT2,CONCLUSION,COPYRIGHT,CTV,D90,DVH,IIB,INDIVIDUAL,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PDR,PURPOSE,RESULTS,SEVENTY,YET
009,169,811,ABSENCE,AMONG,BACKGROUND,BCA,COPYRIGHT,COX,INCIDENCE,IRR,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SEVERAL,SWEDISH,UROLOGY
001,003,004,169,AMONG,BACKGROUND,BCA,COPYRIGHT,COX,EASTERN,GROUP,IQR,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PBT,PUBLISHED,RECEIPT,RESULTS,SETTING,UROLOGY,WHILE
001,018,025,139,169,209,296,404,AMONG,ASA,CLAVIEN,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADICAL,RESULTS,SOCIETY,UNIVARIATE
169,235,ASYMMETRIC,CONCLUSION,COPYRIGHT,CTV,FIFTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PTV,PURPOSE,RESULTS,SMALL
140,160,169,208,749,976,BACKGROUND,CASES,CKD,COMPETING,HCC,INSURANCE,JANUARY,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS,SPC,THERE,URINARY,WILEY
003,154,169,283,425,647,BJU,COX,CSS,LABEL,METHODS,OBJECTIVE,PSM,RESULTS
SNP,THEREAFTER
109,138,144,AZD4877,BACKGROUND,EARLY,EG5,GIVEN,LABEL,METHODS,OVERALL,PHASE,RESULTS,TRAES
CK7,SEVERAL
003,013,027,035,169,245,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,192,233,AGE,BASEL,BCG,COPYRIGHT,CSS,LABEL,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,GREENLIGHT,KTP,LABEL,MATERIALS,METHODS,OBJECTIVE,RECURRENCE,RESULTS,SEPTEMBER,THERE
DOX
BLADDER,CYSTOSCOPY,THESE,VARIOUS
157,BACKGROUND,BIOMARKERS,CHI,CLINICIANS,FINAL,LABEL,METHODS,RESULTS,RFC
626,813,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POISSON,PREVENTIVE,RESULTS,SIR,SWEDISH,TOTAL
FOXM1,HOWEVER,PCR,T24,THESE,TNM,WESTERN
169,450,ADD,BASED,BCS,BETWEEN,BJU,BLADDER,CONCLUSION,CT1,CTX,HOWEVER,JANUARY,KNOWN,LABEL,METHODS,OBJECTIVE,RESULTS,SUBJECT,THERE,UNLABELLED
001,005,233,421,586,BCG,DDX20,DGCR8,HAPLOTYPE,MICRO,NMIBC,SNP,TAKEN,TUR
EXCRETORY,LABEL,METHODS,OBJECTIVE,RESULTS
954,AP1,HOWEVER,SPARC,SYNGENEIC,THESE,USING
000,100,ASR,BACKGROUND,CENTRAL,CONCLUSION,DESPITE,FINALLY,INCREASING,LABEL,METHODS,RESULTS,SERBIAN,THESE,USING,VOJVODINA
001,144,169,285,345,356,616,6TH,7TH,980,ANESTHESIA,DIAGNOSIS,INDEX,PROCEDURE,UROLOGICAL
130,169,ADD,BJU,KNOWN,LABEL,METHODS,OBJECTIVE,RESULTS,SUBJECT,TURBT,UCB,UNLABELLED,UROTHELIAL,WOMEN
160,169,AIM,AUTHORS,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,EIGHT,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TRANS,TREATMENT
127,169,198,201,361,492,651,COPYRIGHT,COX,HRS,MHT,NIH,WOMEN
118,161,169,309,613,CIS,COPYRIGHT,GIVEN,OPIUM,ORS,THERE
001,005,006,014,018,032,040,169,212,AGE,BACKGROUND,BAX,BCL,COPYRIGHT,INCREASING,LABEL,METHODS,PREDICTIVE,PRIMARY,RESULTS,SMOKING,SOCIETY
250,AAA,AIR,DOSIMETRIC,GTV,HOUNSFIELD,PTV,RED,THERE,WHILE
ASPIRATION,SCHWANN,THESE
169,177,COPYRIGHT,DESPITE,DIFFUSE,INC,VP1
916,CLAUDIN,NH2
169,COPYRIGHT,EDUCATION,HEREGULIN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WESTERN
001,002,007,169,576,757,769,770,798,891,ASA,AUC,COPYRIGHT,COX,EASTERN,EDUCATION,ELIXHAUSER,FURTHER,GROUP,INC,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,PUBLISHED,PURPOSE,RADICAL,RESULTS,SOCIETY,UROLOGICAL
086,169,322,BID,CHANGES,COPYRIGHT,DOJINDO,EDUCATION,ESPECIALLY,INC,KIT,LABEL,MATERIALS,METHODS,MICROARRAY,MOLECULAR,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T24,T24R2,UROLOGICAL,WESTERN
169,184,BACKGROUND,BCA,BLADDER,CONTEXT,COPYRIGHT,ENGLISH,LABEL,MAJOR,METHODS,OBJECTIVE,OTHER,POPULATION,PUBLISHED,RCT,RESULTS,SCREENING,SYNTHESIS,THERE,UROLOGY
169,346,363,933,946,BACKGROUND,BED,CDK,CONCLUSION,COPYRIGHT,GUSTAVE,IGFR1,LABEL,LTD,METHODS,RADIATION,RESULTS,SIXTEEN,TGF,VDA
284,289,AMINO,FUNCTIONAL,ISOTOPE,LABELLING,SILAC,T24
001,006,037,126,ACCORDING,COX,CSC,MEIER,PCR,T24
DESPITE,FEW,MAY,MST,PLD,TCC,THREE,TREATMENT,TTP,UNTIL
009,019,039,041,047,100,233,243,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
169,HOWEVER,RAD51,RAD51KD,RES,RT112,TAKEN
165,233,CIC,CLEAN,FINALLY,LABEL,METHODS,OBJECTIVE,ORTHOTOPIC,RESULTS,SIXTEEN,SKINNER,TCC,TUMOURS
160,169,1ST,APPRAISAL,BACKGROUND,BLACKWELL,CONCLUSION,DIEKELMANN,KNOWLEDGE,LABEL,LTD,MEN,METHODS,NLN,NURSING,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHING,RELEVANCE,RESULTS,STUDIES
132,173,645,BACKGROUND,BETWEEN,CONCLUSION,LABEL,METHODS,MMC,NMIBC,RESULTS,THERE,TURBT
000,169,400,AKT,COPYRIGHT,CYTOMETRY,EPCAM,ERK,FOLLOWING,GDC,SIGNALING,SOCIETY
1980S,243,378,447,673,BOWEN,COX,NEWLY
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,THESE
109,112,ABL,BCR,CML,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SUDAN,TRANSCRIPT
160,169,170,AIM,AMONG,ASSOCIATES,BACKGROUND,BILIARY,BTC,CONCLUSION,COPYRIGHT,III,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,STAGE,SURGERY,VATER
916,LABEL,METHODS,OBJECTIVE,OVH,PTV,PURPOSE,RESULTS,TREATMENT,WHETHER
AKT,GROWING,RESULTS
177,CTV,D90,HDRIB,INSTITUTE,PRE
112,160,277,327,BLADDER,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUDIES,THERE,WHR,WOMEN
582,DIX,HOWEVER,KNOCKDOWN,LRRK2,THESE
AUTOPHAGY,EXPRESSED,HOWEVER,LC3,MATERNALLY,THESE
169,544,AFTER,APRIL,COPYRIGHT,SMOKING
002,011,019,055,152,169,189,CASES,COPYRIGHT,FORTY,NOTABLY,UUC
126,141,142,177,244,289,409,830,834,881,93960,AWARENESS,EIGHT,MDACC
FOLLOWING,INK4A,KSN,MBT,PBS,SKC,TUNEL
009,022,160,169,BWC,COPYRIGHT,COX,DISEASE,INC,NMIBC,THESE,TURBT
002,005,007,026,036,169,COPYRIGHT,CT1,CT2,D10,D15,D20,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V50,V60,V70,V80,V90
160,169,233,BCA,BCG,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,METHODS,NMI,OBJECTIVE,OPTIMAL,OVERALL,RESULTS,TREATMENT
000,142,169,BLACK,CENTERS,CONCLUSION,COPYRIGHT,INC,INPATIENT,LABEL,MATERIALS,METHODS,NATIONWIDE,NES,OBJECTIVE,RADICAL,RESULTS,THESE,USING
000,011,047,100,109,203,250,258,341,355,406,430,459,492,543,572,590,604,605,680,709,719,742,750,794,844,875,912,921,946,958,BACKGROUND,BPH,COX,HOWEVER,INCIDENCES,INSURANCE,JANUARY,LABEL,METFORMIN,METHODS,RESULTS,TAIWANESE
001,036,ERBB3,PCR
120,160,171,177,AUR,GREENLIGHT,HPS,PCA,PSA,PVP,PVR,QOL,SCORE,SYMPTOM
AMONG,BACKGROUND,BCG,DISCUSSION,ENV,FURTHER,HERVS,LABEL,MEL,MONOCLONAL,SUMMARY,WHILE,YFV
150,169,174,260,300,BACKGROUND,BETWEEN,COPYRIGHT,IA2,IB1,LABEL,LTD,METHODS,OCTOBER,RESULTS,ROBOTIC,THREE,VINCI,WILEY
169,ALKBH,EMT,HOWEVER,KU7
AFTER,GERMANY,HODGKIN,HOWEVER,THERE,THESE,TZD
128,954,AKT,FGFR3,INCREASED,INHIBITION,LABEL,LVI,METHODS,OBJECTIVE,OPG,RESULTS,TNF,TRAIL,UCS
207,234,696,CAUCASIAN,CAUCASIANS,GERMANY,HUNGARIAN,HUNGARY,PAKISTANIS,PHASE,SPANISH,VENEZUELA,VENEZUELAN
100,GERMANY,MDE,SINCE
007,010,108,169,177,233,CLASSIC,COPYRIGHT,INC,LABEL,LVI,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,193,COPYRIGHT,COX,DMA,FEW,FINALLY,INC,SMI,SMR,THEREFORE,URINARY
169,BCA,BLADDER,BMP,COPYRIGHT,FIFTY,INC,INCREASED,MED19,SILENCING,TRANSWELL
004,038,12Q13,B13,BLADDER,GLI,HOX,NMIBC,NON,PCR,URINARY
002,624,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS
FURTHER,LZTS2,THESE,TREATMENT,USING
000,100,285,591,COSTS,DISEASE,GIVEN,HOWEVER,INTENSITY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,TREATMENT
001,004,007,015,117,704,CANCEROUS,CIP2A,KNOCKDOWN,MEIER,MYC,PCR,T24,UCC,WESTERN
441,DEMOCRATIC,DNT,HOWEVER,LABEL,LAENDER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR
001,009,169,962,BACKGROUND,COPYRIGHT,LABEL,LIBRARY,LTD,METHODS,ORC,RCT,RESULTS,ROBOT,STUDIES
001,101,108,156,169,4EBP1,AKT,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
ANN,BLADDER,BLC,HOWEVER,LDA,STRUCTURE
BACKGROUND,CONCLUSION,DBT,DUE,LABEL,METHODS,STAGE
945,954,AMONG,ERK,FINALLY,JAK,JNK,MMP,THESE,U0126
100,169,AFTER,ARRAY,ECTOPIC,PCR,TAKEN
119,138,157,185,399,629,670,927,ASIAN,CAUCASIAN,CIS,FURTHER,LYS939GLN,ORS,XPC
250,BACKGROUND,CONCLUSION,DUE,HOWEVER,LABEL,METHODS,RESULTS,THROUGH
169,BLADDER,DESPITE
103,105,141,15A,182,183,18A,190,191,400,425,601,639,644,649,956,BCA,KIT,LABEL,METHODS,NMIBC,OBJECTIVE,PARIS,PCR,PURPOSE,RESULTS,TOTAL
173,215,278
INC,OWING,PUBLISHED,SEVERAL,SMALL
169,BOWEL,COPYRIGHT,INC,MEDICAL,PUBLISHED,V50GY
100,123,169,300,352,BACKGROUND,CONTINUOUS,COPYRIGHT,ESTIMATED,INFECTIONS,KRUSKAL,LABEL,MARIONETTE,METHODS,OBJECTIVE,OUTCOME,OVERALL,PUBLISHED,QUALITY,RESULTS,RICIC,RICUD,ROBOT,SETTING,THERE,UROLOGY
169,956,ARRAY,AUSTRALIAN,CHRONIC,COMET,COPYRIGHT,DETECTION,DIODE,ERS,GIVEN,INC,IONISATION,PREVIOUSLY,SEA,SOCIETY,SPRAY
169,954,AKT,ATP,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,P2Y11,PATIENT,RESULTS,SIX,WESTERN,Y11
000,100,128,132,156,169,AEU,APC,BACKGROUND,BETWEEN,C67,COPYRIGHT,ICD,INCIDENCE,INE,INSTITUTE,LABEL,METHODS,MODEL,MORTALITY,PERCENTAGE,PUBLISHED,RESULTS,SPAIN,STATISTICS
002,GSTA1,GSTP1,NUCLEAR,THESE
001,955,BLADDER,CYT,FAS,GCV,HSV,THEREFORE,WHILE
000,100,169,185,APRIL,BACKGROUND,BASEL,COPYRIGHT,LABEL,METHODS,REGARDING,RESULTS
019,169,301,COPYRIGHT,JANUARY,PUBLISHED,WHILE
AREAS,BACKGROUND,COVERED,LABEL,METHODS,NMIBC,OPINION,THEREFORE
AFTER,DRF,EXCRETION,NOVEL
CBCTS,CTV,FRACTIONS,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PTV,RESULTS
006,007,169,233,801,ADD,BCG,BJU,DESPITE,FURTHER,KNOWN,LABEL,METHODS,NMIBC,NON,OBJECTIVE,RESULTS,SEVERAL,STUDIES,SUBJECT,TIS,UNLABELLED
FURTHER,IMMEDIATE,UPPER,USING
BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS,THERE,UCP
HOWEVER,OTHER
130,169,304,450,AEU,AIM,CONCLUSION,COPYRIGHT,CYP,LABEL,METHODS,OBJECTIVE,PROBE,PUBLISHED,RESULTS,XPC,XPG,XRCC1
COMPARING,ENDOCAN,NOTABLY,TAKEN,VEGFR
290,803,MGC,MTT,SUCROSE
100,ACCORDING,AMONG,BACKGROUND,BAJORIN,FURTHER,HENCE,IRINOTECAN,LABEL,METHODS,RESULTS,SIXTEEN
200,205,205HG,916,945,CONVERSELY,EMT,EPITHELIAL,FINALLY,POL,UC3,UC6
ANNEXIN,ANXB1,APOPTOTIC,FAS,PET,SFB,SINCE,STABILITY,THERE
823,C30,CYSTECTOMY,EORTC,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,QOL,RESULTS,THESE
107,169,BLADDER,COPYRIGHT,EXAMS,IRELAND,LABEL,LTD,METHODS,MRU,OBJECTIVE,OBJECTIVES,RESULTS,TCC
169,AFTER,BASEL,CDH13,COPYRIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TCC
BPV,EBH,HOWEVER,STUDIES,THERE
BLADDER,FGFR3,LOW,RAS
034,169,1M0,4N0,EIGHT,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,SEQUENTIAL,TUR,UROLOGICAL
169,BKV,WILEY
002,005,018,037,171,326,370,689,842,992,BETWEEN,COX,EASTERN,GROUP,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE
946,HOWEVER,MTT,PCR,RESULTS,SMAD4,T24,THEREFORE,WESTERN
169,800,BACKGROUND,COPYRIGHT,DUE,GCS,GRADE,INC,LABEL,METHODS,RESULTS,SIMON,THESE,TRIAL
169,663,AMONG,COPYRIGHT,HOWEVER,IRELAND,LTD,OVERALL
169,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,SWEDISH,UROLOGICAL
169,AVERAGE,COPYRIGHT,EDUCATION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TOTAL,TREATMENT,UROLOGICAL
169,ADDITIONAL,COPYRIGHT,EDUCATION,HEMATURIA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAMPLES,THREE,UROLOGICAL
001,011,368,6TH,7TH,ASIAN,COMMITTEE,JOINT,LABEL,METHODS,OBJECTIVE,RESULTS,TNM
947,AKT,ARG,ERK,FINALLY,FUNCTIONAL,KININ,MAP,PCR,RT4,SSR240612,T24,USING
BLADDER
ACR,ANA,CONCLUSION,DETAILS,EULAR,LABEL,METHODS,OBJECTIVE,RESULTS,SSC,THERE,THREE
100,169,BASEL,CONCLUSION,COPYRIGHT,ENDORECTAL,FNA,FORTY,HOPKINS,JOHNS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,176,946,956,ATP,COPYRIGHT,THESE,UROTHELIAL
160,169,947,BECAUSE,BHPRE,COPYRIGHT,HINDGUT,INC,KSM,PATHOLOGY,PUBLISHED,SOCIETY,STROMAL,THESE,WHEREAS
001,003,016,031,037,039,160,169,BACKGROUND,COPYRIGHT,CRT,DHI,FIF,LABEL,LTD,MATERIALS,METHODS,OAR,PTV,PUBLISHED,RESULTS,TEN
169,COPYRIGHT,CROWN,LTD,PEDIATRIC,PUBLISHED
169,241,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,FIFTY,LABEL,METHODS,PET,RESULTS
008,169,ANZ,AUSTRALIA,AUSTRALIAN,AUTHORS,BACKGROUND,BLADDER,CIS,COLLEGE,CONCLUSION,JOURNAL,LABEL,LARGE,METHODS,RCP,RESULTS,ROYAL,SOUTH,SURGERY,WALES
169,BRITAIN,COPYRIGHT,EPIDERMAL,GREAT,IRELAND,LEUCINE,LOH,LRIG1,LTD,MUTATIONS,PUBLISHED,SOCIETY,WILEY
006,007,160,BACKGROUND,COX,ENE,EXTRANODAL,LABEL,LND,METHODS,NEITHER,OVERALL,PROGNOSTIC,RESULTS,TNM
DOSES,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,002,004,012,016,037,169,AMONG,BACKGROUND,CIGARETTE,COPYRIGHT,CPD,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SMOKING,THERE,UCB,UROLOGY
100,101,118,123,128,169,200,COPYRIGHT,EDUCATION,IMIQUIMOD,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THERE,TLR,TMX,UROLOGICAL
055,060,065,086,126,168,169,964,COPYRIGHT,EDUCATION,END,INC,KENDALL,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEX,UROLOGICAL
133,AFTER,LABEL,METHODS,OBJECTIVE,RESULTS,T24,WESTERN
233,945,946,CLIC3,INCUBATING,WHILE
945,946,FRS
140,177,340,410,DBR,LABEL,METHODS,OBJECTIVE,RADICAL,RESULTS
CONCLUSION,EXTENSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN
169,COPYRIGHT,FINALLY,INC,THESE,WILEY
DESPITE,SUI
ACCEPTABLE,CONDUIT,ILEAL,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TECHNICAL
LABEL,MINIMALLY,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
169,199,388,587,AFTER,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,METHODS,MUSCULARIS,OBJECTIVE,PREDICTIVE,PUBLISHED,PURPOSE,RESULTS,SUBSEQUENT,T1A,T1B,THERE,UROLOGICAL
169,223,954,BACKGROUND,CONTEXT,COPYRIGHT,DENOSUMAB,FURTHER,LABEL,MET,METHODS,OBJECTIVE,OPTIMAL,OSTEOCLAST,PCA,PUBLISHED,RESULTS,SRC,SYNTHESIS,UROLOGY,ZOLEDRONIC
136,169,552,716,COMBINING,COPYRIGHT,EDUCATION,FGFR3,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RAS,RESULTS,UROLOGICAL
001,069,123,129,169,982,986,CONCEPTION,CONGENITAL,COPYRIGHT,EDUCATION,EPISPADIE,FEDERAL,GERMANY,HOWEVER,INC,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,URO,UROLOGICAL,VITRO
001,003,169,283,576,859,ADDITIONAL,COPYRIGHT,COX,FINALLY,IHC,INC,PATHOLOGY,PROTEIN,PUBLISHED,SOCIETY,SPAIN,SPANISH,SWEDISH,TAIWANESE,UBE2C,WESTERN
120,124,137,146,169,664,916,AMONG,BACKGROUND,BCA,BISULFITE,COPYRIGHT,CPG,ECTOPIC,LABEL,METHODS,OBJECTIVE,OUTCOME,PBA,PUBLISHED,RESULTS,ROC,SETTING,T24,UROLOGY,USA
001,169,691,ACCORDING,AGGRESSIVE,BACKGROUND,COPYRIGHT,CRT,DESPITE,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,T4A,THESE,TREATMENTS,UROLOGY,USING
169,177,CD44A,CD44S,COPYRIGHT,DIFFUSE,INC,RAD
002,174,AIM,CONCLUSION,CREMOPHOR,DISCUSSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIGMA,TARGETING,USA
012,017,026,071,093,101,104,190,234,359,365,634,677,717,724,916,BCG,CIS,COX,IVT,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THERE,UCB
003,004,005,215,CONCLUSION,INTENSE,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,RESULTS,SUVMEAN
169,956,BMDLS,CELLS,COPYRIGHT,INC,LOELS,NOELS,SIMILAR,THISSTUDY,WILEY
169,ACCORDING,ASC,AUC,BACKGROUND,COPYRIGHT,GREATER,HOPKINS,JOHNS,LABEL,METHODS,PATHOLOGY,RESULTS,SOCIETY
169,217,290,AUC,BACKGROUND,COPYRIGHT,LABEL,METHODS,RESULTS,SOCIETY,URINE
169,AGE,AUTHORS,BJU,CONCLUSION,GLEASON,HOWEVER,JANUARY,LABEL,LOCAL,METHODS,NORTH,OBJECTIVE,PSA,RESULTS,RRP,THERE,UNLABELLED
BLADDER,CURRENT,CURRENTLY,ORC,ROBOT,THERE
324,954,983,AGREEMENT,ALGORITHM,BLADDER,DISCUSSION,ENGLAND,GIVEN,HOWEVER,LABEL,LOWER,METHODS,OBJECTIVE,OBJECTIVES,REGRESSION,RESULTS
001,002,006,007,029,031,032,101,307,342,946,EXPRESSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS,TNM,TUBB1,TUBB2,TUBB3,TUBB4,UCB
014,124,220,956,ARSENIC,BLOOD,HOWEVER,TUNISIA
200,345,545,ARG,BESIDES,CAUCASIANS,CIS,FINALLY,FIXED,HOWEVER,ORS,PRO
ACCORDING,ADM,AMONG,ANNEXIN,ANXA2,CONCLUSION,LABEL,MALDI,MDR,METHODS,OBJECTIVE,PCR,PROTEIN,PURPOSE,RESISTANCE,RESULTS,TOF,WESTERN
001,014,025,118,169,177,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MODULES,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERE
169,AES,BASED,BCG,DESPITE,HOWEVER,SINCE,TH1
101,169,177,958,BJU,LABEL,LVI,METHODS,OBJECTIVE,OVERALL,RECORDS,RESULTS,SIX,THESE,TUR,UCB
DEFINITIVE,EAR,ERR,HOWEVER,LSS,RADIATION,SINCE
160,AMONG,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,TURBT

142,147,150,160,BACKGROUND,CAUSE,CLOSE,CONCLUSION,LABEL,METHODS,PATIENT,RESULTS
BACKGROUND,CONCLUSION,DSRCT,FDG,FORTY,FUNCTIONAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PERTINENT,PET,RESULTS,SIXTY
ELISA,HENCE,TCC
124,DESPITE,EUROPEANS,PREVOTELLA,THESE
AGE,LABEL,LOW,METHODS,OBJECTIVE,QALYS,RESULTS,SIMULATION,THESE
169,COPYRIGHT,INC
AFTER,AGGRAVATED,DIAGNOSIS,EARLY,LABEL,METHODS,OBJECTIVE,RESULTS,URINARY,URODYNAMIC,UROLOGICAL
169,ATP,SOCIETY,TREATMENT
3T3,947,EXPRESSION,FGF,FGFR3,IMD,MIM,NIH,PLC,RAC,TACC3,THESE
389,956,DAB,EGF,HISTOLOGIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMULATING,TREATMENT,USING
115,169,808,AUC,BACKGROUND,COMBINING,COPYRIGHT,ELISA,LABEL,METHODS,NEWER,NMP22,RESULTS,SOCIETY
107,169,BASEL,COPYRIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,TCC
169,ACUTE,BLACKWELL,CANDIDA,CANDIDEMIA,HOWEVER,THERE
138,143,145,152,166,169,182,204,804,921,COPYRIGHT,EXPRESSION,NMIBC,PCR
HOWEVER,LABEL,OBJECTIVE,PPI,PURPOSE,RESULTS,SUMMARY
140,169,564,CHINESE,COPYRIGHT,EDUCATION,FANGCHI,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROCESSING,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
035,169,781,CONVERSELY,COPYRIGHT,EDUCATION,END,GOING,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,REDUCTIONS,RESULTS,SECONDARY,SKILLED,UROLOGICAL
001,169,CHICAGO,CLEVELAND,COMMITTEE,COPYRIGHT,EDUCATION,INC,IQR,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RATES,RESULTS,UNIVERSITY,UROLOGICAL
000,176,231,233,2ND,3RD,AFP,AFTER,AIEOP,AUTHORS,BACKGROUND,CLOACAL,CURRARINO,DISEASE,EMATOLOGIA,GROUP,LABEL,LABORATORY,METHODS,ONCOLOGICA,ONCOLOGIE,PEDIATRICA,RESULTS,TABLE,THERE,YST
169,233,BACKGROUND,BESAG,BYM,COPYRIGHT,INTEGRATED,LABEL,LAPLACE,LTD,METHODS,MIXED,MOLLI,OBJECTIVE,OBJECTIVES,POISSON,POPULATION,RESULTS,SPANISH,SPECIAL,USING,WASTE
038,039,100,163,169,177,179,246,BETWEEN,COPYRIGHT,DESPITE,EDUCATION,INC,INCREASED,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TRIAL,UROLOGICAL,UROLOGISTS
005,169,BETWEEN,COPYRIGHT,EDUCATION,ILEAL,INC,INCREASING,LABEL,MATERIALS,METHODS,OBJECTIVE,ORTHOTOPIC,OVERALL,PAD,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,COPYRIGHT,DESPITE,EDUCATION,III,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,TNM,UROLOGICAL
169,BECAUSE,COPYRIGHT,COX,EMT,FURTHER,INC,METASTASIS,SNAIL,T24,UNDER
169,ASSESSMENT,CONCLUSION,CONFUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
001,008,018,169,APOPTOSIS,BLADDER,CONCLUSION,COPYRIGHT,EXPRESSION,INC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS,SILENCING,T24
169,200,947,ADP,C3H,COPYRIGHT,ECTOPIC,GIVEN,HEN,LTD,MBT,PET,PRE,WESTERN
AREAS,LESIONS,MRI,PAGET
233,HOWEVER
277,APRIL,BETWEEN,DEPARTMENT,ESPECIALLY,FIFTY,JANUARY,LABEL,METHODS,NMP22,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE,UROLOGICAL,UROLOGY
169,945,COR,HDAC3,HDAC4,HIF,HOWEVER,III,RES,THROUGH
657,942,BACKGROUND,EARLIER,ENGLAND,III,LABEL,METHODS,RESULTS,STAGE,THERE
000,001,100,349,613,BETWEEN,MEIER,TNM
169,403,446,849,ADD,BJU,CONCLUSION,COX,DSS,FURTHER,HOWEVER,KNOWN,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,RFS,RNU,SUBJECT,UNLABELLED
CYSTOSCOPY,UROTHELIAL
100,169,BASEL,COPYRIGHT,LABEL,METHODS,OBJECTIVE,RESULTS
034,169,BACKGROUND,COPYRIGHT,INC,LABEL,METASTATIC,METHODS,NSE,PFS,RESULTS,SCC,SCCUT,SERUM,SMALL,THERE
150,169,ADD,BECAUSE,BJU,BLADDER,COX,CSS,DESPITE,KNOWN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SINCE,SUBJECT,THERE,THREE,TURBT,UNLABELLED
BLADDER,MOTIVATED,RMS,WHILE
010,016,038,100,101,130,145,169,945,946,ESTRADIOL,FIFTY,INC,MEIER,THESE,UDP,UGT1A,WILEY
010,078,137,143,144,162,166,292,357,469,742,761,778,861,897,921,952,984,992,ASP148GLU,JAN,OVERALL,PUBLISHED,SIMILARLY,STATA
169,254,558,861,COPYRIGHT,DUTCH,EDUCATION,FGFR3,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,APRIL,COPYRIGHT,EDUCATION,EORTC,EVALUATING,EVALUATION,FDG,INC,LABEL,MATERIALS,METABOLIC,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,SOLID,TREATMENT,UROLOGICAL
169,COPYRIGHT,EASTERN,EDUCATION,EIGHT,FURTHER,GROUP,HOWEVER,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,169,174,196,200,ALLELIC,BACKGROUND,COPYRIGHT,DEL,FUNCTIONAL,IMPAIRMENT,INC,LABEL,METHODS,NORTH,OBJECTIVE,PCR,PUBLISHED,RESULTS,SNP,THR399ILE
169,250,707,739,796,834,885,930,956,BCAS1,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MYC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,ROC,THEREFORE,THESE,UCF,URINE
169,242,756,COPYRIGHT,COX,INC,LABEL,LNS,MATERIALS,METHODS,MEYER,NSS,OBJECTIVE,PURPOSE,RESULTS,TIS
001,065,116,169,419,498,4N0M0,634,721,891,COPYRIGHT,COX,CRR,INC,LABEL,MATERIALS,MEIER,METHODS,NAC,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PRR,RESULTS,THERE,THESE,VAC
009,169,233,AFTER,BACKGROUND,BCG,COPYRIGHT,COX,LABEL,METHODS,NMIBC,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,THERE,TIMES,TRIAL,UROLOGY
THERMAL
THESE
150,169,500,956,BFD,BLACKFOOT,CONCLUSION,COPYRIGHT,HOWEVER,INC,INCLUSION,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS
100,169,177,AMICO,BACKGROUND,BLADDER,CONCLUSION,COPYRIGHT,FIFTY,INC,LABEL,MEIER,METHODS,PCA,PSA,RESULTS,WATER
000,169,233,350,BCG,BLACKWELL,CYSTOSCOPY,EXCLUDING,HOWEVER,III,LTD,MITOMYCIN,PALLIATIVE,PHASE,PUBLISHING,RADICAL,TCC
011,ADRIAMYCIN,BACKGROUND,HOWEVER,III,LABEL,METHODS,PFS,PHARMANELL,RESULTS,TRIAL
115,145,215,245,CONCLUSION,CONFIRMED,LABEL,METHODS,MTD,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SEVENTY
123,162,CUTANEOUS,DESPITE,III,METASTASES,PROX1,TCC,THREE
231,CPG,HOWEVER,INCREASED,MDA,MECP2,NF1,NRE,PREVIOUSLY,WESTERN,WHILE
945,947,AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPINION,SINCE
160,215,MRI,THYROID,TOTAL,TRU
BUFALIN,ERK,MMP,PD98059,T24,TER,THESE,TJS
169,2CC,BACKGROUND,COPYRIGHT,CTV,D90,DEPENDING,DVH,HOWEVER,IRELAND,LABEL,LTD,METHODS,MRI,OAR,OBJECTIVE,PRESCRIBED,PURPOSE,RESULTS
169,ACC,AKT,AMPLIFIED,CAIP6,COPYRIGHT,IP6,LTD,MEANWHILE,NPACC,PREVIOUSLY,T24
124,169,AIM,AUTHORS,CONCLUSION,HOWEVER,JOURNAL,LABEL,LTD,METHODS,OBJECTIVE,PACIFIC,PTY,PUBLISHING,RADICAL,RESULTS,RFS,WILEY
169,COPYRIGHT,DIAGNOSIS,EXAMPLE,UROTHELIAL,VCH,WILEY
169,A10,BLADDER,COPYRIGHT,CTA,CURRENT,NMIBC,SEVENTY,THESE
005,006,010,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,PCR,REDUCED,RESULTS,WESTERN
386,AMG,APRIL,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM,THESE,TREBANANIB
164,169,174,APRIL,CISPLATIN,COPYRIGHT,EDUCATION,III,INC,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVEN,SINCE,UROLOGICAL
001,004,045,169,233,239,COPYRIGHT,EDUCATION,INC,IRRITATIVE,LABEL,MATERIALS,METHODS,OBJECTIVE,OXYBUTYNIN,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL,WHILE
169,233,AFTER,COPYRIGHT,DOCETAXEL,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,UROLOGICAL
114,169,BASED,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVEN,UROLOGICAL
400,460,635
169,279,586,CAUSE,CHINA,CHINESE,CHRYSOTILE,OTHER,THEIR
005,017,019,047,169,174,176,360,ARC,CONCLUSION,COPYRIGHT,DESPITE,FURTHER,LABEL,LTD,MATERIALS,MEDICAL,METHODS,MLC,MLCI2,MODULATED,OBJECTIVE,PHILIPS,PUBLISHED,PURPOSE,RESULTS,SYNERGY,SYSTEMS,THERAPY,TPS,VOLUMETRIC
001,169,611,CYSTOSCOPY,LABEL,LIBRARY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCIENCE,SEVEN,UROLOGICAL,WEB
001,035,045,050,121,247,BACKGROUND,COX,LABEL,MEIER,MEMBRANOUS,METHODS,NUCLEAR,PUC,RESULTS,SIXTY,UCS
048,144,169,761,AUTHORS,BJU,IQR,LABEL,METHODS,NMIBT,OBJECTIVE,RESULTS,THRESHOLDS,TUMOURS
169,197,904,967,LABEL,METHODS,OBJECTIVE,PEARSON,RESULTS,UROLOGICAL
AFTER,AICBT,CTV,D50
143,145,169,AKT,COPYRIGHT,IRELAND,LTD,SILENCING,SNK57,T24
160,169,CONCLUSION,COPYRIGHT,GM3,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,T24,WESTERN,YTS
118,250,472,64257,HODGKIN,HOWEVER,NHL,RELATIVELY,RISKS,SMN
003,006,015,017,046,050,177,231,335,ACTUARIAL,BACKGROUND,COX,LABEL,METHODS,PATHOLOGIC,RESULTS,STSMS,UNIVARIATE

CARCINOMA,DIAGNOSIS,HOWEVER,PCR,WESTERN
LGV,STI,TREPONEMA
AFTER,BECAUSE,CYTOKININS,EARLY,SINCE,T24
AMONG,BELOW,ENGLISH,LIMITED,SIXTEEN
CRAVE,GSS,MAF,ULTIMATELY
018,040,047,109,169,199,321,818,911,BACKGROUND,COPYRIGHT,COX,EXPRESSION,IAP,INC,LABEL,METHODS,NEITHER,NIMBC,NMIBC,RFS,TUR,WILEY
045,105,386,AFTER,COX,CSS,LABEL,LVI,MEIER,METHODS,OBJECTIVE,PURPOSE,RCT,RESULTS,SEX,THEREFORE,THESE,TURBT
104,169,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,URACHAL,UROLOGICAL
BACKGROUND,BLADDER,CONCLUSION,INDEX,LABEL,LOWER,METHODS,OBJECTIVE,PATIENT,QOL,RESULTS,SYMPTOM
169,AREAS,AUSTRIA,BACKGROUND,BCA,BLADDER,CONTEXT,COPYRIGHT,LABEL,METHODS,OBJECTIVE,ONGOING,PATHOLOGY,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY
169,COPYRIGHT,DEVELOPED,IRELAND,LTD
169,AFTER,AIM,BACKGROUND,CYSTECTOMY,HOPKINS,IPP,JOHNS,LABEL,METHODS,OBJECTIVE,RADICAL,RESULTS,RETZIUS,SOCIETY,THERE
169,LAPRA,REGARDING,UROLOGICAL
100,178,190,AIM,BACKGROUND,FEW,LABEL,METHODS,NMIBC,OBJECTIVE,PUNLMPS,RESULTS,SEVERAL,THERE,UCS
30D,DESPITE,GRP78
052,BACKGROUND,CIGARETTE,CIS,CONCLUSION,GBC,HOWEVER,JANUARY,LABEL,MEDLINE,METHODS,RESULTS,SUMMARY,THERE,THESE
169,177,AUR,CONCLUSION,COPYRIGHT,CTU,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,THREE
150,159,169,302,ADDITIONAL,BLADDER,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,5MM,AIM,COPYRIGHT,CROSS,FIFTY,LABEL,LTD,LYMPH,METHODS,MRI,NPV,OBJECTIVE,PPV,RESULTS,SEVENTY,USPIO
007,009,051,100,169,AKT,COPYRIGHT,INC,SEVERAL,WHOLE
169,2ND,BLADDER,CONTEXT,COPYRIGHT,CYSTOSCOPY,LABEL,LARGE,MEDLINE,METHODS,MOLECULAR,OBJECTIVE,PHYSICIANS,RESULTS,SYNTHESIS,URINE,UROLOGY,WHITE
169,2ND,BACKGROUND,BLADDER,CONTEXT,COPYRIGHT,LABEL,LARGE,MEDLINE,METHODS,OBJECTIVE,PROVIDING,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY
233,AAA,BCG,MYCOTIC
001,003,158,169,598,856,BACKGROUND,COPYRIGHT,COX,CSS,ENE,HOWEVER,LABEL,LND,LNS,METASTASIS,METHODS,OBJECTIVE,OUTCOME,PERINODAL,PUBLISHED,RESULTS,SETTING,UCB,UROLOGY
FORTY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,UIA
ASSESSMENT,GLEASON,HOWEVER,INCIDENTAL,INCREASED,PCA,PSA,RCP,YET
999,ABOUT,ARIZONA,DVT,THERE
100,180,305,405,500,FOLEY,LABEL,METHODS,NERVE,OBJECTIVE,RESULTS
003,011,036,047,059,109,124,134,169,268,325,418,564,602,685,773,ASIAN,BACKGROUND,CAUCASIAN,CONCLUSION,COPYRIGHT,ELECTRONIC,HOWEVER,LABEL,METHODS,RESULTS,STUDIES
954,BACKGROUND,CLE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WLC
169,COPYRIGHT,EVALUATION,LTD,WILEY
BERBERINE,PCR,T24,THEREFORE,WESTERN
160,2242T,3725C,3725G,436,522,ASP299GLY,BLADDER,CHI,CHINESE,RESULTS,THR399IL3
160,916,936,AKT,BAICALEIN,BAX,BCL,CHINESE,RECURRENCE,T24,TURBT
077,169,BOWEL,BRISTOL,COPYRIGHT,EDUCATION,INC,LABEL,LOWER,MATERIALS,MEN,METHODS,NUTRITION,OBJECTIVE,PUBLISHED,PURPOSE,REPORTING,RESULTS,SCALE,STOOL,THESE,UROLOGICAL
001,112,169,177,937,956,CONSISTENT,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,T24,UROLOGICAL
001,005,009,032,038,101,169,177,BACKGROUND,BLADDER,CONCLUSION,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,RESULTS,RFS,TCC,UNIVARIATE,UUT
100,101,159,170,314,353,409,DLS,EARLY,GBC,HOWEVER,LABEL,MAY,METHODS,OBJECTIVE,OTHER,RESULTS,UDL
100,EXPRESSION,HOWEVER,LOW,PCR,UNC5B,WESTERN
001,002,160,312,361,CHINA,CHONGQING,ORS,PCR
CONCLUSION,COX,FIG,HOWEVER,HUASHAN,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
821,CUMULATIVE,EIGHT,FDR,LYNCH,MANCHESTER,PSA,UPPER,UROLOGICAL
313,428,457,A313G,CAUCASIANS,CHINA,GSTM1,GSTP1,GSTT1,KNOWLEDGE,STUDIES
006,022,103,414,913,BECAUSE,LVI,MS5,THEREFORE
064,160,176,177,956,INFUSED,LASER,SWNHS,UCC
160,BACKGROUND,CONCLUSION,CURRENT,ENGLISH,LABEL,MEDLINE,METHODS,RESULTS,UCC
075,160,169,482,ACTUARIAL,CIS,COX,EXISTENCE,IQR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RNU,THESE,USING
028,160,174,231,261,ABI,BLADDER,GENOTYPING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNP,USING
AG85B,BAX,BCG,HENCE,MTT,PCR,THEREFORE,WESTERN
043,169,652,678,814,825,976,ASIAN,BASEL,CIS,CONCLUSION,COPYRIGHT,FIXED,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTEEN,STRATIFIED
559,EVERY,SWEDISH
169,BECAUSE,LTD,PTY,PUBLISHING,URACHAL,URC,WILEY
009,010,128,154,169,282,367,COPYRIGHT,CROWN,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEPTEMBER,URINARY
RADICAL
169,396,685,790,AGE,BJU,LABEL,METHODS,OBJECTIVE,PCA,RESULTS
169,ICS,SEVERAL,SOCIETY,THERE
1A1,945,947,AHR,CONSISTENT,EJ138,ICT2700,NEGLIGIBLE,RT112
214,774,774CC,774TT,908,CHINESE,T24,THESE,UTR
169,172,791,852,CIS,COPYRIGHT,COX,NUTRITION,PREVENTION,RRS,THERE,THESE
169,174,4N0M0,4TH,8TH,AMONG,CONVERSELY,COPYRIGHT,DUE,EDUCATION,ENGLISH,HOWEVER,INC,LABEL,LEVEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,THEREFORE,UROLOGICAL,UROTHELIAL,WHILE,WOMEN
169,COPYRIGHT,III,IRELAND,JANUARY,LTD,MAJOR,MEDLINE,PREDICTIVE,RANDOMIZED,THROUGH
026,169,381,645,ACUTE,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
169,CERTAIN,COPYRIGHT,FINALLY,JOHNSON,LTD,WILEY
169,CONTROL,COPYRIGHT,EXPRESSION,HRP,REDUCTION,RT112,THESE
100,135,169,300,400,762,800,COPYRIGHT,EDUCATION,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROBOTIC,UROLOGICAL
003,105,169,699,COPYRIGHT,COX,CURRENT,DISEASE,EDUCATION,G1PTA,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,016,027,169,208,237,713,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QUALITY,RESULTS,UROLOGICAL
0MG,169,738,AGS,AUSTRALIA,BACKHOUSIA,CAA,CBMNCYT,CCD,COPYRIGHT,CROWN,HEPG2,INT,LAURACEAE,LTD,MUELL,MYRTACEAE,PUBLISHED,TASMANNIA,THREE,TPL,VICKERY,WINTERACEA
001,048,056,160,177,178,364,ASA,AUSTRIA,BACKGROUND,CSS,LABEL,LOCAL,METHODS,RESULTS,RNU,THROUGH
001,176,ELISA,HNP,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,174,AFFYMETRIX,CCNG1,COPYRIGHT,EXPRESSION,HISTONE,INC,WHSC1L1,WILEY
116,800,AUC,BACKGROUND,BETWEEN,DFS,HOWEVER,LABEL,MARCH,MEIER,METHODS,RESULTS,SECONDARY
169,260,470,730,850,ARSENIC,COPYRIGHT,SEPTEMBER,UCS,UUTUC
169,174,ADDITIONAL,INK4A,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SIXTEEN,WILEY
132,169,BLADDER,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
169,BIM,COPYRIGHT,INC,JNK,SALUBRINAL,T24,TRAF2,URSOLIC
169,233,945,946,954,CCL20,COPYRIGHT,CXCL1,CXCL2,EDUCATION,GRD,HMGB1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIOR,PUBLISHED,PURPOSE,RDG,RESULTS,RGD,UROLOGICAL
200,250,320,BASED,GEOMETRIC,MTD,VINFLUNINE
169,2ND,BACKGROUND,BLADDER,CLAVIEN,CONTEXT,CONTINENCE,COPYRIGHT,ENGLISH,LABEL,METHODS,OBJECTIVE,RENAL,RESULTS,SYNTHESIS,THEREFORE,URINARY,UROLOGY
CIS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,T2A,T2B,T3A,T3B,T4A
169,COPYRIGHT,HTB,SLK,T24
829,APRIL,ASSESSMENT,BACKGROUND,BETWEEN,COMMITTEE,GBC,III,JOINT,LABEL,METASTASES,METHODS,RADICAL,RESULTS
BALKANS,HOWEVER,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PURPOSE,RESULTS,UPPER
160,BACKGROUND,CUMULATIVE,EIGHT,LABEL,LOCAL,MEIER,METHODS,RESULTS,WHETHER
SMALL
001,006,026,037,110,169,190,233,494,699,809,BACKGROUND,BCA,CAMILLE,CARCINOMA,COPYRIGHT,COX,CROWN,DISEASE,DSM,FEW,LABEL,METHODS,OBJECTIVE,OTHER,OUTCOME,PUBLISHED,RESULTS,SETTING
169,233,BCG,CONNAUGHT,COPYRIGHT,EDUCATION,GLAXO,INC,J82,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RT4,RUSSIAN,T24,UROLOGICAL,WHILE
169,ALB,COPYRIGHT,INC,LABEL,MASP2,METHODS,OBJECTIVE,RESULTS,SWISS,WESTERN
160,169,ACTII,COLLEGE,COPYRIGHT,IMRT1,IMRT2,IMRT3,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PHASE,PTV,PUBLISHED,REDUCTIONS,RESULTS,ROYAL,TEN,THREE,WHILE
169,BACKGROUND,BLADDER,CIS,CONTEXT,COPYRIGHT,LABEL,MEDLINE,METHODS,NMIBC,OBJECTIVE,PUBLISHED,RESULTS,SYNTHESIS,UROLOGY,UROTHELIAL
001,169,AFTER,BETWEEN,BJU,LABEL,LEVEL,METHODS,OBJECTIVE,OVERALL,PROGNOSIS,RESULTS,THERAPY,UNIVARIATE,UNLABELLED
004,BMS,FURTHER,PTV,PUBLISHED,TEN,THERE,V10,V15,V20,V30,V40,V50,WHOLE
048,BKV,EBV,HHV,HPV,HSV,JCV,PCR,VARICELLA
001,011,034,169,933,COX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UROLOGICAL
106,150,153,180,375,900,AVERAGE,FOLEY,INVENTORY,LABEL,MARCH,MEN,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS,RSP,SCORE,SYMPTOM,THREE
000,100,182,780,945,946,ACTIVATION,ADP,BLADDER,EXPRESSION,ICI,NOTABLY,RT4,THESE,TREATMENT,USA,USING

156,BACKGROUND,BPH,CURRENT,DEVICES,FIRST,LABEL,MAY,MEDICAL,METHODS,RESULTS
160,1A1,1A2,257,282,2B7,AMONG,ARYLAMINES,GENOTYPES,LABEL,METHODS,NAT,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SMOKING,UDP,UGT
160,950,A375P,ERBB2,PC3MLN4,SN12C,SN12PM6,TAKEN,THESE,USING
169,APOPTOSIS,BACKGROUND,BLADDER,COPYRIGHT,ELISA,INC,LABEL,METHODS,MTT,OBJECTIVE,OBJECTIVES,RESULTS,T24,TAURINE,WILEY
641,CUP,GERMANY,HODGKIN,HOWEVER,RRS,SWEDISH
CONCLUSION,GROUP,LABEL,METHODS,MMP,OBJECTIVE,PCR,POSITIVITY,RESULTS,URINE
169,654,BASED,BJU,BLADDER,COSTING,LABEL,LEVEL,LOW,MATERIALS,METHODS,NMIBC,OBJECTIVE,PIC,RESULTS,SCALE,SIMILARLY,THERAPY,THESE,TURBT,UNLABELLED,VALUE
PERFORMING
211,285,AFTER,BLADDER,HEALTHCARE,LABEL,LVI,METHODS,OBJECTIVE,RESULTS,SOUTHEAST,STAGE,THEREFORE,UCB,WORLD
458,461,956,BAVARIA,CONCLUSION,CURRENT,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS
002,085,169,COPYRIGHT,EFFECTS,EXPRESSION,HDAC2,HDAC4,HDAC5,HDAC7,HDAC8,HDACI,HDACS,INC,LABEL,MATERIALS,METHODS,NUC,OBJECTIVE,PCR,PROMINENT,RESULTS,UCC,VORINOSTAT,WHETHER
002,130,169,254,438,BACKGROUND,COPYRIGHT,IHC,INC,IQR,KAZAL,LABEL,MATERIALS,METHODS,RESULTS,UCB
007,014,169,COPYRIGHT,INC
169,233,AUSTRIA,BACKGROUND,BCG,BLADDER,CIS,CONTEXT,COPYRIGHT,HOWEVER,LABEL,MARCH,METHODS,OBJECTIVE,PUBLISHED,RADICAL,RESULTS,STROMAL,SYNTHESIS,THESE,UROLOGY
001,002,003,169,549,BJU,COX,KNOWLEDGE,LABEL,LEVEL,METHODS,OBJECTIVE,OVERALL,RESULTS,THERAPY,THESE,UNLABELLED
001,012,036,169,239,512,948,AGE,BJU,CALIFORNIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE,UNIVERSITY
100,169,238,ADD,BJU,KNOWN,LABEL,MEDLINE,MESHS,METHODS,OBJECTIVE,RCT,RESULTS,SUBJECT,UNLABELLED,URINARY,VARIOUS
169,CANCERS,CNS,COPYRIGHT,HODGKIN,INCIDENCE,MIXTURE
006,241,319,947,ATM,ATR,DDR,FGFR3,H2A,OVERALL,SNP,STRIKINGLY,TIPIN,TMA,UNIVARIATE
0MM,169,1MM,2MM,3DCRT,8MM,931,963,ATLAS,COLLEGE,CONCLUSION,CONTOURING,COPYRIGHT,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,RADIATION,RESULTS,ROYAL,SOCIETY,SYSTEMATIC,THERAPY,TREATMENT
001,003,036,169,AMONG,BACKGROUND,CIGARETTE,COPYRIGHT,CPD,LABEL,METHODS,NMIBC,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SMOKING,THERE,THESE,UROLOGY
000,018,019,160,169,215,468,572,COPYRIGHT,HODGKIN,LTD,PERIPHERAL,PUBLISHED,VII
169,COPYRIGHT,INC,LABEL,MAY,METASTATIC,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS
001,169,233,239,BACKGROUND,BCG,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,URINE,UROLOGY
AG490,DIM,EFFECTIVE,HOWEVER,J82,JANUS,KNOCKDOWN,MIGRATION,RT112,RT4,STAT1,STAT3,STAT5,T24,TAKEN,UMUC3
169,BACKGROUND,CLAVIEN,CONTEXT,COPYRIGHT,DELAY,FURTHER,LABEL,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SYNTHESIS,UROLOGICAL,UROLOGY
169,APRIL,BACKGROUND,BLADDER,CISPLATIN,CONTEXT,COPYRIGHT,LABEL,MEDLINE,METHODS,NOVEL,OBJECTIVE,PATHOLOGIC,PUBLISHED,RESULTS,SUFFICIENT,SYNTHESIS,UROLOGY
001,169,BACKGROUND,COPYRIGHT,DSS,HOWEVER,LABEL,METHODS,PATHOLOGIC,RESULTS,SEQUENTIAL,SOCIETY,T3B,T4A,THERE,VARIANT
GAPDH
001,017,019,040,048,169,192,342,EXPRESSION,HOWEVER,UROLOGICAL,WORLD
016,ACTUARIAL,GROUP,INITIAL,JANUARY,LNS,RADIATION,RECURRENCE,THERAPY,THEREFORE
174,BACKGROUND,DESPITE,DIRECTIONS,HENCE,HODGKIN,III,LABEL,NEWER,NOVEL,PHASE,RESULTS,THEREFORE
486,946,FUNCTIONAL,HOWEVER,TAKEN,TGF
169,175,CONCLUSION,GRADE,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,TCC,WILEY
169,BASED,TAKEN,UROLOGICAL
169,237,284,AWARENESS,BACKGROUND,COPYRIGHT,INDEX,LABEL,METHODS,PREDICTORS,RESULTS,SOCIETY,THEREFORE,VTE
001,113,CIS,CYT,ELISA,FALSE,LABEL,METHODS,NMP22,OBJECTIVE,PURPOSE,RESULTS
160,169,COLLEGE,CONCLUSION,COPYRIGHT,GRADE,HOWEVER,INADEQUATE,INDIA,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,COPYRIGHT,INC,MEDICAL,OAR,PTV,PUBLISHED,THEREFORE
001,129,169,177,321,BACKGROUND,BCA,COPYRIGHT,END,IHC,LABEL,LYNCH,METHODS,MMR,MUTATIONS,OBJECTIVE,ONTARIO,OUTCOME,PUBLISHED,RESULTS,SETTING,TORONTO,UROLOGY
001,007,169,375,748,BACKGROUND,COPYRIGHT,COX,ENE,HOWEVER,KNOWLEDGE,LABEL,LNM,LNS,LYMPH,METHODS,NORTH,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,UROLOGY
000,110,169,200,500,7TH,BACKGROUND,CONTEXT,COPYRIGHT,ENGLISH,INCREASING,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SMOKING,SYNTHESIS,UBC,UNION,UROLOGY,UROTHELIAL
174,CONCLUSION,DESPITE,DSS,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,RFS
BLADDER
11R,AZ12908010,AZD4547,BASAL,FGFR1,FGFR3,FGFRS,FIBROBLAST,KMS,SEQUENCING,THESE,V555M,Y373C
CENTRAL,CTCAE,HOWEVER,IOERT,LABEL,MEIER,METHODS,MORTALITY,NCI,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SIXTEEN
169,869,936,BIOVIEW,COPYRIGHT,EXACT,INC,UROVYSION,WILEY
002,012,014,018,019,034,048,058,169,186,842,981,COPYRIGHT,COX,DFS,ERCC1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGIC,PATIENT,PROGNOSTIC,PURPOSE,RESULTS
100,169,BACKGROUND,BLADDER,COPYRIGHT,FDR,INC,LABEL,MATERIALS,METHODS,NIMBC,NMIBC,OBJECTIVE,RESULTS,SAMPLES,SEVENTY
112,CHI,DAILY,EBI,GROUP,HDRBT,IIIC1,IIIC2,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGY,PURPOSE,RESULTS,SEPTEMBER,STATISTICS
110,160,AFTER,BCE,CIS,COLLINS,FACTORS,LABEL,METASTASES,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS,STAGE,THREE,TUI
169,COPYRIGHT,INC,INDIVIDUAL,METASTATIC,SES,UNIVERSITY,WILEY
146,200,206,265,500,622,ANALGESICS,BETWEEN,CONCLUSION,III,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
309,343,442,628,686,BACKGROUND,DIETARY,FFQ,HODGKIN,LABEL,METHODS,NHL,ORS,RESULTS
000,169,248,562,686,BPS,COPYRIGHT,COX,INC,INSURANCE,LABEL,METHODS,OBJECTIVE,RESULTS,WILEY
000,001,100,807,945,AFTER,CD138,CIS,OVERALL,ROC,THESE,USING
169,CBCTS,COPYRIGHT,CTS,CTV,DOSES,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RED,RESULTS
001,151,160,205,352,369,503,574,CONCLUSION,LABEL,LIKELIHOOD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,THERE,TORONTO,TURKU,UUT
001,004,007,009,023,025,026,169,215,381,ABOUT,AUTHORS,BJU,CSS,IQR,LABEL,LNS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UCB,WHILE
001,177,336,377,554,BACKGROUND,CYT,IMMUNOCYT,LABEL,MAKER,METHODS,NMP22,OVERALL,RESULTS,SEVERAL,URINARY,UROVYSION,UTI
001,100,169,201,828,ADD,BJU,KNOWN,LABEL,LVI,METHODS,NACTX,NOC,OBJECTIVE,PRE,PREDICTIVE,RESULTS,SUBJECT,TIS,TURBT,UCB,UNLABELLED,UPSTAGING
LLC,MBT,THERE,THESE
048,169,385,COPYRIGHT,COX,HOWEVER,INC,LABEL,LIFESTYLE,LITERATURE,MATERIALS,METHODS,NSAID,OBJECTIVE,PURPOSE,RESULTS,STATE,TEN,THERE,VITAL,WASHINGTON
014,177,276,369,CLAVIEN,EARLY,ESTIMATED,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THERE,WOMEN
100,GRADE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS
169,APOPTOSIS,BACKGROUND,BLADDER,COPYRIGHT,DICER,ELISA,INC,LABEL,METHODS,MICRORNAS,MTT,OBJECTIVE,OBJECTIVES,RESULTS,SILENCING,T24,WILEY
161,169,213,222,368,657,AMONG,CONCLUSION,COPYRIGHT,FIFTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RATES,RESULTS,TCC,THERE
001,103,169,218,362,450,4N0M0,ADD,BJU,FORTY,KNOWN,LABEL,MEIER,METHODS,OBJECTIVE,RADICAL,RESULTS,RNU,SUBJECT,UNLABELLED,UPPER
169,226,240,317,340,431,450,B12,BETWEEN,COPYRIGHT,EARLY,FUNCTIONAL,INC,JANUARY,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,945,BCA,BMP,COPYRIGHT,INC,TNF
PRIMARY
001,019,169,186,AKT,BACKGROUND,BCA,COPYRIGHT,CXCR4,CXCR7,ERK,LABEL,METHODS,RESULTS,SDF,SOCIETY,TRANSIENT
000,100,169,BACKGROUND,BECAUSE,COLORECTAL,COPYRIGHT,DIFFERENT,LABEL,METHODS,OVARIAN,REGRESSION,RESULTS,SCREENING,SOCIETY,TRIAL,USING
100,169,COPYRIGHT,GLEASON,HMB,INC,MALIGNANT,MELAN,SUBSEQUENT,URINE,WILEY
169,COPYRIGHT,CRT,INC,MEDICAL,PUBLISHED
169,2CM,2GY,945,946,ADVERSE,COPYRIGHT,D90,EARLY,ESCCS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
169,BACKGROUND,BCA,COPYRIGHT,LABEL,LVI,METHODS,OBJECTIVE,OUTCOME,OVERALL,PUBLISHED,RADICAL,RESULTS,SETTING,UROLOGY
001,006,169,BJU,BMI,LABEL,METHODS,OBESITY,OBJECTIVE,RESULTS,THEMAIN,UCB
003,017,169,184,52E,962,ADDITIONAL,CHINESE,HOWEVER,INC,MYC,TACC3,THESE,WILEY
CHOCHRANE,HOWEVER,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,013,157,169,614,967,AFTER,BACKGROUND,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OUTCOME,PEARSON,PUBLISHED,RESULTS,SECONDARY,SERUM,SETTING,SEVENTY,TPN,UROLOGY
003,018,169,174,17A,17F,301,446,ASSAY,GENOTYPING,INC,RESULTS,SNP,WILEY
BACKGROUND,BLADDER,CONCLUSION,LABEL,METHODS,SRC
169,COPYRIGHT,DVH,FBX,FOLEY,HOWEVER,LTD,MUPIT,PUBLISHED,TIB,TLD
005,127,141,147,169,177,192,781,892,COMPARING,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OTHER,RECURRENCE,RESULTS,RNU,THEREFORE
169,404,AFRICAN,CHANGES,COPYRIGHT,DESPITE,HVH,ICD,INC,LABEL,LVH,MATERIALS,METHODS,MVH,OBJECTIVE,OBJECTIVES,RESULTS,THERE,USING,VHVHS
020,026,032,042,108,169,233,235,910,AMONG,BACKGROUND,BCG,COPYRIGHT,EPIGENETIC,HOWEVER,HRS,LABEL,METHODS,NMI,OBJECTIVE,OUTCOME,PMF,PUBLISHED,RECURRENCE,RESULTS,SETTING,UNIVARIATE,UROLOGY
002,005,009,032,169,177,AFTER,COMMISSION,CONCLUSION,CONVERSELY,COPYRIGHT,D50,D98,DSC,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PLANS,PURPOSE,RADIATION,RESULTS,UNITS,V20,V50,V60,V70,V75
169,CEA,CK903,COPYRIGHT,INC,NAS,NUCLEAR,PSA
169,442,AMONG,COPYRIGHT,CTV,INC,LABEL,LFS,LOCAL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
354,500,750,ACUTE,CONFORMAL,EARLY,HYPOARC,LABEL,LOCAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
117,169,288,BJU,CIGARETTE,DISEASE,FACTORS,KETTERING,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,RESULTS,RNU,SLOAN,SOCIETY,TREATMENT,UNLABELLED,WHILE
100,169,585,950,969,AIM,AUTHORS,CONCLUSION,CONFORMAL,CTV,D90,GYNECOLOGY,IBT,JAPAN,JOURNAL,LABEL,METHODS,OBJECTIVE,OBSTETRICS,RESULTS,SOCIETY
001,002,003,014,026,035,169,233,309,BACKGROUND,COPYRIGHT,COX,CSS,LABEL,METHODS,OBJECTIVE,OUTCOME,PFS,PUBLISHED,RESULTS,RFS,SETTING,UROLOGY
CONCLUSION,CTC,CYSTOSCOPY,LABEL,MATERIALS,METHODS,NPV,OBJECTIVE,OUTCOME,PPV,PURPOSE,RESULTS
091,169,609,BACKGROUND,BCS,COPYRIGHT,CYSTOSCOPY,INC,LABEL,METHODS,NPV,PPV,RESULTS,ROC,UROSCREEN
006,169,339,416,469,AFTER,COPYRIGHT,COX,DIETARY,NUTRITION,THESE
000,169,956,ARRAY,COPYRIGHT,DNMT1,EXPRESSION,GENESPRING,IHC,INC,LABEL,MATERIALS,METHODS,MICROARRAY,MTT,NATURALLY,OBJECTIVE,OBJECTIVES,PANTHER,PROTEIN,RESULTS,THESE,THROUGH,TSA,USA,WESTERN
100,115,169,589,BACKGROUND,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TURBT,UCS,UROTHELIAL,VARIANT
001,004,011,169,173,422,593,COPYRIGHT,COX,CSS,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UUT
169,ABDOMINAL,COMPANY,COPYRIGHT,FURTHER,JOURNAL,LTD,PEDIATRIC,PUBLISHED,UROLOGY
001,169,785,ACTUARIAL,BACKGROUND,CIS,COPYRIGHT,CSS,EXCLUDING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PUBLISHED,RESULTS,RFS,RNU,SETTING,THERE,THREE,UROLOGY
001,004,012,169,200,275,CAB,CAP,CIS,COPYRIGHT,DIAGNOSIS,END,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHILE
169,233,800,A9303,AES,BCG,CIS,COPYRIGHT,DISEASE,III,INC,LABEL,LBAES,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PDE,RESULTS
000,100,166,169,184,249,548,803,AIM,AUTHORS,BRITISH,CONCLUSION,COX,GENERAL,JOURNAL,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY,SOCIETY
001,125,159,169,172,191,BACKGROUND,BETWEEN,COPYRIGHT,COX,DSS,EIGHT,FORTY,LABEL,MDACC,MEIER,METHODS,OBJECTIVE,OUTCOME,OVERALL,PUBLISHED,RESULTS,SETTING,SMALL,UROLOGY
007,047,160,450,673,906,ANOVA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UCC,UPPER,UUT
169,ACCORDING,COPYRIGHT,INC,PUC,WILEY
001,011,028,077,177,182,221,232,364,423,460,509,534,538,695,798,805,819,845,863,902,911,AVERAGE,DSS,LABEL,LYMPH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC
169,442,COMPETING,COPYRIGHT,INC,LABEL,LOCAL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
033,169,275,APRIL,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ONCOLOGIC,PUBLISHED,PURPOSE,RESULTS,SEVENTEEN,THERE
105,160,182,184,305,500,956,EIGHT,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WOMEN
001,003,020,026,042,169,183,221,COPYRIGHT,COX,FIFTY,HISTORY,INC,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RECURRENCE,RESULTS,RNU,USING
107,160,169,215,BACKGROUND,CONCLUSION,COPYRIGHT,DEFAULT,EUD,FINALLY,FWS,HENCE,LABEL,LTD,METHODS,MFS,OBJECTIVE,PFS,PUBLISHED,PURPOSE,RESULTS,TEN,THERE,TREATMENT
506,BACKGROUND,IMMUNOCYT,JANUARY,LABEL,METHODS,NPV,OBJECTIVE,OUTCOME,PPV,PUBLISHED,RECORDS,RESULTS,SCIMEDX,SETTING,THREE,USA,WITHOUT
109,169,1970S,1980S,285,348,BRUNN,COPYRIGHT,EXCLUSION,HOWEVER,INC,IUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROUTINE,UNTIL
169,APAZIQUONE,AUTHORS,BASED,BRITISH,EO9,JOURNAL,SOCIETY
009,015,054,169,171,418,COPYRIGHT,COX,CYP3A,ENGLAND,HOWEVER,NSAID,ORS,REGULAR
001,004,020,026,031,041,169,620,CIS,COPYRIGHT,FLT,INC,ITLVD,LABEL,LVD,LYMPH,LYMPHATIC,MATERIALS,METHODS,NTLVD,OBJECTIVE,PTLVD,RESULTS,TUR,UCB,VEGFR
105,139,169,613,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THESE,WILEY
156,169,177,315,316,500,783,BETWEEN,CONTINENCE,COPYRIGHT,INC,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PVR,RESULTS,THERE,URODYNAMIC
132,169,250,500,956,COPYRIGHT,HOWEVER,INC,LABEL,LIM,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SH3,TCC,WESTERN
154,169,BECAUSE,COPYRIGHT,FINALLY,KENNARD,LARGE,PCA,STONE
102,131,598,DIAGNOSIS,LABEL,METHODS,OBJECTIVE,PRE,PURPOSE,QOL,RESULTS,TRAIT
169,COPYRIGHT,INC,PCR,WILEY
945,946,EXOGENOUS,HOWEVER,KU7,RAL,RALGAPS,RALGEFS,RAS
DCP,DUE,EARLY,FUNCTIONAL,MRI,TECHNICAL
002,006,160,177,731,862,APRIL,CONCLUSION,DVC,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
169,ADVERSE,AES,AFTER,ART,BLADDER,COPYRIGHT,HAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PDT,SEVENTEEN,TRANSIENT,UCC,WORLD
AKT,E542K,E545K,HELICAL
169,253,COPYRIGHT,EMT,INC,J82,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RT4,SNAIL,T24,WESTERN
160,921,BACKGROUND,CONCLUSION,ESPECIALLY,LABEL,MEC,METHODS,RESULTS
BLI,GAUSSIA,HOWEVER,NOTABLY,THESE,THREE,WHOLE
169,BGS,COPYRIGHT,CPG,INC,PCR,SUBSEQUENT,TCC,WILEY
160,BECAUSE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,RRS
001,005,663,AFTER,BECAUSE,COX,END,FURTHER,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SMALL
100,169,179,215,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,SINCE,TURBT
112,169,946,COPYRIGHT,EXPRESSION,INC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,RESULTS,RHAMM,ULTIMATELY
169,6TH,BLADDER,COPYRIGHT,INC,INSTITUTE,NOTABLE,SCIENCE,THINK
169,ACTIVATING,COPYRIGHT,FGFR3,FIBROBLAST,INC,PUBLISHED
169,178,210,956,CONCLUSION,COPYRIGHT,INC,LABEL,LC3,METHODS,NMI,OBJECTIVE,OBJECTIVES,RESULTS,SLS,THESE,TUR,UCC
NEOBLADDER,NVF
DEPOSITION,INCUBATION,T24,TG2,THESE,TUBULAR,USING,WESTERN
147,169,946,BACKGROUND,COPYRIGHT,EMT,INC,INHIBITOR,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,WESTERN
001,039,100,177,AKR1B10,BACKGROUND,FURTHER,LABEL,METHODS,PCR,RESULTS
169,COPYRIGHT,HOWEVER,IRELAND,LTD
169,BLADDER,COPYRIGHT,INC,UROLOGISTS
120,169,BIU,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MTT,OBJECTIVE,OBJECTIVES,RESULTS,T24,THERE,WESTERN
000,001,003,027,169,201,311,CHINESE,COPYRIGHT,COX,FURTHER,GTT,HAN,HAPLOVIEW,INC,LABEL,MATERIALS,METHODS,MYC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,STRUCTURAL,USING
001,169,AKT,CONCLUSION,COPYRIGHT,EVEROLIMUS,ICR,INC,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,T24,THREE,TUNEL
166,169,332,COPYRIGHT,FURTHER,GENOTYPING,GSTM1,GSTP1,GSTT1,ILE,INC,IRANIAN,PCR,STUDIES,TCC,THERE,VAL
110,144,169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NBS,OBJECTIVE,OBJECTIVES,RESULTS,SHORT,VOIDING
169,945,946,ADP,AMP,BLADDER,COPYRIGHT,INC,OTHERWISE,QUERCETIN,STUDIES,T24,TAKEN
000,CURRENTLY,PREVALENCE,TREATMENT
169,COPYRIGHT,DHT,INC,SVHUC,THESE,UDP,UGT,UGT1A,UGT1A10,WESTERN,WILEY
001,002,127,140,143,169,177,179,17PT1,285,34PTA,5PTIS,CHINA,COPYRIGHT,DETECTION,GENERAL,INC,JANUARY,LABEL,MATERIALS,METHODS,NBI,OBJECTIVE,OBJECTIVES,PLA,RESULTS,SUSPECTED,THESE,UCS,WLI
101,294,AMONG,BACKGROUND,LABEL,METHODS,NPV,PPV,RESULTS,THERE
001,003,005,008,020,165,169,192,245,AVERAGE,BACKGROUND,BLADDER,CIS,COPYRIGHT,COX,CSS,DESPITE,INC,IQR,LABEL,LVI,MATERIALS,METHODS,PROGNOSIS,RESULTS,SEVENTEEN,UCB
169,BLADDER,COPYRIGHT,ESSENTIAL,GROUP,INC,LABEL,METHODS,OBJECTIVE,RESULTS,WHILE,WORKING
945,946,AE1,AFP,AUTOPSY,BLOOD,CA125,CK5,CK7,CK8,CLEAR,COA,CYSTOSCOPY,E12,EMA,HMB45,IMAGING,METASTASES
169,215,AFTER,AMONG,COPYRIGHT,FDA,INC,UROVYSION,UTC,WILEY
169,59E22,759B7,BAC,CEP,CONCLUSION,COPYRIGHT,D3S1560,D3S1766,D3S2406,D3S2454,FURTHER,III,INC,LABEL,LOH,MEC,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,PCR,RCC,RESULTS,ROH,VALIDATION,VHL
169,945,AE3,CEA,CKAE1,CLINICALLY,COPYRIGHT,INC,MITOTIC,MRI,SMA,THESE,WILEY
169,COMMITTEE,COPYRIGHT,INC,JOINT
169,947,CD4,CD8,COPYRIGHT,CSF,CTL,ELISA,FINALLY,FOXP3,IFN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PBS,RESULTS
004,134,169,397,467,967,COPYRIGHT,CSM,CUMULATIVE,DESPITE,END,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
001,145,154,169,192,223,254,298,408,469,CONCLUSION,COPYRIGHT,FORTY,INC,IQR,LABEL,MATERIALS,METHODS,NOC,OBJECTIVE,OVERALL,RESULTS,SMALL
169,323,777,967,COPYRIGHT,COX,GIVEN,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PBT,RESULTS,YET
169,BACKGROUND,CISPLATIN,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,MFI,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,TCC,THERE
169,235,AMONG,COPYRIGHT,EXPRESSION,HSP70,INC,KOTCC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SILENCING,SIMILARLY,TREATMENT
169,APF,COPYRIGHT,EXPRESSION,INC,JUN,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PCR,RESULTS,T24,THESE,WESTERN
169,BCG,CAP,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NMIBC,OBJECTIVE,OBJECTIVES,RESULTS,THOSE
104,169,946,COPYRIGHT,EXPRESSION,INC,LABEL,MATERIALS,MEMBRANOUS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,345,410,COPYRIGHT,CYSTECTOMY,INC,INCREASED,LABEL,MEIER,METHODS,MORTALITY,OBESITY,OBJECTIVE,OBJECTIVES,ONCOLOGIC,RESULTS,SHORT,THREE
146,169,263,610,845,ACCORDING,AFTER,BCA,CHINESE,COPYRIGHT,FURTHER,INC,LABEL,LCM,MATERIALS,METHODS,NBE,OBJECTIVE,RESULTS,TEN,THESE
169,289,ADDITIONAL,COMPARISON,COPYRIGHT,END,INC,INSTITUTE,LABEL,LOWER,MATERIALS,METHODS,OBJECTIVE,OLDER,RESULTS,SIR,WHITE
001,006,034,039,042,047,1306C,1306T,169,200,735,799,799CT,967,BCG,CONCLUSION,COPYRIGHT,COX,GENOTYPING,HAPLOTYPE,HENCE,INC,LABEL,MATERIALS,MEIER,METHODS,MMP,NORTH,OBJECTIVE,PCR,RESULTS
169,217,BCG,CD9,COPYRIGHT,COX,FGFR3,INC,LABEL,LARGE,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFS,PROTEIN,RESULTS,RFS,SIMILARLY,WHILE
11P12,124,169,16P12,CGH,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SUCCESSIVE,THERE,UBC
005,016,169,178,374,ANNEXIN,BLOOD,CISPLATIN,COPYRIGHT,DESPITE,GIVEN,HOWEVER,INC,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,RESULTS,TCC
169,494,BACKGROUND,COPYRIGHT,FURTHER,INC,JANUARY,LABEL,MAY,METHODS,OUTCOME,RESULTS,SEVENTY,THERE,THESE
DUE,KNOWLEDGE
000,100,169,239,ADVERSE,AFTER,CIS,CONCLUSION,COPYRIGHT,CRS,CSS,CTCAE,DUE,FAILURE,INC,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,TREATMENT
001,033,169,BECAUSE,CONCLUSION,COPYRIGHT,COX,END,GRADE,HOWEVER,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OTHER,RESULTS,T4A,T4B,TIS,USING
018,025,169,COPYRIGHT,COX,DISCS,DLG,EMT,EPITHELIAL,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UNIVARIATE
169,BOWEL,COPYRIGHT,FIFTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,REGARDING,RESULTS,THERE
000,001,140,160,169,81T,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SNP
001,038,169,430,CONCLUSION,COPYRIGHT,DSS,INC,IQR,LABEL,LND,LYMPH,METHODS,OBJECTIVE,OVERALL,PROGNOSTIC,RESULTS
002,043,064,169,188,507,COPYRIGHT,COX,INC,LABEL,METHODS,OBJECTIVE,RESULTS

169,223,946,CONCLUSION,COPYRIGHT,EXPRESSION,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TCC,TGF
001,008,108,119,169,237,245,270,283,503,574,612,882,APRIL,BETWEEN,CIS,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,SIMILARLY,THERE,UCB,URINARY
005,169,960,BCS,CONCLUSION,COPYRIGHT,GSTP1,INC,LABEL,METHODS,MIR,OBJECTIVE,PCR,RESULTS,WESTERN,XTT
001,002,169,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,POTENTIAL,PRIMARY,RCC,RESULTS,TKI
100,169,177,CONCLUSION,COPYRIGHT,DFS,EGYPT,GIVEN,III,INC,LABEL,LOCAL,MAY,METHODS,NCI,OBJECTIVE,P2B,P3A,P3B,PURPOSE,RADICAL,RESULTS
169,945,ANTIBODIES,CONCLUSION,COPYRIGHT,DECREASED,EXPRESSION,INC,INCREASED,LABEL,LOWER,METHODS,MVD,OBJECTIVE,PIGMENT,RESULTS,SIXTY,TNF,WESTERN
169,COPYRIGHT,INC
169,945,BECAUSE,CONCLUSION,COPYRIGHT,HIF,HOWEVER,INC,LABEL,MATERIALS,MEDLINE,METHODS,MSI,OBJECTIVE,REGARDING,RESULTS,THESE,UCC,UROTHELIAL,UUT
169,1990S,ACCORDING,COPYRIGHT,GIVEN,INC,SINCE,WHILE
169,CONCLUSION,COPYRIGHT,INC,LABEL,MEDLINE,METHODS,OBJECTIVE,RADICAL,RESULTS,STUDIES,WHILE
169,COPYRIGHT,INC
169,BLADDER,COPYRIGHT,EFFORTS,FGFR3,FURTHER,INC,LOW,MOLECULAR,SEVERAL,SINCE,UCC
